
<html lang="en"     class="pb-page"  data-request-id="656a2769-9279-4979-bd75-a719b466a743"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b01011;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2" /></meta><meta name="dc.Creator" content="Michael&#xA;K.  Krapf" /></meta><meta name="dc.Creator" content="Jennifer  Gallus" /></meta><meta name="dc.Creator" content="Vigneshwaran  Namasivayam" /></meta><meta name="dc.Creator" content="Michael  Wiese" /></meta><meta name="dc.Description" content="Several members of the ABC transporter superfamily play a decisive role in the development of multidrug resistance (MDR) in cancer. One of these MDR associated efflux transporters is ABCG2. One way..." /></meta><meta name="Description" content="Several members of the ABC transporter superfamily play a decisive role in the development of multidrug resistance (MDR) in cancer. One of these MDR associated efflux transporters is ABCG2. One way..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 3, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01011" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01011" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01011" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01011" /></link>
        
    
    

<title>2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01011" /></meta><meta property="og:title" content="2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0015.jpeg" /></meta><meta property="og:description" content="Several members of the ABC transporter superfamily play a decisive role in the development of multidrug resistance (MDR) in cancer. One of these MDR associated efflux transporters is ABCG2. One way to overcome this MDR is the coadministration of potent inhibitors of ABCG2. In this study, we identified novel inhibitors containing a 2,4,6-substituted quinazoline scaffold. Introduction of a 6-nitro function led to extraordinarily potent compounds that were highly selective for ABCG2 and also able to reverse the MDR toward the chemotherapeutic drugs SN-38 and mitoxantrone. The binding of substrate Hoechst 33342 and the two potent inhibitors 31 and 41 which differ in their mechanism of inhibition was rationalized using the recently published cryo-EM structures of ABCG2. For a better understanding of the interaction between the inhibitors and ABCG2, additional investigations regarding the ATPase activity, the interaction with Hoechst 33342, and with the conformational sensitive 5D3 antibody were carried out." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01011"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01011">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01011&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01011&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01011&amp;href=/doi/10.1021/acs.jmedchem.8b01011" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7952-7976</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00935" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01045" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Michael K. Krapf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael K. Krapf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael%0AK.++Krapf">Michael K. Krapf</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jennifer Gallus</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer Gallus</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Gallus">Jennifer Gallus</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Vigneshwaran Namasivayam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vigneshwaran Namasivayam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vigneshwaran++Namasivayam">Vigneshwaran Namasivayam</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3031-3377" title="Orcid link">http://orcid.org/0000-0003-3031-3377</a></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Michael Wiese</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Wiese</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 0049-228-735213. E-mail: <a href="/cdn-cgi/l/email-protection#bbd6ccd2dec8defbced5d296d9d4d5d5"><span class="__cf_email__" data-cfemail="432e342a26302603362d2a6e212c2d2d">[emailÂ protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Wiese">Michael Wiese</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5851-5336" title="Orcid link">http://orcid.org/0000-0002-5851-5336</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01011&amp;href=/doi/10.1021%2Facs.jmedchem.8b01011" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7952â7976</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 3, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 June 2018</li><li><span class="item_label"><b>Published</b> online</span>3 August 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01011" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01011</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7952%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%250AK.%2BKrapf%252C%2BJennifer%2BGallus%252C%2BVigneshwaran%2BNamasivayam%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D17%26contentID%3Dacs.jmedchem.8b01011%26title%3D2%252C4%252C6-Substituted%2BQuinazolines%2Bwith%2BExtraordinary%2BInhibitory%2BPotency%2Btoward%2BABCG2%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7976%26publicationDate%3DSeptember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01011"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1070</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01011" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael\nK.&quot;,&quot;last_name&quot;:&quot;Krapf&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Gallus&quot;},{&quot;first_name&quot;:&quot;Vigneshwaran&quot;,&quot;last_name&quot;:&quot;Namasivayam&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Wiese&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;7952-7976&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01011&quot;},&quot;abstract&quot;:&quot;Several members of the ABC transporter superfamily play a decisive role in the development of multidrug resistance (MDR) in cancer. One of these MDR associated efflux transporters is ABCG2. One way to overcome this MDR is the coadministration of potent inhibitors of ABCG2. In this study, we identified novel inhibitors containing a 2,4,6-substituted quinazoline scaffold. Introduction of a 6-nitro function led to extraordinarily potent compounds that were highly selective for ABCG2 and also able to reverse the MDR toward the chemotherapeutic drugs SN-38 and mitoxantrone. The binding of substrate Hoechst 33342 and the two potent inhibitors 31 and 41 which differ in their mechanism of inhibition was rationalized using the recently published cryo-EM structures of ABCG2. For a better understanding of the interaction between the inhibitors and ABCG2, additional investigations regarding the ATPase activity, the interaction with Hoechst 33342, and with the conformational sensitive 5D3 antibody were carried out.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01011&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01011" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01011&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01011" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01011&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01011" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01011&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01011&amp;href=/doi/10.1021/acs.jmedchem.8b01011" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01011" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01011" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01011%26sid%3Dliteratum%253Aachs%26pmid%3D30075623%26genre%3Darticle%26aulast%3DKrapf%26date%3D2018%26atitle%3D2%252C4%252C6-Substituted%2BQuinazolines%2Bwith%2BExtraordinary%2BInhibitory%2BPotency%2Btoward%2BABCG2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D17%26spage%3D7952%26epage%3D7976%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/jmcmar.2018.61.issue-17/20180913/jmcmar.2018.61.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Several members of the ABC transporter superfamily play a decisive role in the development of multidrug resistance (MDR) in cancer. One of these MDR associated efflux transporters is ABCG2. One way to overcome this MDR is the coadministration of potent inhibitors of ABCG2. In this study, we identified novel inhibitors containing a 2,4,6-substituted quinazoline scaffold. Introduction of a 6-nitro function led to extraordinarily potent compounds that were highly selective for ABCG2 and also able to reverse the MDR toward the chemotherapeutic drugs SN-38 and mitoxantrone. The binding of substrate Hoechst 33342 and the two potent inhibitors <b>31</b> and <b>41</b> which differ in their mechanism of inhibition was rationalized using the recently published cryo-EM structures of ABCG2. For a better understanding of the interaction between the inhibitors and ABCG2, additional investigations regarding the ATPase activity, the interaction with Hoechst 33342, and with the conformational sensitive 5D3 antibody were carried out.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ATP-binding cassette transport proteins are widely expressed in different tissues where they perform the efflux of structurally diverse substrates out of the cells. The excretion is powered by ATP hydrolysis, forming ADP and inorganic phosphate, and occurs even against a concentration gradient.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In humans, 48 ABC transport proteins are expressed which can be classified according to their phylogenetic similarity in seven subfamilies labeled ABC A to ABC G.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2â5)</a> ABC transport proteins are often expressed in tissues with a barrier function, where they protect the cells from harmful substances but can also effectuate the membrane transport of nutrients.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Unfortunately, many cytostatic drugs are substrates of ABC transporters, and their overexpression in cancer cells persists as a major obstacle in the chemotherapeutic treatment.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This so-called multidrug resistance (MDR) is mainly related to the expression of the three major MDR-associated transport proteins P-glycoprotein (P-gp, ABCB1), multidrug-resistance associated protein 1 (MRP1, ABCC1), and breast cancer resistance protein (BCRP, ABCG2).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8â10)</a> ABCG2 was discovered last when the workgroup of Doyle et al. identified the transport protein in a human breast cancer cell line, which was selected for doxorubicin resistance in the presence of verapamil, an inhibitor of P-gp.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11â13)</a> High levels of ABCG2 are often found in tissues performing a protective function or tissues which are associated with the homeostasis of nutrients and hormone.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Interestingly, the structure of ABCG2 differs from ABCB1 and ABCC1: being a half-transporter, ABCG2 is assumed to form dimers or tetramers for function while ABCB1 and ABCC1 are expressed in their fully functional form.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15â18)</a> ABCG2 is composed of 655 amino acids and consists of only one cytosolic nucleotide-binding domain (NBD) and one transmembrane domain (TMD).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> To date, the function of ABCG2 remains unclear and further investigations are important to effectively treat ABCG2 overexpressing cancers.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20â22)</a> As mentioned before, a common problem in the chemotherapeutic treatment of cancers is that many cytostatic drugs are substrates of ABC-transport proteins like ABCG2: the anthracene derivative mitoxantrone (MX) for instance is a substrate of ABCG2 and can be used to select cells with an overexpression of ABCG2 based on the resistance toward the cytostatic drug.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> Another substrate of ABCG2 is the cytostatic drug SN-38, which is an active metabolite of irinotecan.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Both MX and SN-38 have already been used in our prior studies to investigate the reversal of the MDR in MDCK II BCRP cells by coadministering inhibitors of ABCG2.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Although coadministration of potent inhibitors is one way to overcome MDR, the scientific community has become more cautious in terms of in vivo application of inhibitors of ABCG2 because the promising in vitro results with inhibitors of ABCB1 led to disappointing outcomes in the clinic. Nevertheless, several studies found a correlation between the overexpression of ABCG2 and a worse clinical outcome, while other studies remain sceptical toward that topic.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28â30)</a></div><div class="NLM_p">The first potent inhibitor of ABCG2 was isolated from <i>Aspergillus fumigatus</i> and named fumitremorgin C. Despite its high inhibitory potency, the high neurotoxic effects prevented any clinical use.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The second-generation inhibitor <b>59</b> was more promising because it exhibited less toxic effects, a high selectivity toward ABCG2 up to 1 Î¼M and an considerably high inhibitory potency.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Its application in photodynamic therapy for instance has already led to promising results, where the efflux of phototoxic agents could be inhibited by coadministration of compound <b>59</b> and resulted in a higher effectiveness of the therapy.<a onclick="showRef(event, 'ref29 ref34'); return false;" href="javascript:void(0);" class="ref ref29 ref34">(29,34)</a> Other inhibitors have already been used in cancer therapy. For instance, some compounds in the class of tyrosine kinase inhibitors (TKIs) were found to be useful drugs in chemotherapeutic treatment. Preliminary in vitro investigations of the workgroup of Ozvegy-Laczka et al. found a high affinity interaction of several TKIs with ABCG2, some even at submicromolar concentration.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> The TKI gefitinib for instance is currently used as a drug for certain breast, lung, and other cancers. However, only very few selective and potent inhibitors of ABCG2 active at a submicromolar concentration have been reported.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">Our workgroup modified the basic quinazoline scaffold of gefitinib and carried out different modifications: in our previous studies, we found that an aromatic residue at position 2 and a substituted aniline linker at position 4 led to a considerably higher inhibitory potency and selectivity toward ABCG2 compared to gefitinib.<a onclick="showRef(event, 'ref27 ref56'); return false;" href="javascript:void(0);" class="ref ref27 ref56">(27,56)</a> We also identified some structural features that have an impact on the selectivity of a substance: in particular, the presence of methoxy substituents was found to increase the inhibitory potency toward ABCB1 and also ABCC1. In contrast, potent and selective compounds often contained nitro functions at the aniline moiety at position 4 of the quinazoline scaffold.</div><div class="NLM_p last">In the current work, we started from our 2,4-disubstituted quinazoline scaffold and introduced nitro, amino, and some other groups at position 6. These new derivatives were compared to some of our previous compounds providing new insights into the structureâactivity relationship of these novel derivatives. Most notably, substitution with nitro at position 6 resulted in extraordinarily potent and selective inhibitors of ABCG2.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The synthetic route for all compounds of this work is illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. First, 2-amino-5-nitrobenzoic acid was reacted with phosgene to form a cyclic anhydride. Subsequently, the anhydride function underwent cleavage when bubbling gaseous ammonia through the reaction mixture to form 2-amino-5-nitrobenzamide <b>1</b>, the precursor for the following steps. The 2-phenylquinazolinone derivatives <b>2</b>â<b>7</b> were obtained by cyclization of <b>1</b> with a substituted benzaldehyde. Substitution of the carbonyl function with chlorine was achieved by reaction with POCl<sub>3</sub> to yield the 4-chloroquinazoline derivatives <b>8</b>â<b>13</b>. A nucleophilic substitution of chlorine at position 4 was carried out with different aniline derivatives using microwave radiation to yield compounds <b>14</b>â<b>42</b>. Compound <b>20</b>, which contains a 3â²,4â²-dimethoxy residue, was treated with boron tribromide to obtain a 3â²,4â²-dihydroxy function at the aniline linker (<b>16</b>). Moreover, the nitro function at position 6 was converted into an amino group. Therefor, a Pd/C catalyzed hydrogenation was performed in a pressure vessel. The obtained 6-amino derivatives <b>43</b>â<b>47</b> were then reacted in a nucleophilic substitution with different acid chlorides to yield compounds <b>48</b>â<b>51</b>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis Route for Compounds <b>1</b>â<b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) triphosgene, THF, reflux, 3 h; (ii) NH<sub>3</sub>, 50 Â°C, 30 min; (iii) I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 90â110 Â°C, 8â12 h; (iv) POCl<sub>3</sub>, reflux, 4â12 h; (v) <i>i</i>-PrOH, substituted aniline, 100 W microwave irradiation, 110 Â°C, 20â40 min; (vi) BBr<sub>3</sub>, DCM, â60 Â°C â RT, 12 h; (vii) THF, 4 bar H<sub>2</sub>, Pd/C, RT, 24 h; (viii) RCOCl, THF, 0 Â°C â RT, 6â12 h; (ix) <i>i</i>-PrOH, substituted aniline, 100 W microwave irradiation, 110 Â°C, 30 min.</p></p></figure><div class="NLM_p">On the basis of our potent 2-phenyl-4-anilinoquinazoline derivatives, we carried out further modifications at position 2 and most notably at position 6. This idea was inspired by the fact that many inhibitors containing a quinazoline structure like gefitinib possess substitution at position 6 and sometimes also at position 7. Therefore, we introduced nitro, amino, and aromatic functions at position 6 to elucidate the impact of these modifications on the inhibitory activity toward ABCG2. In general, we preferred substituents, such as cyano, nitro, fluoro and hydroxy, which exhibited high potencies at position 4 in our previous work.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> There we found that high potencies were obtained in either <i>meta</i> or <i>para</i> position depending on the function introduced at the anilino moiety: functions with negative mesomeric effects were in most cases more beneficial in the <i>para</i> position whereas substituents with positive mesomeric effects mostly led to high potencies in <i>meta</i> position. Thanks to a facile comparison with our compounds investigated in earlier studies, we were able to find structureâactivity relations that could be beneficial for subsequent synthesis.</div><div class="NLM_p last">Identity of all compounds was confirmed by <sup>1</sup>H and <sup>13</sup>C NMR spectra and the purity by elemental analysis.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Biological Evaluation</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Hoechst 33342 Accumulation Assay</h4><div class="NLM_p">The inhibitory potency of the test compounds toward ABCG2 was determined by the well-established Hoechst 33342 accumulation assay. The principle of the assay is based on the efflux of the fluorescent dye Hoechst 33342, a substrate of ABCG2, out of the cell. Hoechst 33342 only shows low fluorescence intensities in watery environment, but fluorescence increases considerably upon binding to DNA or embedding in a lipophilic environment like a cell membrane.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Inhibition of the transport protein results in an increased intracellular accumulation of Hoechst 33342 that leads to higher fluorescence which can be correlated to the inhibitory potency of a compound. Structural formulas of Hoechst 33342 and the other substrates and standard inhibitors of ABCG2 are given in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> for reference.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structures of the reference compounds <b>59</b> (Ko143 (a)), Hoechst 33342 (b), cyclosporine A (CsA (c)), mitoxantrone (MX (d)), the active metabolite of irinotecan (SN-38 (e)), and quercetin (f).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibitory activities of the test compounds <b>14</b>â<b>58</b> from the Hoechst 33342 accumulation assay are presented in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. A quick overview illustrating the SAR of the investigated compounds is provided at the end of this chapter (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities Derived from the Hoechst 33342 Accumulation Assays toward ABCG2 Overexpressing MDCK II Cell Line (the Scaffold with Substitution Pattern is Illustrated Below)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char="Â±">Hoechst 33342 IC<sub>50</sub>  Â± SD [nM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">106Â Â±Â 15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">65.3Â Â±Â 9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3,4-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">119Â Â±Â 17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">33.1Â Â±Â 5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">37.0Â Â±Â 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">48.2Â Â±Â 7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">48.1Â Â±Â 9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">51.5Â Â±Â 9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">49.1Â Â±Â 5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>-4-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">37.4Â Â±Â 5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NHCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">78.7Â Â±Â 13.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">904Â Â±Â 17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">47.0Â Â±Â 4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">57.7Â Â±Â 7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">75.5Â Â±Â 14.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">63.8Â Â±Â 13.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">59.6Â Â±Â 8.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">27.6Â Â±Â 2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">59.0Â Â±Â 5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">30.2Â Â±Â 4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-SMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">101Â Â±Â 16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">44.8Â Â±Â 6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">66.3Â Â±Â 13.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">4-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">61.4Â Â±Â 5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>-4-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">33.0Â Â±Â 4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-NHCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">44.8Â Â±Â 4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">3-OMe-Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">27.8Â Â±Â 3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">3-OMe-Ph</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">23.4Â Â±Â 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">3,4-OMe-Ph</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">57.2Â Â±Â 7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">369Â Â±Â 54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">646Â Â±Â 69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">726Â Â±Â 49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">799Â Â±Â 159</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="Â±">835Â Â±Â 113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left"><i>N</i>-1-iminoethylÂ acetate</td><td class="colsep0 rowsep0" align="char" char="Â±">5310Â Â±Â 240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left"><i>N</i>-3-nitrobenzamide</td><td class="colsep0 rowsep0" align="char" char="Â±">1150Â Â±Â 190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left"><i>N</i>-3-nitrobenzamide</td><td class="colsep0 rowsep0" align="char" char="Â±">1620Â Â±Â 70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left"><i>N</i>-nicotinamide</td><td class="colsep0 rowsep0" align="char" char="Â±">1040Â Â±Â 80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">882Â Â±Â 157</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">152Â Â±Â 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">69.9Â Â±Â 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">355Â Â±Â 53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>-4-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">80.0Â Â±Â 9.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NHCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">278Â Â±Â 33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">6380Â Â±Â 1390</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">227Â Â±Â 14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are means of three independent experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Compounds synthesized in earlier study.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values taken from our previous study.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Used as reference in the assay.</p></div></div></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR of some compounds illustrating structural features impacting the inhibitory potency of a compound. Highest potencies were achieved by 6-nitro derivatives, notably by those containing methoxy or hydroxy functions (a). Regarding substitution at position 6, lower inhibitory potencies resulted from 6-amino (<b>43</b>â<b>47</b>) and 6-<i>N</i>-functionalized (<b>48</b>â<b>51</b>) derivatives compared to nitro (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>14</b>â<b>42</b> all contain a nitro group at R<sup>3</sup>. At first, the unsubstituted basic structure <b>14</b> with phenyl at R<sup>1</sup> and hydrogen at R<sup>2</sup> was investigated. Interestingly, the resulting IC<sub>50</sub> value of 106 nM is considerably lower than its analogue <b>52</b> (IC<sub>50</sub> = 882 nM), lacking the nitro function at R<sup>3</sup>. Subsequently, polar groups were investigated at R<sup>2</sup> using a 3â²-hydroxy (<b>15</b>) and 3â²,4â²-dihydroxy (<b>16</b>) substitution, of which the monosubstitution yielded a low IC<sub>50</sub> value of 65.3 nM and the disubstitution an IC<sub>50</sub> value of 119 nM. Even higher activities resulted by a substitution with 3-methoxy (<b>17</b>) and 3â²,4â²-dimethoxy (<b>18</b>) at R<sup>2</sup>, with remarkably low IC<sub>50</sub> values of 33.1 and 37.0 nM. In contrast, the well-known and highly potent standard inhibitor <b>59</b> yielded a higher IC<sub>50</sub> of 227 nM. In comparison to the 3â²,4â²-dimethoxy quinazoline analogue <b>53</b>, lacking the nitro function at R<sup>3</sup>, compound <b>18</b> is about 4-fold more potent. Derivatives with 3â²-cyano (<b>19</b>) or 4â²-cyano (<b>20</b>) at R<sup>2</sup> possessed IC<sub>50</sub> values of 48.2 and 48.1 nM, respectively. The 2-phenylquinazoline analogue <b>54</b>, which showed the highest activity in our earlier study, yielded in a slightly higher IC<sub>50</sub> of 69.9 nM. Similar activities resulted from a 3â²-fluoro (<b>21</b>, 51.5 nM) and a 3â²-trifluoromethyl (<b>22</b>, 49.1 nM) substituent. Again, the 3â²-fluoro analogue <b>55</b>, lacking the nitro function at R<sup>3</sup>, showed a considerably lower potency with an IC<sub>50</sub> value of 355 nM. Also, the 3â²-nitro-4â²-hydroxy (R<sup>2</sup>) 6-nitro derivative <b>23</b> was more potent (IC<sub>50</sub> = 37.4 nM) than its analogue <b>56</b> (IC<sub>50</sub> = 80.0 nM). Also, compound <b>24</b> containing an acetamido group (IC<sub>50</sub> = 78.7 nM) was significantly more potent than its analogue <b>57</b> without 6-nitro group (IC<sub>50</sub> = 278 nM). Surprisingly, compound <b>25</b> with a carboxyl residue led to an IC<sub>50</sub> in the submicromolar range (904 nM), although it forms an anionic species under physiological conditions decreasing the membrane permeability of this derivative. Comparison with its analogue <b>58</b> (IC<sub>50</sub> = 6380 nM) once again illustrates the beneficial impact of the 6-nitro group.</div><div class="NLM_p">For the next compounds, the phenyl residue at R<sup>1</sup> was replaced by a more hydrophilic pyridyl residue. First, a 3-pyridyl residue was combined with 3â²-methoxy (<b>26</b>: IC<sub>50</sub> = 47 nM) and 4â²-methoxy (<b>27</b>: IC<sub>50</sub> = 57.7 nM) at R<sup>2</sup>, respectively. In comparison to compound <b>27</b>, the 4-pyridyl analogue <b>28</b> led to a comparable potency (IC<sub>50</sub> = 75.5 nM). Also, the interchange of phenyl with pyridyl had no major impact on the IC<sub>50</sub> value, illustrated in the compound pairs <b>17</b>/<b>26</b> and <b>19</b>/<b>29</b>.</div><div class="NLM_p">In the next series, a 3-trifluoromethylphenyl substituent was introduced at R<sup>1</sup>. Interchange of the trifluoromethyl group between the aromatic cores at position 2 and 4 resulted in similar high potencies in the range of 50â60 nM (compare compounds <b>22</b> and <b>30</b>). Extraordinarily high inhibitory activities resulted from substitutions at R<sup>2</sup> with 3â²-hydroxy (compound <b>31</b>, IC<sub>50</sub> = 27.6 nM), 3â²,4â²-dimethoxy (<b>33</b>, IC<sub>50</sub> = 30.2 nM), 3â²-fluoro (compound <b>35</b>, IC<sub>50</sub> = 44.8 nM), 3â²-nitro-4â²-hydroxy (compound <b>38</b>, IC<sub>50</sub> = 33.0 nM), and 3â²-acetamido (compound <b>39</b>, IC<sub>50</sub> = 44.8 nM). Substitution with 3â²-methoxy or 3â²-thiomethyl as well as 3â²- or 4â²-nitro resulted in good activities between 60 and 100 nM (compare compounds <b>32</b>, <b>34</b>, <b>36</b>, and <b>37</b>). Except for compound <b>32</b>, all 3-trifluoromethylphenyl derivatives possessed a similar or even higher potency than their corresponding phenyl analogues.</div><div class="NLM_p">Additionally, two 3-methoxyphenyl (R<sup>1</sup>) derivatives were synthesized containing a 4â²-cyano (<b>40</b>) or 3â²-fluoro substituent (<b>41</b>) at R<sup>2</sup>. Surprisingly, both derivatives yielded very high inhibitory activities with IC<sub>50</sub> values of 27.8 nM for compound <b>40</b> and 23.4 nM for <b>41</b>, which is the most potent compound in the test set. Compared to their phenyl analogues <b>20</b> and <b>21</b>, they are roughly 2-fold more potent, and compound <b>41</b> shows a 9-fold higher activity than the standard inhibitor compound <b>59</b>. Concentrationâresponse curves of <b>40</b>, <b>41</b>, and <b>59</b> are depicted in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. Moreover, the 3,4-dimethoxyphenyl (R<sup>1</sup>), 3â²-trifluoromethyl at R<sup>2</sup> derivative <b>42</b> yielded an IC<sub>50</sub> value of 57.2 nM. Unfortunately, the 3,4-dimethoxy substitution did not increase the potency in comparison to compound <b>22</b>, which contains a phenyl group at R<sup>1</sup> instead.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>40</b> (â, IC<sub>50</sub> = 27.8 nM) and <b>41</b> (â, IC<sub>50</sub> = 23.4 nM) in a Hoechst 33342 accumulation assay with compound <b>59</b> (â , IC<sub>50</sub> = 227 nM) as reference, using the ABCG2 overexpressing MDCK II BCRP cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the next series, the 6-nitro functions of some derivatives were reduced to an amino group. Free amino groups act as H-donor functions and increase the electron density at the attached aromatic cores, whereas nitro groups are H-acceptor functions and decrease the electron density.</div><div class="NLM_p">First, a 3-pyridyl residue at R<sup>1</sup> was combined with either a 3â²-methoxy (<b>43</b>) or a 4â²-methoxy group (<b>44</b>) at R<sup>2</sup>. The 3â²-methoxy derivative yielded an IC<sub>50</sub> value of 369 nM, whereas the <i>para</i> substituted compound had a 2-fold higher IC<sub>50</sub> value of 646 nM. Three more 6-amino derivatives were investigated containing a 3-trifluoromethylphenyl residue at R<sup>1</sup>: compound <b>45</b> with a hydrogen substituent at R<sup>2</sup> possessed an IC<sub>50</sub> of 726 nM, whereas substitution with 3â²-hydroxy and 3â²-methoxy resulted in IC<sub>50</sub> values of 799 and 835 nM for compounds <b>46</b> and <b>47</b>, respectively. The comparison with their 6-nitro analogues illustrates that the amino function at position 6 lowers the inhibitory potency of all compounds to a considerable extent.</div><div class="NLM_p">Subsequently, the amino function at R<sup>3</sup> was modified by introducing aromatic groups and one ester function. Initially, a substitution with 3-pyridyl at R<sup>1</sup>, 3â²-methoxy at R<sup>2</sup> together with <i>N</i>-1-iminoethyl acetate at R<sup>3</sup>, was carried out for compound <b>48</b>. The resulting IC<sub>50</sub> value of 5310 nM illustrates the strong loss of potency in comparison to compound <b>43</b> with the free amine at R<sup>3</sup>. Also, substitution with <i>N</i>-3-nitrobenzamide (<b>49</b>: IC<sub>50</sub> = 1150 nM) and <i>N</i>-nicotinamide (<b>51</b>, IC<sub>50</sub> = 1040 nM) resulted in a decrease of inhibitory potency in comparison to compound <b>43</b>. Also, the 4-methoxy (R<sup>2</sup>) analogue of compound <b>49</b>, namely compound <b>50</b>, yielded a far higher IC<sub>50</sub> value of 1620 nM compared to its 3-methoxy counterpart.</div><div class="NLM_p last">In summary, the investigation of our new 2-substituted-4-anilinoquinazoline derivatives containing additional substitution at position 6 revealed several findings: extraordinary high inhibitory activity toward ABCG2 resulted from nitro functions at R<sup>3</sup>. Most notably, the presence of methoxy and hydroxy groups led to very high potencies, as observed for compounds <b>17</b>, <b>18</b>, <b>23</b>, <b>31</b>, <b>33</b>, <b>38</b>, <b>40</b>, and <b>41</b>. The unsubstituted compound <b>14</b> showed a lower inhibitory activity than the substituted 6-nitro derivatives, which is in good accordance to our previous results for the 4-substituted-2-phenylquinazolines (compare compounds <b>52</b>â<b>58</b>). The most potent compound <b>41</b> containing a 3-methoxyphenyl group at R<sup>1</sup> and 3â²-fluoro substituent at R<sup>2</sup> possessed a nearly 10-fold higher potency than compound <b>59</b>, one of the most potent inhibitors of ABCG2 found in the literature to date. Reduction of the nitro function at R<sup>3</sup> resulting in an amine decreased the inhibitory activity significantly. Further reaction of the free amines with acid chlorides yielded substituted imines and amides. Unfortunately, this modification led to further reduction of the inhibitory activity.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Screening for ABCB1 and ABCC1 Inhibition</h4><div class="NLM_p last">The selectivity toward ABCG2 was investigated by determining the inhibitory activity of some of the most potent compounds in the calcein AM assay using ABCB1 and ABCC1 overexpressing cell lines A2780adr and H69AR, respectively. Initial screening was carried out at a compound concentration of 10 Î¼M by measuring the increase of fluorescence resulting from intracellular calcein produced by the cleavage of the calcein AM esters over time. The standard inhibitor cyclosporine A (CsA) was used as positive control for both cell lines defining the state of âfull inhibitionâ. All tested compounds showed an inhibitory activity of less than 25% of the standard CsA and thus demonstrated a high selectivity toward ABCG2.</div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Determination of the Intrinsic Cytotoxicity via MTT Assay</h4><div class="NLM_p">Determination of the intrinsic cytotoxicity was carried out with parental and ABCG2 overexpressing MDCK II cells which were incubated with different dilutions of selected compounds. Cell viability was measured after 72 h of incubation by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to detect the metabolic activity of the remaining viable cells. Reduction of MTT in living cells leads to the formation of a non water-soluble formazan species which can be detected colorimetrically. Further details are described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The half-maximal growth inhibition (GI<sub>50</sub>) is listed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, and representative concentration effect curves are shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. The therapeutic ratio (TR = GI<sub>50</sub>/IC<sub>50</sub>) was calculated from the GI<sub>50</sub> value of a compound obtained with ABCG2 overexpressing cells.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Intrinsic Toxicity of Selected Compounds in ABCG2 Overexpressing MDCK II BCRP and Parental Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> [Î¼M]<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> BCRP</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> [Î¼M]<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> Parental</th><th class="colsep0 rowsep0" align="center" char=".">therapeutic ratio (GI<sub>50</sub>/IC<sub>50</sub>)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">18.3</td><td class="colsep0 rowsep0" align="char" char=".">36.1</td><td class="colsep0 rowsep0" align="char" char=".">173</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">5.50</td><td class="colsep0 rowsep0" align="char" char=".">6.92</td><td class="colsep0 rowsep0" align="char" char=".">166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">8.13</td><td class="colsep0 rowsep0" align="char" char=".">8.51</td><td class="colsep0 rowsep0" align="char" char=".">220</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>-4-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">13.2</td><td class="colsep0 rowsep0" align="char" char=".">9.75</td><td class="colsep0 rowsep0" align="char" char=".">353</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">84.5</td><td class="colsep0 rowsep0" align="char" char=".">125</td><td class="colsep0 rowsep0" align="char" char=".">1119</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">77.3</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="char" char=".">1212</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.39</td><td class="colsep0 rowsep0" align="char" char=".">3.02</td><td class="colsep0 rowsep0" align="char" char=".">123</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.63</td><td class="colsep0 rowsep0" align="char" char=".">3.16</td><td class="colsep0 rowsep0" align="char" char=".">120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>-4-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">27.4</td><td class="colsep0 rowsep0" align="char" char=".">24.1</td><td class="colsep0 rowsep0" align="char" char=".">830</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">3-OMe-Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">11.0</td><td class="colsep0 rowsep0" align="char" char=".">9.12</td><td class="colsep0 rowsep0" align="char" char=".">395</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">3-OMe-Ph</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">4.38</td><td class="colsep0 rowsep0" align="char" char=".">11.2</td><td class="colsep0 rowsep0" align="char" char=".">187</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">19.1</td><td class="colsep0 rowsep0" align="char" char=".">27.5</td><td class="colsep0 rowsep0" align="char" char=".">29.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">26.6</td><td class="colsep0 rowsep0" align="char" char=".">26.0</td><td class="colsep0 rowsep0" align="char" char=".">30.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">22.5</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td><td class="colsep0 rowsep0" align="char" char=".">148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>-4-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">52.4</td><td class="colsep0 rowsep0" align="char" char=".">152</td><td class="colsep0 rowsep0" align="char" char=".">655</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">12.6</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td><td class="colsep0 rowsep0" align="char" char=".">55.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Concentration accomplishing 50% of cell survival with MDCK II BCRP and parental cells, respectively. The data was obtained from at least two independent experiments as mean values.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Compounds synthesized in earlier study.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">GI<sub>50</sub> value taken from our previous study.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Therapeutic ratio was calculated from the quotient of the GI<sub>50</sub> [Î¼M] obtained with BCRP expressing cells and the IC<sub>50</sub> [Î¼M] obtained from the Hoechst 33342 assay.</p></div></div></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative examples of MTT viability assays of compounds <b>28</b> (â¡), <b>29</b> (â), and <b>41</b> (Î) using the ABCG2 overexpressing MDCK II BCRP cell line. The GI<sub>50</sub> values were determined as 84.5 Î¼M (â¡), 77.3 Î¼M (â), and 9.46 Î¼M (Î), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the unsubstituted basic structure <b>14</b>, containing a phenyl group at R<sup>1</sup>, hydrogen at R<sup>2</sup>, and nitro at R<sup>3</sup>, a GI<sub>50</sub> of 18.3 Î¼M and a TR of 173 was found. For the analogue <b>52</b>, lacking the nitro group at R<sup>3</sup>, a GI<sub>50</sub> of 26.6 Î¼M and a TR of 30.1 resulted. Despite the increased toxicity caused by the 6-nitro substitution, the benefit of the high inhibitory potency of compound <b>14</b> becomes apparent, yielding a TR that is more than 3-fold higher than that of compound <b>59</b> (TR = 55.5). Compound <b>17</b> with phenyl group at R<sup>1</sup>, 3â²-methoxy at R<sup>2</sup> and nitro at R<sup>3</sup> displayed a pronounced cytotoxicity of 5.50 Î¼M but still accomplished a TR of 166. Compound <b>18</b>, which is analogous to <b>17</b> but contains 3â²,4â²-dimethoxy at R<sup>2</sup>, yielded a similar GI<sub>50</sub> of 8.13 Î¼M with a calculated TR of 220. In comparison, compound <b>53</b> without substitution with nitro at R<sup>3</sup> had a lower TR of 148. Another disubstituted derivative was investigated containing a phenyl group at R<sup>1</sup>, a 3â²-nitro-4â²-hydroxy at R<sup>2</sup>, and a nitro at R<sup>3</sup> (compound <b>23</b>). Because of its high inhibitory potency together with a GI<sub>50</sub> of 13.2 Î¼M, a TR of 353 was found. Its analogue <b>56</b>, without a 6-nitro group, possessed a TR of 655, which was the highest ratio observed in our previous study.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Interestingly, the 2-pyridyl derivatives <b>28</b> and <b>29</b> showed almost no toxic effects with excellent GI<sub>50</sub> values of 84.5 and 77.3 Î¼M, respectively. This is in accordance to our findings in the investigation of the cytotoxic effects of 4-anilino-2-pyridylquinazolines, where the pyridyl group was highly preferable over a phenyl group.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Moreover, for compound <b>29</b>, the highest TR of 1212 among the investigated compounds was found.</div><div class="NLM_p">Compounds <b>31</b>, <b>33</b>, and <b>38</b> all contain a 3-trifluoromethylphenyl residue at R<sup>1</sup> and nitro at R<sup>3</sup>. Unfortunately, low GI<sub>50</sub> values around 3.5 Î¼M resulted for <b>31</b> and <b>33</b> with 3â²-hydroxy and 3â²,4â²-dimethoxy substituents, respectively. The 3â²-nitro-4â²-hydroxy derivative possessed a considerably higher GI<sub>50</sub> value of 27.4 Î¼M, resulting in a high TR of 830. In our previous study, the benefit of a 3-nitro-4-hydroxy substitution was already observed, illustrated by compound <b>52</b>. Also, the highly potent compounds <b>40</b> and <b>41</b>, both containing 3-methoxyphenyl at R<sup>1</sup> and 3â²-nitro at R<sup>3</sup>, were investigated. Compound <b>40</b> with 4â²-cyano substituent at R<sup>2</sup> yielded a GI<sub>50</sub> value of 11.0 Î¼M, resulting in a TR of 395, whereas the most potent compound <b>41</b> (3â²-fluoro at R<sup>2</sup>) unfortunately possessed a low GI<sub>50</sub> value of 4.38 Î¼M, giving a TR of 187. Finally, compound <b>44</b> with a 3-pyridyl residue at R<sup>1</sup>, 4â²-methoxy at R<sup>2</sup>, and amino at R<sup>3</sup> yielded a GI<sub>50</sub> of 19.1 Î¼M and giving the lowest TR of 29.6, which is due to a relatively high cytotoxicity along with a relatively low inhibitory potency.</div><div class="NLM_p last">Despite of the increased cytotoxicity caused by the nitro function in R<sup>3</sup>, this modification shows its advantage in the context of inhibitory potency: the very low IC<sub>50</sub> values found for the investigated 6-nitro derivatives led to high therapeutic ratios. The highest TR was found for compounds <b>28</b> and <b>29</b> containing a pyridyl group at position 2. It is notable that a pyridyl substituent at position 2 led to only negligible intrinsic cytotoxicity but retained high inhibitory potency resulting in a remarkable TR.</div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Determination of the Ability to Reverse MDR via MTT Assay</h3><div class="NLM_p">The ability to reverse the MDR toward the cytostatic drug SN-38 was investigated for compounds <b>23</b>, <b>28</b>, <b>29</b>, <b>38</b>, and <b>41</b>. Different dilutions of the test compounds were added to the cells, inhibiting the efflux of the cytostatic drug to a different extent. Inhibition of the transport protein therefore leads to a higher intracellular concentration of SN-38 and thus to a decreased cell viability. As positive control served MDCK II parental cells, representing the state of âfull inhibitionâ due to the lack of ABCG2 expression.</div><div class="NLM_p">Compounds <b>23</b> (IC<sub>50</sub> = 37.4 nM), <b>28</b> (IC<sub>50</sub> = 75.5 nM), <b>29</b> (IC<sub>50</sub> = 63.8 nM), <b>38</b> (IC<sub>50</sub> = 33.0 nM), and <b>41</b> (IC<sub>50</sub> = 23.4 nM) were investigated in coadministration with the cytostatic drug SN-38. They were chosen due to their high inhibitory potency in the Hoechst 33342 accumulation assay (compounds <b>23</b>, <b>38</b>, and <b>41</b>) as well as their considerably low cytotoxic effects in the cell viability assay (compounds <b>28</b> and <b>29</b>). The shift of the pGI<sub>50</sub> values toward the sensitive cells with increasing compound concentrations is depicted in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a,c,d for selected compounds, indicated by the gray arrows. Full reversal of the MDR was achieved by all compounds at a concentration of about 1 Î¼M, obtaining approximately the same pGI<sub>50</sub> value as the parental cells (Î). To preclude unwanted transporter unspecific effects of the compound, an analogous assay was carried out using parental cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b). The resulting pGI<sub>50</sub> values for each compound were all comparable, giving no indication of unspecific effects. On the basis of the data derived from the graphs presented in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, the power of reversal of the compounds was calculated by plotting each pGI<sub>50</sub> value of the corresponding concentrationâviability curves against the logarithm of the compound concentration (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Because the parental cells show no resistance against SN-38, they are expected to show the highest pEC<sub>50</sub> values independently from the compound concentration with a low deviation among each concentration (â). In contrast, the BCRP overexpressing cells show a resistance dependent on the degree of inhibition by the compound. ABCG2 overexpressing cells without compound should obtain the lowest pEC<sub>50</sub> value, increasing simultaneously with an increasing compound concentration (â). From the doseâeffect plot, it can be concluded that all compounds reach a plateau at the same level as the sensitive cells. The EC<sub>50</sub> values were calculated by nonlinear regression using the logistic equation to generate concentrationâeffect curves. By this method, for compound <b>23</b> an EC<sub>50</sub> value of 34.0 nM, for <b>28</b> an EC<sub>50</sub> value of 71.2 nM, for <b>29</b> an EC<sub>50</sub> value of 48.3 nM, for <b>38</b> an EC<sub>50</sub> value of 57.0 nM, and for <b>41</b> an EC<sub>50</sub> value of 51.1 nM were calculated.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MDR reversal assay to determine the ability of compound <b>23</b>, <b>28</b>, and <b>41</b> to reverse the MDR against the cytostatic drug SN-38, using the ABCG2 overexpressing cell line (a,c,d). The following concentrations were used: control (â), 0.01 Î¼M (â ), 0.03 Î¼M (closed triangle), 0.1 Î¼M (â¼), 1 Î¼M (â³), 5 Î¼M (â¡), and parental cell line (â). The gray arrow indicates the increasing sensitization of the ABCG2 overexpressing cells with higher compound concentrations. At a compound concentration of 1 Î¼M, full reversal is achieved, indicated by a similar pGI<sub>50</sub> as the parental cells. Exemplarily is shown for compound <b>23</b> that there is no effect on the parental MDCK II cells (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Nonlinear regression of the pGI<sub>50</sub> values determined in the MDR reversal assay (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a,c,d) against the corresponding concentration of compounds <b>23</b>, <b>28</b>, and <b>41</b>. EC<sub>50</sub> is the concentration that reduces resistance of the ABCG2 overexpressing cells to 50%. The following EC<sub>50</sub> values were calculated: 34.0 nM (<b>23</b>), 71.2 nM (<b>28</b>), and 51.5 nM (<b>41</b>). The pGI<sub>50</sub> values of the parental cells determined in an analogous assay are depicted by open circles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A second MDR reversal assay was carried out by coadministering the cytostatic drug mitoxantrone (MX), which is also a substrate of ABCG2, with the two most potent compounds in the test set, namely <b>31</b> and <b>41</b>. The assay was carried out similar to the assay with SN-38 but using only MDCK II ABCG2 overexpressing cells. Different compound concentrations were investigated in the presence of 0.5 Î¼M MX as well as in the absence of MX. The cell viability after an incubation period of 72 h is depicted in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> as bar chart. The control was performed using only cells without modulator in the absence and presence of MX. Increasing compound concentrations are expected to lead to an increasing sensitization of the cells toward MX, resulting in a decrease of the cell viability. At a concentration of 1 Î¼M, compounds <b>31</b> and <b>41</b> led to full reversal of the MDR (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, light-gray bars). Analogously, EC<sub>50</sub> values were derived for both compounds, resulting in EC<sub>50</sub> values of 21.8 and 19.5 nM for compounds <b>31</b> and <b>41</b>, respectively. Cytotoxic effects of both compounds in the absence of MX can be observed by the decrease of the cell viability with increasing compound concentration (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, dark-gray bars). However, cytotoxic effects are only noticeable at concentrations â¥1 Î¼M. Both compounds show an excellent correlation between the EC<sub>50</sub> resulting from the MDR reversal assay with MX and the Hoechst 33342 accumulation assay.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. MDR reversal assay of compounds <b>31</b> ((a) EC<sub>50</sub> 21.8 nM) and <b>41</b> ((b) EC<sub>50</sub> 19.5 nM), demonstrating their ability to reverse MDR toward the cytostatic MX, using the ABCG2 overexpressing cell line MDCK II. The bars represent the cell viability at a given modulator concentration in the presence (light gray) and absence (dark gray) of 0.5 Î¼M MX. The standard deviation is expressed by error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Investigation of ATPase Activity</h4><div class="NLM_p">ATPase activity was measured using High Five insect cell membranes, which have previously been infected by baculovirus containing ABCG2 cDNA. The released inorganic phosphate, which is closely related to the transport activity of ABCG2, was detected by a colorimetric method. More details are provided in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_p">Despite being an inhibitor of ABCG2, synthesized compounds could also be transported substrates of ABCG2 and therefore stimulate ATPase activity. In earlier studies of our working group, we showed that closely related compounds displayed different behavior in ATPase activity and enzyme kinetic investigations. To investigate the behavior of the 6-nitro derivatives, we carried out vanadate-sensitive ATPase activity studies with highly potent compounds in Hoechst 33342 inhibition assay and compounds displaying structural similarities. The investigated compounds can be divided into three groups with different behavior in ATPase activity assay, as illustrated in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Eight of the tested compounds had no observable effect on the ATPase activity in all tested concentrations (<b>14</b>, <b>17</b>, <b>21</b>, <b>31</b>, <b>32</b>, <b>37</b>, <b>41</b>, and <b>44</b>). This may be an indication that these compounds are not transported by ABCG2 and represent only inhibitors of ABCG2 detected in Hoechst 33342 accumulation assay. Another eight compounds showed a stimulation of ATPase activity, from which two compounds (<b>26</b> and <b>47</b>) possessed a strong activating effect to nearly the same extent as the standard activator quercetin. All other compounds were moderately stimulating, ranging between 35% and 52%. With regard to the potency of activation, five compounds had EC<sub>50</sub> values in the low nanomolar range (<b>18</b>, <b>20</b>, <b>28</b>, <b>30</b>, <b>40</b>), while one compound (<b>19</b>) showed an EC<sub>50</sub> value in the range of quercetin and two compounds (<b>26</b>, <b>47</b>) possessed even higher values in the low micromolar range. Interestingly, the two compounds with the highest activation contained both a <i>meta</i> methoxy substituent at the phenyl ring at position 4 of the quinazoline scaffold but different substituents at positions 2 and 6.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. EC<sub>50</sub> Values of Selected Compounds in the ATPase Activity Assay<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">activating compds</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> [nM]<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>max</sub> [% of control]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">136</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">326</td><td class="colsep0 rowsep0" align="char" char=".">135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">690</td><td class="colsep0 rowsep0" align="char" char=".">168</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">112</td><td class="colsep0 rowsep0" align="char" char=".">134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">152</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">143</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">1230</td><td class="colsep0 rowsep0" align="char" char=".">168</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">quercetin<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">278</td><td class="colsep0 rowsep0" align="char" char=".">177</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compds with biphasic behavior</th><th class="colsep0 rowsep0" align="center" char=".">concn of maximal activity [nM]</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>max</sub> [% of control]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">1000</td><td class="colsep0 rowsep0" align="char" char=".">138</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">1000</td><td class="colsep0 rowsep0" align="char" char=".">115</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">131</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">122</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup><sup>a</sup></sup><p class="last">All values are relative vanadate-sensitive ATPase activities in relation to the basal activity, which is set to 100%. Compounds <b>14</b>, <b>17</b>, <b>21</b>, <b>31</b>, <b>32</b>, <b>37</b>, <b>41</b>, and <b>44</b> had no observable effect on ATPase activity.</p></div><div class="footnote" id="t3fn1"><sup><sup>b</sup></sup><p class="last">Compound tested in earlier study.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div><div class="footnote" id="t3fn2"><sup><sup>c</sup></sup><p class="last">Results were obtained by at least two independent experiments.</p></div></div></div><div class="NLM_p">Four compounds (<b>22</b>, <b>27</b>, <b>33</b>, <b>43</b>) showed a bell-shaped concentrationâresponse curve with an activating effect at low concentrations and an inhibiting effect at higher concentrations. Inspection of the concentration of the maximal activity revealed one compound (<b>33</b>) in the low nanomolar range, one compound (<b>43</b>) with a concentration seven times higher, and two compounds (<b>22</b>, <b>27</b>) with an about 30 times higher maximal concentration in the micromolar range. Inspection of the maximal stimulation (<i>V</i><sub>max</sub>) caused by the biphasic compounds showed that two compounds possessed a negligible effect of less than 30% (<b>27</b>, <b>43</b>). The other two compounds ranged between 30% and 40% at the maximum. All biphasic compounds were not stimulating the ATPase activity very well. With the exception of compounds <b>26</b> and <b>47</b>, all investigated compounds showed low ATPase activity stimulation or even no observable effect and can therefore be seen as very good inhibitors of ABCG2 with nearly no impact on ATPase activity. This is probably due to the nitro function at position 6 of the quinazoline scaffold as most quinazolines investigate so far stimulated ATPase activity. This modification leads to higher inhibitory potency in the Hoechst 33342 accumulation assay and no impact on ATPase activity.</div><div class="NLM_p">Representative concentrationâresponse curves of compounds <b>22</b> (biphasic), <b>26</b> (stimulating), and quercetin (activating standard) are illustrated in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>. Compound <b>26</b> showed solely stimulation of ATPase activity over the whole range of concentrations similar to the standard activator quercetin. This activating effect on ATPase activity may point to substrate properties of the compound despite the inhibitory activity in the Hoechst 33342 accumulation assay. However, in earlier studies of our working group, the assumption of transport by ABCG2 in relation to ATPase activity stimulation was challenged by a fluorescent heterodimeric ABCG2 inhibitor comprised of a quinazoline and chalcone moiety, which was also stimulating ATPase activity to a high extent. In confocal microscopy studies, this compound accumulated to the same extent in transfected MDCK II BCRP cells as in parenteral MDCK cells without the transporter protein, pointing to absence of transport.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> For compound <b>22</b>, a bell-shaped ATPase activity curve was observed. The occurrence of such bell-shaped curves is presumed to be due to two different binding sites for substrates. In most cases, it is supposed that the activating and in some cases also transporting site has a high affinity for substrates and the inhibitory site has a low affinity for substrates.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> The bell-shaped behavior in ATPase activity can be due to the assumption that different binding pockets for one compound exist and the different behavior of closely related structures with small differences in their substitution pattern led to the proposal that multiple binding sites in ABCG2 protein must be present. This phenomenon can further be investigated by enzyme kinetic studies, which is illustrated in the following section.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Concentrationâresponse curves for compounds <b>22</b> (a), <b>26</b> (b), and quercetin (c) in the ATPase activity assay. All values are vanadate-sensitive ATPase activities in relation to the basal activity, which is set to 100%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Investigation of Interaction Type</h4><div class="NLM_p">Investigation of the interaction with the ABCG2 substrate Hoechst 33342 was carried out with compounds <b>17</b>, <b>31</b>, <b>40</b>, and <b>41</b> that were selected according to their different ATPase profiles and their inhibitory potency in the Hoechst 33342 accumulation assay. For this purpose, the ABCG2 overexpressing MDCK II cell line was used. Representative LineweaverâBurk and Cornish-Bowden diagrams are depicted in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> together with a summary of the results from the LineweaverâBurk diagrams in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. LineweaverâBurk plot for compounds <b>17</b> (a), <b>31</b> (c), <b>40</b> (e), and <b>41</b> (g) at various concentrations together with the ABCG2 substrate Hoechst 33342. Plot of the MichaelisâMenten constant <i>K</i><sub>M</sub> (â) and the maximum velocity <i>V</i><sub>max</sub> (â ) derived from the analysis according to Cornish-Bowden against the corresponding compound concentration (<b>17</b> (b)), <b>31</b> (d)), <b>40</b> (f)), <b>41</b>, (h)).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Compounds Interaction Type with Hoechst 33342 Derived from the LineweaverâBurk Double Reciprocal Plot</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">intersection<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">kinetic type of interaction with Hoechst 33342</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 quadrant</td><td class="colsep0 rowsep0" align="left">noncompetitive mixed-type</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 quadrant</td><td class="colsep0 rowsep0" align="left">noncompetitive mixed-type</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left"><i>Y</i>-axis</td><td class="colsep0 rowsep0" align="left">competitive</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">3-OMe-Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2Â quadrant</td><td class="colsep0 rowsep0" align="left">noncompetitive mixed-type</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">3-OMe-Ph</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3Â quadrant</td><td class="colsep0 rowsep0" align="left">noncompetitive mixed-type</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 quadrant</td><td class="colsep0 rowsep0" align="left">noncompetitive mixed-type</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3 quadrant</td><td class="colsep0 rowsep0" align="left">noncompetitive mixed-type</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 quadrant</td><td class="colsep0 rowsep0" align="left">noncompetitive mixed-type</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">2 quadrant</td><td class="colsep0 rowsep0" align="left">noncompetitive mixed-type</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Intersection point of the family of lines resulting from the LineweaverâBurk method (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</p></div></div></div><div class="NLM_p last">With exception of compound <b>31</b>, all other investigated compounds showed a noncompetitive interaction with Hoechst 33342 according to the results of the LineweaverâBurk method. Interestingly, all noncompetitive interactions are of the âmixed-typeâ, illustrated by the intersection of the lines in the second or third quadrant of the coordinate system. Although such âmixed-typeâ inhibitors bind differently from Hoechst 33342, they influence the active site, for instance by conformational changes of the protein. Compound <b>31</b> showed a competitive interaction with Hoechst 33342 for the same binding site according to the intersection of the lines at the <i>Y</i>-axis of the plot. Representative LineweaverâBurk plots for compounds <b>17</b>, <b>31</b>, <b>40</b>, and <b>41</b> are illustrated in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>a,c,e,g. To confirm our results, the direct linear plot according to Cornish-Bowden was carried out, because this method has been claimed to be less sensitive to outliers (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>b,d,f,h): a strong decrease of the maximum velocity <i>V</i><sub>max</sub> and roughly constant <i>K</i><sub>M</sub> values were found for compounds <b>17</b> and <b>41</b> with increasing concentrations, which is characteristic for a noncompetitive interaction. In contrast, compound <b>31</b> displayed constant <i>V</i><sub>max</sub> values and increasing K<sub>M</sub> values, which is characteristic for a competitive interaction. Simultaneously decreasing <i>V</i><sub>max</sub> and increasing <i>K</i><sub>M</sub> values confirmed the âmixed-typeâ properties of compound <b>40</b>. In our previous studies as well as in our ongoing work, we discovered that a noncompetitive interaction with Hoechst 33342 is the predominant mechanism for the quinazoline derivatives.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, some substituents led to a rather competitive interaction with the substrate, which could be explained by the different physicochemical properties of the compounds and for some by the ability to form hydrogen bonds via H-donor and H-acceptor-functions.</div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 5D3 Antibody Binding Assay</h4><div class="NLM_p">To get further insights into the interaction between the compounds and ABCG2, we performed a binding assay with conformation sensitive antibody 5D3 for selected derivatives. Therefore, the monoclonal antibody PerCPâCy5.5 mouse anti-human CD338 was used with the ABCG2 overexpressing PLB-985 cell line. The antibody was conjugated with a fluorescent dye and bound specifically to the CD338 epitope of ABCG2, dependent on the conformational state of the protein. We used the standard ABCG2 inhibitor <b>59</b> at a concentration of 10 Î¼M as a reference due to its significant effect on antibody binding and set it as 100% labeling of ABCG2. Furthermore, we used the ABCG2 substrate Hoechst 33342 for comparison because it is known that substrates in most cases lead to a lower rate of antibody binding than inhibitors.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The unspecific binding of the antibody was taken into account by subtracting the fluorescence detected with an isotype control.</div><div class="NLM_p">We selected our most active compounds together with some 6-amino derivatives and conducted a screening at a compound concentration of 10 Î¼M. The results are presented in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>. The highest amount of labeling with the antibody was found for compound <b>17</b> (88%), which showed a noncompetitive interaction with Hoechst 33342 in the interaction type studies. The lowest immunostaining with 5D3 antibody among the tested compounds was found for the 6-amino derivative <b>47</b> (47%), which is still higher than the labeling for the substrate Hoechst 33342 (35%). Although the differences in labeling among the remaining compounds were rather low, some tendencies were observable: compounds <b>43</b> and <b>44</b> which already exhibited different IC<sub>50</sub> values showed a different rate of labeling with the antibody of 72% and 84%, respectively. Compounds <b>31</b>, <b>33</b>, <b>40</b>,and <b>41</b> gave a similar immunostaining of 66%, 58%, 62%, and 64%, respectively. There was no correlation between the IC<sub>50</sub> value of a compound and the rate of labeling with the antibody. However, the high rate of labeling with the antibody suggests that the compounds are no substrates of ABCG2.</div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) 5D3 immunoreactivity modulation of ABCG2 by various compounds at a concentration of 10 Î¼M. Fluorescence detected by the 5D3-labeling of ABCG2 in the presence of 10 Î¼M compound <b>59</b> was set to 100%, and the fluorescence measured in the absence of any compound taken as 0%. Values are means of at least three independent experiments, and the SD is given as error bar. (b) Histogram of the obtained fluorescence at the FL3-H detector (<i>X</i>-axis) and the cell-count according to the corresponding fluorescence. Depicted is the fluorescence of the isotype control (dotted curve) as well as of 5D3 antibody in the absence of a compound <b>59</b> (dashed curve) and in the presence of compound <b>59</b> (continuous curve).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Molecular Docking</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Docking of Substrate Hoechst 33342</h4><div class="NLM_p">Very recently, the cryo-EM structure of human ABCG2 has been reported and additionally in complex with a structural homologue of the standard inhibitor <b>59</b>.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Additionally, a thorough discussion of the results of mutagenesis studies has been published.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Therefore, we performed docking studies of selected compounds in order to gain insight into the molecular determinants involved in the formation of the receptorâsubstrate complex. First the substrate Hoechst 33342 was docked into the cryo-EM structure of the human ABCG2 and the interactions with the receptor were studied in detail. The results from docking studies show that putative binding modes of Hoechst 33342 occupy two binding sites S1 and S2 as depicted in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>a. The site S1 is located at the interface between the two transmembrane domains, and the site S2 is between the transmembrane regions. As shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>b, 64% of docked poses of Hoechst 33242 occupied site S1 and the remaining 36% of poses were occupying site S2. The previously published literature specified that the site S1 is highly promiscuous, allowing substrates and nonsubstrates to dock in a wide variety of binding poses.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> On the contrary, the site S2 is highly selective and favoring substrates in comparison to nonsubstrates or inhibitors. The new cryo-EM structure (Jackson et. al) specified that the site S1 is occupied by the fumitremorgin C-related inhibitor, MZ29.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> According to interaction type analysis, we had found a noncompetitive mixed-type interaction of compound <b>59</b> and Hoechst 33342. Thus, we considered the binding poses of Hoechst 33342 docked at the site S2 for our analysis.</div><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Binding poses of MZ29 and Hoechst 33342. (a) The binding pose of the inhibitor MZ29 (purple) observed in the cryo-EM structure of the human ABCG2 receptor (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC">6FFC</a>). The putative binding sites of the human ABCG2 receptor are schematically indicated as S1 and S2. (b) Docked poses of the substrate Hoechst 33342 in the binding pockets of the human ABCG2 receptor and (c) 2D interaction diagram. The human ABCG2 receptor (chain A, gray, and chain B, dark gray) is displayed in cartoon representation. Both MZ29 and Hoechst 33342 are shown as stick models. Oxygen atoms are colored in red and nitrogen atoms in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The 2D interaction diagram of the putative binding pose of Hoechst 33342 is shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>c. Hoechst 33342 has many functional groups that could potentially interact with the receptor. The nitrogen in the methylpiperazine might act as a donor and possibly interacts with the main chain of the residue Gly179. The benzimidazole group attached to the methylpiperazine is positioned at the edge of the transmembrane domain, and either N1 or N3 of the benzimidazole group act as donor and acceptor and interact with Asn387. The amino acid Ans387 is from connecting the helix of the interface between the transmembrane and nucleotide binding domains and plays an important role for the efflux function of the receptor. The finding was confirmed by the negative effects of N397A mutant on receptor efflux activity with Hoechst 33342 as substrate.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The mutagenesis study also suggests that the positioning of Asn387 at the interface could be vital for communication between the two domains. The second benzimidazole group is surrounded by hydrophobic residues Leu338, Leu447, and Val450 and polar residues Asn387, Asn391, Glu451, and Asp477. The ethoxyphenyl group is located in a subpocket formed by Gln398, Ser443, Glu446, Met481, and Arg482. Among the residues, the side chains of Gln398, Ser443, and Arg482 interact with the ethoxyphenyl group of Hoechst 33342. The results from different mutagenesis studies specified that the overall efflux activity was decreased for the mutants Q398A, R482G, and R482T.<a onclick="showRef(event, 'ref47 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref47 ref49 ref50 ref51">(47,49â51)</a> The mutants also show a decreasing effect on the ATPase activity. An aromatic residue Tyr489 located at a distance of approximately 6 Ã might act as an edge for the binding site and position the substrate Hoechst 33342 inside the binding pocket. The mutagenesis studies by Tamura et al. show decrease in efflux and ATPase activity for the F489L mutant.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This indicates that an aromatic residue is required for strong hydrophobic interaction between Hoechst 33342 and the amino acids inside the substrate binding pocket.</div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Docking of Inhibitors</h4><div class="NLM_p">To explore binding modes for the quinazoline derivatives and identify a possible explanation for the mechanism of inhibition, we selected compounds <b>31</b> and <b>41</b> for performing molecular docking studies in the cryo-EM structure of the ABCG2 receptor. Compound <b>31</b> was selected as it showed competitive type of interaction with Hoechst 33342, while compound <b>41</b> was the most potent compound showing noncompetitive type of interaction (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_p">Similar to Hoechst 33342, compound <b>31</b> can be accommodated in the binding site S1 and S2 (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>a). In our docking results, only 6% of poses of compound <b>31</b> occupied the site S1 and the remaining 94% of poses were occupied site S2. In particular, the best scoring binding poses were bound near the connecting helix between the transmembrane and nucleotide binding domain. The 2D interaction diagram of the putative binding pose with the receptor is shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>b. The quinazoline moiety of <b>31</b> is placed below the ionic lock formed between Asp127 and Lys453. The 3-CF<sub>3</sub>-phenyl group is located in the subpocket formed by the residues Val449, Val450, Lys452, Lys453, and Ser532. The NH of the 3-hydroxyaniline group possibly forms interaction with the main chain of Asp128. In particular, the hydroxyl substituent at position 3 of the aniline group acts as hydrogen bond donor and acceptorm which forms a strong interaction with the main chain of Val450 and Leu454. Additionally, the nitro group at position 6 of the quinazoline moiety forms electrostatic interactions with the side chain of Arg191 and the main chain of Asp128. The obtained docked poses suggest that compound <b>31</b> possibly binds at the site S1, which is closer to the substrate banding site and exhibits competitive type of inhibition.</div><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Putative binding poses of compound <b>31</b> and <b>41</b>. (a) The docked poses of <b>31</b> (green) observed in the cryo-EM structure of the human ABCG2 receptor (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC">6FFC</a>) and (b) 2D interaction diagram. (c) The docked poses of <b>41</b> (yellow) observed in the cryo-EM structure of the human ABCG2 receptor and (d) 2D interaction diagram. The fluorine atoms are colored in cyan and for the remaining atoms. The human ABCG2 receptor (chain A, gray, and chain B, dark gray) is displayed in cartoon representation. Both MZ29 and Hoechst 33342 are shown as stick models. Oxygen atoms are colored in red and nitrogen atoms in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As a next step, we analyzed the binding poses of compound <b>41</b> which displayed noncompetitive and mixed type of inhibition. The putative binding poses and the interaction with the receptor are shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>c,d. The results from docking show that all 100 binding poses were docked to the site S2. Similar to the bound inhibitor, MZ29 in the cryo-EM structure occupied the binding site S2 interface between the two transmembrane domains. The quinazoline moiety forms a strong aromatic ÏâÏ interaction with Phe439. The nitro group substituted at position 6 of the quinazoline moiety forms electrostatic interactions with Asn436. The NH-group of the 3-fluoro-aniline group forms hydrogen bond interaction with Met549. The phenyl ring is positioned in a subpocket formed by the hydrophobic residues Phe431, Phe432, Thr435, Met549, and Leu555. The 3-methoxyphenyl group forms a Ï-stacking with another aromatic residue Phe439. On the basis of the analysis of binding poses and interaction from docking studies, compound <b>41</b> occupies the site S2 and shows noncompetitive or mixed-type of interaction with the substrate Hoechst 33242.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This study is a continuation of our previous investigations of 2,4-disubstituted-quinazolines. Extraordinary low IC<sub>50</sub> values resulted from introducing a nitro group at position 6 of a 2,4-disubstituted quinazoline scaffold. Further substitution with methoxy residues at the aromatic rings at positions 2 and 4 of the scaffold increased the potency toward ABCG2 even more. The highest potency in the Hoechst 33342 accumulation assay resulted for compound <b>41</b> from a substitution with 3-methoxyphenyl at position 2 and 3â²-fluoroaniline at position 4. It was determined to be about 10-fold more potent than compound <b>59</b>, one of the most potent inhibitors of ABCG2 found in literature. Reduction of the nitro function at position 6 yielded derivatives with an amino group with significantly lower potencies than the corresponding 6-nitro derivatives. Reaction of the amino function at position 6 with acid chlorides yielded aromatic amides with unfortunately even further decreased inhibitory potency. We concluded that the nitro function is preferable over amino groups and amido groups.</div><div class="NLM_p">Moreover, the screening of selected compounds in a calcein AM assay against the transport proteins ABCB1 and ABCC1 showed their high selectivity toward ABCG2. Resulting activities toward both transport proteins were below 25% of the response observed by the control cyclosporine A, confirming the specificity of the inhibitors. Investigation of the intrinsic cytotoxicity showed slightly increased toxic effects for the 6-nitro derivatives compared to their analogues lacking the nitro group. Generally, aromatic nitro groups are considered as toxicologically problematic. Most nitro-containing compounds can cause methemoglobinemia and are potentially mutagenic.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> However, a prominent exception from this rule are calcium channel blockers of the dihydropyridine type. Therefore, additional toxicological studies are necessary to explore the feasibility of future in vivo studies of the ABCG2 inhibitors. The calculated therapeutic ratios (GI<sub>50</sub>/IC<sub>50</sub>) still were relatively high due to the high inhibitory potencies of the compounds. Most notably, a substitution with pyridyl at position 2 turned out to be highly beneficial (see compounds <b>28</b> and <b>29</b>), leading to a therapeutic ratio which is up to 22-fold higher than that of compound <b>59</b>. Moreover, most potent compounds were investigated for their ability to reverse MDR toward the cytostatic drugs SN-38 and mitoxantrone using ABCG2 overexpressing MDCK II BCRP cells. All tested compounds were able to reverse the MDR, restoring the sensitivity toward SN-38 and mitoxantrone at low compound concentrations. Full reversal of the MDR was achieved by all compounds at compound concentrations of about 1 Î¼M. Investigation of the ATPase activity of selected compounds resulted in three different groups: more than one-third of the compounds showed no effect on ATPase activity. This may be an indication that these compounds are not transported by ABCG2 and represent only inhibitors of ABCG2 as detected in Hoechst 33342 accumulation assay. Four compounds showed biphasic ATPase activity curves with an activating/stimulating site at low concentrations and an inhibitory site at higher concentrations (see compounds <b>22</b>, <b>27</b>, <b>33</b>, and <b>43</b>). It is reasonable that different binding regions with different affinities are present in ABCG2. The third group consists of eight compounds with stimulation of ATPase activity, of which almost all showed low stimulation with the exception of compounds <b>26</b> and <b>47</b>. These two compounds both contain a <i>meta</i> methoxy group at the phenyl ring at position 4 of the quinazoline scaffold and showed the same stimulating effect as the standard stimulator quercetin. The nitro substitution at position 6 of the quinazoline scaffold seems to lead to higher inhibitory potencies in the Hoechst 33342 accumulation assay and leads to low or no impact on ATPase activity.</div><div class="NLM_p">Furthermore, the type of interaction with Hoechst 33342 was determined for selected compounds using the methods according to LineweaverâBurk and Cornish-Bowden. Interestingly, the investigated compounds showed different types of interaction with Hoechst 33342 but were mostly noncompetitive, meaning that they bind apart from Hoechst 33342. Some compounds showed competitive portions, which is characteristic for âmixed-typeâ inhibitors or pure competitive inhibitors. Here, one compound (compound <b>31</b>) was found to compete for the same binding site as Hoechst 33342.</div><div class="NLM_p">Additionally the conformation sensitive 5D3 antibody binding assay was carried out to monitor the conformational change of ABCG2 in the presence of selected compounds. All compounds induced a higher level of immunostaining with the antibody than the ABCG2 substrate Hoechst 33342. Only small differences in the rate of labeling resulted for the investigated compounds, whereas no correlation was found with the IC<sub>50</sub> values from the Hoechst 33342 accumulation assay.</div><div class="NLM_p last">As a logical continuation of our earlier work, the quinazoline scaffold was further modified and functionalized, giving more insights into the SAR of this compound class. The study yielded several compounds with extraordinary high inhibitory potencies and selectivity toward ABCG2. On the basis of the promising in vitro results, particularly their ability to reverse MDR toward SN-38 and MX, further in vivo studies should be interesting. Furthermore, molecular modeling studies based on recently published cryo-EM structures of ABCG2 supported the results of the substrate and inhibitors obtained by biological and kinetic studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_0_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div id="sec4_0_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Materials</h4><div class="NLM_p last">Chemicals were purchased from Acros Organics (Geel, Belgium), Alfa Aesar (Karlsruhe, Germany), Sigma-Aldrich (Steinheim, Germany), or Merck (Darmstadt, Germany) and used without further purification. Microwave reactions were carried out in 50 mL vials using a CEM Discover SP (CEM GmbH, Kamp-Lintfort, Germany) and monitored by thin layer chromatography (TLC) employing an aluminum plate coated with silica gel 60 F<sub>254</sub> (Merck Millipore, Billerica, MA, USA). For the preparation of the TLC, a mixture of dichloromethane and methanol in the ratio of 9:1 was used as eluent. Following, the plates were analyzed in a UV cabinet at an excitation wavelength of 254 nm. Identity of the test compounds was confirmed by NMR with the <sup>1</sup>H and <sup>13</sup>C spectra obtained on a Bruker Advance 500 MHz (500/126 MHz) or Bruker Advance 600 MHz (600/151 MHz), respectively. Chemical shifts (Î´) relating to the internal standard DMSO-<i>d</i><sub>6</sub>, also used as solvent for the compounds, are expressed in ppm. For the assignment of the <sup>13</sup>C signals, distortionless enhancement by polarization transfer (DEPT) as well as attached proton test (APT) was applied. Multiplicity of the signals are given as singlet (s), doublet (d), doublet of doublets (dd), triplet of doublets (td), triplet (t), doublet of triplets (dt), quartet (q), and multiplet (m), whereas the coupling constants <i>J</i> are given in Hz. The purity of all biologically evaluated compounds was determined to be >95% by elemental analysis recorded on a Vario EL V24 CHN elemental analyzer (Elementar Analysensysteme GmbH, Hanau, Germany). Found values were in the range of Â±0.4% of the theoretical values unless indicated</div></div><div id="sec4_0_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-Amino-5-nitrobenzamide (<b>1</b>)</h4><div class="NLM_p last">To a solution of 2-amino-5-nitrobenzoic acid (1.80 g, 10 mmol) in 100 mL of dry tetrahydrofuran was slowly added triphosgene (1.19 g, 4 mmol) while stirring at room temperature. The mixture was then refluxed under moisture exclusion for 3 h. Under stirring, a constant stream of ammonia gas was bubbled through the mixture for 30 min at 50 Â°C. Then, 50 mL of water was added and the precipitate filtered off. Additional product was obtained by concentrating the mixture under reduced pressure to one-half of the initial volume to yield <b>1</b> as bright-yellow crystals (1.58 g, 87%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.97 (s, 1H), 8.84 (d, <i>J</i> = 2.7 Hz, 1H), 8.56 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 8.27â8.19 (m, 2H), 7.92 (d, <i>J</i> = 9.0 Hz, 1H), 7.68â7.62 (m, 1H), 7.58 (dd, <i>J</i> = 8.3, 6.7 Hz, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 160.74, 155.16, 152.43, 144.86, 132.40, 128.86, 128.65, 128.24, 127.99, 126.66, 122.18, 121.22.</div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure for the Preparation of Compounds <b>2</b>â<b>7</b></h4><div class="NLM_p">A mixture of 2-amino-5-nitrobenzamide <b>1</b> (3.62 g, 20 mmol), the corresponding aldehyde derivative (20 mmol), iodine (3.17 g, 25 mmol), anhydrous potassium carbonate (2.76 g, 20 mmol), and 20 mL of DMF was stirred at 90â110 Â°C for 8â24 h. The end of the reaction was monitored by TLC and the mixture poured on crushed ice to form a precipitate. Incomplete precipitation can be prevented by adjusting the pH with concentrated HCl solution to 7. After filtration of the precipitate, it was thoroughly washed with 100 mL of a 20% sodium thiosulfate solution followed by 100 mL of hot distilled water. Purification was performed by recrystallization from ethanol.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 6-Nitro-2-phenylquinazolin-4(3<i>H</i>)-one (<b>2</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>1</b> (3.62 g, 20 mmol) and benzaldehyde (2.12 g, 20 mmol) as described in the general procedure for compounds <b>2</b>â<b>7</b> to yield <b>2</b> as a yellow solid (3.85 g, 72%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.97 (s, 1H), 8.84 (d, <i>J</i> = 2.7 Hz, 1H), 8.56 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 8.27â8.19 (m, 2H), 7.92 (d, <i>J</i> = 9.0 Hz, 1H), 7.68â7.62 (m, 1H), 7.58 (dd, <i>J</i> = 8.3, 6.7 Hz, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 144.86, 132.40, 132.24, 128.86, 128.65, 128.39, 122.18.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 6-Nitro-2-(pyridin-3-yl)quinazolin-4(3<i>H</i>)-one (<b>3</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>1</b> (3.62 g, 20 mmol) and nicotinaldehyde (2.14 g, 20 mmol) as described in the general procedure for compounds <b>2</b>â<b>7</b> to yield <b>3</b> as a yellow-orange solid (3.70 g, 69%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.58â9.44 (m, 1H), 8.82 (d, <i>J</i> = 2.8 Hz, 1H), 8.67 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H), 8.61 (dd, <i>J</i> = 4.9, 1.7 Hz, 1H), 8.24 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 7.94 (s, 1H), 7.58 (d, <i>J</i> = 9.0 Hz, 1H), 7.45 (ddd, <i>J</i> = 7.9, 4.7, 0.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 171.52, 163.89, 162.42, 156.83, 150.48, 149.70, 141.89, 135.45, 135.21, 127.35, 125.06, 123.24, 120.82.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 6-Nitro-2-(pyridin-4-yl)quinazolin-4(3<i>H</i>)-one (<b>4</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>1</b> (3.62 g, 20 mmol) and isonicotinaldehyde (2.14 g, 20 mmol) as described in the general procedure for compounds <b>2</b>â<b>7</b> to yield <b>4</b> as a yellow solid (2.74 g, 51%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.18 (s, 1H), 8.82 (dd, <i>J</i> = 8.1, 4.1 Hz, 3H), 8.57 (dd, <i>J</i> = 9.2, 2.7 Hz, 1H), 8.16â8.07 (m, 2H), 7.95 (d, <i>J</i> = 9.3 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.62, 154.18, 152.54, 150.51, 145.35, 139.58, 129.56, 128.73, 122.09, 121.96, 121.77.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 6-Nitro-2-(3-(trifluoromethyl)phenyl)quinazolin-4(3<i>H</i>)-one (<b>5</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>1</b> (3.62 g, 20 mmol) and 3-(trifluoromethyl)benzaldehyde (3.48 g, 20 mmol) as described in the general procedure for compounds <b>2</b>â<b>7</b> to yield <b>5</b> as a yellow solid (5.16 g, 77%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.18 (s, 1H), 8.82 (d, <i>J</i> = 2.7 Hz, 1H), 8.59â8.53 (m, 2H), 8.50 (ddd, <i>J</i> = 8.2, 2.0, 1.1 Hz, 1H), 8.00 (ddt, <i>J</i> = 7.9, 1.9, 1.0 Hz, 1H), 7.97â7.91 (m, 1H), 7.87â7.77 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.67, 154.51, 152.69, 145.07, 133.26, 132.33, 130.07, 129.61 (d, <i>J</i> = 32.3 Hz), 129.37, 128.71 (d, <i>J</i> = 3.5 Hz), 128.65, 127.25, 125.04 (d, <i>J</i> = 3.8 Hz), 122.92, 122.07, 121.36.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 2-(3-Methoxyphenyl)-6-nitroquinazolin-4(3<i>H</i>)-one (<b>6</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>1</b> (3.62 g, 20 mmol) and 3-methoxybenzaldehyde (2.72 g, 20 mmol) as described in the general procedure for compounds <b>2</b>â<b>7</b> to yield <b>6</b> as a yellow solid (4.88 g, 82%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.94 (s, 1H), 8.83 (d, <i>J</i> = 2.7 Hz, 1H), 8.52 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 7.88 (d, <i>J</i> = 8.9 Hz, 1H), 7.85 (ddd, <i>J</i> = 7.8, 1.7, 0.9 Hz, 1H), 7.80 (t, <i>J</i> = 2.2 Hz, 1H), 7.47 (t, <i>J</i> = 8.0 Hz, 1H), 7.18 (ddd, <i>J</i> = 8.2, 2.6, 0.9 Hz, 1H), 3.86 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.65, 161.42, 159.51, 153.03, 144.84, 142.84, 133.43, 130.00, 128.61, 122.13, 120.75, 118.60, 113.11, 55.59.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 2-(3,4-Dimethoxyphenyl)-6-nitroquinazolin-4(3<i>H</i>)-one (<b>7</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>1</b> (3.62 g, 20 mmol) and 3,4-dimethoxybenzaldehyde (3.32 g, 20 mmol) as described in the general procedure for compounds <b>2</b>â<b>7</b> to yield <b>7</b> as a yellow solid (4.19 g, 64%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.81 (s, 1H), 8.80 (d, <i>J</i> = 2.7 Hz, 1H), 8.50 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 7.94 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.88â7.82 (m, 2H), 7.13 (d, <i>J</i> = 8.7 Hz, 1H), 3.88 (s, 3H), 3.85 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 162.24, 155.65, 153.41, 152.49, 148.72, 144.28, 128.86, 128.42, 124.35, 122.24, 122.18, 120.68, 111.58, 111.20, 55.89, 55.87.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Procedure for the Preparation of Compounds <b>8</b>â<b>13</b></h4><div class="NLM_p">The corresponding 2-substituted 6-nitroquinazolin-4(3<i>H</i>)-one derivative <b>2</b>â<b>7</b> (10 mmol) was added to phosphorus oxychloride (30 mL, 0.32 mol) and stirred for 10 min at room temperature. The mixture was then refluxed for 4â12 h and the reaction monitored by TLC. After completion of the reaction, excess POCl<sub>3</sub> was removed under reduced pressure and 50 mL of iceâwater added. Subsequently, 50 mL of DCM was added while stirring and the pH of the mixture slowly adjusted to 7 with 25% ammonium solution. With a separatory funnel, the organic phase was collected, washed with 50 mL of brine, and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure and the obtained solid recrystallized from 2-propanol.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 3-(6-Nitro-4-oxo-3,4-dihydroquinazolin-2-yl)benzonitrile (<b>8</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>2</b> (2.67 g, 10 mmol) as described in the general procedure for compounds <b>8</b>â<b>13</b> to yield <b>8</b> as a yellow solid (2.46 g, 86%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.83 (d, <i>J</i> = 2.7 Hz, 1H), 8.55 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 8.24â8.19 (m, 2H), 7.91 (d, <i>J</i> = 9.0 Hz, 1H), 7.67â7.62 (m, 1H), 7.60â7.55 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.74, 155.85, 152.97, 144.85, 132.41, 132.16, 129.19, 128.85, 128.64, 128.39, 122.16, 121.14.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 4-Chloro-6-nitro-2-(pyridin-3-yl)quinazoline (<b>9</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>3</b> (2.68 g, 10 mmol) as described in the general procedure for compounds <b>8</b>â<b>13</b> to yield <b>9</b> as an orange solid (2.38 g, 83%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.38 (dd, <i>J</i> = 2.3, 0.8 Hz, 1H), 8.88 (dd, <i>J</i> = 5.0, 1.6 Hz, 1H), 8.82 (d, <i>J</i> = 2.7 Hz, 1H), 8.72 (ddd, <i>J</i> = 8.1, 2.3, 1.6 Hz, 1H), 8.60â8.54 (m, 1H), 7.94 (d, <i>J</i> = 8.8 Hz, 1H), 7.79 (ddd, <i>J</i> = 8.1, 5.1, 0.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.49, 153.56, 152.52, 150.29, 147.22, 145.21, 138.43, 129.36, 129.20, 128.77, 124.70, 122.09, 121.42.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 4-Chloro-6-nitro-2-(pyridin-4-yl)quinazoline (<b>10</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>4</b> (2.68 g, 10 mmol) as described in the general procedure for compounds <b>8</b>â<b>13</b> to yield <b>10</b> as an orange solid (2.12 g, 74%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.21 (s, 1H), 8.85â8.81 (m, 2H), 8.57 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 8.18â8.10 (m, 2H), 7.95 (d, <i>J</i> = 9.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.55, 153.98, 152.46, 150.07, 145.44, 140.03, 129.63, 128.80, 122.10, 121.81.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 4-Chloro-6-nitro-2-(3-(trifluoromethyl)phenyl)quinazoline (<b>11</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>5</b> (3.35 g, 10 mmol) as described in the general procedure for compounds <b>8</b>â<b>13</b> to yield <b>11</b> as a yellow solid (3.18 g, 90%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.81 (d, <i>J</i> = 2.7 Hz, 1H), 8.59â8.52 (m, 2H), 8.52â8.46 (m, 1H), 8.03â7.97 (m, 1H), 7.94 (d, <i>J</i> = 8.9 Hz, 1H), 7.82 (t, <i>J</i> = 7.9 Hz, 1H). <sup>13</sup>C NMR (151 MHz, DMSO) Î´ 161.68, 154.53, 152.67, 145.14, 133.24, 132.40, 130.14, 129.66 (d, <i>J</i> = 32.5 Hz), 129.42, 128.80 (d, <i>J</i> = 3.8 Hz), 128.74, 125.09 (t, <i>J</i> = 3.9 Hz), 123.16, 122.13, 121.40.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 4-Chloro-2-(3-methoxyphenyl)-6-nitroquinazoline (<b>12</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>6</b> (2.97 g, 10 mmol) as described in the general procedure for compounds <b>8</b>â<b>13</b> to yield <b>12</b> as a yellow solid (2.81 g, 89%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.83 (d, <i>J</i> = 2.7 Hz, 1H), 8.55 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 7.92 (d, <i>J</i> = 9.0 Hz, 1H), 7.83 (ddd, <i>J</i> = 7.7, 1.7, 0.9 Hz, 1H), 7.78 (dd, <i>J</i> = 2.6, 1.7 Hz, 1H), 7.49 (t, <i>J</i> = 8.0 Hz, 1H), 7.20 (ddd, <i>J</i> = 8.2, 2.6, 0.9 Hz, 1H), 3.87 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.74, 159.51, 155.56, 152.89, 144.87, 133.42, 130.02, 129.23, 128.65, 122.15, 121.18, 120.77, 118.63, 113.14, 55.61.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 4-Chloro-2-(3,4-dimethoxyphenyl)-6-nitroquinazoline (<b>13</b>)</h5><div class="NLM_p last">The compound was synthesized from <b>7</b> (3.27 g, 10 mmol) as described in the general procedure for compounds <b>8</b>â<b>13</b> to yield <b>13</b> as a yellow solid (2.75 g, 71%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.79 (d, <i>J</i> = 2.7 Hz, 1H), 8.50 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 7.92 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.89â7.77 (m, 2H), 7.13 (d, <i>J</i> = 8.6 Hz, 1H), 3.88 (s, 3H), 3.85 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.80, 155.29, 153.05, 152.61, 148.73, 144.43, 128.80, 128.59, 123.85, 122.26, 122.19, 120.66, 111.60, 111.20, 55.91, 55.89.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> General Procedure for the Preparation of Compounds <b>14</b>â<b>42</b></h4><div class="NLM_p">The corresponding 2 substituted 4-chloroquinazoline <b>8</b>â<b>13</b> (1 mmol) and a substituted aniline (1 mmol) were added to a 50 mL microwave tube and suspended in 25 mL of 2-propanol. The tube was sealed and the reaction mixture stirred under 100 W microwave irradiation at 110 Â°C for 20â40 min. Completion of the reaction was monitored by TLC. After cooling, a precipitate was formed and filtered off by suction. Recrystallization was carried out from ethanol.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 6-Nitro-<i>N</i>,2-diphenylquinazolin-4-amine (<b>14</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and aniline (0.93 g, 10 mmol) to yield <b>14</b> as an orange solid (2.40 g, 70%), mp 264â265 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.47 (s, 1H), 9.65 (d, <i>J</i> = 2.5 Hz, 1H), 8.53 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 8.46â8.36 (m, 2H), 7.96 (d, <i>J</i> = 9.2 Hz, 1H), 7.94â7.89 (m, 2H), 7.58â7.44 (m, 5H), 7.23 (tt, <i>J</i> = 7.4, 1.1 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 162.32, 159.06, 154.21, 144.24, 138.67, 137.59, 131.33, 129.68, 128.69, 128.49, 126.90, 124.59, 122.90, 121.05, 113.35. Anal. Calcd for C<sub>20</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>: C, 70.17; H, 4.12; N, 16.37. Found: C, 70.32; H, 4.26; N, 16.17.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 3-((6-Nitro-2-phenylquinazolin-4-yl)amino)phenol (<b>15</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 3-aminophenol (1.09 g, 10 mmol) to yield <b>15</b> as a yellow solid (2.39 g, 66%), mp 277â278 Â°C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.35 (s, 1H), 9.67 (d, <i>J</i> = 2.4 Hz, 1H), 9.53 (s, 1H), 8.53 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 8.49â8.41 (m, 2H), 7.96 (d, <i>J</i> = 9.1 Hz, 1H), 7.57â7.48 (m, 3H), 7.43 (t, <i>J</i> = 2.2 Hz, 1H), 7.38 (ddd, <i>J</i> = 8.1, 2.1, 1.0 Hz, 1H), 7.26 (t, <i>J</i> = 8.0 Hz, 1H), 6.64 (ddd, <i>J</i> = 8.1, 2.4, 1.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 162.38, 159.03, 157.67, 154.22, 144.25, 139.70, 137.63, 131.33, 129.67, 129.29, 128.67, 128.60, 126.89, 121.11, 113.59, 113.41, 111.76, 109.95. Anal. Calcd for C<sub>20</sub>H<sub>14</sub>N<sub>4</sub>O<sub>3</sub>: C, 67.03; H, 3.94; N, 15.63. Found: C, 67.24; H, 4.17; N, 15.41.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 4-((6-Nitro-2-phenylquinazolin-4-yl)amino)benzene-1,2-diol (<b>16</b>)</h5><div class="NLM_p last">The compound was synthesized from a solution of <b>18</b> (4.02 g, 10 mmol) in dry DCM kept at â60 Â°C under moisture exclusion. Boron tribromide was slowly added under stirring via a dropping funnel within 30 min and the cooling bath removed. After another 12 h of stirring at room temperature, the solvent was evaporated under reduced pressure and the obtained solid recrystallized from 75% ethanol to yield <b>16</b> as red solid (3.14 g, 84%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.27 (s, 1H), 9.62 (d, <i>J</i> = 2.5 Hz, 1H), 9.07 (s, 1H), 8.86 (s, 1H), 8.52 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 8.47â8.39 (m, 2H), 7.93 (d, <i>J</i> = 9.2 Hz, 1H), 7.56â7.48 (m, 3H), 7.34 (d, <i>J</i> = 2.5 Hz, 1H), 7.14 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 6.82 (d, <i>J</i> = 8.5 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 162.48, 158.90, 154.19, 145.08, 144.09, 142.75, 137.70, 131.25, 130.22, 129.42, 128.61, 128.59, 126.77, 121.02, 115.24, 114.44, 113.35, 111.57. Anal. Calcd for C<sub>20</sub>H<sub>14</sub>N<sub>4</sub>O<sub>4</sub>: C, 64.17; H, 3.77; N, 14.97. Found: C, 64.15; H, 3.67; N, 14.67.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> <i>N</i>-(3-Methoxyphenyl)-6-nitro-2-phenylquinazolin-4-amine (<b>17</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 3-methoxyaniline (1.23 g, 10 mmol) to yield <b>17</b> as an orange solid (2.20 g, 59%), mp 242â243 Â°C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.42 (s, 1H), 9.66 (d, <i>J</i> = 2.4 Hz, 1H), 8.53 (dd, <i>J</i> = 9.1, 2.4 Hz, 1H), 8.49â8.39 (m, 2H), 7.97 (d, <i>J</i> = 9.1 Hz, 1H), 7.67 (s, 1H), 7.62â7.48 (m, 4H), 7.38 (t, <i>J</i> = 8.1 Hz, 1H), 6.80 (dd, <i>J</i> = 8.1, 2.4 Hz, 1H), 3.83 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) Î´ 162.27, 159.53, 158.98, 154.18, 144.28, 139.95, 137.61, 131.39, 129.73, 129.41, 128.67, 128.47, 126.93, 121.02, 114.87, 113.40, 110.49, 108.09, 55.30. Anal. Calcd for C<sub>21</sub>H<sub>16</sub>N<sub>4</sub>O<sub>3</sub>: C, 67.73; H, 4.33; N, 15.05. Found: C, 67.48; H, 4.25; N, 14.85.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>N</i>-(3,4-Dimethoxyphenyl)-6-nitro-2-phenylquinazolin-4-amine (<b>18</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 3,4-dimethoxyaniline (1.53 g, 10 mmol) to yield <b>18</b> as a red-orange solid (3.10 g, 77%), mp 238â240 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.35 (s, 1H), 9.63 (d, <i>J</i> = 2.5 Hz, 1H), 8.51 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.49â8.42 (m, 2H), 7.94 (d, <i>J</i> = 9.2 Hz, 1H), 7.68 (d, <i>J</i> = 2.5 Hz, 1H), 7.57â7.47 (m, 3H), 7.43 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 7.06 (d, <i>J</i> = 8.7 Hz, 1H), 3.83 (s, 3H), 3.81 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 162.36, 158.78, 154.19, 148.45, 145.98, 144.16, 137.71, 131.99, 131.31, 129.60, 128.60, 128.46, 126.81, 120.91, 114.76, 113.35, 111.85, 107.81, 55.89, 55.66. Anal. Calcd for C<sub>22</sub>H<sub>18</sub>N<sub>4</sub>O<sub>4</sub>: C, 65.66; H, 4.51; N, 13.92. Found: C, 65.74; H, 4.88; N, 13.55.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 3-((6-Nitro-2-phenylquinazolin-4-yl)amino)benzonitrile (<b>19</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 3-aminobenzonitrile (1.18 g, 10 mmol) to yield <b>19</b> as a yellow solid (2.98 g, 81%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.03 (s, 1H), 9.69 (d, <i>J</i> = 2.4 Hz, 1H), 8.59 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.48â8.31 (m, 3H), 8.24 (dt, <i>J</i> = 7.5, 2.1 Hz, 1H), 8.11 (d, <i>J</i> = 9.1 Hz, 1H), 7.78â7.65 (m, 2H), 7.64â7.47 (m, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.54, 159.13, 152.28, 144.68, 139.27, 136.16, 132.05, 130.19, 128.83, 128.70, 128.48, 128.22, 127.67, 127.57, 126.17, 121.14, 118.71, 113.20, 111.57. Anal. Calcd for C<sub>21</sub>H<sub>13</sub>N<sub>5</sub>O<sub>2</sub>: C, 68.66; H, 3.57; N, 19.06. Found: C, 68.70; H, 3.90; N, 18.75.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4-((6-Nitro-2-phenylquinazolin-4-yl)amino)benzonitrile (<b>20</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 4-aminobenzonitrile (1.18 g, 10 mmol) to yield <b>20</b> as a yellow solid (2.53 g, 69%), mp >300 Â°C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.93 (s, 1H), 9.71 (d, <i>J</i> = 2.4 Hz, 1H), 8.60 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.47â8.41 (m, 2H), 8.22â8.14 (m, 2H), 8.08 (d, <i>J</i> = 9.1 Hz, 1H), 7.99â7.92 (m, 2H), 7.61â7.52 (m, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) Î´ 161.79, 159.03, 153.14, 144.64, 143.02, 136.60, 133.08, 131.84, 129.13, 128.88, 128.70, 127.53, 122.69, 121.20, 119.12, 113.45, 106.12. Anal. Calcd for C<sub>21</sub>H<sub>13</sub>N<sub>5</sub>O<sub>2</sub>: C, 68.66; H, 3.57; N, 19.06. Found: C, 68.59; H, 3.80; N, 18.79.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> <i>N</i>-(3-Fluorophenyl)-6-nitro-2-phenylquinazolin-4-amine (<b>21</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 3-fluoroaniline (1.11 g, 10 mmol) to yield <b>21</b> as a yellow solid (3.17 g, 88%), mp 288â289 Â°C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.10 (s, 1H), 9.73 (d, <i>J</i> = 2.5 Hz, 1H), 8.61 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.51â8.36 (m, 2H), 8.18 (d, <i>J</i> = 9.2 Hz, 1H), 7.89 (dt, <i>J</i> = 11.4, 2.3 Hz, 1H), 7.75 (ddd, <i>J</i> = 8.2, 2.0, 0.9 Hz, 1H), 7.67â7.42 (m, 4H), 7.10 (tdd, <i>J</i> = 8.4, 2.5, 0.9 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 162.01 (d, <i>J</i> = 241.9 Hz), 161.25, 159.12, 144.76, 139.82 (d, <i>J</i> = 11.1 Hz), 135.45, 132.28, 130.31 (d, <i>J</i> = 9.4 Hz), 128.86, 127.86, 127.48, 121.23, 118.97, 113.18, 111.73 (d, <i>J</i> = 20.9 Hz), 110.12 (d, <i>J</i> = 26.0 Hz). Anal. Calcd for C<sub>20</sub>H<sub>13</sub>FN<sub>4</sub>O<sub>2</sub>: C, 66.66; H, 3.64; N, 15.55. Found: C, 66.30; H, 3.92; N, 15.30.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 6-Nitro-2-phenyl-<i>N</i>-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>22</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 3-(trifluoromethyl)aniline (1.61 g, 10 mmol) to yield <b>22</b> as a yellow solid (3.08 g, 75%), mp 278â279 Â°C (decomp). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.65 (s, 1H), 9.65 (d, <i>J</i> = 2.4 Hz, 1H), 8.57 (d, <i>J</i> = 2.0 Hz, 1H), 8.54 (dd, <i>J</i> = 9.1, 2.4 Hz, 1H), 8.43 (dt, <i>J</i> = 7.1, 1.4 Hz, 2H), 8.20â8.13 (m, 1H), 7.98 (dd, <i>J</i> = 9.1, 1.8 Hz, 1H), 7.71 (t, <i>J</i> = 8.0 Hz, 1H), 7.59â7.53 (m, 2H), 7.53â7.47 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO) Î´ 162.10, 158.99, 154.15, 144.44, 139.67, 137.40, 131.57, 129.91 (d, <i>J</i> = 5.2 Hz), 129.40 (d, <i>J</i> = 31.6 Hz), 128.71, 128.47, 127.13, 125.94, 124.44 (d, <i>J</i> = 272.5 Hz), 120.98, 120.55 (d, <i>J</i> = 3.7 Hz), 118.99 (d, <i>J</i> = 4.0 Hz), 113.37. Anal. Calcd for C<sub>21</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>: C, 61.47; H, 3.19; N, 13.65. Found: C, 61.77; H, 3.35; N, 13.44.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 2-Nitro-4-((6-nitro-2-phenylquinazolin-4-yl)amino)phenol (<b>23</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 4-amino-2-nitrophenol (1.54 g, 10 mmol) to yield <b>23</b> as an orange-red solid (2.58 g, 64%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.90 (s, 1H), 10.56 (s, 1H), 9.61 (d, <i>J</i> = 2.5 Hz, 1H), 8.80 (d, <i>J</i> = 2.7 Hz, 1H), 8.54 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.51â8.44 (m, 2H), 8.04 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 7.98 (d, <i>J</i> = 9.2 Hz, 1H), 7.60â7.46 (m, 3H), 7.26 (d, <i>J</i> = 9.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 162.19, 158.80, 154.07, 149.22, 144.31, 137.40, 135.70, 131.45, 130.49, 130.16, 129.76, 128.67, 128.57, 127.00, 120.86, 119.39, 118.70, 113.25. Anal. Calcd for C<sub>20</sub>H<sub>13</sub>N<sub>5</sub>O<sub>5</sub>: C, 59.56; H, 3.25; N, 17.36. Found: C, 59.69; H, 3.01; N, 17.22.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> <i>N</i>-(3-((6-Nitro-2-phenylquinazolin-4-yl)amino)phenyl)acetamide (<b>24</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and <i>N</i>-(3-aminophenyl)acetamide (1.50 g, 10 mmol) to yield <b>24</b> as a yellow solid (2.80 g, 70%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.83 (s, 1H), 10.09 (s, 1H), 9.73 (d, <i>J</i> = 2.4 Hz, 1H), 8.60 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 8.54â8.39 (m, 2H), 8.33 (t, <i>J</i> = 2.1 Hz, 1H), 8.08 (d, <i>J</i> = 9.2 Hz, 1H), 7.67â7.47 (m, 4H), 7.41 (t, <i>J</i> = 8.1 Hz, 1H), 7.31 (ddd, <i>J</i> = 8.0, 2.1, 1.0 Hz, 1H), 2.09 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 168.54, 161.74, 159.20, 152.19, 144.58, 139.80, 138.46, 136.12, 131.93, 128.97, 128.76, 128.09, 127.54, 121.33, 118.20, 115.93, 114.17, 113.29, 24.18. Anal. Calcd for C<sub>22</sub>H<sub>17</sub>N<sub>5</sub>O<sub>3</sub>: C, 66.16; H, 4.29; N, 17.53. Found: C, 66.26; H, 4.53; N, 17.25.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 3-((6-Nitro-2-phenylquinazolin-4-yl)amino)benzoic Acid (<b>25</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>8</b> (2.86 g, 10 mmol) and 3-aminobenzoic acid (1.37 g, 10 mmol) to yield <b>25</b> as a yellow solid (2.43 g, 63%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.97 (s, 1H), 9.71 (d, <i>J</i> = 2.5 Hz, 1H), 8.58 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.47â8.35 (m, 2H), 8.14â7.99 (m, 5H), 7.67â7.44 (m, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 167.01, 161.57, 159.04, 152.15, 144.67, 142.47, 136.04, 132.03, 130.16, 128.88, 128.83, 128.30, 127.63, 126.64, 122.28, 121.25, 113.35. Anal. Calcd for C<sub>21</sub>H<sub>14</sub>N<sub>4</sub>O<sub>4</sub>: C, 65.28; H, 3.65; N, 14.50. Found: C, 65.58; H, 3.88; N, 14.29.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> <i>N</i>-(3-Methoxyphenyl)-6-nitro-2-(pyridin-3-yl)quinazolin-4-amine (<b>26</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>9</b> (2.87 g, 10 mmol) and 3-methoxyaniline (1.23 g, 10 mmol) to yield <b>26</b> as a yellow solid (2.17 g, 58%), mp 268â269 Â°C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.38 (s, 1H), 9.56 (d, <i>J</i> = 2.5 Hz, 1H), 9.48â9.44 (m, 1H), 8.67 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.59 (dt, <i>J</i> = 7.8, 2.0 Hz, 1H), 8.46 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 7.88 (d, <i>J</i> = 9.1 Hz, 1H), 7.58 (t, <i>J</i> = 2.2 Hz, 1H), 7.52â7.42 (m, 2H), 7.35 (t, <i>J</i> = 8.1 Hz, 1H), 6.78 (ddd, <i>J</i> = 8.2, 2.5, 0.9 Hz, 1H), 3.81 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 160.63, 159.49, 158.85, 153.77, 151.66, 149.59, 144.39, 139.70, 135.54, 132.91, 129.66, 129.34, 126.89, 123.69, 120.89, 114.95, 113.47, 110.43, 108.29, 55.29. Anal. Calcd for C<sub>20</sub>H<sub>15</sub>N<sub>5</sub>O<sub>3</sub>: C, 64.34; H, 4.05; N, 18.76. Found: C, 64.26; H, 4.16; N, 19.10.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> <i>N</i>-(4-Methoxyphenyl)-6-nitro-2-(pyridin-3-yl)quinazolin-4-amine (<b>27</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>9</b> (2.87 g, 10 mmol) and 4-methoxyaniline (1.23 g, 10 mmol) to yield <b>27</b> as a yellow solid (2.24 g, 60%), mp 269â270 Â°C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.54 (s, 1H), 9.50 (d, <i>J</i> = 2.6 Hz, 1H), 9.47 (dd, <i>J</i> = 2.1, 0.9 Hz, 1H), 8.66 (dd, <i>J</i> = 4.7, 1.7 Hz, 1H), 8.62 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.42 (dd, <i>J</i> = 9.1, 2.5 Hz, 1H), 7.79 (d, <i>J</i> = 9.1 Hz, 1H), 7.75â7.68 (m, 2H), 7.50 (ddd, <i>J</i> = 7.9, 4.7, 0.9 Hz, 1H), 7.08â6.94 (m, 2H), 3.79 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.04, 158.51, 155.77, 154.68, 151.32, 149.68, 143.63, 135.52, 133.70, 128.69, 126.37, 124.72, 123.61, 121.23, 115.36, 113.72, 55.38. Anal. Calcd for C<sub>20</sub>H<sub>15</sub>N<sub>5</sub>O<sub>3</sub>: C, 64.34; H, 4.05; N, 18.76. Found: C, 64.48; H, 4.00; N, 18.39.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> <i>N</i>-(4-Methoxyphenyl)-6-nitro-2-(pyridin-4-yl)quinazolin-4-amine (<b>28</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>10</b> (2.87 g, 10 mmol) and 4-methoxyaniline (1.23 g, 10 mmol) to yield <b>28</b> as an orange-red solid (2.31 g, 62%), mp 297â299 Â°C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.71 (s, 1H), 9.67 (d, <i>J</i> = 2.4 Hz, 1H), 9.02â8.84 (m, 2H), 8.61â8.48 (m, 3H), 8.03 (dd, <i>J</i> = 9.1, 1.2 Hz, 1H), 7.83â7.69 (m, 2H), 7.06 (dq, <i>J</i> = 9.4, 2.6, 1.8 Hz, 2H), 3.82 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 159.30, 158.77, 156.69, 153.35, 150.11, 145.36, 145.24, 130.91, 129.98, 127.32, 124.79, 124.06, 121.01, 114.05, 113.97, 55.42. Anal. Calcd for C<sub>20</sub>H<sub>15</sub>N<sub>5</sub>O<sub>3</sub>: C, 64.34; H, 4.05; N, 18.76. Found: C, 64.56; H, 4.27; N, 18.49.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 3-((6-Nitro-2-(pyridin-4-yl)quinazolin-4-yl)amino)benzonitrile (<b>29</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>10</b> (2.87 g, 10 mmol) and 3-aminobenzonitrile (1.18 g, 10 mmol) to yield <b>29</b> as a yellow solid (2.65 g, 72%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.97 (s, 1H), 9.67 (d, <i>J</i> = 2.4 Hz, 1H), 8.98â8.92 (m, 2H), 8.59 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.55â8.49 (m, 2H), 8.28 (q, <i>J</i> = 1.4 Hz, 1H), 8.27â8.20 (m, 1H), 8.05 (d, <i>J</i> = 9.1 Hz, 1H), 7.72â7.67 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 159.40, 158.49, 153.32, 149.88, 145.51, 145.40, 139.14, 130.33, 130.25, 128.34, 127.66, 126.09, 124.07, 121.03, 118.67, 114.02, 111.67. Anal. Calcd for C<sub>22</sub>H<sub>14</sub>N<sub>6</sub>O<sub>2</sub>: C, 65.21; H, 3.28; N, 22.82. Found: C, 65.43; H, 3.49; N, 22.44.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 6-Nitro-<i>N</i>-phenyl-2-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>30</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and aniline (0.93 g, 10 mmol) to yield <b>30</b> as a yellow solid (3.08 g, 75%), mp 238â240 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.56 (s, 1H), 9.63 (d, <i>J</i> = 2.5 Hz, 1H), 8.68 (dq, <i>J</i> = 1.4, 0.8 Hz, 1H), 8.64 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 8.53 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 7.98 (d, <i>J</i> = 9.2 Hz, 1H), 7.92â7.84 (m, 3H), 7.80â7.68 (m, 1H), 7.53â7.40 (m, 2H), 7.31â7.20 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 160.63, 159.11, 153.96, 144.53, 138.52, 138.42, 132.01, 129.97, 129.79, 129.51 (d, <i>J</i> = 31.7 Hz), 129.13, 128.56, 127.66 (d, <i>J</i> = 3.3 Hz), 127.52, 127.03, 125.35, 124.86, 124.71 (d, <i>J</i> = 3.9 Hz), 123.13, 120.99, 113.55. Anal. Calcd for C<sub>21</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>: C, 61.71; H, 3.29; N, 13.31. Found: C, 61.47; H, 3.19; N, 13.65.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 3-((6-Nitro-2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl)amino)phenol (<b>31</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and 3-aminophenol (1.09 g, 10 mmol) to yield <b>31</b> as a yellow solid (3.54 g, 83%), mp 275â278 Â°C (decomp.). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.64 (s, 1H), 9.68 (d, <i>J</i> = 2.6 Hz, 1H), 8.55 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.46 (ddd, <i>J</i> = 6.4, 3.1, 1.4 Hz, 2H), 8.20â8.09 (m, 2H), 8.11â8.03 (m, 2H), 8.00 (d, <i>J</i> = 9.2 Hz, 1H), 7.65â7.48 (m, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 165.49, 162.17, 158.92, 154.15, 144.43, 143.31, 137.35, 131.46, 130.01, 129.85, 128.80, 128.57, 127.10, 125.07, 121.73, 121.08, 113.46. Anal. Calcd for C<sub>21</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub>: C, 59.16; H, 3.07; N, 13.14. Found: C, 59.29; H, 3.30; N, 12.88.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> <i>N</i>-(3-Methoxyphenyl)-6-nitro-2-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>32</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and 3-methoxyaniline (1.23 g, 10 mmol) to yield <b>32</b> as a yellow solid (3.21 g, 73%), mp 207â209 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.48 (s, 1H), 9.62 (d, <i>J</i> = 2.5 Hz, 1H), 8.71â8.63 (m, 2H), 8.52 (dd, <i>J</i> = 9.1, 2.5 Hz, 1H), 7.98 (d, <i>J</i> = 9.2 Hz, 1H), 7.92â7.85 (m, 1H), 7.75 (tt, <i>J</i> = 7.5, 0.8 Hz, 1H), 7.60 (t, <i>J</i> = 2.2 Hz, 1H), 7.47 (ddd, <i>J</i> = 8.0, 2.0, 0.9 Hz, 1H), 7.36 (t, <i>J</i> = 8.1 Hz, 1H), 6.81 (ddd, <i>J</i> = 8.2, 2.5, 0.9 Hz, 1H), 3.81 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 160.63, 159.56, 159.06, 153.91, 144.56, 139.65, 138.57, 132.04, 129.94, 129.82, 129.55 (d, <i>J</i> = 31.8 Hz), 129.29, 129.17, 127.72, 127.69, 127.04, 125.35, 124.69, 124.66, 123.19, 120.96, 115.09, 113.59, 110.62, 108.51, 55.27. Anal. Calcd for C<sub>22</sub>H<sub>15</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub>: C, 60.00; H, 3.43; N, 12.72. Found: C, 59.99; H, 3.34; N, 12.34.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> <i>N</i>-(3,4-Dimethoxyphenyl)-6-nitro-2-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>33</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and 3,4-dimethoxyaniline (1.53 g, 10 mmol) to yield <b>33</b> as a red solid (2.78 g, 59%), mp 217â218 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.45 (s, 1H), 9.59 (d, <i>J</i> = 2.4 Hz, 1H), 8.69â8.59 (m, 2H), 8.50 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 7.95 (d, <i>J</i> = 9.2 Hz, 1H), 7.92â7.83 (m, 1H), 7.78â7.70 (m, 1H), 7.60 (d, <i>J</i> = 2.4 Hz, 1H), 7.35 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.02 (d, <i>J</i> = 8.7 Hz, 1H), 3.81 (s, 3H), 3.80 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 160.66, 158.88, 153.68, 148.51, 146.22, 144.45, 138.56, 132.09, 131.62, 129.89, 129.53, 129.47 (d, <i>J</i> = 31.8 Hz), 127.69, 127.66, 127.52, 126.96, 124.59 (d, <i>J</i> = 3.7 Hz), 124.28 (d, <i>J</i> = 272.4 Hz), 120.87, 115.10, 113.52, 111.70, 107.98, 55.88, 55.60. Anal. Calcd for C<sub>23</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub>: C, 58.73; H, 3.64; N, 11.91. Found: C, 58.53; H, 3.63; N, 11.58.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> <i>N</i>-(3-(Methylthio)phenyl)-6-nitro-2-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>34</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and 3-(methylthio)aniline (1.39 g, 10 mmol) to yield <b>34</b> as a orange solid (3.56 g, 78%), mp 209â211 Â°C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.48 (s, 1H), 9.58 (d, <i>J</i> = 2.5 Hz, 1H), 8.68â8.61 (m, 2H), 8.50 (dd, <i>J</i> = 9.1, 2.4 Hz, 1H), 7.96 (d, <i>J</i> = 9.1 Hz, 1H), 7.90â7.83 (m, 2H), 7.76â7.70 (m, 1H), 7.66 (ddd, <i>J</i> = 8.1, 2.1, 0.9 Hz, 1H), 7.39 (t, <i>J</i> = 7.9 Hz, 1H), 7.12 (ddd, <i>J</i> = 7.9, 1.9, 0.9 Hz, 1H), 2.51 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) Î´ 160.55, 159.03, 153.87, 144.53, 139.01, 138.64, 138.49, 132.06, 129.89, 129.82, 129.56 (d, <i>J</i> = 31.8 Hz), 129.03, 127.76, 127.05, 125.16, 124.61 (d, <i>J</i> = 4.0 Hz), 123.35, 122.17, 120.91, 120.12, 119.36, 113.54, 14.94. Anal. Calcd for C<sub>22</sub>H<sub>15</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>S: C, 57.89; H, 3.31; N, 12.27. Found: C, 57.99; H, 3.25; N, 12.03.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> <i>N</i>-(3-Fluorophenyl)-6-nitro-2-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>35</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and 3-fluoroaniline (1.11 g, 10 mmol) to yield <b>35</b> as a yellow solid (3.47 g, 81%), mp 238â239 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.52 (s, 1H), 9.54 (d, <i>J</i> = 2.5 Hz, 1H), 8.61 (td, <i>J</i> = 1.7, 0.8 Hz, 1H), 8.59 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 8.48 (dd, <i>J</i> = 9.1, 2.5 Hz, 1H), 7.98â7.82 (m, 3H), 7.77â7.68 (m, 1H), 7.65 (ddd, <i>J</i> = 8.1, 2.0, 0.9 Hz, 1H), 7.46 (td, <i>J</i> = 8.2, 6.8 Hz, 1H), 7.04 (tdd, <i>J</i> = 8.4, 2.6, 0.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 163.02, 161.10, 160.41, 158.86, 153.76, 144.55, 140.25 (d, <i>J</i> = 11.0 Hz), 138.30, 131.89, 130.08, 130.01, 129.92, 129.84, 129.67, 129.42, 129.16, 127.72, 127.69, 127.47, 127.04, 125.30, 124.65 (d, <i>J</i> = 3.9 Hz), 123.14, 120.81, 118.32 (d, <i>J</i> = 2.3 Hz), 113.43, 111.05 (d, <i>J</i> = 21.0 Hz), 109.62 (d, <i>J</i> = 26.2 Hz). Anal. Calcd for C<sub>21</sub>H<sub>12</sub>F<sub>4</sub>N<sub>4</sub>O<sub>2</sub>: C, 58.88; H, 2.82; N, 13.08. Found: C, 58.91; H, 2.73; N, 12.81.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 6-Nitro-<i>N</i>-(3-nitrophenyl)-2-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>36</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and 3-nitroaniline (1.38 g, 10 mmol) to yield <b>36</b> as a yellow solid (3.92 g, 86%), mp 278â279 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.87 (s, 1H), 9.69 (s, 1H), 9.10 (d, <i>J</i> = 2.6 Hz, 1H), 8.74 (d, <i>J</i> = 16.3 Hz, 2H), 8.63â8.56 (m, 1H), 8.30 (d, <i>J</i> = 8.2 Hz, 1H), 8.08 (t, <i>J</i> = 8.1 Hz, 2H), 7.93 (d, <i>J</i> = 8.0 Hz, 1H), 7.77 (q, <i>J</i> = 8.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 160.46, 159.11, 153.84, 147.92, 144.79, 138.27, 132.17, 130.07, 129.98, 128.39, 127.89, 127.35, 124.65, 120.93, 118.85, 116.87. Anal. Calcd for C<sub>21</sub>H<sub>12</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub>: C, 55.39; H, 2.66; N, 15.38. Found: C, 55.35; H, 2.61; N, 15.08.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 6-Nitro-<i>N</i>-(4-nitrophenyl)-2-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>37</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and 4-nitroaniline (1.38 g, 10 mmol) to yield <b>37</b> as a bright-yellow solid (3.23 g, 71%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.86 (s, 1H), 9.63 (d, <i>J</i> = 2.4 Hz, 1H), 8.68 (s, 1H), 8.66 (d, <i>J</i> = 7.9 Hz, 1H), 8.57 (dd, <i>J</i> = 9.1, 2.5 Hz, 1H), 8.36â8.30 (m, 2H), 8.25â8.19 (m, 2H), 8.05 (d, <i>J</i> = 9.2 Hz, 1H), 7.91 (d, <i>J</i> = 7.7 Hz, 1H), 7.80 (q, <i>J</i> = 8.3, 7.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 160.41, 158.98, 153.87, 145.14, 144.84, 142.85, 138.11, 132.24, 130.25, 130.09, 129.73, 129.48, 127.92, 127.89, 127.41, 124.69, 124.66, 124.54, 123.17, 122.09, 121.00, 120.32, 120.27, 113.76. Anal. Calcd for C<sub>21</sub>H<sub>12</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub>: C, 55.39; H, 2.66; N, 15.38. Found: C, 55.42; H, 2.67; N, 15.12.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 2-Nitro-4-((6-nitro-2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl)amino)phenol (<b>38</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and 4-amino-2-nitrophenol (1.54 g, 10 mmol) to yield <b>38</b> as a yellow solid (3.25 g, 69%), mp 280â281 Â°C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.89 (s, 1H), 10.50 (s, 1H), 9.49 (d, <i>J</i> = 2.5 Hz, 1H), 8.66â8.57 (m, 3H), 8.46 (dd, <i>J</i> = 9.1, 2.4 Hz, 1H), 7.97 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 7.91 (d, <i>J</i> = 9.1 Hz, 1H), 7.85 (ddt, <i>J</i> = 7.7, 1.9, 1.0 Hz, 1H), 7.73â7.66 (m, 1H), 7.20 (d, <i>J</i> = 9.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 160.45, 158.71, 153.68, 149.33, 144.48, 138.27, 135.57, 132.08, 130.15, 130.12, 129.81 (d, <i>J</i> = 3.5 Hz), 129.67, 129.41, 127.71, 127.69, 126.98, 124.61, 124.58, 124.21 (d, <i>J</i> = 272.4 Hz), 120.69, 119.19, 118.72, 113.34. Anal. Calcd for C<sub>21</sub>H<sub>12</sub>F<sub>3</sub>N<sub>5</sub>O<sub>5</sub>: C, 53.51; H, 2.57; N, 14.86. Found: C, 53.75; H, 2.61; N, 14.59.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> <i>N</i>-(3-((6-Nitro-2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl)amino)phenyl)acetamide (<b>39</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>11</b> (3.54 g, 10 mmol) and <i>N</i>-(3-aminophenyl)acetamide (1.50 g, 10 mmol) to yield <b>39</b> as a yellow solid (2.85 g, 61%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.63 (s, 1H), 10.04 (s, 1H), 9.68 (d, <i>J</i> = 2.5 Hz, 1H), 8.80â8.63 (m, 2H), 8.55 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 8.43 (t, <i>J</i> = 2.1 Hz, 1H), 8.01 (d, <i>J</i> = 9.1 Hz, 1H), 7.89 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.75 (t, <i>J</i> = 7.8 Hz, 1H), 7.53 (ddd, <i>J</i> = 8.0, 2.2, 1.1 Hz, 1H), 7.37 (t, <i>J</i> = 8.0 Hz, 1H), 7.29 (ddd, <i>J</i> = 8.0, 2.1, 1.1 Hz, 1H), 2.07 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 168.46, 160.66, 159.16, 153.79, 144.58, 139.76, 138.62, 138.32, 132.32, 129.91, 129.62, 129.39, 129.14, 128.55, 127.75, 127.73, 127.12, 125.02, 124.99, 124.28 (d, <i>J</i> = 272.3 Hz), 121.14, 117.85, 115.55, 114.05, 113.58, 24.10. Anal. Calcd for C<sub>23</sub>H<sub>16</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub>: C, 59.10; H, 3.45; N, 14.98. Found: C, 59.42; H, 3.59; N, 14.73.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 4-((2-(3-Methoxyphenyl)-6-nitroquinazolin-4-yl)amino)benzonitrile (<b>40</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>12</b> (3.16 g, 10 mmol) and 4-aminobenzonitrile (1.18 g, 10 mmol) to yield <b>40</b> as a yellow solid (2.34 g, 59%), mp 184â186 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.63 (s, 1H), 9.56 (d, <i>J</i> = 2.4 Hz, 1H), 8.50 (dt, <i>J</i> = 9.0, 2.8 Hz, 1H), 8.20â8.11 (m, 2H), 7.99â7.92 (m, 2H), 7.91â7.87 (m, 3H), 7.40 (t, <i>J</i> = 7.9 Hz, 1H), 7.09 (ddd, <i>J</i> = 8.2, 2.7, 0.9 Hz, 1H), 3.83 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.71, 159.53, 158.73, 154.03, 144.44, 143.21, 138.64, 132.93, 129.90, 129.81, 127.11, 122.36, 120.96, 120.91, 119.15, 117.66, 113.42, 113.05, 105.82, 55.20. Anal. Calcd for C<sub>22</sub>H<sub>15</sub>N<sub>5</sub>O<sub>3</sub>: C, 66.49; H, 3.80; N, 17.62. Found: C, 66.24; H, 4.00; N, 17.33.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> <i>N</i>-(3-Fluorophenyl)-2-(3-methoxyphenyl)-6-nitroquinazolin-4-amine (<b>41</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>12</b> (3.16 g, 10 mmol) and 3-fluoroaniline (1.11 g, 10 mmol) to yield <b>41</b> as a yellow-orange solid (3.44 g, 88%), mp 276â277 Â°C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.51 (s, 1H), 9.61 (d, <i>J</i> = 2.5 Hz, 1H), 8.51 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 8.05â7.91 (m, 4H), 7.71 (ddd, <i>J</i> = 8.3, 2.0, 0.9 Hz, 1H), 7.49 (td, <i>J</i> = 8.3, 6.9 Hz, 1H), 7.42 (t, <i>J</i> = 7.9 Hz, 1H), 7.10 (ddd, <i>J</i> = 8.2, 2.8, 1.0 Hz, 1H), 7.03 (tdd, <i>J</i> = 8.4, 2.6, 0.9 Hz, 1H), 3.83 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 162.07 (d, <i>J</i> = 241.3 Hz), 161.84, 159.53, 158.80, 154.04, 144.34, 140.53 (d, <i>J</i> = 11.1 Hz), 138.88, 130.13 (d, <i>J</i> = 9.4 Hz), 129.81, 129.74, 126.96, 120.91, 120.82, 118.26, 118.24, 117.70, 113.32, 112.96, 110.83 (d, <i>J</i> = 21.1 Hz), 109.47 (d, <i>J</i> = 26.2 Hz), 55.08. Anal. Calcd for C<sub>21</sub>H<sub>15</sub>FN<sub>4</sub>O<sub>3</sub>: C, 64.61; H, 3.87; N, 14.35. Found: C, 64.84; H, 3.93; N, 14.23.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 2-(3,4-Dimethoxyphenyl)-6-nitro-<i>N</i>-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>42</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>14</b>â<b>42</b> from <b>13</b> (3.46 g, 10 mmol) and 3-(trifluoromethyl)aniline (1.61 g, 10 mmol) to yield <b>42</b> as a orange solid (3.39 g, 72%), mp >300 Â°C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.63 (s, 1H), 9.64 (d, <i>J</i> = 2.4 Hz, 1H), 8.54 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.41 (d, <i>J</i> = 2.0 Hz, 1H), 8.31â8.23 (m, 1H), 8.07 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 8.01 (d, <i>J</i> = 2.0 Hz, 1H), 7.97 (d, <i>J</i> = 9.1 Hz, 1H), 7.72 (t, <i>J</i> = 8.0 Hz, 1H), 7.55 (d, <i>J</i> = 7.9 Hz, 1H), 7.08 (d, <i>J</i> = 8.5 Hz, 1H), 3.85 (s, 3H), 3.84 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 161.85, 158.65, 154.21, 152.00, 148.67, 143.93, 139.69, 129.79, 129.74, 129.51, 126.94, 126.09, 125.46, 123.29, 122.15, 120.91, 120.49 (d, <i>J</i> = 3.5 Hz), 118.73 (d, <i>J</i> = 3.8 Hz), 112.94, 111.36, 55.74, 55.38. Anal. Calcd for C<sub>23</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub>: C, 58.73; H, 3.64; N, 11.91. Found: C, 58.79; H, 3.92; N, 11.65.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> General Procedure for the Preparation of Compounds <b>43</b>â<b>47</b></h4><div class="NLM_p">The corresponding 2- and 4-substituted 6-nitroquinazoline derivative (1 mmol) was dissolved in dry THF (200 mL) and added to a pressure vessel together with 1% (by weight of the educt) of Pd activated charcoal. After evacuating and flushing the vessel with N<sub>2</sub> three times, it was pressurized with hydrogen gas (4 bar) and sealed. The mixture was stirred for 24 h at room temperature until completion of the reaction as indicated by TLC. Charcoal was removed by several filtration cycles and the remaining solvent evaporated under reduced pressure to obtain the corresponding compound as a solid product. Purification was carried out by column chromatography using DCM and methanol as eluent.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> <i>N</i>4-(3-Methoxyphenyl)-2-(pyridin-3-yl)quinazoline-4,6-diamine (<b>43</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>43</b>â<b>47</b> from <b>26</b> (3.73 g, 10 mmol) to yield <b>43</b> as a yellow solid (1.65 g, 45%), mp 209â211 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.50 (dd, <i>J</i> = 2.1, 0.9 Hz, 1H), 9.44 (s, 1H), 8.68â8.57 (m, 2H), 7.72 (t, <i>J</i> = 2.3 Hz, 1H), 7.64 (d, <i>J</i> = 8.8 Hz, 1H), 7.56â7.52 (m, 1H), 7.49 (ddd, <i>J</i> = 7.9, 4.8, 0.9 Hz, 1H), 7.41 (d, <i>J</i> = 2.4 Hz, 1H), 7.33 (d, <i>J</i> = 8.2 Hz, 1H), 7.31â7.25 (m, 1H), 6.69 (ddd, <i>J</i> = 8.2, 2.5, 0.9 Hz, 1H), 5.65 (s, 2H), 3.81 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 159.53, 156.25, 152.87, 150.10, 148.73, 147.73, 143.12, 141.26, 134.36, 134.31, 129.28, 125.01, 124.04, 123.60, 115.91, 113.89, 108.86, 107.15, 101.49, 55.17. Anal. Calcd for C<sub>20</sub>H<sub>17</sub>N<sub>5</sub>O: C, 69.96; H, 4.99; N, 20.40. Found: C, 69.83; H, 5.21; N, 20.47.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> <i>N</i>4-(4-Methoxyphenyl)-2-(pyridin-3-yl)quinazoline-4,6-diamine (<b>44</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>43</b>â<b>47</b> from <b>27</b> (3.73 g, 10 mmol) to yield <b>44</b> as a yellow solid (2.13 g, 62%), mp 202â203 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.45 (d, <i>J</i> = 2.1 Hz, 1H), 9.39 (s, 1H), 8.63â8.54 (m, 2H), 7.86â7.75 (m, 2H), 7.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 7.40 (d, <i>J</i> = 2.4 Hz, 1H), 7.25 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.07â6.95 (m, 2H), 5.60 (s, 2H), 3.79 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 156.46, 155.47, 153.04, 149.97, 148.75, 147.55, 142.90, 139.28, 134.36, 132.88, 129.15, 125.01, 123.69, 123.54, 115.72, 113.74, 101.63, 55.36. Anal. Calcd for C<sub>20</sub>H<sub>17</sub>N<sub>5</sub>O: C, 69.96; H, 4.99; N, 20.40. Found: C, 70.16; H, 5.32; N, 20.56.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> <i>N</i>4-Phenyl-2-(3-(trifluoromethyl)phenyl)quinazoline-4,6-diamine (<b>45</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>43</b>â<b>47</b> from <b>30</b> (4.10 g, 10 mmol) to yield <b>45</b> as a beige solid (2.40 g, 63%), mp 191â192 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.50 (s, 1H), 8.67 (d, <i>J</i> = 1.7 Hz, 1H), 8.62 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.96â7.90 (m, 2H), 7.80â7.74 (m, 1H), 7.75â7.68 (m, 1H), 7.66 (d, <i>J</i> = 8.8 Hz, 1H), 7.45â7.37 (m, 3H), 7.28 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 7.12 (tt, <i>J</i> = 7.4, 1.2 Hz, 1H), 5.66 (s, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 156.36, 153.02, 147.79, 143.11, 140.02, 139.96, 130.84, 129.71, 129.35 (d, <i>J</i> = 31.5 Hz), 129.35, 128.42, 125.77 (d, <i>J</i> = 3.5 Hz), 125.58, 124.05, 123.57 (d, <i>J</i> = 3.8 Hz), 123.25, 122.00, 115.90, 101.52. Anal. Calcd for C<sub>21</sub>H<sub>15</sub>F<sub>3</sub>N<sub>4</sub>: C, 66.31; H, 3.98; N, 14.73. Found: C, 66.42; H, 4.07; N, 14.45.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> 3-((6-Amino-2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl)amino)phenol (<b>46</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>43</b>â<b>47</b> from <b>31</b> (4.26 g, 10 mmol) to yield <b>46</b> as a yellow solid (2.89 g, 73%), mp 190â192 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.72 (s, 1H), 8.42â8.36 (m, 2H), 8.21â8.13 (m, 2H), 8.04â7.99 (m, 2H), 7.65 (d, <i>J</i> = 8.9 Hz, 1H), 7.54â7.47 (m, 2H), 7.47â7.38 (m, 2H), 7.30 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 5.66 (s, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 165.65, 155.88, 154.46, 147.57, 144.96, 143.68, 138.77, 130.03, 129.50, 129.30, 128.53, 127.34, 124.37, 123.37, 120.23, 115.87, 101.34. Anal. Calcd for C<sub>21</sub>H<sub>15</sub>F<sub>3</sub>N<sub>4</sub>O: C, 63.63; H, 3.81; N, 14.14. Found: C, 63.49; H, 4.14; N, 14.08.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> <i>N</i>4-(3-Methoxyphenyl)-2-(3-(trifluoromethyl)phenyl)quinazoline-4,6-diamine (<b>47</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>43</b>â<b>47</b> from <b>32</b> (4.40 g, 10 mmol) to yield <b>47</b> as a beige solid (2.42 g, 59%), mp 203â205 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.46 (s, 1H), 8.71â8.61 (m, 2H), 7.81â7.75 (m, 1H), 7.74â7.68 (m, 2H), 7.66 (d, <i>J</i> = 8.9 Hz, 1H), 7.50 (ddd, <i>J</i> = 8.1, 2.0, 0.9 Hz, 1H), 7.41 (d, <i>J</i> = 2.4 Hz, 1H), 7.33â7.26 (m, 2H), 6.69 (ddd, <i>J</i> = 8.2, 2.5, 0.9 Hz, 1H), 5.67 (s, 2H), 3.80 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 159.54, 156.27, 152.97, 147.80, 143.08, 141.20, 140.04, 130.86, 129.65, 129.50, 129.35, 129.24, 129.10, 127.71, 125.80, 125.55, 124.07, 123.50, 123.38, 115.95, 113.95, 108.99, 107.22, 101.46, 55.11. Anal. Calcd for C<sub>22</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>O: C, 64.39; H, 4.18; N, 13.65. Found: C, 64.32; H, 4.29; N, 13.40.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> General Procedure for the Preparation of Compounds <b>48</b>â<b>51</b></h4><div class="NLM_p">The corresponding 6-amino-derivative <b>43</b> or <b>44</b> (10 mmol) was dissolved in a solution of 20 mL TAM in 80 mL of THF under nitrogen in a Schlenk flask. The temperature was adjusted with a cooling bath to 0 Â°C and a solution of two (20 mmol) or one equivalent (10 mmol) of the corresponding acid chloride in THF added dropwise, respectively. After 30 min, the cooling bath was removed and the solution was stirred for further 6â12 h. Completion of the reaction was monitored by TLC and the excess THF removed under reduced pressure. Water was added to the mixture until precipitation of the product was visible. The formed precipitate was then filtered with suction and washed thoroughly with water. Recrystallization of the product was carried out with MeOH/H<sub>2</sub>O to yield compounds <b>48</b>â<b>51</b>.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> (<i>E</i>)-Acetic (<i>E</i>)-<i>N</i>-(4-((3-Methoxyphenyl)amino)-2-(pyridin-3-yl)quinazolin-6-yl)acetimidic Anhydride (<b>48</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>48</b>â<b>51</b> from <b>43</b> (4.28 g, 10 mmol) and acetyl chloride (0.78 g, 20 mmol) to yield <b>48</b> as a beige-white solid (3.16 g, 74%), mp 242â244 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.50 (s, 1H), 9.56 (s, 1H), 8.77â8.67 (m, 2H), 8.60 (d, <i>J</i> = 2.3 Hz, 1H), 8.17â8.08 (m, 2H), 7.58 (dd, <i>J</i> = 7.7, 5.0 Hz, 1H), 7.52â7.46 (m, 2H), 7.04â6.96 (m, 2H), 3.74 (s, 3H), 2.15 (s, 3H), 2.10 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 170.67, 169.36, 162.31, 158.82, 156.77, 151.46, 149.33, 149.09, 139.44, 135.17, 133.36, 132.55, 129.45, 128.62, 124.03, 120.74, 114.87, 111.37, 55.49, 24.32, 22.98. Anal. Calcd for C<sub>24</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub>: C, 67.44; H, 4.95; N; 16.38. Found: C, 67.72; H, 5.20; N; 16.07.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> <i>N</i>-(4-((3-Methoxyphenyl)amino)-2-(pyridin-3-yl)quinazolin-6-yl)-3-nitrobenzamide (<b>49</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>48</b>â<b>51</b> from <b>43</b> (4.28 g, 10 mmol) and 3-nitrobenzoyl chloride (1.86 g, 10 mmol) to yield <b>49</b> as a beige-white solid (3.99 g, 81%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.97 (s, 1H), 9.97 (s, 1H), 9.55 (d, <i>J</i> = 1.9 Hz, 1H), 8.98â8.84 (m, 2H), 8.68 (td, <i>J</i> = 6.9, 5.8, 1.9 Hz, 2H), 8.56â8.42 (m, 2H), 8.10 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.94 (d, <i>J</i> = 8.8 Hz, 1H), 7.89 (t, <i>J</i> = 8.0 Hz, 1H), 7.67 (t, <i>J</i> = 2.3 Hz, 1H), 7.59â7.50 (m, 2H), 7.36 (t, <i>J</i> = 8.1 Hz, 1H), 6.75 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 3.82 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 163.56, 159.52, 157.89, 156.81, 150.94, 149.21, 148.00, 147.77, 140.64, 136.43, 135.92, 135.00, 134.30, 133.77, 130.53, 129.31, 128.78, 128.76, 126.57, 123.71, 122.51, 114.55, 114.51, 109.63, 107.84, 55.22. Anal. Calcd for C<sub>27</sub>H<sub>20</sub>N<sub>6</sub>O<sub>4</sub>: C, 65.85; H, 4.09; N; 17.06. Found: C, 65.73; H, 4.37 N; 17.03.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> <i>N</i>-(4-((4-Methoxyphenyl)amino)-2-(pyridin-3-yl)quinazolin-6-yl)-3-nitrobenzamide (<b>50</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>48</b>â<b>51</b> from <b>44</b> (4.28 g, 10 mmol) and 3-nitrobenzoyl chloride (1.86 g, 10 mmol) to yield <b>50</b> as a yellow solid (3.35 g, 68%), mp >300 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.03 (s, 1H), 9.96 (s, 1H), 9.50 (d, <i>J</i> = 2.1 Hz, 1H), 8.93 (s, 1H), 8.90 (s, 1H), 8.67â8.62 (m, 2H), 8.51 (s, 1H), 8.48 (d, <i>J</i> = 8.2 Hz, 1H), 8.09 (d, <i>J</i> = 8.9 Hz, 1H), 7.90 (d, <i>J</i> = 8.7 Hz, 2H), 7.81 (d, <i>J</i> = 8.4 Hz, 2H), 7.55â7.48 (m, 1H), 7.04 (d, <i>J</i> = 8.5 Hz, 2H), 3.80 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 163.51, 158.01, 156.92, 155.93, 150.81, 149.22, 148.00, 147.62, 136.30, 135.96, 135.01, 134.31, 133.85, 132.24, 130.49, 128.63, 128.50, 126.53, 124.30, 123.66, 122.55, 114.57, 114.37, 113.79, 55.38. Anal. Calcd for C<sub>27</sub>H<sub>20</sub>N<sub>6</sub>O<sub>4</sub>: C, 65.85; H, 4.09; N, 17.06. Found: C, 65.61; H, 4.44; N, 16.77.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> <i>N</i>-(4-((3-Methoxyphenyl)amino)-2-(pyridin-3-yl)quinazolin-6-yl)-3-nitrobenzamide (<b>51</b>)</h5><div class="NLM_p last">The compound was synthesized according to the general procedure for compounds <b>48</b>â<b>51</b> from <b>43</b> (4.28 g, 10 mmol) and nicotinoyl chloride (1.42 g, 10 mmol) to yield <b>51</b> as a yellow solid (2.56 g, 57%), mp 204â206 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.96 (s, 1H), 9.55 (d, <i>J</i> = 2.0 Hz, 1H), 9.21 (d, <i>J</i> = 2.3 Hz, 1H), 8.94 (d, <i>J</i> = 2.2 Hz, 1H), 8.80 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.75â8.65 (m, 2H), 8.39 (dt, <i>J</i> = 7.8, 2.1 Hz, 1H), 8.05 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.93 (d, <i>J</i> = 8.9 Hz, 1H), 7.67 (t, <i>J</i> = 2.3 Hz, 1H), 7.62 (ddd, <i>J</i> = 7.9, 4.8, 0.9 Hz, 1H), 7.58â7.51 (m, 2H), 7.36 (t, <i>J</i> = 8.1 Hz, 1H), 6.80â6.70 (m, 1H), 3.82 (d, <i>J</i> = 0.8 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) Î´ 164.29, 159.54, 157.90, 156.75, 152.53, 150.94, 149.22, 148.86, 147.70, 140.69, 136.59, 135.59, 135.00, 133.80, 130.26, 129.31, 128.79, 128.64, 123.78, 123.73, 114.58, 114.55, 114.25, 109.63, 107.86, 55.24. Anal. Calcd for C<sub>26</sub>H<sub>20</sub>N<sub>6</sub>O<sub>2</sub>: C, 69.63; H, 4.50; N, 18.74. Found: C, 69.91; H, 4.77; N, 18.36.</div></div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Biological Investigations</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Materials for Biological Investigation</h4><div class="NLM_p">All chemicals were purchased from Sigma-Aldrich (Taufkirchen, Germany) besides compound <b>59</b> (Ko143) ((3<i>S</i>,6<i>S</i>,12a<i>S</i>)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1â²,2â²:1,6]pyrido[3,4-<i>b</i>]indole-3-propanoicacid-1,1-dimethylethyl ester), which was purchased from Tocris Bioscience (Bristol, United Kingdom).</div><div class="NLM_p last">All assays performed with cells were carried out with 10 mM stock solutions of the test compound in DMSO. KrebsâHEPES buffer (KHB) was prepared from a solution of 118.6 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO<sub>4</sub>, 2.5 mM CaCl, and 11.7 mM <span class="smallcaps smallerCapital">d</span>-glucose monohydrate with addition of 10.0 mM HEPES in doubly distilled water. The pH of the solution was adjusted by an aqueous 4 N NaOH solution at 37 Â°C and sterilized by using a 0.2 Î¼M membrane filter.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Cell Culture</h4><div class="NLM_p last">MDCK II BCRP cells were generated by transfection of the canine kidney epithelial cell line MDCK II with human wild-type cDNA C-terminally linked to the cDNA of the green fluorescent protein (GFP) and were a kind gift of Dr. A. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands). Culturing of those cells was carried out with Dulbeccoâs Modified Eagleâs Medium (DMEM) containing 10% fetal calf serum (FCS), 50 Î¼g/mL streptomycin, 50 U/mL penicillin G, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine. Furthermore, the human ovarian carcinoma cell line A2780adr was purchased from European Collection of Animal Cell Culture (ECACC, no. 93112520) with an overexpression of P-gp and resistance against doxorubicin. For culturing RPMI-1640 medium supplemented with 20% FCS, 50 Î¼g/mL streptomycin, 50 U/mL penicillin G, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine was used. By treatment with doxorubicin every 10 passages for less than 40 passages the overexpression of P-gp was sustained. Moreover, small cell lung cancer cell line H69AR with overexpression of MRP1 was purchased from American Type Culture Collection (ATCC, CRL-11351). Culture of the cells was performed in RPMI 1640 medium enriched with 20% FCS, 50 mg/mL streptomycin, 50 U/mL penicillin G, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine and stored under a 5% CO<sub>2</sub> humidified atmosphere at 37 Â°C. Cells were harvested at a confluence of 80â90% and the subculturing of cells performed with 0.05% Trypsin and 0.02% EDTA. To remove excess medium cell were washed with PBS prior to trypsination. The detached cells were collected with medium and centrifuged in a 50 mL falcon (266<i>g</i>, 4 Â°C, 4 min). Excess liquid was removed by suction followed by resuspension of the obtained cell pellet in fresh medium. Measurement of the cell density for all cells was carried out with a CASY1 model TT cell counter equipped with a 150 Î¼M capillary (Schaerfe System GmbH, Reutlingen, Germany). Before using the cells in the corresponding assay, they were washed with KHB three times. Myeloid leukemia cell line PLB-985 was cultured in RPMI 1640 medium with 10% FCS, 50 mg/mL streptomycin, 50 U/mL penicillin G, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine under a 5% CO<sub>2</sub> humidified atmosphere at 37 Â°C. The suspension cells were harvested by centrifugation in a 50 mL falcon at (266<i>g</i>, 4 Â°C, 4 min), obtaining a cell pellet. Preparation for the cell based assay was carried out accordingly as described for the other cell lines above.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Hoechst 33342 Accumulation Assay</h4><div class="NLM_p">In the Hoechst 33342 accumulation assay, the inhibitory effect on ABCG2 was determined for all test compounds with small modifications, described earlier in literature.<a onclick="showRef(event, 'ref42 ref43 ref54 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref57'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref54 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref57">(42,43,54,45â53,57)</a> Test compounds were dissolved in DMSO to yield stock solutions of a concentration of 10 mM. Dilution series were performed with the corresponding stock solution together with sterile filtered KHB.</div><div class="NLM_p">Cells were detached at a confluence of 80â90% by gentle trypsination (0.05% trypsin/0.02% EDTA) and centrifuged (266<i>g</i>, 4 Â°C, 4 min) to form a cell pellet. Cell density was determined after resuspension of the cells in fresh medium with a CASY1 model TT cell counter device. Subsequently, the desired amount of cells was washed three times in KHB to remove excess medium.</div><div class="NLM_p last">Cell based assay was carried out in 96-well plates (Greiner, Frickenhausen, Germany) containing 90 Î¼L of the washed cell suspension with 10 Î¼L of the different compound dilutions to a cell density of about 30000 cells per well. The plates were incubated for 30 min at 37 Â°C and 5% CO<sub>2</sub>, followed by addition of 20 Î¼L of a 6 Î¼M Hoechst 33342 solution (protected from light) to each well. The prepared plates were then measured with a POLARstar microplate reader (BMG Labtech, Offenburg, Germany), obtaining the fluorescence in constant time intervals (60 s) up to 120 min using an excitation wavelength of 355 nm and an emission wavelength of 460 nm. From the obtained total fluorescence, the background induced by the MDCK II cells, potential fluorescence of the compound as well as KHB was subtracted. Average of the fluorescence between 100 and 109 min obtained in the steady state was calculated and plotted against the logarithm of the compound concentration. Doseâresponse curves were fitted by nonlinear regression using the four-parameter or three-parameter logistic equation, whichever was statistically preferred (GraphPad Prism, version 5.0, San Diego, CA, USA).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Calcein AM Assay</h4><div class="NLM_p last">Selected compounds were investigated for their inhibitory activity toward ABCB1 and ABCC1. Selectivity toward ABCG2 was determined in a calcein AM assay as described in literature.<a onclick="showRef(event, 'ref55 ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64 ref65 ref66 ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64 ref65 ref66 ref67 ref68 ref69">(55â69)</a> The ABCB1 overexpressing cell line A2780adr and the ABCC1 overexpressing cell line H69AR were cultured and harvested according to the description in the section â<a class="ref internalNav" href="#sec4_7" aria-label="Cell Culture">Cell Culture</a>â above. Washed cells were transferred to the wells of a colorless flat bottom 96-well plate (Greiner, Frickenhausen, Germany) as cell suspension in KHB of a final volume of 90 Î¼L. Then, 10 Î¼L of the corresponding compound was added to each well and the plates incubated at 5% CO<sub>2</sub> and 37 Â°C for a period of 30 min. Following, 33 Î¼L of a 1.25 Î¼M calcein AM solution (protected from light) was added quickly to each well and promptly measured in a 37 Â°C tempered BMG POLARstar microplate reader. Fluorescence was measured over a period of 60 min with constant intervals of 60 s using an excitation wavelength of 485 nm and an emission wavelength of 520 nm to obtain fluorescenceâtime curves. For this purpose, the slope of the initial linear part of the curves was calculated to obtain slope concentrationâresponse curves to each concentration by fitting them with nonlinear regression using the four-parameter or three-parameter logistic equation, whichever was statistically preferred.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> MTT Viability Assay</h4><div class="NLM_p">Determination of the intrinsic cytotoxicity of selected compounds was investigated with the MTT cytotoxicity assay as described earlier with slight modifications.<a onclick="showRef(event, 'ref45 ref46 ref49 ref50 ref51 ref53 ref70'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref49 ref50 ref51 ref53 ref70">(45,46,49â51,53,70)</a></div><div class="NLM_p last">Therefore, MDCK II BCRP and parental cells suspended in culture medium were seeded in 96 well tissue culture plates (Sarsted, Newton, USA) at a cell density of approximately 2000 cells per well using a volume of 180 Î¼L for each well. Plates were incubated under 5% CO<sub>2</sub> and 37 Â°C for 12 h to allow the cells to attach on the bottom of the wells. Old medium was then removed and quickly replaced with the same volume of fresh medium, followed by addition of 20 Î¼L of different compound dilutions in medium to the wells for a final volume of 200 Î¼L. Prepared plates were incubated for a period of 72 h, storing the plates at 5% CO<sub>2</sub> and 37 Â°C. Additionally, a negative control with solely medium was carried out. After the incubation period of 72 h, 40 Î¼L of MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added to each well and incubated under the same conditions for an additional hour. Subsequently, the supernatants were removed and 100 Î¼L of DMSO added for lysis of the cells and solubilization of the formed formazan. Measurement of the absorbance was performed with a BMG POLARstar microplate reader at a wavelength of 544 nm and a background correction at 710 nm.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> MDR Reversal Assay</h4><div class="NLM_p">A MDR reversal assay was performed to evaluate a compoundsâ ability to reverse MDR toward the cytostatic agent and substrate of ABCG2 SN-38, using MDCK II BCRP and parental cells. For this purpose 160 Î¼L of a suspension each containing one of both cell types in culture medium was added to the wells of a clear 96-well tissue culture plate (Sarsted, Newton, USA) with a cell density of 2000 cells per well. As described above, the plate was incubated and the old medium replaced with the same initial amount of fresh medium. Following, 20 Î¼L of different compound dilutions in culture medium were added to each row together with 20 Î¼L of different dilutions of SN-38 in culture medium added column-wise to a final volume of 200 Î¼L. Moreover, a positive control was performed using parental MDCK II cells without modulator. Plates were then incubated for 72 h and prepared as well as measured as described for above in the section â<a class="ref internalNav" href="#sec4_10" aria-label="MTT Viability Assay">MTT Viability Assay</a>â.</div><div class="NLM_p last">Cells for the MDR reversal assay performed with MX as cytostatic agent were prepared analogously to the method described above for SN-38. Row-wise, 20 Î¼L of different compound dilutions in medium was added to the wells with the freshly replaced culture medium. Additionally, 20 Î¼L of either 5 Î¼M MX in culture medium or solely culture medium was added, alternating to the rows to a final volume of 200 Î¼L. Moreover, complete cell death was induced by adding 10% (v/v) DMSO to some of the wells. The plates were then incubated for 72 h at 37 Â°C and 5% CO<sub>2</sub>. Preparation and measurement of the plates was carried out as described above in the section â<a class="ref internalNav" href="#sec4_10" aria-label="MTT Viability Assay">MTT Viability Assay</a>â.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Protein Expression in Insect Cells and ATPase Activity Measurements of ABCG2 Membranes</h4><div class="NLM_p">For protein expression in High Five  insect cells, cells were seeded in culture flasks with Express Five medium and were incubated at 27 Â°C. After a few passages when cells were homogeneous and healthy, cells were counted and about 20 million cells per flask were seeded for baculovirus infection with <i>Autographa californica</i> multicapsid nuclear polyhedrosis virus (AcMNPV). Then 72 h after infection, cells were harvested and centrifuged, and afterward a membrane preparation of the harvested cell pellet was performed.</div><div class="NLM_p">For this, 1 mL of membrane preparation homogenization buffer (50 mM Tris pH 7.5, 2 mM EGTA pH 7.0, 50 mM mannitol, 2 mM DTT, 1 mM PMSF, 2 Î¼M pepstatin, 1 Î¼M leupeptin,1 mM benzamidine) was added per 20 million cells. After an incubation period of 30 min on ice, cells were disrupted by a dounce homogenizer and the cellular debris was pelleted by centrifugation at 500<i>g</i> for 10 min at 4 Â°C. The resulting pellet was discarded and the supernatant was ultracentrifuged at 300000<i>g</i> for 30 min at 4 Â°C to obtain a pellet of enriched plasma membranes. Finally, membranes were resuspended in 100 Î¼L of resuspension buffer (50 mM Tris pH 7.5, 1 mM EGTA at pH 7.0, 10% (v/v) glycerol, 0.3 M mannitol, 1 mM DTT, 1 mM PMSF, 2 Î¼M pepstatin, 1 Î¼M leupeptin, 1 mM benzamidine) per flask and stored at â80 Â°C until use.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> ATPase activity measurements of selected compounds were performed by a colorimetric ascorbic acid ammonia molybdate reaction.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Vanadate-sensitive basal ATPase activity was compared to vanadate-sensitive drug-stimulated or -inhibited activity. Compound <b>59</b> was used as standard for ATPase inhibition, and quercetin was used as positive control with high stimulation of ABCG2 transport activity. Investigated compounds were dissolved in DMSO and final concentration of DMSO was 1%, which showed no observable effect on basal ATPase activity. All measurements were repeated at least three times.</div><div class="NLM_p last">Concentrationâresponse curves were fitted by nonlinear regression using the three-parameter logistic equation with a fixed Hill slope of one (GraphPad Prism, version 5.0, San Diego, CA, USA).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Inhibition Kinetics</h4><div class="NLM_p last">To clarify the type of interaction between inhibitor, the substrate Hoechst 33342 and ABCG2, an enzyme kinetic study was carried out. Thus, different compounds were selected and various concentrations of the corresponding compound as well as of Hoechst 33342 (0.4â2.4 Î¼M) applied. The remainder of the experimental parameters were chosen as described in the section â<a class="ref internalNav" href="#sec2_2_1" aria-label="Hoechst 33342 Accumulation Assay">Hoechst 33342 Accumulation Assay</a>â. Additionally, the response in the absence of compound was set as control. The obtained values were then used in the LineweaverâBurk linearization technique as well as the direct linear Cornish-Bowden plot to confirm the results. Both methods provide information about the underlying interaction type of the compound with Hoechst 33342.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 5D3 Antibody Binding Assay</h4><div class="NLM_p last">To estimate the degree of conformational change of ABCG2 in the presence of an inhibitor, the conformational sensitive monoclonal antibody PerCP-Cy5.5 mouse anti-human CD338 was employed. The conjugated antibody binds specifically to an epitope of ABCG2, the human CD338 antigen, and emits light at a wavelength of 695 nm upon excitation. Unwanted, nonspecific staining was subtracted by using an isotype control. The flow cytometric assay was carried out with mammalian PLB-985 acute myeloid leukemia cell line with an overexpression of ABCG2. Those suspension cells were centrifuged and washed with DPBS containing 0.25% BSA adjusting to a final cell density of 2.5 million cells per mL. Then 98 Î¼L of the suspension was transferred to a 1.5 mL Eppendorf reaction tube and incubated (37 Â°C, 5 min, shaking at 500 rpm) with 1 Î¼L of a solution containing DMSO and corresponding compound at the desired concentration. After a 5 min preincubation period, 1 Î¼L of the antibody was added and incubation continued for further 30 min. Subsequently, the sample was centrifuged and the liquids removed. The formed cell pellet was then resuspended in 1 mL of DPBS and immediately measured with a FACSCalibur flow cytometer. For the excitation, a blue laser with an excitation wavelength of 488 nM was used and the fluorescence detected in the FL3 channel. As a comparison, a sample with the same amount of DMSO in the absence of compound was measured as described above. After subtraction of the fluorescence of the isotype control from the fluorescence with the antibody, the median of the corrected fluorescence of the sample with only DMSO was subtracted from the corrected fluorescence in the presence of a compound to obtain a âshiftâ.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Molecular Docking</h4><div class="NLM_p last">The recent cryo-electron microscopy (cryo-EM) structure of the human ABCG2 transporter (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC">6FFC</a>) with the fumitremorgin C-related inhibitor, MZ29 was downloaded from RCSB Protein Data Bank.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The downloaded structure was prepared by using the protein structure preparation tools implemented in Molecular Operating Environment (MOE) 2018.01.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The hydrogen atoms for the receptor were assigned according to Protonate-3D module implemented in MOE2018.01. The prepared receptor structure of the human ABCG2 was applied for flexible ligand docking using LeadIT from BioSolveIT, GmbH Germany.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> During the docking simulations, the ligands were fully flexible while the residues of the receptor were treated as rigid. The binding site for the receptor was defined in 20 Ã spacing of the amino acid residues centered based on the ligand, MZ29. By FlexX module implemented in LeadIT, docking of compounds was performed.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> To predict the binding modes of the compounds, selected compounds were docked into the active site of the receptors using FlexX module implemented in LeadIT. Default docking and scoring parameters were applied, and top 100 highest scoring docked positions were stored for further analysis. Each receptorâligand complex having the lowest binding free energy for interactions was examined and 3D putative binding modes were visualized using MOE2018.01 and PyMOL.<a onclick="showRef(event, 'ref72 ref76'); return false;" href="javascript:void(0);" class="ref ref72 ref76">(72,76)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01011" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01011" class="ext-link">10.1021/acs.jmedchem.8b01011</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and the biological data(<a href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">ABCG2â<b>31</b> complex (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">ABCG2â<b>41</b> complex (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_003.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_001.csv">jm8b01011_si_001.csv (3.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_002.pdb">jm8b01011_si_002.pdb (707.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_003.pdb">jm8b01011_si_003.pdb (706.92 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC">6FFC</a> (<b>31</b>, <b>41</b>). Authors will release the atomic coordinates upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01011" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64371" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64371" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Wiese</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn, Germany</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5851-5336" title="Orcid link">http://orcid.org/0000-0002-5851-5336</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#325f455b57415772475c5b1f505d5c5c"><span class="__cf_email__" data-cfemail="a9c4dec0ccdacce9dcc7c084cbc6c7c7">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael
K. Krapf</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Gallus</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vigneshwaran Namasivayam</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn, Germany</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3031-3377" title="Orcid link">http://orcid.org/0000-0003-3031-3377</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e7805-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61142" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61142" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank BioSolveIT GmbH, Germany, for providing the evaluation license for LeadIT.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">ATP-binding cassette</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein (ABCG2)</p></td></tr><tr><td class="NLM_term">cyro-EM</td><td class="NLM_def"><p class="first last">cryo-electron microscopy</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MOE</td><td class="NLM_def"><p class="first last">Molecular Operating Environment</p></td></tr><tr><td class="NLM_term">MX</td><td class="NLM_def"><p class="first last">mitoxantrone</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 76 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slamon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poplack, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastan, I.</span></span> <span> </span><span class="NLM_article-title">Expression of a Multidrug-resistance Gene in Human Tumors and Tissues</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">265</span>â <span class="NLM_lpage">269</span>, <span class="refDoi">Â DOI: 10.1073/pnas.84.1.265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1073%2Fpnas.84.1.265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=2432605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaL2sXhtFCmsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=265-269&author=A.+T.+Fojoauthor=K.+Uedaauthor=D.+J.+Slamonauthor=D.+G.+Poplackauthor=M.+M.+Gottesmanauthor=I.+Pastan&title=Expression+of+a+Multidrug-resistance+Gene+in+Human+Tumors+and+Tissues&doi=10.1073%2Fpnas.84.1.265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of a multidrug-resistance gene in human tumors and tissues</span></div><div class="casAuthors">Fojo, A. T.; Ueda, K.; Slamon, D. J.; Poplack, D. G.; Gottesman, M. M.; Pastan, I.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">265-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The identification and cloning of a segment of a human multidrug resistance gene (mdr1) has been reported.  To examine the mol. basis of one type of multidrug resistance, RNA was prepd. from human tumors and normal tissues and their content of mdr1 RNA was measured.  The mdr1 gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at intermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues.  The mdr1 gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon.  In addn., increased expression was detected in a few tumors at the time of relapse following initial chemotherapy.  Although controlled clin. studies will be required, the results suggest that measurement of mdr1 RNA may prove to be a valuable tool in the design of chemotherapy protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZJTrls19i7Vg90H21EOLACvtfcHk0lgqwpsqR9cwfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtFCmsr4%253D&md5=b75baa0e65eb1e16ac2e192ac0f05965</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.1.265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.1.265%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DA.%2BT.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DPoplack%26aufirst%3DD.%2BG.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DPastan%26aufirst%3DI.%26atitle%3DExpression%2520of%2520a%2520Multidrug-resistance%2520Gene%2520in%2520Human%2520Tumors%2520and%2520Tissues%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D265%26epage%3D269%26doi%3D10.1073%2Fpnas.84.1.265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unadkat, J. D.</span></span> <span> </span><span class="NLM_article-title">Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transportâan Update</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">65</span>â <span class="NLM_lpage">82</span>, <span class="refDoi">Â DOI: 10.1208/s12248-014-9668-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1208%2Fs12248-014-9668-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=65-82&author=Q.+Maoauthor=J.+D.+Unadkat&title=Role+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29+in+Drug+Transport%E2%80%94an+Update&doi=10.1208%2Fs12248-014-9668-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1208%2Fs12248-014-9668-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-014-9668-6%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DRole%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%2520in%2520Drug%2520Transport%25E2%2580%2594an%2520Update%26jtitle%3DAAPS%2520J.%26date%3D2015%26volume%3D17%26spage%3D65%26epage%3D82%26doi%3D10.1208%2Fs12248-014-9668-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, R.</span></span> <span> </span><span class="NLM_article-title">Purification and Structural Analyses of ABCG2</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">57</span>â <span class="NLM_lpage">65</span>, <span class="refDoi">Â DOI: 10.1016/j.addr.2008.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.addr.2008.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=19124053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1alu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=57-65&author=C.+A.+McDevittauthor=R.+Collinsauthor=I.+D.+Kerrauthor=R.+Callaghan&title=Purification+and+Structural+Analyses+of+ABCG2&doi=10.1016%2Fj.addr.2008.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and structural analyses of ABCG2</span></div><div class="casAuthors">McDevitt, Christopher A.; Collins, Richard; Kerr, Ian D.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ABCG2/BRCP protein is best known as a multidrug transporter capable of conferring resistance to cancer cells.  However, the protein is also inherently expressed in numerous barrier tissues and intriguingly within hematopoietic stem cells.  Unlike its partners, ABCB1 and ABCC1, there is considerably less information available on the mol. mechanism of ABCG2/BRCP.  The transporter has a distinct topol. and is presumed to function as a homodimer.  However, a no. of biochem. studies have presented data to suggest that the protein adopts higher order oligomers.  This review focuses on this controversial issue with particular ref. to findings from low resoln. structural data.  In addn., a no. of mol. models of ABCG2/BRCP based on high-resoln. structures of bacterial ABC transporters have recently become available and are critically assessed.  ABCG2/BRCP is a structurally distinct member of the triumvirate of human multidrug transporters and continues to evade description of a unifying mol. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-26N0eXV32LVg90H21EOLACvtfcHk0lgqwpsqR9cwfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1alu7g%253D&md5=8afc7467f79e661e505d5bccbc17cfbf</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcDevitt%26aufirst%3DC.%2BA.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DPurification%2520and%2520Structural%2520Analyses%2520of%2520ABCG2%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D57%26epage%3D65%26doi%3D10.1016%2Fj.addr.2008.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristensen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brangi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning of cDNAs Which Are Highly Overexpressed in Mitoxantrone resistant Cells: Demonstration of Homology to ABC Transport Genes</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8</span>â <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=8-13&author=K.+Miyakeauthor=L.+Mickleyauthor=T.+Litmanauthor=Z.+Zhanauthor=R.+Robeyauthor=B.+Cristensenauthor=M.+Brangiauthor=L.+Greenbergerauthor=M.+Deanauthor=T.+Fojoauthor=S.+E.+Bates&title=Molecular+Cloning+of+cDNAs+Which+Are+Highly+Overexpressed+in+Mitoxantrone+resistant+Cells%3A+Demonstration+of+Homology+to+ABC+Transport+Genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DMickley%26aufirst%3DL.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DCristensen%26aufirst%3DB.%26aulast%3DBrangi%26aufirst%3DM.%26aulast%3DGreenberger%26aufirst%3DL.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMolecular%2520Cloning%2520of%2520cDNAs%2520Which%2520Are%2520Highly%2520Overexpressed%2520in%2520Mitoxantrone%2520resistant%2520Cells%253A%2520Demonstration%2520of%2520Homology%2520to%2520ABC%2520Transport%2520Genes%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D8%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-T.</span></span> <span> </span><span class="NLM_article-title">Human ABCG2: Structure, Function, and its Role in Multidrug Resistance</span>. <i>Int. J. Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=1-27&author=W.+Moauthor=J.-T.+Zhang&title=Human+ABCG2%3A+Structure%2C+Function%2C+and+its+Role+in+Multidrug+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.-T.%26atitle%3DHuman%2520ABCG2%253A%2520Structure%252C%2520Function%252C%2520and%2520its%2520Role%2520in%2520Multidrug%2520Resistance%26jtitle%3DInt.%2520J.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D1%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkens, S.</span></span> <span> </span><span class="NLM_article-title">Structure and Mechanism of ABC Transporters</span>. <i>F1000Prime Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi">Â DOI: 10.12703/P7-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.12703%2FP7-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=25750732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhvFWhsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=14&author=S.+Wilkens&title=Structure+and+Mechanism+of+ABC+Transporters&doi=10.12703%2FP7-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of ABC transporters</span></div><div class="casAuthors">Wilkens Stephan</div><div class="citationInfo"><span class="NLM_cas:title">F1000prime reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn">2051-7599</span>.
    </div><div class="casAbstract">All living organisms depend on primary and secondary membrane transport for the supply of external nutrients and removal or sequestration of unwanted (toxic) compounds.  Due to the chemical diversity of cellular molecules, it comes as no surprise that a significant part of the proteome is dedicated to the active transport of cargo across the plasma membrane or the membranes of subcellular organelles.  Transport against a chemical gradient can be driven by, for example, the free energy change associated with ATP hydrolysis (primary transport), or facilitated by the potential energy of the chemical gradient of another molecule (secondary transport).  Primary transporters include the rotary motor ATPases (F-, A-, and V-ATPases), P-type ATPases and a large family of integral membrane proteins referred to as "ABC" (ATP binding cassette) transporters.  ABC transporters are widespread in all forms of life and are characterized by two nucleotide-binding domains (NBD) and two transmembrane domains (TMDs).  ATP hydrolysis on the NBD drives conformational changes in the TMD, resulting in alternating access from inside and outside of the cell for unidirectional transport across the lipid bilayer.  Common to all ABC transporters is a signature sequence or motif, LSGGQ, that is involved in nucleotide binding.  Both importing and exporting ABC transporters are found in bacteria, whereas the majority of eukaryotic family members function in the direction of export.  Recent progress with the X-ray crystal structure determination of a variety of bacterial and eukaryotic ABC transporters has helped to advance our understanding of the ATP hydrolysis-driven transport mechanism but has also illustrated the large structural and functional diversity within the family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnMdLvCnsfMK__Jf7-eMvJfW6udTcc2ebGlmZkKI3Dvbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhvFWhsA%253D%253D&md5=c33f6447d0f32735fae9b6e48f5e18e9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.12703%2FP7-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12703%252FP7-14%26sid%3Dliteratum%253Aachs%26aulast%3DWilkens%26aufirst%3DS.%26atitle%3DStructure%2520and%2520Mechanism%2520of%2520ABC%2520Transporters%26jtitle%3DF1000Prime%2520Rep.%26date%3D2015%26volume%3D7%26spage%3D14%26doi%3D10.12703%2FP7-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-T.</span></span> <span> </span><span class="NLM_article-title">Use of Arrays to Investigate the Contribution of ATP-binding Cassette Transporters to Drug Resistance in Cancer Chemotherapy and Prediction of Chemosensitivity</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">311</span>â <span class="NLM_lpage">323</span>, <span class="refDoi">Â DOI: 10.1038/cr.2007.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fcr.2007.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=17404598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Chtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=311-323&author=J.-T.+Zhang&title=Use+of+Arrays+to+Investigate+the+Contribution+of+ATP-binding+Cassette+Transporters+to+Drug+Resistance+in+Cancer+Chemotherapy+and+Prediction+of+Chemosensitivity&doi=10.1038%2Fcr.2007.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity</span></div><div class="casAuthors">Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-323</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a major problem in cancer chemotherapy.  One of the best known mechanisms of MDR is the elevated expression of ATP-binding cassette (ABC) transporters.  While some members of human ABC transporters have been shown to cause drug resistance with elevated expression, it is not yet known whether the over-expression of other members could also contribute to drug resistance in many model cancer cell lines and clinics.  The recent development of microarrays and quant. PCR arrays for expression profiling anal. of ABC transporters has helped address these issues.  In this article, various arrays with limited or full list of ABC transporter genes and their use in identifying ABC transporter genes in drug resistance and chemo-sensitivity prediction will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFJxltRNjjorVg90H21EOLACvtfcHk0lijisDTrMgrrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Chtb0%253D&md5=28d341004d5cfc22a14048234ba704d3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fcr.2007.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2007.15%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-T.%26atitle%3DUse%2520of%2520Arrays%2520to%2520Investigate%2520the%2520Contribution%2520of%2520ATP-binding%2520Cassette%2520Transporters%2520to%2520Drug%2520Resistance%2520in%2520Cancer%2520Chemotherapy%2520and%2520Prediction%2520of%2520Chemosensitivity%26jtitle%3DCell%2520Res.%26date%3D2007%26volume%3D17%26spage%3D311%26epage%3D323%26doi%3D10.1038%2Fcr.2007.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, V.</span></span> <span> </span><span class="NLM_article-title">A Surface Glycoprotein Modulating Drug Permeability in Chinese Hamster Ovary Cell Mutants</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">152</span>â <span class="NLM_lpage">162</span>, <span class="refDoi">Â DOI: 10.1016/0005-2736(76)90160-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2F0005-2736%2876%2990160-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=990323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaE28XlvV2qs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=1976&pages=152-162&author=R.+L.+Julianoauthor=V.+Ling&title=A+Surface+Glycoprotein+Modulating+Drug+Permeability+in+Chinese+Hamster+Ovary+Cell+Mutants&doi=10.1016%2F0005-2736%2876%2990160-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants</span></div><div class="casAuthors">Juliano, R. L.; Ling, V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-62</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    </div><div class="casAbstract">Chinese hamster ovary cells selected for resistance to colchicine displayed pleiotropic cross-resistance to a wide range of amphiphilic drugs.  The drug-resistant Chinese hamster ovary cell membranes possessed a carbohydrate-contg. component of 170,000 daltons apparent mol. wt. which was not obsd. in wild type cells.  This component was a cell surface glycoprotein, and was designated as P glycoprotein.  The relative amt. of surface labeled P glycoprotein correlated with the degree of drug resistance in a no. of independent mutant and revertant clones.  A similar high mol. wt. glycoprotein was also present in drug-resistant mutants from another hamster cell line.  Thus, certain surface glycoproteins may control drug permeation by modulating the properties of hydrophobic membrane regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ZxAfIismuLVg90H21EOLACvtfcHk0lijisDTrMgrrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XlvV2qs70%253D&md5=04dae856aaeb328d977c36df532b0072</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0005-2736%2876%2990160-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2736%252876%252990160-7%26sid%3Dliteratum%253Aachs%26aulast%3DJuliano%26aufirst%3DR.%2BL.%26aulast%3DLing%26aufirst%3DV.%26atitle%3DA%2520Surface%2520Glycoprotein%2520Modulating%2520Drug%2520Permeability%2520in%2520Chinese%2520Hamster%2520Ovary%2520Cell%2520Mutants%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D1976%26volume%3D455%26spage%3D152%26epage%3D162%26doi%3D10.1016%2F0005-2736%2876%2990160-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almquist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, E. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span> <span> </span><span class="NLM_article-title">Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">1650</span>â <span class="NLM_lpage">1654</span>, <span class="refDoi">Â DOI: 10.1126/science.1360704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1126%2Fscience.1360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1360704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1650-1654&author=S.+P.+Coleauthor=G.+Bhardwajauthor=J.+H.+Gerlachauthor=J.+E.+Mackieauthor=C.+E.+Grantauthor=K.+C.+Almquistauthor=A.+J.+Stewartauthor=E.+U.+Kurzauthor=A.+M.+Duncanauthor=R.+G.+Deeley&title=Overexpression+of+a+Transporter+Gene+in+a+Multidrug-Resistant+Human+Lung+Cancer+Cell+Line&doi=10.1126%2Fscience.1360704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span></div><div class="casAuthors">Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5088</span>),
    <span class="NLM_cas:pages">1650-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents.  However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on ATP and is assocd. with multidrug resistance.  CDNA clones corresponding to mRNAs overexpressed in H69AR cells were isolated.  One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells.  Overexpression was assocd. with amplification of the cognate gene located on chromosome 16 at band p13.1.  Reversion to drug sensitivity was assocd. with loss of gene amplification and a marked decrease in mRNA expression.  The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS-PschUsW7Vg90H21EOLACvtfcHk0lg65NUngWvDJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D&md5=7002d3f14cd64c4f39e44d938db665f7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1360704%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DBhardwaj%26aufirst%3DG.%26aulast%3DGerlach%26aufirst%3DJ.%2BH.%26aulast%3DMackie%26aufirst%3DJ.%2BE.%26aulast%3DGrant%26aufirst%3DC.%2BE.%26aulast%3DAlmquist%26aufirst%3DK.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BJ.%26aulast%3DKurz%26aufirst%3DE.%2BU.%26aulast%3DDuncan%26aufirst%3DA.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26atitle%3DOverexpression%2520of%2520a%2520Transporter%2520Gene%2520in%2520a%2520Multidrug-Resistant%2520Human%2520Lung%2520Cancer%2520Cell%2520Line%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1650%26epage%3D1654%26doi%3D10.1126%2Fscience.1360704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, K. H.</span></span> <span> </span><span class="NLM_article-title">Reduced Intracellular Drug Accumulation in the Absence of P-Glycoprotein (mdrl) Overexpression in Mitoxantrone-Resistant Human MCF-7 Breast Cancer Cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6175</span>â <span class="NLM_lpage">6181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=6175-6181&author=M.+Nakagawaauthor=E.+Schneiderauthor=K.+H.+Dixonauthor=J.+Hortonauthor=K.+Kelleyauthor=C.+Morrowauthor=K.+H.+Cowan&title=Reduced+Intracellular+Drug+Accumulation+in+the+Absence+of+P-Glycoprotein+%28mdrl%29+Overexpression+in+Mitoxantrone-Resistant+Human+MCF-7+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DDixon%26aufirst%3DK.%2BH.%26aulast%3DHorton%26aufirst%3DJ.%26aulast%3DKelley%26aufirst%3DK.%26aulast%3DMorrow%26aufirst%3DC.%26aulast%3DCowan%26aufirst%3DK.%2BH.%26atitle%3DReduced%2520Intracellular%2520Drug%2520Accumulation%2520in%2520the%2520Absence%2520of%2520P-Glycoprotein%2520%2528mdrl%2529%2520Overexpression%2520in%2520Mitoxantrone-Resistant%2520Human%2520MCF-7%2520Breast%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D6175%26epage%3D6181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Drug Transporters: Recent Advances Concerning BCRP and Tyrosine Kinase Inhibitors</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">857</span>â <span class="NLM_lpage">862</span>, <span class="refDoi">Â DOI: 10.1038/sj.bjc.6604213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fsj.bjc.6604213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=18253130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVOgt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=857-862&author=C.+Lemosauthor=G.+Jansenauthor=G.+J.+Peters&title=Drug+Transporters%3A+Recent+Advances+Concerning+BCRP+and+Tyrosine+Kinase+Inhibitors&doi=10.1038%2Fsj.bjc.6604213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors</span></div><div class="casAuthors">Lemos, C.; Jansen, G.; Peters, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">857-862</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance is often assocd. with the (over)expression of drug efflux transporters of the ATP-binding cassette (ABC) protein family.  This minireview discusses the role of one selected ABC-transporter family member, the breast cancer resistance protein (BCRP/ABCG2), in the (pre)clin. efficacy of novel exptl. anticancer drugs, in particular tyrosine kinase inhibitors.  British Journal of Cancer (2008) 98, 857-862. doi:10.1038/sj.bjc.6604213 www.bjcancer.com Published online 5 Feb. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXa5TRFWT8LVg90H21EOLACvtfcHk0lg65NUngWvDJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVOgt7o%253D&md5=8f5e7070b71052b6f52ea6c90078d24c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604213%26sid%3Dliteratum%253Aachs%26aulast%3DLemos%26aufirst%3DC.%26aulast%3DJansen%26aufirst%3DG.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DDrug%2520Transporters%253A%2520Recent%2520Advances%2520Concerning%2520BCRP%2520and%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D857%26epage%3D862%26doi%3D10.1038%2Fsj.bjc.6604213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. D.</span></span> <span> </span><span class="NLM_article-title">Multidrug Resistance Mediated by the Breast Cancer Resistance Protein BCRP (ABCG2)</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">7340</span>â <span class="NLM_lpage">7358</span>, <span class="refDoi">Â DOI: 10.1038/sj.onc.1206938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fsj.onc.1206938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=14576842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BD3svpvFCjug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7340-7358&author=L.+A.+Doyleauthor=D.+D.+Ross&title=Multidrug+Resistance+Mediated+by+the+Breast+Cancer+Resistance+Protein+BCRP+%28ABCG2%29&doi=10.1038%2Fsj.onc.1206938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)</span></div><div class="casAuthors">Doyle L Austin; Ross Douglas D</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">7340-58</span>
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines without overexpression of P-glycoprotein or multidrug resistance protein (MRP) family members suggested the existence of another ATP-binding cassette (ABC) transporter capable of causing cancer drug resistance.  In one such cell line (MCF-7/AdrVp), the overexpression of a novel member of the G subfamily of ABC transporters was found.  The new transporter was termed the breast cancer resistance protein (BCRP), because of its identification in MCF-7 human breast carcinoma cells.  BCRP is a 655 amino-acid polypeptide, formally designated as ABCG2.  Like all members of the ABC G (white) subfamily, BCRP is a half transporter.  Transfection and enforced overexpression of BCRP in drug-sensitive MCF-7 or MDA-MB-231 cells recapitulates the drug-resistance phenotype of MCF-7/AdrVp cells, consistent with current evidence suggesting that functional BCRP is a homodimer.  BCRP maps to chromosome 4q22, downstream from a TATA-less promoter.  The spectrum of anticancer drugs effluxed by BCRP includes mitoxantrone, camptothecin-derived and indolocarbazole topoisomerase I inhibitors, methotrexate, flavopiridol, and quinazoline ErbB1 inhibitors.  Transport of anthracyclines is variable and appears to depend on the presence of a BCRP mutation at codon 482.  Potent and specific inhibitors of BCRP are now being developed, opening the door to clinical applications of BCRP inhibition.  Owing to tissue localization in the placenta, bile canaliculi, colon, small bowel, and brain microvessel endothelium, BCRP may play a role in protecting the organism from potentially harmful xenobiotics.  BCRP expression has also been demonstrated in pluripotential "side population" stem cells, responsible for the characteristic ability of these cells to exclude Hoechst 33342 dye, and possibly for the maintenance of the stem cell phenotype.  Studies are emerging on the role of BCRP expression in drug resistance in clinical cancers.  More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional assays, in order to determine the contribution of BCRP to drug resistance in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVhfZWKJa6Ui6Ufuk_1xoTfW6udTcc2eZudJd53EgJw7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svpvFCjug%253D%253D&md5=e47830ac42603a5253b8148ca0e86fe2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206938%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DMultidrug%2520Resistance%2520Mediated%2520by%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520BCRP%2520%2528ABCG2%2529%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7340%26epage%3D7358%26doi%3D10.1038%2Fsj.onc.1206938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abruzzo, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rishi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. D.</span></span> <span> </span><span class="NLM_article-title">A Multidrug Resistance Transporter from Human MCF-7 Breast Cancer Cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">15665</span>â <span class="NLM_lpage">15670</span>, <span class="refDoi">Â DOI: 10.1073/pnas.95.26.15665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=T.+Krogmannauthor=Y.+Gaoauthor=A.+K.+Rishiauthor=D.+D.+Ross&title=A+Multidrug+Resistance+Transporter+from+Human+MCF-7+Breast+Cancer+Cells&doi=10.1073%2Fpnas.95.26.15665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0ljEoKZRwhIVNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DA%2520Multidrug%2520Resistance%2520Transporter%2520from%2520Human%2520MCF-7%2520Breast%2520Cancer%2520Cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670%26doi%3D10.1073%2Fpnas.95.26.15665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westover, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">New Trends for Overcoming ABCG2/BCRP-Mediated Resistance to Cancer Therapies</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">159</span>, <span class="refDoi">Â DOI: 10.1186/s13046-015-0275-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1186%2Fs13046-015-0275-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=26714461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFCmtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=159&author=D.+Westoverauthor=F.+Li&title=New+Trends+for+Overcoming+ABCG2%2FBCRP-Mediated+Resistance+to+Cancer+Therapies&doi=10.1186%2Fs13046-015-0275-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New trends for overcoming ABCG2/BCRP mediated resistance to cancer therapies</span></div><div class="casAuthors">Westover, David; Li, Fengzhi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159/1-159/9</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">ATP-binding cassette (ABC) transporters make up a superfamily of transmembrane proteins that play a crit. role in the development of drug resistance.  This phenomenon is esp. important in oncol., where superfamily member ABCG2 (also called BCRP - breast cancer resistance protein) is known to interact with dozens of anticancer agents that are ABCG2 substrates.  In addn. to the well-studied and well-reviewed list of cytotoxic and targeted agents that are substrates for the ABCG2 transporter, a growing body of work links ABCG2 to multiple photodynamic therapy (PDT) agents, and there is a limited body of evidence suggesting that ABCG2 may also play a role in resistance to radiation therapy.  In addn., the focus of ABC transporter research in regards to therapeutic development has begun to shift in the past few years.  The shift has been away from using pump inhibitors for reversing resistance, toward the development of therapeutic agents that are poor substrates for these efflux pump proteins.  This approach may result in the development of drug regimens that circumvent ABC transporter-mediated resistance entirely.  Here, it is our intention to review: (1) recent discoveries that further characterize the role of ABCG2 in oncol., and (2) advances in reversing and circumventing ABC transporter-mediated resistance to anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkbggbUBffW7Vg90H21EOLACvtfcHk0ljEoKZRwhIVNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFCmtbY%253D&md5=afd4146e72bb46ca30e5ebb81a7af1be</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2Fs13046-015-0275-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-015-0275-x%26sid%3Dliteratum%253Aachs%26aulast%3DWestover%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DNew%2520Trends%2520for%2520Overcoming%2520ABCG2%252FBCRP-Mediated%2520Resistance%2520to%2520Cancer%2520Therapies%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D34%26spage%3D159%26doi%3D10.1186%2Fs13046-015-0275-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">19781</span>â <span class="NLM_lpage">19789</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M310785200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1074%2Fjbc.M310785200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=15001581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Wit7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=19781-19789&author=J.+Xuauthor=Y.+Liuauthor=Y.+Yangauthor=S.+Batesauthor=J.+T.+Zhang&title=Characterization+of+Oligomeric+Human+Half-ABC+Transporter+ATP-binding+Cassette+G2&doi=10.1074%2Fjbc.M310785200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2</span></div><div class="casAuthors">Xu, Junkang; Liu, Yang; Yang, Youyun; Bates, Susan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">19781-19789</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human ATP-binding cassette G2 (ABCG2, also known as mitoxantrone resistance protein, breast cancer-resistance protein, ABC placenta) is a member of the superfamily of ATP-binding cassette (ABC) transporters that have a wide variety of substrates.  Overexpression of human ABCG2 in model cancer cell lines causes multidrug resistance by actively effluxing anticancer drugs.  Unlike most of the other ABC transporters which usually have two nucleotide-binding domains and two transmembrane domains, ABCG2 consists of only one nucleotide-binding domain followed by one transmembrane domain.  Thus, ABCG2 has been thought to be a half-transporter that may function as a homodimer.  In this study, we characterized the oligomeric feature of human ABCG2 using non-denaturing detergent perfluoro-octanoic acid and Triton X-100 in combination with gel filtration, sucrose d. gradient sedimentation, and gel electrophoresis.  Unexpectedly, we found that human ABCG2 exists mainly as a tetramer, with a possibility of a higher form of oligomerization.  Monomeric and dimeric ABCG2 did not appear to be the major form of the protein.  Further immunopptn. anal. showed that the oligomeric ABCG2 did not contain any other proteins.  Taken together, we conclude that human ABCG2 likely exists and functions as a homotetramer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS9hRAh_FSbVg90H21EOLACvtfcHk0ljEoKZRwhIVNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Wit7g%253D&md5=c45adb759c2de874ef4c299eb3d0c99e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M310785200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M310785200%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBates%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DCharacterization%2520of%2520Oligomeric%2520Human%2520Half-ABC%2520Transporter%2520ATP-binding%2520Cassette%2520G2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D19781%26epage%3D19789%26doi%3D10.1074%2Fjbc.M310785200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mc
Devitt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, R.</span></span> <span> </span><span class="NLM_article-title">Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1623</span>â <span class="NLM_lpage">1632</span>, <span class="refDoi">Â DOI: 10.1016/j.str.2006.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.str.2006.08.014" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1623-1632&author=C.+A.+Mc%0ADevittauthor=R.+F.+Collinsauthor=M.+Conwayauthor=S.+Modokauthor=J.+Stormauthor=I.+D.+Kerrauthor=R.+C.+Fordauthor=R.+Callaghan&title=Purification+and+3D+Structural+Analysis+of+Oligomeric+Human+Multidrug+Transporter+ABCG2&doi=10.1016%2Fj.str.2006.08.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2006.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2006.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DMc%2BDevitt%26aufirst%3DC.%2BA.%26aulast%3DCollins%26aufirst%3DR.%2BF.%26aulast%3DConway%26aufirst%3DM.%26aulast%3DModok%26aufirst%3DS.%26aulast%3DStorm%26aufirst%3DJ.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DFord%26aufirst%3DR.%2BC.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DPurification%2520and%25203D%2520Structural%2520Analysis%2520of%2520Oligomeric%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D1623%26epage%3D1632%26doi%3D10.1016%2Fj.str.2006.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velamakanni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veen, H.</span></span> <span> </span><span class="NLM_article-title">The Emerging Pharmacotherapeutic Significance of the Breast Cancer Resistance Protein (ABCG2)</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">163</span>â <span class="NLM_lpage">174</span>, <span class="refDoi">Â DOI: 10.1038/sj.bjp.0707218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fsj.bjp.0707218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=17375082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Wku74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2007&pages=163-174&author=L.+Hardwickauthor=S.+Velamakanniauthor=H.+van+Veen&title=The+Emerging+Pharmacotherapeutic+Significance+of+the+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1038%2Fsj.bjp.0707218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2)</span></div><div class="casAuthors">Hardwick, L. J. A.; Velamakanni, S.; van Veen, H. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-174</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The breast cancer resistance protein (also termed ABCG2) is an ATP-binding cassette transporter, which mediates the extrusion of toxic compds. from the cell, and which was originally identified in relation to the development of multidrug resistance of cancer cells.  ABCG2 interacts with a range of substrates including clin. drugs but also substances such as sterols, porphyrins and a variety of dietary compds.  Physiol. functions of ABCG2 at both cellular and systemic levels are reviewed.  For example, ABCG2 expression in erythrocytes may function in porphyrin homeostasis.  In addn., ABCG2 expression at apical membranes of cells such as hepatocytes, enterocytes, endothelial and syncytiotrophoblast cells may correlate to protective barrier or secretory functions against environmental or clin. administered substances.  ABCG2 also appears influential in the inter-patient variation and generally poor oral bioavailability of certain chemotherapeutic drugs such as topotecan.  As this often precludes an oral drug administration strategy, genotypic and environmental factors altering ABCG2 expression and activity are considered.  Finally, clin. modulation of ABCG2 activity is discussed.  Some of the more recent strategies include co-administered modulating agents, hammerhead ribozymes or antisense oligonucleotides, and with specificity in cell targeting, these may be used to reduce drug resistance and increase drug bioavailability to improve the profile of chemotherapeutic efficacy vs. toxicity.  While many such strategies remain in relative infancy at present, increased knowledge of modulators of ABCG2 could hold the key to novel approaches in medical treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3w5nPxaNRLVg90H21EOLACvtfcHk0lhcKWoHkpiKtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Wku74%253D&md5=fdd17189ef8fdb4a95c21d96fd0fd7a5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707218%26sid%3Dliteratum%253Aachs%26aulast%3DHardwick%26aufirst%3DL.%26aulast%3DVelamakanni%26aufirst%3DS.%26aulast%3Dvan%2BVeen%26aufirst%3DH.%26atitle%3DThe%2520Emerging%2520Pharmacotherapeutic%2520Significance%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D151%26spage%3D163%26epage%3D174%26doi%3D10.1038%2Fsj.bjp.0707218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ãzvegy-Laczka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemet, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ¡radi, A.</span></span> <span> </span><span class="NLM_article-title">ABCG2 â a Transporter for all Seasons</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>567</i></span>,  <span class="NLM_fpage">116</span>â <span class="NLM_lpage">120</span>, <span class="refDoi">Â DOI: 10.1016/j.febslet.2004.03.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.febslet.2004.03.123" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=567&publication_year=2004&pages=116-120&author=B.+Sarkadiauthor=C.+%C3%96zvegy-Laczkaauthor=K.+Nemetauthor=A.+V%C3%A1radi&title=ABCG2+%E2%80%93+a+Transporter+for+all+Seasons&doi=10.1016%2Fj.febslet.2004.03.123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2004.03.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2004.03.123%26sid%3Dliteratum%253Aachs%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3D%25C3%2596zvegy-Laczka%26aufirst%3DC.%26aulast%3DNemet%26aufirst%3DK.%26aulast%3DV%25C3%25A1radi%26aufirst%3DA.%26atitle%3DABCG2%2520%25E2%2580%2593%2520a%2520Transporter%2520for%2520all%2520Seasons%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D567%26spage%3D116%26epage%3D120%26doi%3D10.1016%2Fj.febslet.2004.03.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briddon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holliday, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span> <span> </span><span class="NLM_article-title">Plasma Membrane Dynamics and Tetrameric Organisation of ABCG2 Transporters in Mammalian Cells Revealed by Single Particle Imaging Techniques</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">19</span>â <span class="NLM_lpage">29</span>, <span class="refDoi">Â DOI: 10.1016/j.bbamcr.2015.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bbamcr.2015.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=26453803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Chtb%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2016&pages=19-29&author=K.+Wongauthor=S.+J.+Briddonauthor=N.+D.+Hollidayauthor=I.+D.+Kerr&title=Plasma+Membrane+Dynamics+and+Tetrameric+Organisation+of+ABCG2+Transporters+in+Mammalian+Cells+Revealed+by+Single+Particle+Imaging+Techniques&doi=10.1016%2Fj.bbamcr.2015.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane dynamics and tetrameric organisation of ABCG2 transporters in mammalian cells revealed by single particle imaging techniques</span></div><div class="casAuthors">Wong, Kelvin; Briddon, Stephen J.; Holliday, Nicholas D.; Kerr, Ian D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-29</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ABCG2 is one of three human ATP binding cassette (ABC) transporters involved in the export from cells of a chem. and structurally diverse range of compds.  This multidrug efflux capability, together with a broad tissue distribution in the body, means that ABCG2 exerts a range of effects on normal physiol. such as kidney urate transport, as well as contributing towards the pharmacokinetic profiles of many exogenous drugs.  The primary sequence of ABCG2 contains only half the no. of domains required for a functioning ABC transporter and so it must oligomerise in order to function, yet its oligomeric state in intact cell membranes remains uncharacterized.  We have analyzed ABCG2 in living cell membranes using a combination of fluorescence correlation spectroscopy, photon counting histogram anal., and stepwise photobleaching to demonstrate a predominantly tetrameric structure for ABCG2 in the presence or absence of transport substrates.  These results provide the essential basis for exploring pharmacol. manipulation of oligomeric state as a strategy to modulate ABCG2 activity in future selective therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCBGt4Y70W5LVg90H21EOLACvtfcHk0lhcKWoHkpiKtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Chtb%252FN&md5=89fe45505b932fa860e4c9151fc610e0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2015.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2015.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DK.%26aulast%3DBriddon%26aufirst%3DS.%2BJ.%26aulast%3DHolliday%26aufirst%3DN.%2BD.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26atitle%3DPlasma%2520Membrane%2520Dynamics%2520and%2520Tetrameric%2520Organisation%2520of%2520ABCG2%2520Transporters%2520in%2520Mammalian%2520Cells%2520Revealed%2520by%2520Single%2520Particle%2520Imaging%2520Techniques%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2016%26volume%3D1863%26spage%3D19%26epage%3D29%26doi%3D10.1016%2Fj.bbamcr.2015.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Multidrug Resistance in Cancer: Role of ATP-Dependent Transporters</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">48</span>â <span class="NLM_lpage">58</span>, <span class="refDoi">Â DOI: 10.1038/nrc706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+Resistance+in+Cancer%3A+Role+of+ATP-Dependent+Transporters&doi=10.1038%2Fnrc706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0li3p5JepBUUxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520Resistance%2520in%2520Cancer%253A%2520Role%2520of%2520ATP-Dependent%2520Transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58%26doi%3D10.1038%2Fnrc706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C. H.</span></span> <span> </span><span class="NLM_article-title">ABC Transporters as Multidrug Resistance Mechanisms and the Development of Chemosensitizers for Their Reversal</span>. <i>Cancer Cell Int.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">30</span>, <span class="refDoi">Â DOI: 10.1186/1475-2867-5-30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1186%2F1475-2867-5-30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=16202168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BD2Mrpt1Cktw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=30&author=C.+H.+Choi&title=ABC+Transporters+as+Multidrug+Resistance+Mechanisms+and+the+Development+of+Chemosensitizers+for+Their+Reversal&doi=10.1186%2F1475-2867-5-30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal</span></div><div class="casAuthors">Choi Cheol-Hee</div><div class="citationInfo"><span class="NLM_cas:title">Cancer cell international</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">One of the major problems related with anticancer chemotherapy is resistance against anticancer drugs.  The ATP-binding cassette (ABC) transporters are a family of transporter proteins that are responsible for drug resistance and a low bioavailability of drugs by pumping a variety of drugs out cells at the expense of ATP hydrolysis.  One strategy for reversal of the resistance of tumor cells expressing ABC transporters is combined use of anticancer drugs with chemosensitizers.  In this review, the physiological functions and structures of ABC transporters, and the development of chemosensitizers are described focusing on well-known proteins including P-glycoprotein, multidrug resistance associated protein, and breast cancer resistance protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB3dpAGea7Lv6AExegM5LLfW6udTcc2eaLsiJcKKfTDLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mrpt1Cktw%253D%253D&md5=8c71bb7c9430849683582877cfb64a19</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1475-2867-5-30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2867-5-30%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DC.%2BH.%26atitle%3DABC%2520Transporters%2520as%2520Multidrug%2520Resistance%2520Mechanisms%2520and%2520the%2520Development%2520of%2520Chemosensitizers%2520for%2520Their%2520Reversal%26jtitle%3DCancer%2520Cell%2520Int.%26date%3D2005%26volume%3D5%26spage%3D30%26doi%3D10.1186%2F1475-2867-5-30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikadi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span> <span> </span><span class="NLM_article-title">The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes With Mitoxantrone</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">482</span>â <span class="NLM_lpage">493</span>, <span class="refDoi">Â DOI: 10.1016/j.str.2010.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.str.2010.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=20399185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKnu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=482-493&author=M.+F.+Rosenbergauthor=Z.+Bikadiauthor=J.+Chanauthor=X.+Liuauthor=Z.+Niauthor=X.+Caiauthor=R.+C.+Fordauthor=Q.+Mao&title=The+Human+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29+Shows+Conformational+Changes+With+Mitoxantrone&doi=10.1016%2Fj.str.2010.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone</span></div><div class="casAuthors">Rosenberg, Mark F.; Bikadi, Zsolt; Chan, Janice; Liu, Xiaoping; Ni, Zhanglin; Cai, Xiaokun; Ford, Robert C.; Mao, Qingcheng</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">482-493</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">BCRP/ABCG2 mediates efflux of drugs and xenobiotics.  BCRP was expressed in Pichia pastoris, purified to > 90% homogeneity, and subjected to two-dimensional (2D) crystn.  The 2D crystals showed a p121 symmetry and projection maps were detd. at 5 Ã resoln. by cryo-electron microscopy.  Two crystal forms with and without mitoxantrone were obsd. with unit cell dimensions of a = 55.4 Ã, b = 81.4 Ã, Î³ = 89.8Â°, and a = 57.3 Ã, b = 88.0 Ã, Î³ = 89.7Â°, resp.  The projection map without mitoxantrone revealed an asym. structure with ring-shaped d. features probably corresponding to a bundle of transmembrane Î± helixes, and appeared more open and less sym. than the map with mitroxantrone.  The open and closed inward-facing forms of BCRP were generated by homol. modeling, representing the substrate-free and substrate-bound conformations in the absence of nucleotide, resp.  These models are consistent with the exptl. obsd. conformational change upon substrate binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy41Lg_ARysLVg90H21EOLACvtfcHk0li3p5JepBUUxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKnu7s%253D&md5=259f90447cbb30589018f12c155cf19e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2010.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2010.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DM.%2BF.%26aulast%3DBikadi%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DFord%26aufirst%3DR.%2BC.%26aulast%3DMao%26aufirst%3DQ.%26atitle%3DThe%2520Human%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%2520Shows%2520Conformational%2520Changes%2520With%2520Mitoxantrone%26jtitle%3DStructure%26date%3D2010%26volume%3D18%26spage%3D482%26epage%3D493%26doi%3D10.1016%2Fj.str.2010.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abruzzo, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rishi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. D.</span></span> <span> </span><span class="NLM_article-title">A Multidrug Resistance Transporter From Human MCF-7 Breast Cancer Cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">15665</span>â <span class="NLM_lpage">15670</span>, <span class="refDoi">Â DOI: 10.1073/pnas.95.26.15665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=T.+Krogmannauthor=Y.+Gaoauthor=A.+K.+Rishiauthor=D.+D.+Ross&title=A+Multidrug+Resistance+Transporter+From+Human+MCF-7+Breast+Cancer+Cells&doi=10.1073%2Fpnas.95.26.15665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0li3p5JepBUUxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DA%2520Multidrug%2520Resistance%2520Transporter%2520From%2520Human%2520MCF-7%2520Breast%2520Cancer%2520Cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670%26doi%3D10.1073%2Fpnas.95.26.15665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abruzzo, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. A.</span></span> <span> </span><span class="NLM_article-title">Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell Lines</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">429</span>â <span class="NLM_lpage">433</span>, <span class="refDoi">Â DOI: 10.1093/jnci/91.5.429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1093%2Fjnci%2F91.5.429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10070941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFKitL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=429-433&author=D.+D.+Rossauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=W.+S.+Daltonauthor=E.+Schneiderauthor=H.+Lageauthor=M.+Dietelauthor=L.+Greenbergerauthor=S.+P.+Coleauthor=L.+A.+Doyle&title=Atypical+Multidrug+Resistance%3A+Breast+Cancer+Resistance+Protein+Messenger+RNA+Expression+in+Mitoxantrone-Selected+Cell+Lines&doi=10.1093%2Fjnci%2F91.5.429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines</span></div><div class="casAuthors">Ross, Douglas D.; Yang, Weidong; Abruzzo, Lynne V.; Dalton, William S.; Schneider, Erasmus; Lage, Hermann; Dietel, Manfred; Greenberger, Lee; Cole, Susan P. C.; Doyle, L. Austin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">429-433</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Human cancer cell lines grown in the presence of the cytotoxic agent mitoxantrone frequently develop resistance assocd. with a redn. in intracellular drug accumulation without increased expression of the known drug resistance transporters P-glycoprotein and multidrug resistance protein (also known as multidrug resistance-assocd. protein).  Breast cancer resistance protein (BCRP) is a recently described ATP-binding cassette transporter assocd. with resistance to mitoxantrone and anthracyclines.  This study was undertaken to test the prevalence of BCRP overexpression in cell lines selected for growth in the presence of mitoxantrone.  Total cellular RNA or poly A+ RNA and genomic DNA were isolated from parental and drug-selected cell lines.  Expression of BCRP mRNA (mRNA) and amplification of the BCRP gene were analyzed by northern and Southern blot hybridization, resp.  A variety of drug-resistant human cancer cell lines derived by selection with mitoxantrone markedly overexpressed BCRP mRNA; these cell lines included sublines of human breast carcinoma (MCF-7), colon carcinoma (S1 and HT29), gastric carcinoma (EPG85-257), fibrosarcoma (EPF86-079), and myeloma (8226) origins.  Anal. of genomic DNA from BCRP-overexpressing MCF-7/MX cells demonstrated that the BCRP gene was also amplified in these cells.  Overexpression of BCRP mRNA is frequently obsd. in multidrug-resistant cell lines selected with mitoxantrone, suggesting that BCRP is likely to be a major cellular defense mechanism elicited in response to exposure to this drug.  It is likely that BCRP is the putative "mitoxantrone transporter" hypothesized to be present in these cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzGmjzgx9WyLVg90H21EOLACvtfcHk0liLbEIKY0oDGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFKitL8%253D&md5=04bd7b3c3d73f64ea10f9bb43b9d67e5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.5.429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.5.429%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%2BD.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DDalton%26aufirst%3DW.%2BS.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DLage%26aufirst%3DH.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DGreenberger%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26atitle%3DAtypical%2520Multidrug%2520Resistance%253A%2520Breast%2520Cancer%2520Resistance%2520Protein%2520Messenger%2520RNA%2520Expression%2520in%2520Mitoxantrone-Selected%2520Cell%2520Lines%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D429%26epage%3D433%26doi%3D10.1093%2Fjnci%2F91.5.429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span> <span> </span><span class="NLM_article-title">Cross-Resistance to Camptothecin Analogues in a Mitoxantrone-Resistant Human Breast Carcinoma Cell Line is Not Due to DNA Topoisomerase I Alterations</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4004</span>â <span class="NLM_lpage">4009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=4004-4009&author=C.+J.+Yangauthor=J.+K.+Hortonauthor=K.+H.+Cowanauthor=E.+Schneider&title=Cross-Resistance+to+Camptothecin+Analogues+in+a+Mitoxantrone-Resistant+Human+Breast+Carcinoma+Cell+Line+is+Not+Due+to+DNA+Topoisomerase+I+Alterations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BJ.%26aulast%3DHorton%26aufirst%3DJ.%2BK.%26aulast%3DCowan%26aufirst%3DK.%2BH.%26aulast%3DSchneider%26aufirst%3DE.%26atitle%3DCross-Resistance%2520to%2520Camptothecin%2520Analogues%2520in%2520a%2520Mitoxantrone-Resistant%2520Human%2520Breast%2520Carcinoma%2520Cell%2520Line%2520is%2520Not%2520Due%2520to%2520DNA%2520Topoisomerase%2520I%2520Alterations%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D4004%26epage%3D4009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacy, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">(2013). Molecular Pharmacology of ABCG2 and its Role in Chemoresistance</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">655</span>â <span class="NLM_lpage">669</span>, <span class="refDoi">Â DOI: 10.1124/mol.113.088609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1124%2Fmol.113.088609" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=655-669&author=A.+E.+Stacyauthor=P.+J.+Janssonauthor=D.+R.+Richardson&title=%282013%29.+Molecular+Pharmacology+of+ABCG2+and+its+Role+in+Chemoresistance&doi=10.1124%2Fmol.113.088609"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.088609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.088609%26sid%3Dliteratum%253Aachs%26aulast%3DStacy%26aufirst%3DA.%2BE.%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3D%25282013%2529.%2520Molecular%2520Pharmacology%2520of%2520ABCG2%2520and%2520its%2520Role%2520in%2520Chemoresistance%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D655%26epage%3D669%26doi%3D10.1124%2Fmol.113.088609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krapf, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5449</span>â <span class="NLM_lpage">5461</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b00330</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00330" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCnurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5449-5461&author=M.+K.+Krapfauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+4-Anilino-quinazolines+and+-quinolines+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1021%2Facs.jmedchem.6b00330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span></div><div class="casAuthors">Krapf, Michael K.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5449-5461</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemotherapeutic treatment of cancer often fails due to overexpression of the ATP-binding cassette (ABC) transport proteins, like ABCG2, triggering active efflux of various structurally unrelated drugs.  This so-called multidrug resistance (MDR) may be reversed by selective, potent, and nontoxic inhibitors of ABCG2.  As only a few potent inhibitors are known, new compds. based on a 4-substituted-2-phenylquinazoline scaffold were investigated.  Substitution with hydroxy, cyano, nitro, acetamido, and fluoro, e.g., I, led to high inhibitory activities toward ABCG2.  The ability to reverse MDR of the most active compds. was confirmed in a MTT efficacy assay.  Moreover, a negligibly low intrinsic cytotoxicity was found resulting in a high therapeutic ratio.  Investigations of the inhibitory activity toward ABCB1 and ABCC1 yielded a high selectivity toward ABCG2 for the quinazoline compds.  Quinoline-based analogs showed lower inhibitory activity and selectivity.  The study yielded a variety of promising compds., some with superior properties compared to those of the std. inhibitor Ko143.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdz9Uvqz3i6rVg90H21EOLACvtfcHk0liYsWSEZlwtVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCnurY%253D&md5=a127c60fe7ecf9d5fc76a13903e794db</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00330%26sid%3Dliteratum%253Aachs%26aulast%3DKrapf%26aufirst%3DM.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25204-Anilino-quinazolines%2520and%2520-quinolines%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5449%26epage%3D5461%26doi%3D10.1021%2Facs.jmedchem.6b00330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benderra, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faussat, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayada, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaoui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morjani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzac, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marie, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, O.</span></span> <span> </span><span class="NLM_article-title">MRP3, BCRP, and P-glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">7764</span>â <span class="NLM_lpage">7772</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-04-1895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1158%2F1078-0432.CCR-04-1895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=16278398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2isL7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=7764-7772&author=Z.+Benderraauthor=A.+M.+Faussatauthor=L.+Sayadaauthor=J.+Y.+Perrotauthor=R.+Tangauthor=D.+Chaouiauthor=H.+Morjaniauthor=C.+Marzacauthor=J.+P.+Marieauthor=O.+Legrand&title=MRP3%2C+BCRP%2C+and+P-glycoprotein+Activities+are+Prognostic+Factors+in+Adult+Acute+Myeloid+Leukemia&doi=10.1158%2F1078-0432.CCR-04-1895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia</span></div><div class="casAuthors">Benderra, Zineb; Faussat, Anne Marie; Sayada, Lydia; Perrot, Jean-Yves; Tang, Ruoping; Chaoui, Driss; Morjani, Hamid; Marzac, Christophe; Marie, Jean-Pierre; Legrand, Ollivier</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7764-7772</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: P-Glycoprotein (Pgp) is assocd. with poor outcome in acute myeloid leukemia (AML).  We have investigated other ATP-binding cassette proteins such as BCRP, MRP1, MRP2, MRP3, and MRP5 for their potential implication in chemoresistance.  Exptl. Design and Results: Eighty five AML patient samples were analyzed in this study.  First, MRP3 function was higher in patients which had a high level of leukocytes (P = 0.01), a M5 FAB subtype (P = 0.04), and an intermediate or poor cytogenesis (P = 0.05).  BCRP activity was not correlated with clin. or biol. variables, but high Pgp activity was correlated with the following variables: CD34 expression (P = 0.002), FAB subtype (P = 0.002), intermediate or poor cytogenesis (P = 0.02), and elderly patients (P = 0.03).  Second, Pgp, MRP3, and BCRP activities were correlated with complete remission (P = 0.02, P = 0.04, and P = 0.04, resp.), disease-free survival (P = 0.02, P = 0.03, and P = 0.25, resp.), and overall survival (P = 0.04, P = 0.04, and P = 0.05, resp.) in multivariate anal.  The patient samples expressing one or none of these Pgp, MRP3, or BCRP functional proteins have a better prognosis than the patients expressing two or three of these functional proteins (complete remission, P = 0.02; disease-free survival, P = 0.01; overall survival, P < 0.001).  CONCLUSIONS: BCRP and MRP3 may also be involved in chemoresistance in AML, esp. MRP3 in patients with M5 FAB.  Addnl. modulation of BCRP or MRP3 to Pgp modulation may be necessary in some patients in order to improve the treatment outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzcXu2YFnW5rVg90H21EOLACvtfcHk0liYsWSEZlwtVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2isL7J&md5=9ca416f2f8183a2db04ac4993dc2af02</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1895%26sid%3Dliteratum%253Aachs%26aulast%3DBenderra%26aufirst%3DZ.%26aulast%3DFaussat%26aufirst%3DA.%2BM.%26aulast%3DSayada%26aufirst%3DL.%26aulast%3DPerrot%26aufirst%3DJ.%2BY.%26aulast%3DTang%26aufirst%3DR.%26aulast%3DChaoui%26aufirst%3DD.%26aulast%3DMorjani%26aufirst%3DH.%26aulast%3DMarzac%26aufirst%3DC.%26aulast%3DMarie%26aufirst%3DJ.%2BP.%26aulast%3DLegrand%26aufirst%3DO.%26atitle%3DMRP3%252C%2520BCRP%252C%2520and%2520P-glycoprotein%2520Activities%2520are%2520Prognostic%2520Factors%2520in%2520Adult%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D7764%26epage%3D7772%26doi%3D10.1158%2F1078-0432.CCR-04-1895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M. G.</span></span> <span> </span><span class="NLM_article-title">Enhanced Efficacy of Photodynamic Therapy by Inhibiting ABCG2 in Colon Cancers</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">504</span>, <span class="refDoi">Â DOI: 10.1186/s12885-015-1514-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1186%2Fs12885-015-1514-4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=504&author=J.+H.+Kimauthor=J.+M.+Parkauthor=Y.+J.+Rohauthor=I.+W.+Kimauthor=T.+Hasanauthor=M.+G.+Choi&title=Enhanced+Efficacy+of+Photodynamic+Therapy+by+Inhibiting+ABCG2+in+Colon+Cancers&doi=10.1186%2Fs12885-015-1514-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1514-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1514-4%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BM.%26aulast%3DRoh%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DI.%2BW.%26aulast%3DHasan%26aufirst%3DT.%26aulast%3DChoi%26aufirst%3DM.%2BG.%26atitle%3DEnhanced%2520Efficacy%2520of%2520Photodynamic%2520Therapy%2520by%2520Inhibiting%2520ABCG2%2520in%2520Colon%2520Cancers%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D504%26doi%3D10.1186%2Fs12885-015-1514-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, A.</span></span> <span> </span><span class="NLM_article-title">Expression of Breast Cancer Resistance Protein is Associated With a Poor Clinical Outcome in Patients With Small-Cell Lung Cancer</span>. <i>Lung Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">105</span>â <span class="NLM_lpage">111</span>, <span class="refDoi">Â DOI: 10.1016/j.lungcan.2008.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.lungcan.2008.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=19036469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BD1Mzotl2hsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=105-111&author=Y.+H.+Kimauthor=G.+Ishiiauthor=K.+Gotoauthor=S.+Otaauthor=K.+Kubotaauthor=Y.+Murataauthor=M.+Mishimaauthor=N.+Saijoauthor=Y.+Nishiwakiauthor=A.+Ochiai&title=Expression+of+Breast+Cancer+Resistance+Protein+is+Associated+With+a+Poor+Clinical+Outcome+in+Patients+With+Small-Cell+Lung+Cancer&doi=10.1016%2Fj.lungcan.2008.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer</span></div><div class="casAuthors">Kim Young Hak; Ishii Genichiro; Goto Koichi; Ota Shuji; Kubota Kaoru; Murata Yukinori; Mishima Michiaki; Saijo Nagahiro; Nishiwaki Yutaka; Ochiai Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Lung cancer (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  ATP-binding cassette (ABC) transporter and DNA excision repair proteins play a pivotal role in the mechanisms of drug resistance.  The aim of this study was to investigate the expression of ABC transporter and DNA excision repair proteins, and to elucidate the clinical significance of their expression in biopsy specimens from patients with small-cell lung cancer (SCLC).  METHODS:  We investigated expression of the ABC transporter proteins, P-glycoprotein (Pgp), multidrug resistance associated-protein 1 (MRP1), MRP2, MRP3, and breast cancer resistance protein (BCRP), and the DNA excision repair proteins, excision repair cross-complementation group 1 (ERCC1) protein and breast cancer susceptibility gene 1 (BRCA1) protein, in tumor biopsy specimens obtained before chemotherapy from 130 SCLC patients who later received platinum-based combination chemotherapy, and investigated the relationship between their expression and both response and survival.  RESULTS:  No significant associations were found between expression of Pgp, MRP1, MRP2, MRP3, ERCC1, or BRCA1 and either response or survival.  However, there was a significant association between BCRP expression and both response (p=0.026) and progression-free survival (PFS; p=0.0103).  CONCLUSIONS:  BCRP expression was significantly predictive of both response and progression-free survival (PFS) in SCLC patients receiving chemotherapy.  These findings suggest that BCRP may play a crucial role in drug resistance mechanisms, and that it may serve as an ideal molecular target for the treatment of SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbY9UEAyJVSs-crCu0nI_sfW6udTcc2eb3zhlUKVX0Hbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mzotl2hsw%253D%253D&md5=879423621387778616666b1a58bb5f6f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2008.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2008.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DIshii%26aufirst%3DG.%26aulast%3DGoto%26aufirst%3DK.%26aulast%3DOta%26aufirst%3DS.%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DMishima%26aufirst%3DM.%26aulast%3DSaijo%26aufirst%3DN.%26aulast%3DNishiwaki%26aufirst%3DY.%26aulast%3DOchiai%26aufirst%3DA.%26atitle%3DExpression%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520is%2520Associated%2520With%2520a%2520Poor%2520Clinical%2520Outcome%2520in%2520Patients%2520With%2520Small-Cell%2520Lung%2520Cancer%26jtitle%3DLung%2520Cancer%26date%3D2009%26volume%3D65%26spage%3D105%26epage%3D111%26doi%3D10.1016%2Fj.lungcan.2008.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabindran, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annable, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, L. M.</span></span> <span> </span><span class="NLM_article-title">Reversal of a Novel Multidrug Resistance Mechanism in Human Colon Carcinoma Cells by Fumitremorgin C</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5850</span>â <span class="NLM_lpage">5858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=9865745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXivFah" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=5850-5858&author=S.+K.+Rabindranauthor=H.+Heauthor=M.+Singhauthor=E.+Brownauthor=K.+I.+Collinsauthor=T.+Annableauthor=L.+M.+Greenberger&title=Reversal+of+a+Novel+Multidrug+Resistance+Mechanism+in+Human+Colon+Carcinoma+Cells+by+Fumitremorgin+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C</span></div><div class="casAuthors">Rabindran, Sridhar K.; He, Haiyin; Singh, Maya; Brown, Eileen; Collins, Karen I.; Annable, Tami; Greenberger, Lee M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5850-5858</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">We selected a human colon carcinoma cell line in increasing concns. of mitoxantrone to obtain a resistant subline, S1-M1-3.2, with the following characteristics: profound resistance to mitoxantrone; significant cross-resistance to doxorubicin, bisantrene, and topotecan; and very low levels of resistance to Taxol, vinblastine, colchicine, and camptothecin.  This multidrug resistance (MDR) phenotype, which was not reversed by verapamil or another potent P-glycoprotein (Pgp) inhibitor, CL 329,753, was dependent, in part, upon an energy-dependent drug efflux mechanism.  Pgp and the multidrug resistance protein (MRP) were not elevated in the resistant cells relative to the drug-sensitive parent, suggesting that resistance was mediated by a novel pathway of drug transport.  A cell-based screen with S1-M1-3.2 cells was used to identify agents capable of circumventing this non-Pgp, non-MRP MDR.  One of the active agents identified was a mycotoxin, fumitremorgin C.  This mol. was extremely effective in reversing resistance to mitoxantrone, doxorubicin, and topotecan in multidrug-selected cell lines showing this novel phenotype.  Reversal of resistance was assocd. with an increase in drug accumulation.  The compd. did not reverse drug resistance in cells with elevated expression of Pgp or MRP.  We suggest that fumitremorgin C is a highly selective chemosensitizing agent for the resistance pathway we have identified and can be used as a specific pharmacol. probe to distinguish between the diverse resistance mechanisms that occur in the MDR cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-Y6qf2FmRbVg90H21EOLACvtfcHk0lhPATsVDOz2ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFah&md5=cacafc261f829003219cdd9f518ac900</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DK.%2BI.%26aulast%3DAnnable%26aufirst%3DT.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26atitle%3DReversal%2520of%2520a%2520Novel%2520Multidrug%2520Resistance%2520Mechanism%2520in%2520Human%2520Colon%2520Carcinoma%2520Cells%2520by%2520Fumitremorgin%2520C%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D5850%26epage%3D5858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loevezijn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakhai, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Valk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Tellingen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koomen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">Potent and Specific Inhibition of the Breast Cancer Resistance Protein Multidrug Transporter in Vitro and in Mouse Intestine by a Novel Analogue of Fumitremorgin C</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">417</span>â <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.4161%2Fcbt.1.4.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=12477054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=417-425&author=J.+D.+Allenauthor=A.+van+Loevezijnauthor=J.+M.+Lakhaiauthor=M.+van+der+Valkauthor=O.+van+Tellingenauthor=G.+Reidauthor=J.+H.+Schellensauthor=G.+J.+Koomenauthor=A.+H.+Schinkel&title=Potent+and+Specific+Inhibition+of+the+Breast+Cancer+Resistance+Protein+Multidrug+Transporter+in+Vitro+and+in+Mouse+Intestine+by+a+Novel+Analogue+of+Fumitremorgin+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C</span></div><div class="casAuthors">Allen, John D.; Van Loevezijn, Arnold; Lakhai, Jeany M.; Van der Valk, Martin; Van Tellingen, Olaf; Reid, Glen; Schellens, Jan H. M.; Koomen, Gerrit-Jan; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">417-425</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitors of the breast cancer resistance protein (BCRP/ABCG2) multidrug transporter are of interest as chemosensitizers for clin. drug resistance, for improving the pharmacokinetics of substrate chemotherapeutic drugs, and in functional assays of BCRP activity for tailoring chemotherapy.  The fungal toxin fumitremorgin C (FTC) is a potent and specific inhibitor of BCRP, but its neurotoxic effects preclude use in vivo.  We have therefore evaluated a new tetracyclic analog of FTC, Ko143, as a practical inhibitor of BCRP, comparing it with two other analogs in the same class and with GF120918.  All three FTC analogs are effective inhibitors of both mouse Bcrp1 and human BCRP, proving highly active for increasing the intracellular drug accumulation and reversing Bcrp1/BCRP-mediated multidrug resistance.  Indeed, Ko143 appears to be the most potent BCRP inhibitor known thus far.  In contrast, the compds. have only low activity against P-glycoprotein, the multidrug resistance-assocd. protein (MRP1), or other known drug transporters.  They are nontoxic in vitro at useful concns. and evinced no signs of toxicity in mice at high oral or i.p. doses.  Administered p.o. to inhibit intestinal Bcrp1, Ko143 markedly increased the oral availability of topotecan in mice.  It is thus the first highly potent and specific BCRP inhibitor applicable in vivo.  As such, Ko143 and other FTC analogs of this type represent valuable reagents for anal. of drug resistance mechanisms and may be candidates for development as clin. BCRP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdmIQAa5j5rVg90H21EOLACvtfcHk0lhPATsVDOz2ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7g%253D&md5=8a54c6c38d9639ec70faa97a279d0a12</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.4161%2Fcbt.1.4.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.1.4.22%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3Dvan%2BLoevezijn%26aufirst%3DA.%26aulast%3DLakhai%26aufirst%3DJ.%2BM.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DM.%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DKoomen%26aufirst%3DG.%2BJ.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DPotent%2520and%2520Specific%2520Inhibition%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520Multidrug%2520Transporter%2520in%2520Vitro%2520and%2520in%2520Mouse%2520Intestine%2520by%2520a%2520Novel%2520Analogue%2520of%2520Fumitremorgin%2520C%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D417%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weidner, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambudkar, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span> <span> </span><span class="NLM_article-title">The Inhibitor Ko143 is Not Specific for ABCG2</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">384</span>â <span class="NLM_lpage">393</span>, <span class="refDoi">Â DOI: 10.1124/jpet.115.225482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1124%2Fjpet.115.225482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=26148857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=384-393&author=L.+D.+Weidnerauthor=S.+S.+Zoghbiauthor=S.+Luauthor=S.+Shuklaauthor=S.+V.+Ambudkarauthor=V.+W.+Pikeauthor=J.+Mulderauthor=M.+M.+Gottesmanauthor=R.+B.+Innisauthor=M.+D.+Hall&title=The+Inhibitor+Ko143+is+Not+Specific+for+ABCG2&doi=10.1124%2Fjpet.115.225482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitor Ko143 is not specific for ABCG2</span></div><div class="casAuthors">Weidner, Lora D.; Zoghbi, Sami S.; Lu, Shuiyu; Shukla, Suneet; Ambudkar, Suresh V.; Pike, Victor W.; Mulder, Jan; Gottesman, Michael M.; Innis, Robert B.; Hall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-393</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Imaging ATP-binding cassette (ABC) transporter activity in vivo with positron emission tomog. requires both a substrate and a transporter inhibitor.  However, for ABCG2, there is no inhibitor proven to be specific to that transporter alone at the blood-brain barrier.  Ko143 [(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester], a nontoxic analog of fungal toxin fumitremorgin C, is a potent inhibitor of ABCG2, although its specificity in mouse and human systems is unclear.  This study examd. the selectivity of Ko143 using human embryonic kidney cell lines transfected with ABCG2, ABCB1, or ABCC1 in several in vitro assays.  The stability of Ko143 in rat plasma was measured using high performance liq. chromatog.  Our results show that, in addn. to being a potent inhibitor of ABCG2, at higher concns. (â¥1 Î¼M) Ko143 also has an effect on the transport activity of both ABCB1 and ABCC1.  Furthermore, Ko143 was found to be unstable in rat plasma.  These findings indicate that Ko143 lacks specificity for ABCG2 and this should be taken into consideration when using Ko143 for both in vitro and in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqWjvTByDwbLVg90H21EOLACvtfcHk0lhPATsVDOz2ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L&md5=4336228ff99f608f6452dca312e78a5a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.225482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.225482%26sid%3Dliteratum%253Aachs%26aulast%3DWeidner%26aufirst%3DL.%2BD.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DS.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DHall%26aufirst%3DM.%2BD.%26atitle%3DThe%2520Inhibitor%2520Ko143%2520is%2520Not%2520Specific%2520for%2520ABCG2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D384%26epage%3D393%26doi%3D10.1124%2Fjpet.115.225482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barron, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moseley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, J. A.</span></span> <span> </span><span class="NLM_article-title">Differential Sensitivity in Cell Lines to Photodynamic Therapy in Combination with ABCG2 Inhibition</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1016/j.jphotobiol.2013.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.jphotobiol.2013.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=23911860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGrurvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=87-96&author=G.+A.+Barronauthor=H.+Moseleyauthor=J.+A.+Woods&title=Differential+Sensitivity+in+Cell+Lines+to+Photodynamic+Therapy+in+Combination+with+ABCG2+Inhibition&doi=10.1016%2Fj.jphotobiol.2013.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition</span></div><div class="casAuthors">Barron, Gemma A.; Moseley, Harry; Woods, Julie A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ABCG2 is an ATP-binding cassette transporter protein which has a role in the regulation of endogenous protoporphyrin IX (PpIX) levels.  To understand the influence of ABCG2 on porphyrin-based photodynamic therapy (PDT) and fluorescence diagnosis (FD), we examd. the role of endogenous ABCG2 in four human cell lines from the epidermis (HaCaT keratinocytes), esophagus (OE19 adenocarcinoma), brain (SH-SY5Y neuroblastoma) and bladder (HT1197 carcinoma).  Cells were incubated with ALA or MAL in the presence or absence of the ABCG2 activity inhibitor Ko-143.  Porphyrin accumulation was detected by spectrofluorimetric anal. and high performance liq. chromatog. (HPLC) with porphyrin localization obsd. by confocal laser scanning microscopy.  PDT efficacy was assessed 24 h post irradn. (1.5 J/cm2 red light) by the neutral red (NR) assay.  We show cell-specific differences when Ko-143 was co-incubated with ALA or, in particular with, MAL.  Enhanced PDT-induced cell kill was shown in HaCaT, OE19 and HT1197 cells, but not SH-SY5Y cells and could be explained by porphyrin accumulation and expression of ABCG2.  We have also found that despite high levels of intracellular PpIX, the OE19 cells were protected from phototoxic cell death by PpIX compartmentalization.  This could be reversed by Ko-143.  The results from this study show a possible cause of reduced sensitivity to ALA/MAL-PDT, with a potential soln. to overcome this effect in certain tissue types.  The potential to improve PDT with Ko-143 remains promising.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrYmt0BikYq7Vg90H21EOLACvtfcHk0ljWDCzASIhSjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGrurvE&md5=379430547d7baba8aca03101681d1b30</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2013.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2013.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DBarron%26aufirst%3DG.%2BA.%26aulast%3DMoseley%26aufirst%3DH.%26aulast%3DWoods%26aufirst%3DJ.%2BA.%26atitle%3DDifferential%2520Sensitivity%2520in%2520Cell%2520Lines%2520to%2520Photodynamic%2520Therapy%2520in%2520Combination%2520with%2520ABCG2%2520Inhibition%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2013%26volume%3D126%26spage%3D87%26epage%3D96%26doi%3D10.1016%2Fj.jphotobiol.2013.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozvegy-Laczka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegedus, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ¡rady, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujhelly, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuetz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ¡radi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ©ri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orfi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">NÃ©met, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">High-affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2Multidrug Transporter</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1485</span>â <span class="NLM_lpage">1495</span>, <span class="refDoi">Â DOI: 10.1124/mol.65.6.1485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1124%2Fmol.65.6.1485" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=1485-1495&author=C.+Ozvegy-Laczkaauthor=T.+Hegedusauthor=G.+V%C3%A1radyauthor=O.+Ujhellyauthor=J.+D.+Schuetzauthor=A.+V%C3%A1radiauthor=G.+K%C3%A9riauthor=L.+Orfiauthor=K.+N%C3%A9metauthor=B.+Sarkadi&title=High-affinity+Interaction+of+Tyrosine+Kinase+Inhibitors+with+the+ABCG2Multidrug+Transporter&doi=10.1124%2Fmol.65.6.1485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fmol.65.6.1485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.65.6.1485%26sid%3Dliteratum%253Aachs%26aulast%3DOzvegy-Laczka%26aufirst%3DC.%26aulast%3DHegedus%26aufirst%3DT.%26aulast%3DV%25C3%25A1rady%26aufirst%3DG.%26aulast%3DUjhelly%26aufirst%3DO.%26aulast%3DSchuetz%26aufirst%3DJ.%2BD.%26aulast%3DV%25C3%25A1radi%26aufirst%3DA.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DOrfi%26aufirst%3DL.%26aulast%3DN%25C3%25A9met%26aufirst%3DK.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DHigh-affinity%2520Interaction%2520of%2520Tyrosine%2520Kinase%2520Inhibitors%2520with%2520the%2520ABCG2Multidrug%2520Transporter%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D1485%26epage%3D1495%26doi%3D10.1124%2Fmol.65.6.1485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harwood, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuetz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchdunger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traxler, P.</span></span> <span> </span><span class="NLM_article-title">Imatinib Mesylate is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in Vitro</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">2333</span>â <span class="NLM_lpage">2337</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-03-3344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1158%2F0008-5472.CAN-03-3344" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=2333-2337&author=P.+J.+Houghtonauthor=G.+S.+Germainauthor=F.+C.+Harwoodauthor=J.+D.+Schuetzauthor=C.+F.+Stewartauthor=E.+Buchdungerauthor=P.+Traxler&title=Imatinib+Mesylate+is+a+Potent+Inhibitor+of+the+ABCG2+%28BCRP%29+Transporter+and+Reverses+Resistance+to+Topotecan+and+SN-38+in+Vitro&doi=10.1158%2F0008-5472.CAN-03-3344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-3344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-3344%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DGermain%26aufirst%3DG.%2BS.%26aulast%3DHarwood%26aufirst%3DF.%2BC.%26aulast%3DSchuetz%26aufirst%3DJ.%2BD.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3DImatinib%2520Mesylate%2520is%2520a%2520Potent%2520Inhibitor%2520of%2520the%2520ABCG2%2520%2528BCRP%2529%2520Transporter%2520and%2520Reverses%2520Resistance%2520to%2520Topotecan%2520and%2520SN-38%2520in%2520Vitro%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D2333%26epage%3D2337%26doi%3D10.1158%2F0008-5472.CAN-03-3344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SzakÃ¡cs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boumendjel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachadourian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baubichon-Cortay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, A.</span></span> <span> </span><span class="NLM_article-title">Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">5753</span>â <span class="NLM_lpage">5774</span>, <span class="refDoi">Â DOI: 10.1021/cr4006236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4006236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmslSqs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=5753-5774&author=G.+Szak%C3%A1csauthor=M.+D.+Hallauthor=M.+M.+Gottesmanauthor=A.+Boumendjelauthor=R.+Kachadourianauthor=B.+J.+Dayauthor=H.+Baubichon-Cortayauthor=A.+Di+Pietro&title=Targeting+the+Achilles+Heel+of+Multidrug-Resistant+Cancer+by+Exploiting+the+Fitness+Cost+of+Resistance&doi=10.1021%2Fcr4006236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance</span></div><div class="casAuthors">Szakacs, Gergely; Hall, Matthew D.; Gottesman, Michael M.; Boumendjel, Ahcene; Kachadourian, Remy; Day, Brian J.; Baubichon-Cortay, Helene; Di Pietro, Attilio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5753-5774</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of multidrug resistance (MDR) in patients suffering cancer remains a significant clin. challenge, with drug efflux by ABC (ATP-binding cassette) transporters contributing significantly.  Strategies to circumvent the reduced drug accumulation conferred by these polyspecific efflux transporters have relied on attempts to develop drugs that bypass extrusion or the exploration of clin. inhibitors that, although showing promise in vitro, have not translated to the clinic.  Alterations that confer selective advantage during the evolution of cancer cells might also create vulnerabilities that can be exploited therapeutically.  As defined by Szybalski and Bryson, collateral sensitivity is a "phenomenon in drug-resistant cells (prokaryotic or eukaryotic) identified during most in vitro studies... [whereby] the development of resistance in cells to one agent can confer higher sensitivity to an alternate agent than seen in the original (parental) line" .  In other words, the resistant cell line is more sensitive to a cytotoxin than the parental line from which it is derived.  From this perspective, resistance can be interpreted as a trait that could be targeted by new drugs.  In this review, we discuss general mechanisms underlying collateral sensitivity and focus on small mols. reported to elicit increased toxicity in cells overexpressing one of the 3 major multidrug transporters.  Such mols. (termed MDR-selective compds.) target multidrug-resistant cycling cells, suggesting that MDR Abc transporters could be considered as the ultimate "Achilles' heel" - the exquisite spot to fatally wound a multidrug-resistant cancer cell.  Herein, we discuss the potential of this emerging technol., cataloging MDR-selective compds. reported in the literature and highlighting chem. features that are assocd. with MDR-selective toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMLnJNMfm0QLVg90H21EOLACvtfcHk0ljWDCzASIhSjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmslSqs7Y%253D&md5=7d834ffe642887c535fc295efc772d73</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr4006236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4006236%26sid%3Dliteratum%253Aachs%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DKachadourian%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26aulast%3DBaubichon-Cortay%26aufirst%3DH.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520Achilles%2520Heel%2520of%2520Multidrug-Resistant%2520Cancer%2520by%2520Exploiting%2520the%2520Fitness%2520Cost%2520of%2520Resistance%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D5753%26epage%3D5774%26doi%3D10.1021%2Fcr4006236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tawar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwarakanath, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhury, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaitan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tandon, V.</span></span> <span> </span><span class="NLM_article-title">Influence of Phenyl Ring Disubstitution on Benzimidazole and Terbenzimidazole Cytotoxicity: Synthesis and Evaluation as Radioprotectors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3785</span>â <span class="NLM_lpage">3792</span>, <span class="refDoi">Â DOI: 10.1021/jm030114w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030114w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3785-3792&author=U.+Tawarauthor=A.+K.+Jainauthor=B.+S.+Dwarakanathauthor=R.+Chandraauthor=Y.+Singhauthor=N.+K.+Chaudhuryauthor=D.+Khaitanauthor=V.+Tandon&title=Influence+of+Phenyl+Ring+Disubstitution+on+Benzimidazole+and+Terbenzimidazole+Cytotoxicity%3A+Synthesis+and+Evaluation+as+Radioprotectors&doi=10.1021%2Fjm030114w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm030114w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030114w%26sid%3Dliteratum%253Aachs%26aulast%3DTawar%26aufirst%3DU.%26aulast%3DJain%26aufirst%3DA.%2BK.%26aulast%3DDwarakanath%26aufirst%3DB.%2BS.%26aulast%3DChandra%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DY.%26aulast%3DChaudhury%26aufirst%3DN.%2BK.%26aulast%3DKhaitan%26aufirst%3DD.%26aulast%3DTandon%26aufirst%3DV.%26atitle%3DInfluence%2520of%2520Phenyl%2520Ring%2520Disubstitution%2520on%2520Benzimidazole%2520and%2520Terbenzimidazole%2520Cytotoxicity%253A%2520Synthesis%2520and%2520Evaluation%2520as%2520Radioprotectors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3785%26epage%3D3792%26doi%3D10.1021%2Fjm030114w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krapf, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4474</span>â <span class="NLM_lpage">4495</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00441</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00441" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFSks7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4474-4495&author=M.+K.+Krapfauthor=J.+Gallusauthor=M.+Wiese&title=4-Anilino-2-pyridylquinazolines+and+-pyrimidines+as+Highly+Potent+and+Nontoxic+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1021%2Facs.jmedchem.7b00441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span></div><div class="casAuthors">Krapf, Michael K.; Gallus, Jennifer; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4474-4495</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transport proteins remains a major problem in the chemotherapeutic treatment of cancer and might be overcome by inhibition of the transporter.  Because of the lack of understanding, the complex mechanisms involved in the transport process, in particular for breast cancer resistance protein (BCRP/ABCG2), there is a persistent need for studies of inhibitors of ABCG2.  In this study, the authors investigated a systematic series of 4-substituted-2-pyridylquinazolines in terms of their inhibitory potency as well as selectivity toward ABCG2.  For comparison, the quinazoline scaffold was reduced to the significantly smaller 4-methylpyrimidine basic structure.  Furthermore, the cytotoxicity and the ability to reverse MDR was tested with the chemotherapeutic agents SN-38 and mitoxantrone (MX).  Interaction of the compds. with ABCG2 was investigated by a colorimetric ATPase assay.  Enzyme kinetic studies were carried out with Hoechst 33342 as fluorescent dye and substrate of ABCG2 to elucidate the compds. binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBVIj0DPElPrVg90H21EOLACvtfcHk0li8ipdL5rp4Ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFSks7k%253D&md5=cd9380f0b33fb110c3cde721345f6fe5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00441%26sid%3Dliteratum%253Aachs%26aulast%3DKrapf%26aufirst%3DM.%2BK.%26aulast%3DGallus%26aufirst%3DJ.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3D4-Anilino-2-pyridylquinazolines%2520and%2520-pyrimidines%2520as%2520Highly%2520Potent%2520and%2520Nontoxic%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4474%26epage%3D4495%26doi%3D10.1021%2Facs.jmedchem.7b00441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraege, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">The Combination of Quinazoline and Chalcone Moieties Leads to Novel Potent Heterodimeric Modulators of Breast Cancer Resistance Protein (BCRP/ABCG2)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">212</span>â <span class="NLM_lpage">229</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.03.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.ejmech.2016.03.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=27100033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFyms7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=212-229&author=S.+Kraegeauthor=K.+Stefanauthor=K.+Juvaleauthor=T.+Rossauthor=T.+Willmesauthor=M.+Wiese&title=The+Combination+of+Quinazoline+and+Chalcone+Moieties+Leads+to+Novel+Potent+Heterodimeric+Modulators+of+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29&doi=10.1016%2Fj.ejmech.2016.03.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kraege, Stefanie; Stefan, Katja; Juvale, Kapil; Ross, Thomas; Willmes, Thomas; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">212-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">During the last decade it has been found that chalcones and quinazolines are promising inhibitors of ABCG2.  The combination of these two scaffolds offers a new class of heterocyclic compds. with potentially high inhibitory activity against ABCG2.  For this purpose we investigated 22 different heterodimeric derivs.  In this series only methoxy groups were used as substituents as these had been proven superior for inhibitory activity of chalcones.  All compds. were tested for their inhibitory activity, specificity and cytotoxicity.  The most potent ABCG2 inhibitor in this series showed an IC50 value of 0.19 Î¼M.  It possesses low cytotoxicity (GI50 = 93 Î¼M), the ability to reverse MDR and is nearly selective toward ABCG2.  Most compds. contg. dimethoxy groups showed slight activity against ABCB1 too.  Among these three compds. (17, 19 and 24) showed even higher activity toward ABCB1 than ABCG2.  All inhibitors were further screened for their effect on basal ATPase activity.  Although the basal ATPase activity was partially stimulated, the compds. were not transported by ABCG2.  Thus, quinazoline-chalcones are a new class of effective ABCG2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAiBrpQVZkPrVg90H21EOLACvtfcHk0li8ipdL5rp4Ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFyms7Y%253D&md5=91877b15d0301ec2bbcd468f63ea1a2b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.067%26sid%3Dliteratum%253Aachs%26aulast%3DKraege%26aufirst%3DS.%26aulast%3DStefan%26aufirst%3DK.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DRoss%26aufirst%3DT.%26aulast%3DWillmes%26aufirst%3DT.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DThe%2520Combination%2520of%2520Quinazoline%2520and%2520Chalcone%2520Moieties%2520Leads%2520to%2520Novel%2520Potent%2520Heterodimeric%2520Modulators%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D212%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2016.03.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Litman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skovsgaard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeuthen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, W.-D.</span></span> <span> </span><span class="NLM_article-title">ATPase Activity of P-glycoprotein Related to Emergence of Drug Resistance in Ehrlich Ascites Tumor Cell Lines</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1361</i></span>,  <span class="NLM_fpage">147</span>â <span class="NLM_lpage">158</span>, <span class="refDoi">Â DOI: 10.1016/S0925-4439(97)00025-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2FS0925-4439%2897%2900025-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=9300796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK2sXks12gur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=1997&pages=147-158&author=T.+Litmanauthor=D.+Nielsenauthor=T.+Skovsgaardauthor=T.+Zeuthenauthor=W.-D.+Stein&title=ATPase+Activity+of+P-glycoprotein+Related+to+Emergence+of+Drug+Resistance+in+Ehrlich+Ascites+Tumor+Cell+Lines&doi=10.1016%2FS0925-4439%2897%2900025-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines</span></div><div class="casAuthors">Litman, Thomas; Nielsen, Dorte; Skovsgaard, Torben; Zeuthen, Thomas; Stein, Wilfred D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ATPase activities of a sensitive and five progressively daunorubicin-resistant Ehrlich ascites tumor cell lines passaged in mice were characterized.  For the nine different modulators of drug resistance that the authors have studied, the ATPase activity first rose with the modulator concn. and then declined.  The authors analyzed the ATPase activity profiles in terms of an activation const. and an inhibition const. for each of the nine drugs and six cell lines.  In this series of cell lines, the drug-stimulatable ATPase activity was directly proportional to the amt. of P-glycoprotein.  Pumping of daunorubicin was also correlated with the amt. of P-glycoprotein, except that, for a highly passaged line more daunorubicin was pumped than could be accounted for by the content of P-glycoprotein.  Between the 12th and the 36th passage an addnl. source of resistance emerged, which was not correlated with P-glycoprotein.  Pumping of daunorubicin was neg. correlated with the cell vol. for the different lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4nNQbXUAWILVg90H21EOLACvtfcHk0li8ipdL5rp4Ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXks12gur4%253D&md5=1a125c51d7d41d1451958f014693bd30</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2897%2900025-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252897%252900025-2%26sid%3Dliteratum%253Aachs%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DNielsen%26aufirst%3DD.%26aulast%3DSkovsgaard%26aufirst%3DT.%26aulast%3DZeuthen%26aufirst%3DT.%26aulast%3DStein%26aufirst%3DW.-D.%26atitle%3DATPase%2520Activity%2520of%2520P-glycoprotein%2520Related%2520to%2520Emergence%2520of%2520Drug%2520Resistance%2520in%2520Ehrlich%2520Ascites%2520Tumor%2520Cell%2520Lines%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D1997%26volume%3D1361%26spage%3D147%26epage%3D158%26doi%3D10.1016%2FS0925-4439%2897%2900025-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, E.</span></span> <span> </span><span class="NLM_article-title">Co-operating ATP Sites in the Multiple Drug Resistance Transporter Mdr1</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">54</span>â <span class="NLM_lpage">63</span>, <span class="refDoi">Â DOI: 10.1046/j.1432-1327.1999.00643.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1046%2Fj.1432-1327.1999.00643.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10491157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFKlu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1999&pages=54-63&author=E.+Buxbaum&title=Co-operating+ATP+Sites+in+the+Multiple+Drug+Resistance+Transporter+Mdr1&doi=10.1046%2Fj.1432-1327.1999.00643.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Co-operating ATP sites in the multiple drug resistance transporter Mdr1</span></div><div class="casAuthors">Buxbaum, Engelbert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-63</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The ATPase activity of the multiple drug resistance transporter Mdr1 (P-glycoprotein, gp170) depended on the concn. of ATP with both pos. and neg. co-operativity both in the absence and in the presence of verapamil.  Four co-operating binding sites for ATP were required to adequately model the exptl. findings.  The activation energy for the ATPase activity increased from â 385 kJÂ·mol-1 at 10 Î¼M ATP to 512 kJÂ·mol-1 at 1600 Î¼M, while changes in verapamil concn. had little effect.  This indicates that the reaction mechanism of ATP hydrolysis depends on ATP concn. and is further evidence for co-operation of ATP binding sites.  Free ATP in higher concn. was inhibitory; however, this inhibition could be reduced by complexing the ATP with Mg2+.  Free Mg2+ had little effect on Mdrl apart from complexing ATP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_Ls-awEH0bVg90H21EOLACvtfcHk0lgcWmDE5nrx-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFKlu70%253D&md5=bdf80cb1013bf698360a5dadd8492c9d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1999.00643.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1999.00643.x%26sid%3Dliteratum%253Aachs%26aulast%3DBuxbaum%26aufirst%3DE.%26atitle%3DCo-operating%2520ATP%2520Sites%2520in%2520the%2520Multiple%2520Drug%2520Resistance%2520Transporter%2520Mdr1%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1999%26volume%3D265%26spage%3D54%26epage%3D63%26doi%3D10.1046%2Fj.1432-1327.1999.00643.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telbisz, Ã.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HegedÃ¼s, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ãzvegy-Laczka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ¡rady, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TakÃ¡ts, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrentino, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">Antibody Binding Shift Assay for Rapid Screening of Drug Interactions With the Human ABCG2Multidrug Transporter</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">101</span>â <span class="NLM_lpage">109</span>, <span class="refDoi">Â DOI: 10.1016/j.ejps.2011.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.ejps.2011.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=22115866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Cqt7bF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=101-109&author=%C3%81.+Telbiszauthor=C.+Heged%C3%BCsauthor=C.+%C3%96zvegy-Laczkaauthor=K.+Godaauthor=G.+V%C3%A1radyauthor=Z.+Tak%C3%A1tsauthor=E.+Szaboauthor=B.+P.+Sorrentinoauthor=A.+Varadiauthor=B.+Sarkadi&title=Antibody+Binding+Shift+Assay+for+Rapid+Screening+of+Drug+Interactions+With+the+Human+ABCG2Multidrug+Transporter&doi=10.1016%2Fj.ejps.2011.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter</span></div><div class="casAuthors">Telbisz, Agnes; Hegedues, Csilla; Oezvegy-Laczka, Csilla; Goda, Katalin; Varady, Gyoergy; Takats, Zoltan; Szabo, Eszter; Sorrentino, Brian P.; Varadi, Andras; Sarkadi, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ABCG2 multidrug transporter protein has been identified as a key player in cancer drug resistance and xenobiotic elimination, as its actively transported substrates include anticancer drugs, intermediates of heme metab., xenobiotics, and also drug conjugates.  Several transported substrates at higher concns., and some anticancer agents even at low concns. directly inhibit the ABCG2 transporter, thus it is difficult to provide estn. for pharmacol. important ABCG2-dependent interactions.  In addn., as documented here, in mutant variants of the transporter, inhibitors of the wild-type ABCG2 may become actively transported substrates.  In this paper we describe a rapid in vitro assay to identify transport modulation by measuring the cell surface interaction of a conformation sensitive monoclonal antibody (5D3) with ABCG2 in intact cells.  As documented, in conjunction with membrane ATPase, transport and cytotoxicity measurements, this assay provides a reliable est. of concn.-dependent modulation of ABCG2 by newly emerging pharmacophores.  A high-throughput, 96-well plate assay platform is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3a5A3vWQ8HrVg90H21EOLACvtfcHk0lgcWmDE5nrx-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Cqt7bF&md5=7d1d81b876abcccbf0d963eff1bd3b25</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2011.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2011.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DTelbisz%26aufirst%3D%25C3%2581.%26aulast%3DHeged%25C3%25BCs%26aufirst%3DC.%26aulast%3D%25C3%2596zvegy-Laczka%26aufirst%3DC.%26aulast%3DGoda%26aufirst%3DK.%26aulast%3DV%25C3%25A1rady%26aufirst%3DG.%26aulast%3DTak%25C3%25A1ts%26aufirst%3DZ.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DSorrentino%26aufirst%3DB.%2BP.%26aulast%3DVaradi%26aufirst%3DA.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DAntibody%2520Binding%2520Shift%2520Assay%2520for%2520Rapid%2520Screening%2520of%2520Drug%2520Interactions%2520With%2520the%2520Human%2520ABCG2Multidrug%2520Transporter%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D45%26spage%3D101%26epage%3D109%26doi%3D10.1016%2Fj.ejps.2011.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolaridis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locher, K. P.</span></span> <span> </span><span class="NLM_article-title">Structure of the Human Multidrug Transporter ABCG2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>546</i></span>,  <span class="NLM_fpage">504</span>â <span class="NLM_lpage">509</span>, <span class="refDoi">Â DOI: 10.1038/nature22345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fnature22345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=28554189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosFWntbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=504-509&author=N.+M.+I.+Taylorauthor=I.+Manolaridisauthor=S.+M.+Jacksonauthor=J.+Kowalauthor=H.+Stahlbergauthor=K.+P.+Locher&title=Structure+of+the+Human+Multidrug+Transporter+ABCG2&doi=10.1038%2Fnature22345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human multidrug transporter ABCG2</span></div><div class="casAuthors">Taylor, Nicholas M. I.; Manolaridis, Ioannis; Jackson, Scott M.; Kowal, Julia; Stahlberg, Henning; Locher, Kaspar P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7659</span>),
    <span class="NLM_cas:pages">504-509</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ABCG2 is a constitutively expressed ATP-binding cassette (ABC) transporter that protects many tissues against xenobiotic mols.  Its activity affects the pharmacokinetics of commonly used drugs and limits the delivery of therapeutics into tumor cells, thus contributing to multidrug resistance.  Here we present the structure of human ABCG2 detd. by cryo-electron microscopy, providing the first high-resoln. insight into a human multidrug transporter.  We visualize ABCG2 in complex with two antigen-binding fragments of the human-specific, inhibitory antibody 5D3 that recognizes extracellular loops of the transporter.  We observe two cholesterol mols. bound in the multidrug-binding pocket that is located in a central, hydrophobic, inward-facing translocation pathway between the transmembrane domains.  Combined with functional in vitro analyses, our results suggest a multidrug recognition and transport mechanism of ABCG2, rationalize disease-causing single nucleotide polymorphisms (SNP) and the allosteric inhibition by the 5D3 antibody, and provide the structural basis of cholesterol recognition by other G-subfamily ABC transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYOlfrPNtVhrVg90H21EOLACvtfcHk0lgcWmDE5nrx-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosFWntbk%253D&md5=a3fd5157f639d2958e5abd996e2a6470</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnature22345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22345%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DN.%2BM.%2BI.%26aulast%3DManolaridis%26aufirst%3DI.%26aulast%3DJackson%26aufirst%3DS.%2BM.%26aulast%3DKowal%26aufirst%3DJ.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DLocher%26aufirst%3DK.%2BP.%26atitle%3DStructure%2520of%2520the%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DNature%26date%3D2017%26volume%3D546%26spage%3D504%26epage%3D509%26doi%3D10.1038%2Fnature22345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolaridis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zechner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bause, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomaeus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locher, K. P.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Small-Molecule Inhibition of Human Multidrug Transporter ABCG2</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">333</span>â <span class="NLM_lpage">340</span>, <span class="refDoi">Â DOI: 10.1038/s41594-018-0049-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fs41594-018-0049-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=29610494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOjsr7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=333-340&author=S.+M.+Jacksonauthor=I.+Manolaridisauthor=J.+Kowalauthor=M.+Zechnerauthor=N.+M.+I.+Taylorauthor=M.+Bauseauthor=S.+Bauerauthor=R.+Bartholomaeusauthor=G.+Bernhardtauthor=B.+Koenigauthor=A.+Buschauerauthor=H.+Stahlbergauthor=K.-H.+Altmannauthor=K.+P.+Locher&title=Structural+Basis+of+Small-Molecule+Inhibition+of+Human+Multidrug+Transporter+ABCG2&doi=10.1038%2Fs41594-018-0049-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of small-molecule inhibition of human multidrug transporter ABCG2</span></div><div class="casAuthors">Jackson, Scott M.; Manolaridis, Ioannis; Kowal, Julia; Zechner, Melanie; Taylor, Nicholas M. I.; Bause, Manuel; Bauer, Stefanie; Bartholomaeus, Ruben; Bernhardt, Guenther; Koenig, Burkhard; Buschauer, Armin; Stahlberg, Henning; Altmann, Karl-Heinz; Locher, Kaspar P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">333-340</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">ABCG2 is an ATP-binding cassette (ABC) transporter that protects tissues against xenobiotics, affects the pharmacokinetics of drugs and contributes to multidrug resistance.  Although many inhibitors and modulators of ABCG2 have been developed, understanding their structure-activity relationship requires high-resoln. structural insight.  Here, we present cryo-EM structures of human ABCG2 bound to synthetic derivs. of the fumitremorgin C-related inhibitor Ko143 or the multidrug resistance modulator tariquidar.  Both compds. are bound to the central, inward-facing cavity of ABCG2, blocking access for substrates and preventing conformational changes required for ATP hydrolysis.  The high resolns. allowed for de novo building of the entire transporter and also revealed tightly bound phospholipids and cholesterol interacting with the lipid-exposed surface of the transmembrane domains (TMDs).  Extensive chem. modifications of the Ko143 scaffold combined with in vitro functional analyses revealed the details of ABCG2 interactions with this compd. family and provide a basis for the design of novel inhibitors and modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJBdcwrlGmAbVg90H21EOLACvtfcHk0ljzdsuW3fyE-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOjsr7M&md5=b892ceb7a3ede9784a09c2cc98042d03</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fs41594-018-0049-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-018-0049-1%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BM.%26aulast%3DManolaridis%26aufirst%3DI.%26aulast%3DKowal%26aufirst%3DJ.%26aulast%3DZechner%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DN.%2BM.%2BI.%26aulast%3DBause%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DBartholomaeus%26aufirst%3DR.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DKoenig%26aufirst%3DB.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DLocher%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520Basis%2520of%2520Small-Molecule%2520Inhibition%2520of%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D333%26epage%3D340%26doi%3D10.1038%2Fs41594-018-0049-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khunweeraphong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchler, K.</span></span> <span> </span><span class="NLM_article-title">The Structure of the Human ABC Transporter ABCG2 Reveals a Novel Mechanism for Drug Extrusion</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13767</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-11794-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fs41598-017-11794-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=29061978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BC1M7js1yksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=13767&author=N.+Khunweeraphongauthor=T.+Stocknerauthor=K.+Kuchler&title=The+Structure+of+the+Human+ABC+Transporter+ABCG2+Reveals+a+Novel+Mechanism+for+Drug+Extrusion&doi=10.1038%2Fs41598-017-11794-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion</span></div><div class="casAuthors">Khunweeraphong Narakorn; Kuchler Karl; Stockner Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13767</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The human ABC transporter ABCG2 (Breast Cancer Resistance Protein, BCRP) is implicated in anticancer resistance, in detoxification across barriers and linked to gout.  Here, we generate a novel atomic model of ABCG2 using the crystal structure of ABCG5/G8.  Extensive mutagenesis verifies the structure, disclosing hitherto unrecognized essential residues and domains in the homodimeric ABCG2 transporter.  The elbow helix, the first intracellular loop (ICL1) and the nucleotide-binding domain (NBD) constitute pivotal elements of the architecture building the transmission interface that borders a central cavity which acts as a drug trap.  The transmission interface is stabilized by salt-bridge interactions between the elbow helix and ICL1, as well as within ICL1, which is essential to control the conformational switch of ABCG2 to the outward-open drug-releasing conformation.  Importantly, we propose that ICL1 operates like a molecular spring that holds the NBD dimer close to the membrane, thereby enabling efficient coupling of ATP hydrolysis during the catalytic cycle.  These novel mechanistic data open new opportunities to therapeutically target ABCG2 in the context of related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9zxYb5ouxkL0AGQpJZWpJfW6udTcc2eaAJwqEgr_eObntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7js1yksQ%253D%253D&md5=13b9d4f177ed8f979a173b5e2ce45fb8</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-11794-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-11794-w%26sid%3Dliteratum%253Aachs%26aulast%3DKhunweeraphong%26aufirst%3DN.%26aulast%3DStockner%26aufirst%3DT.%26aulast%3DKuchler%26aufirst%3DK.%26atitle%3DThe%2520Structure%2520of%2520the%2520Human%2520ABC%2520Transporter%2520ABCG2%2520Reveals%2520a%2520Novel%2520Mechanism%2520for%2520Drug%2520Extrusion%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D13767%26doi%3D10.1038%2Fs41598-017-11794-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegedus, T.</span></span> <span> </span><span class="NLM_article-title">Jump into a New Fold - A Homology Based Model for the ABCG2/BCRP Multidrug Transporter</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0164426</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0164426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1371%2Fjournal.pone.0164426" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0164426&author=L.+Laszloauthor=B.+Sarkadiauthor=T.+Hegedus&title=Jump+into+a+New+Fold+-+A+Homology+Based+Model+for+the+ABCG2%2FBCRP+Multidrug+Transporter&doi=10.1371%2Fjournal.pone.0164426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0164426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0164426%26sid%3Dliteratum%253Aachs%26aulast%3DLaszlo%26aufirst%3DL.%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DHegedus%26aufirst%3DT.%26atitle%3DJump%2520into%2520a%2520New%2520Fold%2520-%2520A%2520Homology%2520Based%2520Model%2520for%2520the%2520ABCG2%252FBCRP%2520Multidrug%2520Transporter%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0164426%26doi%3D10.1371%2Fjournal.pone.0164426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikadi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span> <span> </span><span class="NLM_article-title">Transmembrane Helices 1 and 6 of the Human Breast Cancer Resistance Protein (BCRP/ABCG2): Identification of Polar Residues Important for Drug Transport</span>. <i>Am. J. Physiol. Cell Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>299</i></span>,  <span class="NLM_fpage">C1100</span>â <span class="NLM_lpage">11009</span>, <span class="refDoi">Â DOI: 10.1152/ajpcell.00160.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1152%2Fajpcell.00160.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=20739628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSgu7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=C1100-11009&author=Z.+Niauthor=Z.+Bikadiauthor=X.+Caiauthor=M.+F.+Rosenbergauthor=Q.+Mao&title=Transmembrane+Helices+1+and+6+of+the+Human+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29%3A+Identification+of+Polar+Residues+Important+for+Drug+Transport&doi=10.1152%2Fajpcell.00160.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport</span></div><div class="casAuthors">Ni, Zhanglin; Bikadi, Zsolt; Cai, Xiaokun; Rosenberg, Mark F.; Mao, Qingcheng</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">5, Pt. 1</span>),
    <span class="NLM_cas:pages">C1100-C1109</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">The human breast cancer resistance protein (BCRP/ABCG2) mediates efflux of drugs and xenobiotics.  In this study, we investigated the role of polar residues within or near the predicted transmembrane Î±-helixes 1 and 6 of BCRP in drug transport.  We substituted Asn387, Gln398, Asn629, and Thr642 with Ala, Thr402 with Ala and Arg, and Tyr645 with Phe, and the mutants were stably expressed in human embryonic kidney-293 or Flp-In-293 cells.  Immunoblotting and confocal microscopy anal. revealed that all of the mutants were well expressed and predominantly targeted to the plasma membrane.  While T402A and T402R showed a significant global redn. in the efflux of mitoxantrone, Hoechst 33342, and BODIPY-prazosin, N629A exhibited significantly increased efflux activities for all of the substrates.  N387A and Q398A displayed significantly impaired efflux for mitoxantrone and Hoechst 33342, but not for BODIPY-prazosin.  In contrast, T642A and Y645F showed a moderate redn. in Hoechst 33342 efflux only.  Drug resistance profiles of human embryonic kidney-293 cells expressing the mutants generally correlated with the efflux data.  Furthermore, N629A was assocd. with a marked increase, and N387A and T402A with a significant redn., in BCRP ATPase activity.  Mutations of some of the polar residues may cause conformational changes, as manifested by the altered binding of the 5D3 antibody to BCRP in the presence of prazosin.  The inward-facing homol. model of BCRP indicated that Thr402 within transmembrane 1 may be important for helical interactions, and Asn629 may be involved in BCRP-substrate interaction.  In conclusion, we have demonstrated the functional importance of some of these polar residues in BCRP activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBqeiT17Gj47Vg90H21EOLACvtfcHk0ljzdsuW3fyE-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSgu7jK&md5=116e4feb0a454e8782a804c526832398</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00160.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00160.2010%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DZ.%26aulast%3DBikadi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DRosenberg%26aufirst%3DM.%2BF.%26aulast%3DMao%26aufirst%3DQ.%26atitle%3DTransmembrane%2520Helices%25201%2520and%25206%2520of%2520the%2520Human%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%253A%2520Identification%2520of%2520Polar%2520Residues%2520Important%2520for%2520Drug%2520Transport%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell%2520Physiol.%26date%3D2010%26volume%3D299%26spage%3DC1100%26epage%3D11009%26doi%3D10.1152%2Fajpcell.00160.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honjo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Q. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Perez, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Laar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Acquired Mutations in the MXR/BCRP/ABCP Gene Alter Substrate Specificity in MXR/BCRP/ABCP-Overexpressing Cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6635</span>â <span class="NLM_lpage">6639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=11559526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFaisr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=6635-6639&author=Y.+Honjoauthor=C.+A.+Hrycynaauthor=Q.+W.+Yanauthor=W.+Y.+Medina-Perezauthor=R.+W.+Robeyauthor=A.+van+de+Laarauthor=T.+Litmanauthor=M.+Deanauthor=S.+E.+Bates&title=Acquired+Mutations+in+the+MXR%2FBCRP%2FABCP+Gene+Alter+Substrate+Specificity+in+MXR%2FBCRP%2FABCP-Overexpressing+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells</span></div><div class="casAuthors">Honjo, Yasumasa; Hrycyna, Christine A.; Yan, Qing-Wu; Medina-Perez, Wilma Y.; Robey, Robert W.; Van de Laar, Anne; Litman, Thomas; Dean, Michael; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6635-6639</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A disparity was noted in the transport of rhodamine 123 among nine MXR/BCRP/ABCP-overexpressing cells studied; all demonstrated mitoxantrone transport, whereas only two effluxed rhodamine 123.  When the MXR/BCRP/ABCP gene was sequenced in the cell lines studied, differences were noted at amino acid 482, predicted to be at the start of the third transmembrane domain.  Sequencing genomic DNA revealed wild-type MXR/BCRP/ABCP to have an arginine at position 482.  Cells having a threonine or glycine at position 482 were able to efflux rhodamine 123, whereas cells having an arginine were not.  A vaccinia virus expression system confirmed that rhodamine as well as doxorubicin efflux is obsd. with R482T or R482G but not with the wild-type R482; all three MXR/BCRP/ABCP forms transported mitoxantrone.  Cross-resistance studies suggest that, compared with wild-type MXR/BCRP/ABCP, cells having an R482T mutation have higher anthracycline resistance, whereas an R482G mutation seems to confer relatively less resistance to SN-38 and topotecan.  These results suggest that amino acid 482 has a crucial role in MXR/BCRP/ABCP function and that mutation of a single amino acid residue significantly changes substrate specificity, thus altering the drug resistance phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmMsJibyZBJrVg90H21EOLACvtfcHk0lgt9DYfw-jj6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFaisr0%253D&md5=7d803180613f9f5fb9031bced175dbca</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHonjo%26aufirst%3DY.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DYan%26aufirst%3DQ.%2BW.%26aulast%3DMedina-Perez%26aufirst%3DW.%2BY.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3Dvan%2Bde%2BLaar%26aufirst%3DA.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DAcquired%2520Mutations%2520in%2520the%2520MXR%252FBCRP%252FABCP%2520Gene%2520Alter%2520Substrate%2520Specificity%2520in%2520MXR%252FBCRP%252FABCP-Overexpressing%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D6635%26epage%3D6639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozvegy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">Characterization of Drug Transport, ATP Hydrolysis, and Nucleotide Trapping by the Human ABCG2Multidrug Transporter. Modulation of Substrate Specificity by a Point Mutation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">47980</span>â <span class="NLM_lpage">47990</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M207857200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1074%2Fjbc.M207857200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=47980-47990&author=C.+Ozvegyauthor=A.+Varadiauthor=B.+Sarkadi&title=Characterization+of+Drug+Transport%2C+ATP+Hydrolysis%2C+and+Nucleotide+Trapping+by+the+Human+ABCG2Multidrug+Transporter.+Modulation+of+Substrate+Specificity+by+a+Point+Mutation&doi=10.1074%2Fjbc.M207857200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M207857200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M207857200%26sid%3Dliteratum%253Aachs%26aulast%3DOzvegy%26aufirst%3DC.%26aulast%3DVaradi%26aufirst%3DA.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520Drug%2520Transport%252C%2520ATP%2520Hydrolysis%252C%2520and%2520Nucleotide%2520Trapping%2520by%2520the%2520Human%2520ABCG2Multidrug%2520Transporter.%2520Modulation%2520of%2520Substrate%2520Specificity%2520by%2520a%2520Point%2520Mutation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D47980%26epage%3D47990%26doi%3D10.1074%2Fjbc.M207857200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volk, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span> <span> </span><span class="NLM_article-title">Overexpression of Wild-Type Breast Cancer Resistance Protein Mediates Methotrexate Resistance</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5035</span>â <span class="NLM_lpage">5040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=5035-5040&author=E.+L.+Volkauthor=K.+M.+Farleyauthor=Y.+Wuauthor=F.+Liauthor=R.+W.+Robeyauthor=E.+Schneider&title=Overexpression+of+Wild-Type+Breast+Cancer+Resistance+Protein+Mediates+Methotrexate+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolk%26aufirst%3DE.%2BL.%26aulast%3DFarley%26aufirst%3DK.%2BM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DSchneider%26aufirst%3DE.%26atitle%3DOverexpression%2520of%2520Wild-Type%2520Breast%2520Cancer%2520Resistance%2520Protein%2520Mediates%2520Methotrexate%2520Resistance%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D5035%26epage%3D5040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Functional Validation of the Genetic Polymorphisms of Human ATP-binding Cassette (ABC) Transporter ABCG2: Identification of Alleles that are Defective in Porphyrin Transport</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">287</span>â <span class="NLM_lpage">296</span>, <span class="refDoi">Â DOI: 10.1124/mol.106.023556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1124%2Fmol.106.023556" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=287-296&author=A.+Tamuraauthor=M.+Watanabeauthor=H.+Saitoauthor=H.+Nakagawaauthor=T.+Kamachiauthor=I.+Okuraauthor=T.+Ishikawa&title=Functional+Validation+of+the+Genetic+Polymorphisms+of+Human+ATP-binding+Cassette+%28ABC%29+Transporter+ABCG2%3A+Identification+of+Alleles+that+are+Defective+in+Porphyrin+Transport&doi=10.1124%2Fmol.106.023556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.023556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.023556%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DKamachi%26aufirst%3DT.%26aulast%3DOkura%26aufirst%3DI.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DFunctional%2520Validation%2520of%2520the%2520Genetic%2520Polymorphisms%2520of%2520Human%2520ATP-binding%2520Cassette%2520%2528ABC%2529%2520Transporter%2520ABCG2%253A%2520Identification%2520of%2520Alleles%2520that%2520are%2520Defective%2520in%2520Porphyrin%2520Transport%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D287%26epage%3D296%26doi%3D10.1124%2Fmol.106.023556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Purohit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, A.</span></span> <span> </span><span class="NLM_article-title">Mutagenicity of nitroaromatic compounds</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">673</span>â <span class="NLM_lpage">692</span>, <span class="refDoi">Â DOI: 10.1021/tx000002x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx000002x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFSitLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=673-692&author=V.+Purohitauthor=A.+Basu&title=Mutagenicity+of+nitroaromatic+compounds&doi=10.1021%2Ftx000002x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenicity of Nitroaromatic Compounds</span></div><div class="casAuthors">Purohit, Vandana; Basu, Ashis K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">673-692</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review and discussion with 222 refs.  Metab. and DNA binding, mechanism of mutagenesis and repair in bacteria, mutagenesis in mammalian systems, and structure-activity relationship are discussed in relation to the title topic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybDHR1RJ20rVg90H21EOLACvtfcHk0lgt9DYfw-jj6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFSitLg%253D&md5=74477b2805d2365e208538cdce0dec39</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Ftx000002x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx000002x%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DV.%26aulast%3DBasu%26aufirst%3DA.%26atitle%3DMutagenicity%2520of%2520nitroaromatic%2520compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2000%26volume%3D13%26spage%3D673%26epage%3D692%26doi%3D10.1021%2Ftx000002x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity Relationships of New Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">8224</span>â <span class="NLM_lpage">8236</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2008.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2008.07.034" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8224-8236&author=A.+Pickauthor=H.+M%C3%BCllerauthor=M.+Wiese&title=Structure-activity+Relationships+of+New+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1016%2Fj.bmc.2008.07.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-activity%2520Relationships%2520of%2520New%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8224%26epage%3D8236%26doi%3D10.1016%2Fj.bmc.2008.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells Via the PI3K/Akt Signaling Pathway</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">650</span>â <span class="NLM_lpage">662</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201100543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1002%2Fcmdc.201100543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=22354538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFyis78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=650-662&author=A.+Pickauthor=M.+Wiese&title=Tyrosine+Kinase+Inhibitors+Influence+ABCG2+Expression+in+EGFR-Positive+MDCK+BCRP+Cells+Via+the+PI3K%2FAkt+Signaling+Pathway&doi=10.1002%2Fcmdc.201100543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway</span></div><div class="casAuthors">Pick, Anne; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">650-662</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Multidrug resistance obsd. in cancer chemotherapy is commonly attributed to overexpression of efflux transporter proteins.  These proteins act as ATP-dependent drug efflux pumps, actively extruding chemotherapeutic agents from cells and causing a decrease in intracellular drug accumulation.  Besides the well-recognized role of P-glycoprotein (P-gp, ABCB1), the breast cancer resistance protein (BCRP, ABCG2) is becoming increasingly accepted as playing an important role in multidrug resistance.  In contrast to P-glycoprotein, only a few inhibitors of ABCG2 are known.  According to the literature, tyrosine kinase inhibitors (TKIs) can be considered to be broad-spectrum inhibitors, interacting with ABCB1, ABCC1 and ABCG2.  Here, the authors investigated seven different TKIs, gefitinib, erlotinib, AG1478, PD158780, PD153035, nilotinib and imatinib, for their potential to restore ABCG2 sensitivity to cells.  Furthermore, the authors analyzed the alteration of ABCG2 expression caused by TKIs and demonstrated that EGFR inhibitors such as gefitinib and PD158780 reduced both total and surface expression of ABCG2 in EGRF-pos. MDCK BCRP cells by interaction with the PI3K/Akt signaling pathway.  The reduced ABCG2 content led to an increased effect of XR9577, a well-known ABCG2 modulator, lowering the concn. required for half maximal inhibition.  BCR-ABL inhibitors had no influence on ABCG2 expression and modulator activity.  Interestingly, a combination of an EGFR inhibitor with the PI3K/Akt inhibitor LY294002 led to a significant redn. of ABCG2 expression at low concns. of the drugs.  Based on the authors' results, the authors assume that EGFR exerts a post-transcriptional enhancing effect on ABCG2 expression via the PI3K/Akt signaling pathway, which can be attenuated by EGFR inhibitors.  Blocking the key signaling pathway regulating ABCG2 expression with EGFR inhibitors, combined with the inhibition of ABCG2 with potent modulators might be a promising approach to circumvent MDR in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouvP7V8QMUi7Vg90H21EOLACvtfcHk0lin8SiISsz14w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFyis78%253D&md5=c78fc69da2c5a134dd3f669c165364c2</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100543%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors%2520Influence%2520ABCG2%2520Expression%2520in%2520EGFR-Positive%2520MDCK%2520BCRP%2520Cells%2520Via%2520the%2520PI3K%252FAkt%2520Signaling%2520Pathway%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D650%26epage%3D662%26doi%3D10.1002%2Fcmdc.201100543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">4-Substituted-2-phenylquinazolines as Inhibitors of BCRP</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6766</span>â <span class="NLM_lpage">6769</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2012.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmcl.2012.08.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=23017888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6766-6769&author=K.+Juvaleauthor=M.+Wiese&title=4-Substituted-2-phenylquinazolines+as+Inhibitors+of+BCRP&doi=10.1016%2Fj.bmcl.2012.08.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">4-Substituted-2-phenylquinazolines as inhibitors of BCRP</span></div><div class="casAuthors">Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6766-6769</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated several 2-phenylquinazolines with different substitutions at position 4 for their BCRP inhibition.  Compds. with Ph ring attached via an amine-contg. linker at position 4 were found to be potent inhibitors of BCRP.  In general compds. with meta substitution of Ph ring at position 4 were found to have higher inhibitory effect, compd. 12 being the most potent and selective towards BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf-v9OH4Nxr7Vg90H21EOLACvtfcHk0lin8SiISsz14w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrbJ&md5=e96d4566ff6ae54c8e454bda7b50c873</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3D4-Substituted-2-phenylquinazolines%2520as%2520Inhibitors%2520of%2520BCRP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6766%26epage%3D6769%26doi%3D10.1016%2Fj.bmcl.2012.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinkhammer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1498</span>â <span class="NLM_lpage">1505</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201000216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1002%2Fcmdc.201000216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=20632361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWgsbnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1498-1505&author=A.+Pickauthor=W.+Klinkhammerauthor=M.+Wiese&title=Specific+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%29&doi=10.1002%2Fcmdc.201000216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)</span></div><div class="casAuthors">Pick, Anne; Klinkhammer, Werner; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1498-1505</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A new class of specific breast cancer resistance protein (BCRP) inhibitors was identified, showing no inhibition of the ATP binding cassette (ABC) transporters P-gp and MRP1.  Some of these modulators inhibit BCRP with high potency; they are only slightly less potent than Ko143 and could serve as promising lead structures for the design of novel effective BCRP inhibitors.  These inhibitors are structurally related to tariquidar (XR9576) and belong to a library of multidrug-resistance modulators synthesized by our research group.  The absence of the tetrahydroisoquinoline substructure appears to play a crucial role for specificity; we found that the presence of this substructure is not essential for interaction with BCRP.  To det. the type of interaction between pheophorbide A and compds. with and without the tetrahydroisoquinoline substructure, various substrate pheophorbide A concns. were used in enzyme kinetics assays.  The resulting data show that these compds. share a noncompetitive-type interaction with pheophorbide A.  Expts. with imatinib and pheophorbide A revealed a mixed-type interaction.  The combination of imatinib and compds. with and without the tetrahydroisoquinoline substructure resulted in a pos. cooperative effect, indicating that imatinib engages a binding site distinct from that of the new compds. on one side and distinct from that of pheophorbide A on the other side as well.  The results of this study suggest that the category of BCRP-specific inhibitors, which includes only fumitremorgin C, Ko143 and analogs, and novobiocin needs to be extended by this new class of inhibitors, which possess three key characteristics: specificity, potency, and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbFkR4oCa3bVg90H21EOLACvtfcHk0lin8SiISsz14w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWgsbnK&md5=751e5cb7fb4a5db8645196ff3b3ae28a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000216%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSpecific%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%2529%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1498%26epage%3D1505%26doi%3D10.1002%2Fcmdc.201000216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marighetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steggemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Quantitative Structure-Activity Relationships of Selective BCRP Inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">125</span>â <span class="NLM_lpage">135</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201200377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1002%2Fcmdc.201200377" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=125-135&author=F.+Marighettiauthor=K.+Steggemannauthor=M.+Hanlauthor=M.+Wiese&title=Synthesis+and+Quantitative+Structure-Activity+Relationships+of+Selective+BCRP+Inhibitors&doi=10.1002%2Fcmdc.201200377"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200377%26sid%3Dliteratum%253Aachs%26aulast%3DMarighetti%26aufirst%3DF.%26aulast%3DSteggemann%26aufirst%3DK.%26aulast%3DHanl%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Quantitative%2520Structure-Activity%2520Relationships%2520of%2520Selective%2520BCRP%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D125%26epage%3D135%26doi%3D10.1002%2Fcmdc.201200377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marighetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steggemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Scaffold Identification of a New Class of Potent and Selective BCRP-inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">742</span>â <span class="NLM_lpage">751</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201402498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1002%2Fcmdc.201402498" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=742-751&author=F.+Marighettiauthor=K.+Steggemannauthor=M.+Karbaumauthor=M.+Wiese&title=Scaffold+Identification+of+a+New+Class+of+Potent+and+Selective+BCRP-inhibitors&doi=10.1002%2Fcmdc.201402498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402498%26sid%3Dliteratum%253Aachs%26aulast%3DMarighetti%26aufirst%3DF.%26aulast%3DSteggemann%26aufirst%3DK.%26aulast%3DKarbaum%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DScaffold%2520Identification%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520and%2520Selective%2520BCRP-inhibitors%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D742%26epage%3D751%26doi%3D10.1002%2Fcmdc.201402498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haenisch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajeva, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¶nisch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationships of Flavonoids as Inhibitors of Breast Cancer Resistance Protein (BCRP)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2090</span>â <span class="NLM_lpage">2102</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2010.12.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2010.12.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=21354800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFCnu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2090-2102&author=A.+Pickauthor=H.+M%C3%BCllerauthor=R.+Mayerauthor=B.+Haenischauthor=I.+K.+Pajevaauthor=M.+Weigtauthor=H.+B%C3%B6nischauthor=C.+E.+M%C3%BCllerauthor=M.+Wiese&title=Structure-Activity+Relationships+of+Flavonoids+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28BCRP%29&doi=10.1016%2Fj.bmc.2010.12.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)</span></div><div class="casAuthors">Pick, Anne; Mueller, Henrik; Mayer, Ralf; Haenisch, Britta; Pajeva, Ilza K.; Weigt, Mathias; Boenisch, Heinz; Mueller, Christa E.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2090-2102</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Flavonoids are an interesting group of natural products ubiquitously present in human diet.  Their consumption has been assocd. with various and differing beneficial health effects.  However, several flavonoids have been reported to inhibit the breast cancer resistance protein (BCRP) encoded by the ABCG2 gene.  Thus, the consumption of flavonoids with high inhibitory activity could change pharmacokinetics and drug levels of drugs that are BCRP substrates.  In cancer patients receiving chemotherapy an increased intake of such flavonoids could lead to adverse effects.  We investigated a structurally diverse set of flavonoids, including derivs. with a rare C-methylated structure that were isolated from plants used in traditional medicine.  The flavones retusin and ayanin were found to be highly potent inhibitors of BCRP, showing only slightly less potency than Ko143, the most potent ABCG2 inhibitor known so far.  The activity data were analyzed by 2D and 3D QSAR analyses and the results revealed the impact of the different substituents at the various positions of the flavonoid core on activity.  Addnl., a lateral 2D QSAR anal. of data collected from the literature was performed aiming to derive more general information about the influence of distinct structural features on the inhibitory potency of flavonoids.  The comparative QSAR analyses led to a consistent picture of the effects of the different substituents at various positions of the flavone backbone.  The following structural features were found to contribute pos. to BCRP inhibition: a hydroxyl group in position 5, double bond between position 2 and 3, and a methoxy group in position 3.  The exchange of a 3-methoxy group by an OH-group acting also as a hydrogen bond donor, resulted in decrease in activity underlining the potential role of the hydrogen bond acceptor 3-OCH3 for the interaction with BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre-4pma6sNmrVg90H21EOLACvtfcHk0lhGU-3uPEN3ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFCnu7g%253D&md5=2a9156b065c5df1a3e517cca93f59db8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.043%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DR.%26aulast%3DHaenisch%26aufirst%3DB.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWeigt%26aufirst%3DM.%26aulast%3DB%25C3%25B6nisch%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-Activity%2520Relationships%2520of%2520Flavonoids%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2090%26epage%3D2102%26doi%3D10.1016%2Fj.bmc.2010.12.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinkhammer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Globisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajeva, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">New Functional Assay of P-glycoprotein Activity Using Hoechst 33342</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">7470</span>â <span class="NLM_lpage">7479</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2007.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2007.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=17890094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKitb3E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7470-7479&author=H.+M%C3%BCllerauthor=W.+Klinkhammerauthor=C.+Globischauthor=M.+U.+Kassackauthor=I.+K.+Pajevaauthor=M.+Wiese&title=New+Functional+Assay+of+P-glycoprotein+Activity+Using+Hoechst+33342&doi=10.1016%2Fj.bmc.2007.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">New functional assay of P-glycoprotein activity using Hoechst 33342</span></div><div class="casAuthors">Mueller, Henrik; Klinkhammer, Werner; Globisch, Christoph; Kassack, Matthias U.; Pajeva, Ilza K.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7470-7479</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study the authors describe a simplified, HTS-capable functional assay for the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) based on its substrate Hoechst 33342.  The physicochem. properties of Hoechst 33342 and the enormous milieu dependency of its fluorescence intensity allowed performing the assay in a homogeneous manner.  This new assay served as an effective tool to est. the potency of 10 well recognized P-gp substrates and modulators.  Further, the potency of these compds. was also estd. in the calcein AM assay.  The Hoechst 33342 and calcein AM assays yielded significantly comparable results for all compds. tested.  Principal component anal. (PCA) applied to literature data on inhibition of P-gp activity and the authors' results obtained in the Hoechst 33342 and calcein AM assay indicated similarity of compared functional transport assays.  However, no correlation could be detected between these functional assays and the ATPase activity assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSVlzt7xQp7Vg90H21EOLACvtfcHk0lhGU-3uPEN3ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKitb3E&md5=265484311a72ee68d952e31d700195b0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DNew%2520Functional%2520Assay%2520of%2520P-glycoprotein%2520Activity%2520Using%2520Hoechst%252033342%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7470%26epage%3D7479%26doi%3D10.1016%2Fj.bmc.2007.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Investigation of Chalcones and Benzochalcones as Inhibitors of Breast Cancer Resistance Protein</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">346</span>â <span class="NLM_lpage">355</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2011.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2011.10.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=22112540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=346-355&author=K.+Juvaleauthor=V.+F.+Papeauthor=M.+Wiese&title=Investigation+of+Chalcones+and+Benzochalcones+as+Inhibitors+of+Breast+Cancer+Resistance+Protein&doi=10.1016%2Fj.bmc.2011.10.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein</span></div><div class="casAuthors">Juvale, Kapil; Pape, Veronika F. S.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast cancer resistance protein (BCRP/ABCG2) belongs to the ATP binding cassette family of transport proteins.  BCRP has been found to confer multidrug resistance in cancer cells.  A strategy to overcome resistance due to BCRP overexpression is the investigation of potent and specific BCRP inhibitors.  The aim of the current study was to investigate different multi-substituted chalcones for their BCRP inhibition.  We synthesized chalcones and benzochalcones with different substituents (viz. OH, OCH3, Cl) on ring A and B of the chalcone structure.  All synthesized compds. were tested by Hoechst 33342 accumulation assay to det. inhibitory activity in MCF-7 MX and MDCK cells expressing BCRP.  The compds. were also screened for their P-glycoprotein (P-gp) and Multidrug resistance-assocd. protein 1 (MRP1) inhibitory activity in the calcein AM accumulation assay and were found to be selective towards inhibition of BCRP.  Substituents at position 2' and 4' on chalcone ring A were found to be essential for activity; addnl. there was a great influence of substituents on ring B. Presence of 3,4-dimethoxy substitution on ring B was found to be optimal, while presence of 2- and 4-chloro substitution also showed a pos. effect on BCRP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoTQiCUqdyrLVg90H21EOLACvtfcHk0liWcCEOYdlsxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGgtw%253D%253D&md5=0884fa3575f8e159c7500abbacb31c9b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DPape%26aufirst%3DV.%2BF.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DInvestigation%2520of%2520Chalcones%2520and%2520Benzochalcones%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D346%26epage%3D355%26doi%3D10.1016%2Fj.bmc.2011.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, A.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Dual P-gp-BCRP Inhibitors as Nanoparticle Formulation</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">8</span>, <span class="refDoi">Â DOI: 10.1016/j.ejps.2015.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.ejps.2015.04.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=25976226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGntrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=1-8&author=M.+S.+Singhauthor=K.+Juvaleauthor=M.+Wieseauthor=A.+Lamprecht&title=Evaluation+of+Dual+P-gp-BCRP+Inhibitors+as+Nanoparticle+Formulation&doi=10.1016%2Fj.ejps.2015.04.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulation</span></div><div class="casAuthors">Singh, Manu Smriti; Juvale, Kapil; Wiese, Michael; Lamprecht, Alf</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Overcoming multidrug resistance (MDR) in cancer is a major challenge and efforts are on-going to develop inhibitors against the most characterized and ubiquitous MDR transporters: P-glycoprotein (P-gp), multidrug resistance-assocd. protein (MRP1) and breast cancer resistance protein (BCRP).  Recently reported, two 4-anilinoquinazolines (compds. 1 and 2), demonstrate potential MDR reversal activity against BCRP and to a lesser extent, P-gp.  In this work, we formulated the compds. as polymeric nanoparticles (NPs) and assessed their MDR inhibitory activity in relevant BCRP and P-gp over-expressing cell line models.  Particles in the size range 300-365 nm with a loading efficiency of 69% (compd. 1 NP) and 77% (compd. 2 NP) resp. were obtained.  BCRP inhibition was obsd. in Hoechst 33342 and pheophorbide A assays while P-gp inhibition was evaluated in calcein AM and rhodamine-123 assays.  In cytotoxicity studies, while BCRP expressing cells showed complete reversal of drug resistance in nearly all treatment groups (both compds. and their resp. NP); a higher reversal in NP treated group was obtained as compared with inhibitory compd. treated group in P-gp expressing cells.  These results demonstrate promising inhibitory activity of both formulations, esp. against P-gp expressing cells; which is possibly due to a prolonged presence of encapsulated compds. in NPs and consequently a prolonged sensitization of transmembrane drug transporter.  These formulations can therefore be considered as dual-transporter inhibitors and it is imperative to investigate both inhibitors in animal models of MDR owing to the presence of multiple efflux transporters in several cancer models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB94y74OV717Vg90H21EOLACvtfcHk0liWcCEOYdlsxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGntrY%253D&md5=b0cb7e6ed2815efd7d7471776525bc31</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2015.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2015.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DM.%2BS.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26aulast%3DLamprecht%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520Dual%2520P-gp-BCRP%2520Inhibitors%2520as%2520Nanoparticle%2520Formulation%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D77%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.ejps.2015.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Flavones and Benzoflavones as Inhibitors of BCRP/ABCG2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">115</span>â <span class="NLM_lpage">126</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2013.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.ejmech.2013.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=23851114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeis73E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=115-126&author=K.+Juvaleauthor=K.+Stefanauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+Flavones+and+Benzoflavones+as+Inhibitors+of+BCRP%2FABCG2&doi=10.1016%2Fj.ejmech.2013.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2</span></div><div class="casAuthors">Juvale, Kapil; Stefan, Katja; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) often leads to a failure of cancer chemotherapy.  Breast Cancer Resistance Protein (BCRP/ABCG2), a member of the superfamily of ATP binding cassette proteins has been found to confer MDR in cancer cells by transporting mols. with amphiphilic character out of the cells using energy from ATP hydrolysis.  Inhibiting BCRP can be a soln. to overcome MDR.  The authors synthesized a series of flavones, 7,8-benzoflavones and 5,6-benzoflavones with varying substituents at positions 3, 3' and 4' of the (benzo)flavone structure.  All synthesized compds. were tested for BCRP inhibition in Hoechst 33342 and pheophorbide A accumulation assays using MDCK cells expressing BCRP.  All the compds. were further screened for their P-glycoprotein (P-gp) and Multidrug resistance-assocd. protein 1 (MRP1) inhibitory activity by calcein AM accumulation assay to check the selectivity towards BCRP.  In addn. most active compds. were investigated for their cytotoxicity.  It was obsd. that in most cases 7,8-benzoflavones are more potent in comparison to the 5,6-benzoflavones.  In general it was found that presence of a 3-OCH3 substituent leads to increase in activity in comparison to presence of OH or no substitution at position 3.  Also, it was found that presence of 3',4'-OCH3 on Ph ring lead to increase in activity as compared to other substituents.  Compd. 24, a 7,8-benzoflavone deriv. was found to be most potent being 50 times selective for BCRP and showing very low cytotoxicity at higher concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoep2o4_wG7XrVg90H21EOLACvtfcHk0liWcCEOYdlsxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeis73E&md5=961e1899a816717d108c5c8e71944f70</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DStefan%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Flavones%2520and%2520Benzoflavones%2520as%2520Inhibitors%2520of%2520BCRP%252FABCG2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D67%26spage%3D115%26epage%3D126%26doi%3D10.1016%2Fj.ejmech.2013.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajeva, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Globisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Functional Assay and Structure-Activity Relationships of New Third-Generation P-glycoprotein Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2448</span>â <span class="NLM_lpage">2462</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2007.11.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2007.11.057" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2448-2462&author=H.+M%C3%BCllerauthor=I.+K.+Pajevaauthor=C.+Globischauthor=M.+Wiese&title=Functional+Assay+and+Structure-Activity+Relationships+of+New+Third-Generation+P-glycoprotein+Inhibitors&doi=10.1016%2Fj.bmc.2007.11.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.11.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.11.057%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DFunctional%2520Assay%2520and%2520Structure-Activity%2520Relationships%2520of%2520New%2520Third-Generation%2520P-glycoprotein%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2448%26epage%3D2462%26doi%3D10.1016%2Fj.bmc.2007.11.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶hler, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3910</span>â <span class="NLM_lpage">3921</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3910-3921&author=S.+C.+K%C3%B6hlerauthor=M.+Wiese&title=HM30181+Derivatives+as+Novel+Potent+and+Selective+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29&doi=10.1021%2Facs.jmedchem.5b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kohler Sebastian C; Wiese Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3910-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The breast cancer resistance protein (BCRP, ABCG2) belongs to the superfamily of ATP binding-cassette (ABC) proteins.  In addition to other physiological functions, it transports potentially cell-damaging compounds out of the cell using the energy from ATP hydrolysis.  Certain tumors overexpressing BCRP were found to become resistant against various anticancer drugs.  In previous work, we found that tariquidar analogues lacking the tetrahydroisoquinoline moiety selectively inhibit BCRP.  In the present study, we synthesized 21 derivatives of the third-generation P-gp inhibitor HM30181, which is structurally related to tariquidar.  The compounds were tested for their inhibitory activities against BCRP and screened against P-glycoprotein (P-gp, ABCB1) and multidrug resistance protein 1 (MRP1, ABCC1) to confirm the selectivity toward BCRP.  The most potent compounds are selective toward BCRP and 2-fold more potent than the reference Ko143.  Qualitative structure-activity relationship (SAR) analysis revealed that the presence of a methoxy group in the ortho or para position of at least one phenyl ring is beneficial for inhibitory activity.  Furthermore, the cytotoxicity and multidrug resistance (MDR)-reversal ability of selected compounds were investigated.  It was shown that they have a low cytotoxicity and the ability to reverse the BCRP-mediated SN-38 resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_-1BYW7HmO9-cVm4E2RlLfW6udTcc2eYfZ4tWYZh2yLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D&md5=777b13f427105e8909ae751d11e8c7b4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00188%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DS.%2BC.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DHM30181%2520Derivatives%2520as%2520Novel%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3910%26epage%3D3921%26doi%3D10.1021%2Facs.jmedchem.5b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leyers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HÃ¤cker, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiendlocha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¼tschow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">A 4-aminobenzoic Acid Derivative as Novel Lead For Selective Inhibitors of Multidrug Resistance-Associated Proteins</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4761</span>â <span class="NLM_lpage">4763</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2008.07.127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmcl.2008.07.127" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4761-4763&author=S.+Leyersauthor=H.-G.+H%C3%A4ckerauthor=J.+Wiendlochaauthor=M.+G%C3%BCtschowauthor=M.+Wiese&title=A+4-aminobenzoic+Acid+Derivative+as+Novel+Lead+For+Selective+Inhibitors+of+Multidrug+Resistance-Associated+Proteins&doi=10.1016%2Fj.bmcl.2008.07.127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.127%26sid%3Dliteratum%253Aachs%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.-G.%26aulast%3DWiendlocha%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DA%25204-aminobenzoic%2520Acid%2520Derivative%2520as%2520Novel%2520Lead%2520For%2520Selective%2520Inhibitors%2520of%2520Multidrug%2520Resistance-Associated%2520Proteins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4761%26epage%3D4763%26doi%3D10.1016%2Fj.bmcl.2008.07.127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klinkhammer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Globisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajeva, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of a Small Molecule Library of 3rd Generation Multidrug Resistance Modulators</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2524</span>â <span class="NLM_lpage">2535</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2009.01.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2009.01.072" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2524-2535&author=W.+Klinkhammerauthor=H.+M%C3%BCllerauthor=C.+Globischauthor=I.+K.+Pajevaauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+a+Small+Molecule+Library+of+3rd+Generation+Multidrug+Resistance+Modulators&doi=10.1016%2Fj.bmc.2009.01.072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.072%26sid%3Dliteratum%253Aachs%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520Small%2520Molecule%2520Library%2520of%25203rd%2520Generation%2520Multidrug%2520Resistance%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2524%26epage%3D2535%26doi%3D10.1016%2Fj.bmc.2009.01.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">HÃ¤cker, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiendlocha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¼tschow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Aromatic 2-(Thio)ureidocarboxylic Acids As a New Family of Modulators of Multidrug Resistance-Associated Protein 1: Synthesis, Biological Evaluation, and Structure-Activity Relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4586</span>â <span class="NLM_lpage">4595</span>, <span class="refDoi">Â DOI: 10.1021/jm900688v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900688v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4586-4595&author=H.-G.+H%C3%A4ckerauthor=S.+Leyersauthor=J.+Wiendlochaauthor=M.+G%C3%BCtschowauthor=M.+Wiese&title=Aromatic+2-%28Thio%29ureidocarboxylic+Acids+As+a+New+Family+of+Modulators+of+Multidrug+Resistance-Associated+Protein+1%3A+Synthesis%2C+Biological+Evaluation%2C+and+Structure-Activity+Relationships&doi=10.1021%2Fjm900688v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm900688v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900688v%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.-G.%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DWiendlocha%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DAromatic%25202-%2528Thio%2529ureidocarboxylic%2520Acids%2520As%2520a%2520New%2520Family%2520of%2520Modulators%2520of%2520Multidrug%2520Resistance-Associated%2520Protein%25201%253A%2520Synthesis%252C%2520Biological%2520Evaluation%252C%2520and%2520Structure-Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4586%26epage%3D4595%26doi%3D10.1021%2Fjm900688v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Characterization of 3-Methoxy Flavones for Their Interaction With ABCG2 as Suggested by ATPase Activity</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1838</i></span>,  <span class="NLM_fpage">2929</span>â <span class="NLM_lpage">2938</span>, <span class="refDoi">Â DOI: 10.1016/j.bbamem.2014.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bbamem.2014.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=25128152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKmt7vE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=2929-2938&author=J.+Gallusauthor=K.+Juvaleauthor=M.+Wiese&title=Characterization+of+3-Methoxy+Flavones+for+Their+Interaction+With+ABCG2+as+Suggested+by+ATPase+Activity&doi=10.1016%2Fj.bbamem.2014.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity</span></div><div class="casAuthors">Gallus, Jennifer; Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2929-2938</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast Cancer Resistance Protein (BCRP/ABCG2) belongs to the superfamily of ATP binding cassette (ABC) transporters.  Characteristic of some of these transporter proteins is the transport of a variety of structurally unrelated substances against a concn. gradient by using the energy of ATP hydrolysis.  ABCG2 has been found to confer multidrug resistance (MDR) in cancer cells.  Several anticancer drugs have been identified as ABCG2 substrates including mitoxantrone, etoposide and topotecan.  As inhibition of the transporter is one of the strategies to overcome MDR, we have synthesized and tested several 3-methoxy flavones and investigated them for their ABCG2 inhibition.  Among these, pentamethyl quercetin (compd. 4) and pentamethyl morin (compd. 5) were found to be fluorescent and hence screened for their possible transport by ABCG2 using confocal microscopy.  This study showed that pentamethyl quercetin was far less accumulated in ABCG2 overexpressing MDCK BCRP cells as compared to MDCK sensitive cells, suggesting possible efflux of this compd. by ABCG2.  Pentamethyl morin showed no visible difference in both cell lines.  Based on this observation, we studied several other fluorescent 3-methoxy flavones for their accumulation in ABCG2 overexpressing cells.  To confirm the substrate or inhibitor nature of the tested compds., these compds. were further investigated by ATPase assay.  If stimulation of the transporter ATPase activity is detected, one can conclude that the compd. is probably a transported substrate.  All compds. except pentamethyl morin (compd. 5) and tetra-Me quercetin (compd. 6) were found to stimulate ATPase activity pointing to possible substrates despite being potent inhibitors of ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTbvTdBi-Ut7Vg90H21EOLACvtfcHk0lhgWdU_P8aYLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKmt7vE&md5=a7418d37edaaec640ebadd9305d152b1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2014.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2014.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DGallus%26aufirst%3DJ.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DCharacterization%2520of%25203-Methoxy%2520Flavones%2520for%2520Their%2520Interaction%2520With%2520ABCG2%2520as%2520Suggested%2520by%2520ATPase%2520Activity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26spage%3D2929%26epage%3D2938%26doi%3D10.1016%2Fj.bbamem.2014.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germann, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarborough, G. A.</span></span> <span> </span><span class="NLM_article-title">Expression of the Human Multidrug Resistance cDNA in Insect Cells Generates a High Activity Drug-Stimulated Membrane ATPase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">4854</span>â <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=4854-4858&author=B.+Sarkadiauthor=E.+M.+Priceauthor=R.+C.+Boucherauthor=U.+A.+Germannauthor=G.+A.+Scarborough&title=Expression+of+the+Human+Multidrug+Resistance+cDNA+in+Insect+Cells+Generates+a+High+Activity+Drug-Stimulated+Membrane+ATPase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DE.%2BM.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DScarborough%26aufirst%3DG.%2BA.%26atitle%3DExpression%2520of%2520the%2520Human%2520Multidrug%2520Resistance%2520cDNA%2520in%2520Insect%2520Cells%2520Generates%2520a%2520High%2520Activity%2520Drug-Stimulated%2520Membrane%2520ATPase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D4854%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolaridis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zechner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bause, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomaeus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locher, K. P.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Small-Molecule Inhibition of Human Multidrug Transporter ABCG2</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">333</span>â <span class="NLM_lpage">340</span>, <span class="refDoi">Â DOI: 10.1038/s41594-018-0049-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fs41594-018-0049-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=29610494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOjsr7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=333-340&author=S.+M.+Jacksonauthor=I.+Manolaridisauthor=J.+Kowalauthor=M.+Zechnerauthor=N.+M.+I.+Taylorauthor=M.+Bauseauthor=S.+Bauerauthor=R.+Bartholomaeusauthor=G.+Bernhardtauthor=B.+Koenigauthor=A.+Buschauerauthor=H.+Stahlbergauthor=K.-H.+Altmannauthor=K.+P.+Locher&title=Structural+Basis+of+Small-Molecule+Inhibition+of+Human+Multidrug+Transporter+ABCG2&doi=10.1038%2Fs41594-018-0049-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of small-molecule inhibition of human multidrug transporter ABCG2</span></div><div class="casAuthors">Jackson, Scott M.; Manolaridis, Ioannis; Kowal, Julia; Zechner, Melanie; Taylor, Nicholas M. I.; Bause, Manuel; Bauer, Stefanie; Bartholomaeus, Ruben; Bernhardt, Guenther; Koenig, Burkhard; Buschauer, Armin; Stahlberg, Henning; Altmann, Karl-Heinz; Locher, Kaspar P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">333-340</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">ABCG2 is an ATP-binding cassette (ABC) transporter that protects tissues against xenobiotics, affects the pharmacokinetics of drugs and contributes to multidrug resistance.  Although many inhibitors and modulators of ABCG2 have been developed, understanding their structure-activity relationship requires high-resoln. structural insight.  Here, we present cryo-EM structures of human ABCG2 bound to synthetic derivs. of the fumitremorgin C-related inhibitor Ko143 or the multidrug resistance modulator tariquidar.  Both compds. are bound to the central, inward-facing cavity of ABCG2, blocking access for substrates and preventing conformational changes required for ATP hydrolysis.  The high resolns. allowed for de novo building of the entire transporter and also revealed tightly bound phospholipids and cholesterol interacting with the lipid-exposed surface of the transmembrane domains (TMDs).  Extensive chem. modifications of the Ko143 scaffold combined with in vitro functional analyses revealed the details of ABCG2 interactions with this compd. family and provide a basis for the design of novel inhibitors and modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJBdcwrlGmAbVg90H21EOLACvtfcHk0lg8Hzh2U6Urrg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOjsr7M&md5=b892ceb7a3ede9784a09c2cc98042d03</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fs41594-018-0049-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-018-0049-1%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BM.%26aulast%3DManolaridis%26aufirst%3DI.%26aulast%3DKowal%26aufirst%3DJ.%26aulast%3DZechner%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DN.%2BM.%2BI.%26aulast%3DBause%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DBartholomaeus%26aufirst%3DR.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DKoenig%26aufirst%3DB.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DLocher%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520Basis%2520of%2520Small-Molecule%2520Inhibition%2520of%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D333%26epage%3D340%26doi%3D10.1038%2Fs41594-018-0049-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span> <i>Molecular Operating Environment (MOE)</i>, <span class="NLM_edition">2013.08</span>; <span class="NLM_publisher-name">Chemical Computing Group ULC</span>: <span class="NLM_publisher-loc">1010 Sherbooke St. West, Suite #910, Montreal, QC,
Canada, H3A 2R7</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating+Environment+%28MOE%29%2C+2013.08%3B+Chemical+Computing+Group+ULC%3A+1010+Sherbooke+St.+West%2C+Suite+%23910%2C+Montreal%2C+QC%2C%0ACanada%2C+H3A+2R7%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520ULC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span> <i>LeadIT</i>, <span class="NLM_edition">version 2.3.2</span>; <span class="NLM_publisher-name">BioSolveIT GmbH</span>: <span class="NLM_publisher-loc">Sankt Augustin,
Germany</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LeadIT%2C+version+2.3.2%3B+BioSolveIT+GmbH%3A+Sankt+Augustin%2C%0AGermany%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLeadIT%26pub%3DBioSolveIT%2520GmbH%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rarey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">A Fast Flexible Docking Method Using an Incremental Construction Algorithm</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">470</span>â <span class="NLM_lpage">489</span>, <span class="refDoi">Â DOI: 10.1006/jmbi.1996.0477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1006%2Fjmbi.1996.0477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=8780787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK28XltlKisLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1996&pages=470-489&author=M.+Rareyauthor=B.+Kramerauthor=T.+Lengauerauthor=G.+Klebe&title=A+Fast+Flexible+Docking+Method+Using+an+Incremental+Construction+Algorithm&doi=10.1006%2Fjmbi.1996.0477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A fast flexible docking method using an incremental construction algorithm</span></div><div class="casAuthors">Rarey, Matthias; Kramer, Bernd; Lengauer, Thomas; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">470-489</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">We present an automatic method for docking org. ligands into protein binding sites.  The method can be used in the design process of specific protein ligands.  It combines an appropriate model of the physico-chem. properties of the docked mols. with efficient methods for sampling the conformational space of the ligand.  If the ligand is flexible, it can adopt a large variety of different conformations.  Each such min. in conformational space presents a potential candidate for the conformation of the ligand in the complexed state.  Our docking method samples the conformation space of the ligand on the basis of a discrete model and uses a tree-search technique for placing the ligand incrementally into the active site.  For placing the first fragment of the ligand into the protein, we use hashing techniques adapted from computer vision.  The incremental construction algorithm is based on a greedy strategy combined with efficient methods for overlap detection and for the search of new interactions.  We present results on 19 complexes of which the binding geometry has been crystallog. detd.  All considered ligands are docked in at most three minutes on a current workstation.  The exptl. obsd. binding mode of the ligand is reproduced with 0.5 to 1.2 Ã rms deviation.  It is almost always found among the highest-ranking conformations computed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx9N2sFXkOfLVg90H21EOLACvtfcHk0lg8Hzh2U6Urrg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlKisLo%253D&md5=8cd8f384906ed90e894d118399e4dc4a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0477%26sid%3Dliteratum%253Aachs%26aulast%3DRarey%26aufirst%3DM.%26aulast%3DKramer%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DT.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DA%2520Fast%2520Flexible%2520Docking%2520Method%2520Using%2520an%2520Incremental%2520Construction%2520Algorithm%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D261%26spage%3D470%26epage%3D489%26doi%3D10.1006%2Fjmbi.1996.0477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span> <i>The PyMOL Molecular Graphics System</i>, <span class="NLM_edition">version
1.8</span>; <span class="NLM_publisher-name">Schrodinger, LLC</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+PyMOL+Molecular+Graphics+System%2C+version%0A1.8%3B+Schrodinger%2C+LLC%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchrodinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yongdi Wu, Na Liu, Meifang Qi, Huihao Qiao, Xuelian Lu, Li Ma, Yirong Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Fang-Lin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Monodentate Transient Directing Group Assisted Ruthenium(II)-Catalyzed Direct ortho-CâH Imidation of Benzaldehydes for Diverse Synthesis of Quinazoline and Fused Isoindolinone. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (10)
                                     , 3923-3927. <a href="https://doi.org/10.1021/acs.orglett.1c01083" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01083%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DMonodentate%252BTransient%252BDirecting%252BGroup%252BAssisted%252BRuthenium%252528II%252529-Catalyzed%252BDirect%252Bortho-C%2525E2%252580%252593H%252BImidation%252Bof%252BBenzaldehydes%252Bfor%252BDiverse%252BSynthesis%252Bof%252BQuinazoline%252Band%252BFused%252BIsoindolinone%26aulast%3DWu%26aufirst%3DYongdi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30032021%26date%3D03052021%26volume%3D23%26issue%3D10%26spage%3D3923%26epage%3D3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Katja Silbermann, Jiyang Li, Vigneshwaran Namasivayam, Fabian Baltes, Gerd Bendas, Sven Marcel Stefan, <span class="NLM_string-name hlFld-ContribAuthor">Michael Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10412-10432. <a href="https://doi.org/10.1021/acs.jmedchem.0c00961" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00961%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSuperior%252BPyrimidine%252BDerivatives%252Bas%252BSelective%252BABCG2%252BInhibitors%252Band%252BBroad-Spectrum%252BABCB1%25252C%252BABCC1%25252C%252Band%252BABCG2%252BAntagonists%26aulast%3DSilbermann%26aufirst%3DKatja%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05062020%26date%3D11092020%26date%3D31072020%26volume%3D63%26issue%3D18%26spage%3D10412%26epage%3D10432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sheng Han, Yali Sang, Yan Wu, Yuan Tao, Christophe Pannecouque, Erik De Clercq, Chunlin Zhuang, <span class="NLM_string-name hlFld-ContribAuthor">Fen-Er Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (5)
                                     , 787-801. <a href="https://doi.org/10.1021/acsinfecdis.9b00229" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00229%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DMolecular%252BHybridization-Inspired%252BOptimization%252Bof%252BDiarylbenzopyrimidines%252Bas%252BHIV-1%252BNonnucleoside%252BReverse%252BTranscriptase%252BInhibitors%252Bwith%252BImproved%252BActivity%252Bagainst%252BK103N%252Band%252BE138K%252BMutants%252Band%252BPharmacokinetic%252BProfiles%26aulast%3DHan%26aufirst%3DSheng%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D19062019%26date%3D24102019%26date%3D10102019%26volume%3D6%26issue%3D5%26spage%3D787%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuezhen Zhu, Iris L. K. Wong, Kin-Fai Chan, Jiahua Cui, Man Chun Law, Tsz Cheung Chong, Xuesen Hu, Larry M. C. Chow, <span class="NLM_string-name hlFld-ContribAuthor">Tak Hang Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8578-8608. <a href="https://doi.org/10.1021/acs.jmedchem.9b00963" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00963%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTriazole%252BBridged%252BFlavonoid%252BDimers%252Bas%252BPotent%25252C%252BNontoxic%25252C%252Band%252BHighly%252BSelective%252BBreast%252BCancer%252BResistance%252BProtein%252B%252528BCRP%25252FABCG2%252529%252BInhibitors%26aulast%3DZhu%26aufirst%3DXuezhen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17062019%26date%3D12092019%26date%3D29082019%26volume%3D62%26issue%3D18%26spage%3D8578%26epage%3D8608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minh-Tri  Le</span>, <span class="hlFld-ContribAuthor ">Viet-Nham  Hoang</span>, <span class="hlFld-ContribAuthor ">Dac-Nhan  Nguyen</span>, <span class="hlFld-ContribAuthor ">Thi-Hoang-Linh  Bui</span>, <span class="hlFld-ContribAuthor ">Thien-Vy  Phan</span>, <span class="hlFld-ContribAuthor ">Phuong Nguyen-Hoai  Huynh</span>, <span class="hlFld-ContribAuthor ">Thanh-Dao  Tran</span>, <span class="hlFld-ContribAuthor ">Khac-Minh  Thai</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3115. <a href="https://doi.org/10.3390/molecules26113115" title="DOI URL">https://doi.org/10.3390/molecules26113115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113115%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BABCG2%252BInhibitors%25253A%252BA%252BHomology%252BProtein-Based%252BPharmacophore%252BModeling%252Band%252BMolecular%252BDocking%252BApproach%26aulast%3DLe%26aufirst%3DMinh-Tri%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luis C.  Vesga</span>, <span class="hlFld-ContribAuthor ">Thales  Kronenberger</span>, <span class="hlFld-ContribAuthor ">Arun Kumar  Tonduru</span>, <span class="hlFld-ContribAuthor ">Diogo Henrique  Kita</span>, <span class="hlFld-ContribAuthor ">Ingrid Fatima  Zattoni</span>, <span class="hlFld-ContribAuthor ">Cristian Camilo  Bernal</span>, <span class="hlFld-ContribAuthor ">Arnold R. Romero  BohÃ³rquez</span>, <span class="hlFld-ContribAuthor ">Stelia Carolina  MendezâSÃ¡nchez</span>, <span class="hlFld-ContribAuthor ">Suresh V.  Ambudkar</span>, <span class="hlFld-ContribAuthor ">Glaucio  Valdameri</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydroquinoline/4,5âDihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>59 </em><a href="https://doi.org/10.1002/cmdc.202100188" title="DOI URL">https://doi.org/10.1002/cmdc.202100188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100188%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTetrahydroquinoline%25252F4%25252C5%2525E2%252580%252590Dihydroisoxazole%252BMolecular%252BHybrids%252Bas%252BInhibitors%252Bof%252BBreast%252BCancer%252BResistance%252BProtein%252B%252528BCRP%25252FABCG2%252529%26aulast%3DVesga%26aufirst%3DLuis%2BC.%26date%3D2021%26date%3D2021%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaista  Amin</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">A. K.  Najmi</span>, <span class="hlFld-ContribAuthor ">Nadeem  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Asif  Husain</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">A review on synthetic procedures and applications of phosphorus oxychloride (POCl
              3
              ) in the last biennial period (2018â19). </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2021,</strong> <em>196 </em>
                                    (3)
                                     , 211-274. <a href="https://doi.org/10.1080/10426507.2020.1831499" title="DOI URL">https://doi.org/10.1080/10426507.2020.1831499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2020.1831499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2020.1831499%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DA%252Breview%252Bon%252Bsynthetic%252Bprocedures%252Band%252Bapplications%252Bof%252Bphosphorus%252Boxychloride%252B%252528POCl%252B3%252B%252529%252Bin%252Bthe%252Blast%252Bbiennial%252Bperiod%252B%2525282018%2525E2%252580%25259319%252529%26aulast%3DAmin%26aufirst%3DShaista%26date%3D2021%26date%3D2020%26volume%3D196%26issue%3D3%26spage%3D211%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katja  Silbermann</span>, <span class="hlFld-ContribAuthor ">Jiyang  Li</span>, <span class="hlFld-ContribAuthor ">Vigneshwaran  Namasivayam</span>, <span class="hlFld-ContribAuthor ">Sven Marcel  Stefan</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Rational drug design of 6-substituted 4-anilino-2-phenylpyrimidines for exploration of novel ABCG2 binding site. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113045. <a href="https://doi.org/10.1016/j.ejmech.2020.113045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdrug%252Bdesign%252Bof%252B6-substituted%252B4-anilino-2-phenylpyrimidines%252Bfor%252Bexploration%252Bof%252Bnovel%252BABCG2%252Bbinding%252Bsite%26aulast%3DSilbermann%26aufirst%3DKatja%26date%3D2021%26volume%3D212%26spage%3D113045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalie  Guragossian</span>, <span class="hlFld-ContribAuthor ">Billel  Belhani</span>, <span class="hlFld-ContribAuthor ">Alexis  Moreno</span>, <span class="hlFld-ContribAuthor ">Magda Teixeira  Nunes</span>, <span class="hlFld-ContribAuthor ">Lucia  Gonzalez-Lobato</span>, <span class="hlFld-ContribAuthor ">Christelle  Marminon</span>, <span class="hlFld-ContribAuthor ">Laurent  Berthier</span>, <span class="hlFld-ContribAuthor ">Amanda Do  Rocio Andrade Pires</span>, <span class="hlFld-ContribAuthor ">Csilla  Ãzvegy-Laczka</span>, <span class="hlFld-ContribAuthor ">BalÃ¡zs  Sarkadi</span>, <span class="hlFld-ContribAuthor ">RaphaÃ«l  Terreux</span>, <span class="hlFld-ContribAuthor ">Zouhair  Bouaziz</span>, <span class="hlFld-ContribAuthor ">Malika  Berredjem</span>, <span class="hlFld-ContribAuthor ">Joachim  Jose</span>, <span class="hlFld-ContribAuthor ">Attilio  Di Pietro</span>, <span class="hlFld-ContribAuthor ">Pierre  Falson</span>, <span class="hlFld-ContribAuthor ">Marc  Le Borgne</span>. </span><span class="cited-content_cbyCitation_article-title">Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113017. <a href="https://doi.org/10.1016/j.ejmech.2020.113017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUncompetitive%252Bnanomolar%252Bdimeric%252Bindenoindole%252Binhibitors%252Bof%252Bthe%252Bhuman%252Bbreast%252Bcancer%252Bresistance%252Bpump%252BABCG2%26aulast%3DGuragossian%26aufirst%3DNathalie%26date%3D2021%26volume%3D211%26spage%3D113017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranju  Bansal</span>, <span class="hlFld-ContribAuthor ">Anjleena  Malhotra</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic progression of quinazolines as targeted chemotherapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113016. <a href="https://doi.org/10.1016/j.ejmech.2020.113016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bprogression%252Bof%252Bquinazolines%252Bas%252Btargeted%252Bchemotherapeutic%252Bagents%26aulast%3DBansal%26aufirst%3DRanju%26date%3D2021%26volume%3D211%26spage%3D113016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Yanzhen  Huang</span>, <span class="hlFld-ContribAuthor ">Chao  Pi</span>, <span class="hlFld-ContribAuthor ">Xiuling  Cui</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-catalyzed [4â+â2] annulation of N-arylbenzamidines with 1,4,2-dioxazol-5-ones: Easy access to 4-aminoquinazolines via highly selective C H bond activation. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>25 </em><a href="https://doi.org/10.1016/j.cclet.2021.02.061" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.02.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.02.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.02.061%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DRhodium%252528III%252529-catalyzed%252B%25255B4%2525E2%252580%252589%25252B%2525E2%252580%2525892%25255D%252Bannulation%252Bof%252BN-arylbenzamidines%252Bwith%252B1%25252C4%25252C2-dioxazol-5-ones%25253A%252BEasy%252Baccess%252Bto%252B4-aminoquinazolines%252Bvia%252Bhighly%252Bselective%252BC%252BH%252Bbond%252Bactivation%26aulast%3DRen%26aufirst%3DJie%26date%3D2021%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frauke  Antoni</span>, <span class="hlFld-ContribAuthor ">David  Wifling</span>, <span class="hlFld-ContribAuthor ">GÃ¼nther  Bernhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Water-soluble inhibitors of ABCG2 (BCRP) â A fragment-based and computational approach. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112958. <a href="https://doi.org/10.1016/j.ejmech.2020.112958" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112958%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWater-soluble%252Binhibitors%252Bof%252BABCG2%252B%252528BCRP%252529%252B%2525E2%252580%252593%252BA%252Bfragment-based%252Band%252Bcomputational%252Bapproach%26aulast%3DAntoni%26aufirst%3DFrauke%26date%3D2021%26volume%3D210%26spage%3D112958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vigneshwaran  Namasivayam</span>, <span class="hlFld-ContribAuthor ">Katja  Silbermann</span>, <span class="hlFld-ContribAuthor ">Jens  Pahnke</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>, <span class="hlFld-ContribAuthor ">Sven Marcel  Stefan</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="adeeedfdec">[emailÂ protected]</a>). </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2021,</strong> <em>19 </em>, 3269-3283. <a href="https://doi.org/10.1016/j.csbj.2021.05.018" title="DOI URL">https://doi.org/10.1016/j.csbj.2021.05.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2021.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2021.05.018%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DScaffold%252Bfragmentation%252Band%252Bsubstructure%252Bhopping%252Breveal%252Bpotential%25252C%252Brobustness%25252C%252Band%252Blimits%252Bof%252Bcomputer-aided%252Bpattern%252Banalysis%252B%252528C%252540PA%252529%26aulast%3DNamasivayam%26aufirst%3DVigneshwaran%26date%3D2021%26volume%3D19%26spage%3D3269%26epage%3D3283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Bao</span>, <span class="hlFld-ContribAuthor ">Zhi-Yuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Ye-Ting  Mao</span>, <span class="hlFld-ContribAuthor ">Li-Xiong  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">N-heterocyclic carbene-Pd(II)-1-methylimidazole complex-catalyzed Suzuki-Miyaura coupling of 2-chloro-4-aminoquinazolines with arylboronic acids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (44)
                                     , 131548. <a href="https://doi.org/10.1016/j.tet.2020.131548" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131548</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131548%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DN-heterocyclic%252Bcarbene-Pd%252528II%252529-1-methylimidazole%252Bcomplex-catalyzed%252BSuzuki-Miyaura%252Bcoupling%252Bof%252B2-chloro-4-aminoquinazolines%252Bwith%252Barylboronic%252Bacids%26aulast%3DBao%26aufirst%3DZhen%26date%3D2020%26volume%3D76%26issue%3D44%26spage%3D131548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Jia-Cheng  Zeng</span>, <span class="hlFld-ContribAuthor ">Li-Li  Duan</span>, <span class="hlFld-ContribAuthor ">Zhao-Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Xie-Huang  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical insight into the multiple interactions of quinazoline inhibitors with breast cancer resistance protein (BCRP/ABCG2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (14)
                                     , 4336-4343. <a href="https://doi.org/10.1080/07391102.2019.1677503" title="DOI URL">https://doi.org/10.1080/07391102.2019.1677503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1677503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1677503%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DTheoretical%252Binsight%252Binto%252Bthe%252Bmultiple%252Binteractions%252Bof%252Bquinazoline%252Binhibitors%252Bwith%252Bbreast%252Bcancer%252Bresistance%252Bprotein%252B%252528BCRP%25252FABCG2%252529%26aulast%3DLi%26aufirst%3DWen-Jing%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D14%26spage%3D4336%26epage%3D4343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  M. F. GonÃ§alves</span>, <span class="hlFld-ContribAuthor ">David  S. P. Cardoso</span>, <span class="hlFld-ContribAuthor ">Maria-JosÃ©  U. Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3364. <a href="https://doi.org/10.3390/molecules25153364" title="DOI URL">https://doi.org/10.3390/molecules25153364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153364%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DOvercoming%252BMultidrug%252BResistance%25253A%252BFlavonoid%252Band%252BTerpenoid%252BNitrogen-Containing%252BDerivatives%252Bas%252BABC%252BTransporter%252BModulators%26aulast%3DM.%2BF.%2BGon%25C3%25A7alves%26aufirst%3DBruno%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Wiese</span>, <span class="hlFld-ContribAuthor ">Sven Marcel  Stefan</span>. </span><span class="cited-content_cbyCitation_article-title">The AâBâC of smallâmolecule ABC transport protein modulators: From inhibition to activationâa case study of multidrug resistanceâassociated protein 1 (ABCC1). </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2031-2081. <a href="https://doi.org/10.1002/med.21573" title="DOI URL">https://doi.org/10.1002/med.21573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21573%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DThe%252BA%2525E2%252580%252590B%2525E2%252580%252590C%252Bof%252Bsmall%2525E2%252580%252590molecule%252BABC%252Btransport%252Bprotein%252Bmodulators%25253A%252BFrom%252Binhibition%252Bto%252Bactivation%2525E2%252580%252594a%252Bcase%252Bstudy%252Bof%252Bmultidrug%252Bresistance%2525E2%252580%252590associated%252Bprotein%252B1%252B%252528ABCC1%252529%26aulast%3DWiese%26aufirst%3DMichael%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2031%26epage%3D2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Szumilak</span>, <span class="hlFld-ContribAuthor ">Anna  Lichota</span>, <span class="hlFld-ContribAuthor ">Andrzej  Olczak</span>, <span class="hlFld-ContribAuthor ">MaÅgorzata  Szczesio</span>, <span class="hlFld-ContribAuthor ">Andrzej  StaÅczak</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular insight into quinazoline derivatives with cytotoxic activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1194 </em>, 28-34. <a href="https://doi.org/10.1016/j.molstruc.2019.05.042" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DMolecular%252Binsight%252Binto%252Bquinazoline%252Bderivatives%252Bwith%252Bcytotoxic%252Bactivity%26aulast%3DSzumilak%26aufirst%3DMarta%26date%3D2019%26volume%3D1194%26spage%3D28%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yao  Wu</span>, <span class="hlFld-ContribAuthor ">Xin-Ying  Gao</span>, <span class="hlFld-ContribAuthor ">Xin-Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Shao-Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen-Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Xie-Huang  Sheng</span>, <span class="hlFld-ContribAuthor ">De-Zhan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-centric topographic mapping method guides the understanding of ABCG2-inhibitor interactions. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (14)
                                     , 7757-7766. <a href="https://doi.org/10.1039/C8RA09789E" title="DOI URL">https://doi.org/10.1039/C8RA09789E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA09789E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA09789E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DFragment-centric%252Btopographic%252Bmapping%252Bmethod%252Bguides%252Bthe%252Bunderstanding%252Bof%252BABCG2-inhibitor%252Binteractions%26aulast%3DWu%26aufirst%3DYao%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D14%26spage%3D7757%26epage%3D7766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katja  Silbermann</span>, <span class="hlFld-ContribAuthor ">Chetan P.  Shah</span>, <span class="hlFld-ContribAuthor ">Niteshkumar U.  Sahu</span>, <span class="hlFld-ContribAuthor ">Kapil  Juvale</span>, <span class="hlFld-ContribAuthor ">Sven Marcel  Stefan</span>, <span class="hlFld-ContribAuthor ">Prashant S.  Kharkar</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 193-213. <a href="https://doi.org/10.1016/j.ejmech.2018.12.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bchalcone%252Band%252Bflavone%252Bderivatives%252Bas%252Bselective%252Band%252Bdual%252Binhibitors%252Bof%252Bthe%252Btransport%252Bproteins%252BABCB1%252Band%252BABCG2%26aulast%3DSilbermann%26aufirst%3DKatja%26date%3D2019%26volume%3D164%26spage%3D193%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis Route for Compounds <b>1</b>â<b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) triphosgene, THF, reflux, 3 h; (ii) NH<sub>3</sub>, 50 Â°C, 30 min; (iii) I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 90â110 Â°C, 8â12 h; (iv) POCl<sub>3</sub>, reflux, 4â12 h; (v) <i>i</i>-PrOH, substituted aniline, 100 W microwave irradiation, 110 Â°C, 20â40 min; (vi) BBr<sub>3</sub>, DCM, â60 Â°C â RT, 12 h; (vii) THF, 4 bar H<sub>2</sub>, Pd/C, RT, 24 h; (viii) RCOCl, THF, 0 Â°C â RT, 6â12 h; (ix) <i>i</i>-PrOH, substituted aniline, 100 W microwave irradiation, 110 Â°C, 30 min.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structures of the reference compounds <b>59</b> (Ko143 (a)), Hoechst 33342 (b), cyclosporine A (CsA (c)), mitoxantrone (MX (d)), the active metabolite of irinotecan (SN-38 (e)), and quercetin (f).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR of some compounds illustrating structural features impacting the inhibitory potency of a compound. Highest potencies were achieved by 6-nitro derivatives, notably by those containing methoxy or hydroxy functions (a). Regarding substitution at position 6, lower inhibitory potencies resulted from 6-amino (<b>43</b>â<b>47</b>) and 6-<i>N</i>-functionalized (<b>48</b>â<b>51</b>) derivatives compared to nitro (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>40</b> (â, IC<sub>50</sub> = 27.8 nM) and <b>41</b> (â, IC<sub>50</sub> = 23.4 nM) in a Hoechst 33342 accumulation assay with compound <b>59</b> (â , IC<sub>50</sub> = 227 nM) as reference, using the ABCG2 overexpressing MDCK II BCRP cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative examples of MTT viability assays of compounds <b>28</b> (â¡), <b>29</b> (â), and <b>41</b> (Î) using the ABCG2 overexpressing MDCK II BCRP cell line. The GI<sub>50</sub> values were determined as 84.5 Î¼M (â¡), 77.3 Î¼M (â), and 9.46 Î¼M (Î), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MDR reversal assay to determine the ability of compound <b>23</b>, <b>28</b>, and <b>41</b> to reverse the MDR against the cytostatic drug SN-38, using the ABCG2 overexpressing cell line (a,c,d). The following concentrations were used: control (â), 0.01 Î¼M (â ), 0.03 Î¼M (closed triangle), 0.1 Î¼M (â¼), 1 Î¼M (â³), 5 Î¼M (â¡), and parental cell line (â). The gray arrow indicates the increasing sensitization of the ABCG2 overexpressing cells with higher compound concentrations. At a compound concentration of 1 Î¼M, full reversal is achieved, indicated by a similar pGI<sub>50</sub> as the parental cells. Exemplarily is shown for compound <b>23</b> that there is no effect on the parental MDCK II cells (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Nonlinear regression of the pGI<sub>50</sub> values determined in the MDR reversal assay (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a,c,d) against the corresponding concentration of compounds <b>23</b>, <b>28</b>, and <b>41</b>. EC<sub>50</sub> is the concentration that reduces resistance of the ABCG2 overexpressing cells to 50%. The following EC<sub>50</sub> values were calculated: 34.0 nM (<b>23</b>), 71.2 nM (<b>28</b>), and 51.5 nM (<b>41</b>). The pGI<sub>50</sub> values of the parental cells determined in an analogous assay are depicted by open circles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. MDR reversal assay of compounds <b>31</b> ((a) EC<sub>50</sub> 21.8 nM) and <b>41</b> ((b) EC<sub>50</sub> 19.5 nM), demonstrating their ability to reverse MDR toward the cytostatic MX, using the ABCG2 overexpressing cell line MDCK II. The bars represent the cell viability at a given modulator concentration in the presence (light gray) and absence (dark gray) of 0.5 Î¼M MX. The standard deviation is expressed by error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Concentrationâresponse curves for compounds <b>22</b> (a), <b>26</b> (b), and quercetin (c) in the ATPase activity assay. All values are vanadate-sensitive ATPase activities in relation to the basal activity, which is set to 100%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. LineweaverâBurk plot for compounds <b>17</b> (a), <b>31</b> (c), <b>40</b> (e), and <b>41</b> (g) at various concentrations together with the ABCG2 substrate Hoechst 33342. Plot of the MichaelisâMenten constant <i>K</i><sub>M</sub> (â) and the maximum velocity <i>V</i><sub>max</sub> (â ) derived from the analysis according to Cornish-Bowden against the corresponding compound concentration (<b>17</b> (b)), <b>31</b> (d)), <b>40</b> (f)), <b>41</b>, (h)).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) 5D3 immunoreactivity modulation of ABCG2 by various compounds at a concentration of 10 Î¼M. Fluorescence detected by the 5D3-labeling of ABCG2 in the presence of 10 Î¼M compound <b>59</b> was set to 100%, and the fluorescence measured in the absence of any compound taken as 0%. Values are means of at least three independent experiments, and the SD is given as error bar. (b) Histogram of the obtained fluorescence at the FL3-H detector (<i>X</i>-axis) and the cell-count according to the corresponding fluorescence. Depicted is the fluorescence of the isotype control (dotted curve) as well as of 5D3 antibody in the absence of a compound <b>59</b> (dashed curve) and in the presence of compound <b>59</b> (continuous curve).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Binding poses of MZ29 and Hoechst 33342. (a) The binding pose of the inhibitor MZ29 (purple) observed in the cryo-EM structure of the human ABCG2 receptor (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC">6FFC</a>). The putative binding sites of the human ABCG2 receptor are schematically indicated as S1 and S2. (b) Docked poses of the substrate Hoechst 33342 in the binding pockets of the human ABCG2 receptor and (c) 2D interaction diagram. The human ABCG2 receptor (chain A, gray, and chain B, dark gray) is displayed in cartoon representation. Both MZ29 and Hoechst 33342 are shown as stick models. Oxygen atoms are colored in red and nitrogen atoms in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/medium/jm-2018-01011a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Putative binding poses of compound <b>31</b> and <b>41</b>. (a) The docked poses of <b>31</b> (green) observed in the cryo-EM structure of the human ABCG2 receptor (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC">6FFC</a>) and (b) 2D interaction diagram. (c) The docked poses of <b>41</b> (yellow) observed in the cryo-EM structure of the human ABCG2 receptor and (d) 2D interaction diagram. The fluorine atoms are colored in cyan and for the remaining atoms. The human ABCG2 receptor (chain A, gray, and chain B, dark gray) is displayed in cartoon representation. Both MZ29 and Hoechst 33342 are shown as stick models. Oxygen atoms are colored in red and nitrogen atoms in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01011/20180907/images/large/jm-2018-01011a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01011&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 76 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slamon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poplack, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastan, I.</span></span> <span> </span><span class="NLM_article-title">Expression of a Multidrug-resistance Gene in Human Tumors and Tissues</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">265</span>â <span class="NLM_lpage">269</span>, <span class="refDoi">Â DOI: 10.1073/pnas.84.1.265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1073%2Fpnas.84.1.265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=2432605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaL2sXhtFCmsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=265-269&author=A.+T.+Fojoauthor=K.+Uedaauthor=D.+J.+Slamonauthor=D.+G.+Poplackauthor=M.+M.+Gottesmanauthor=I.+Pastan&title=Expression+of+a+Multidrug-resistance+Gene+in+Human+Tumors+and+Tissues&doi=10.1073%2Fpnas.84.1.265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of a multidrug-resistance gene in human tumors and tissues</span></div><div class="casAuthors">Fojo, A. T.; Ueda, K.; Slamon, D. J.; Poplack, D. G.; Gottesman, M. M.; Pastan, I.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">265-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The identification and cloning of a segment of a human multidrug resistance gene (mdr1) has been reported.  To examine the mol. basis of one type of multidrug resistance, RNA was prepd. from human tumors and normal tissues and their content of mdr1 RNA was measured.  The mdr1 gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at intermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues.  The mdr1 gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon.  In addn., increased expression was detected in a few tumors at the time of relapse following initial chemotherapy.  Although controlled clin. studies will be required, the results suggest that measurement of mdr1 RNA may prove to be a valuable tool in the design of chemotherapy protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZJTrls19i7Vg90H21EOLACvtfcHk0li8h6SVRm06Uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtFCmsr4%253D&md5=b75baa0e65eb1e16ac2e192ac0f05965</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.1.265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.1.265%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DA.%2BT.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DPoplack%26aufirst%3DD.%2BG.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DPastan%26aufirst%3DI.%26atitle%3DExpression%2520of%2520a%2520Multidrug-resistance%2520Gene%2520in%2520Human%2520Tumors%2520and%2520Tissues%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D265%26epage%3D269%26doi%3D10.1073%2Fpnas.84.1.265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unadkat, J. D.</span></span> <span> </span><span class="NLM_article-title">Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transportâan Update</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">65</span>â <span class="NLM_lpage">82</span>, <span class="refDoi">Â DOI: 10.1208/s12248-014-9668-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1208%2Fs12248-014-9668-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=65-82&author=Q.+Maoauthor=J.+D.+Unadkat&title=Role+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29+in+Drug+Transport%E2%80%94an+Update&doi=10.1208%2Fs12248-014-9668-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1208%2Fs12248-014-9668-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-014-9668-6%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DRole%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%2520in%2520Drug%2520Transport%25E2%2580%2594an%2520Update%26jtitle%3DAAPS%2520J.%26date%3D2015%26volume%3D17%26spage%3D65%26epage%3D82%26doi%3D10.1208%2Fs12248-014-9668-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, R.</span></span> <span> </span><span class="NLM_article-title">Purification and Structural Analyses of ABCG2</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">57</span>â <span class="NLM_lpage">65</span>, <span class="refDoi">Â DOI: 10.1016/j.addr.2008.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.addr.2008.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=19124053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1alu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=57-65&author=C.+A.+McDevittauthor=R.+Collinsauthor=I.+D.+Kerrauthor=R.+Callaghan&title=Purification+and+Structural+Analyses+of+ABCG2&doi=10.1016%2Fj.addr.2008.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and structural analyses of ABCG2</span></div><div class="casAuthors">McDevitt, Christopher A.; Collins, Richard; Kerr, Ian D.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ABCG2/BRCP protein is best known as a multidrug transporter capable of conferring resistance to cancer cells.  However, the protein is also inherently expressed in numerous barrier tissues and intriguingly within hematopoietic stem cells.  Unlike its partners, ABCB1 and ABCC1, there is considerably less information available on the mol. mechanism of ABCG2/BRCP.  The transporter has a distinct topol. and is presumed to function as a homodimer.  However, a no. of biochem. studies have presented data to suggest that the protein adopts higher order oligomers.  This review focuses on this controversial issue with particular ref. to findings from low resoln. structural data.  In addn., a no. of mol. models of ABCG2/BRCP based on high-resoln. structures of bacterial ABC transporters have recently become available and are critically assessed.  ABCG2/BRCP is a structurally distinct member of the triumvirate of human multidrug transporters and continues to evade description of a unifying mol. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-26N0eXV32LVg90H21EOLACvtfcHk0li8h6SVRm06Uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1alu7g%253D&md5=8afc7467f79e661e505d5bccbc17cfbf</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcDevitt%26aufirst%3DC.%2BA.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DPurification%2520and%2520Structural%2520Analyses%2520of%2520ABCG2%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D57%26epage%3D65%26doi%3D10.1016%2Fj.addr.2008.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristensen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brangi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning of cDNAs Which Are Highly Overexpressed in Mitoxantrone resistant Cells: Demonstration of Homology to ABC Transport Genes</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8</span>â <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=8-13&author=K.+Miyakeauthor=L.+Mickleyauthor=T.+Litmanauthor=Z.+Zhanauthor=R.+Robeyauthor=B.+Cristensenauthor=M.+Brangiauthor=L.+Greenbergerauthor=M.+Deanauthor=T.+Fojoauthor=S.+E.+Bates&title=Molecular+Cloning+of+cDNAs+Which+Are+Highly+Overexpressed+in+Mitoxantrone+resistant+Cells%3A+Demonstration+of+Homology+to+ABC+Transport+Genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DMickley%26aufirst%3DL.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DCristensen%26aufirst%3DB.%26aulast%3DBrangi%26aufirst%3DM.%26aulast%3DGreenberger%26aufirst%3DL.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMolecular%2520Cloning%2520of%2520cDNAs%2520Which%2520Are%2520Highly%2520Overexpressed%2520in%2520Mitoxantrone%2520resistant%2520Cells%253A%2520Demonstration%2520of%2520Homology%2520to%2520ABC%2520Transport%2520Genes%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D8%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-T.</span></span> <span> </span><span class="NLM_article-title">Human ABCG2: Structure, Function, and its Role in Multidrug Resistance</span>. <i>Int. J. Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=1-27&author=W.+Moauthor=J.-T.+Zhang&title=Human+ABCG2%3A+Structure%2C+Function%2C+and+its+Role+in+Multidrug+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.-T.%26atitle%3DHuman%2520ABCG2%253A%2520Structure%252C%2520Function%252C%2520and%2520its%2520Role%2520in%2520Multidrug%2520Resistance%26jtitle%3DInt.%2520J.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D1%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkens, S.</span></span> <span> </span><span class="NLM_article-title">Structure and Mechanism of ABC Transporters</span>. <i>F1000Prime Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi">Â DOI: 10.12703/P7-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.12703%2FP7-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=25750732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhvFWhsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=14&author=S.+Wilkens&title=Structure+and+Mechanism+of+ABC+Transporters&doi=10.12703%2FP7-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of ABC transporters</span></div><div class="casAuthors">Wilkens Stephan</div><div class="citationInfo"><span class="NLM_cas:title">F1000prime reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn">2051-7599</span>.
    </div><div class="casAbstract">All living organisms depend on primary and secondary membrane transport for the supply of external nutrients and removal or sequestration of unwanted (toxic) compounds.  Due to the chemical diversity of cellular molecules, it comes as no surprise that a significant part of the proteome is dedicated to the active transport of cargo across the plasma membrane or the membranes of subcellular organelles.  Transport against a chemical gradient can be driven by, for example, the free energy change associated with ATP hydrolysis (primary transport), or facilitated by the potential energy of the chemical gradient of another molecule (secondary transport).  Primary transporters include the rotary motor ATPases (F-, A-, and V-ATPases), P-type ATPases and a large family of integral membrane proteins referred to as "ABC" (ATP binding cassette) transporters.  ABC transporters are widespread in all forms of life and are characterized by two nucleotide-binding domains (NBD) and two transmembrane domains (TMDs).  ATP hydrolysis on the NBD drives conformational changes in the TMD, resulting in alternating access from inside and outside of the cell for unidirectional transport across the lipid bilayer.  Common to all ABC transporters is a signature sequence or motif, LSGGQ, that is involved in nucleotide binding.  Both importing and exporting ABC transporters are found in bacteria, whereas the majority of eukaryotic family members function in the direction of export.  Recent progress with the X-ray crystal structure determination of a variety of bacterial and eukaryotic ABC transporters has helped to advance our understanding of the ATP hydrolysis-driven transport mechanism but has also illustrated the large structural and functional diversity within the family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnMdLvCnsfMK__Jf7-eMvJfW6udTcc2eYOCjSgojMC4bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhvFWhsA%253D%253D&md5=c33f6447d0f32735fae9b6e48f5e18e9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.12703%2FP7-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12703%252FP7-14%26sid%3Dliteratum%253Aachs%26aulast%3DWilkens%26aufirst%3DS.%26atitle%3DStructure%2520and%2520Mechanism%2520of%2520ABC%2520Transporters%26jtitle%3DF1000Prime%2520Rep.%26date%3D2015%26volume%3D7%26spage%3D14%26doi%3D10.12703%2FP7-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-T.</span></span> <span> </span><span class="NLM_article-title">Use of Arrays to Investigate the Contribution of ATP-binding Cassette Transporters to Drug Resistance in Cancer Chemotherapy and Prediction of Chemosensitivity</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">311</span>â <span class="NLM_lpage">323</span>, <span class="refDoi">Â DOI: 10.1038/cr.2007.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fcr.2007.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=17404598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Chtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=311-323&author=J.-T.+Zhang&title=Use+of+Arrays+to+Investigate+the+Contribution+of+ATP-binding+Cassette+Transporters+to+Drug+Resistance+in+Cancer+Chemotherapy+and+Prediction+of+Chemosensitivity&doi=10.1038%2Fcr.2007.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity</span></div><div class="casAuthors">Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-323</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a major problem in cancer chemotherapy.  One of the best known mechanisms of MDR is the elevated expression of ATP-binding cassette (ABC) transporters.  While some members of human ABC transporters have been shown to cause drug resistance with elevated expression, it is not yet known whether the over-expression of other members could also contribute to drug resistance in many model cancer cell lines and clinics.  The recent development of microarrays and quant. PCR arrays for expression profiling anal. of ABC transporters has helped address these issues.  In this article, various arrays with limited or full list of ABC transporter genes and their use in identifying ABC transporter genes in drug resistance and chemo-sensitivity prediction will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFJxltRNjjorVg90H21EOLACvtfcHk0lgZZ9q5Rq4Y8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Chtb0%253D&md5=28d341004d5cfc22a14048234ba704d3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fcr.2007.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2007.15%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-T.%26atitle%3DUse%2520of%2520Arrays%2520to%2520Investigate%2520the%2520Contribution%2520of%2520ATP-binding%2520Cassette%2520Transporters%2520to%2520Drug%2520Resistance%2520in%2520Cancer%2520Chemotherapy%2520and%2520Prediction%2520of%2520Chemosensitivity%26jtitle%3DCell%2520Res.%26date%3D2007%26volume%3D17%26spage%3D311%26epage%3D323%26doi%3D10.1038%2Fcr.2007.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, V.</span></span> <span> </span><span class="NLM_article-title">A Surface Glycoprotein Modulating Drug Permeability in Chinese Hamster Ovary Cell Mutants</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">152</span>â <span class="NLM_lpage">162</span>, <span class="refDoi">Â DOI: 10.1016/0005-2736(76)90160-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2F0005-2736%2876%2990160-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=990323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaE28XlvV2qs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=1976&pages=152-162&author=R.+L.+Julianoauthor=V.+Ling&title=A+Surface+Glycoprotein+Modulating+Drug+Permeability+in+Chinese+Hamster+Ovary+Cell+Mutants&doi=10.1016%2F0005-2736%2876%2990160-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants</span></div><div class="casAuthors">Juliano, R. L.; Ling, V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-62</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    </div><div class="casAbstract">Chinese hamster ovary cells selected for resistance to colchicine displayed pleiotropic cross-resistance to a wide range of amphiphilic drugs.  The drug-resistant Chinese hamster ovary cell membranes possessed a carbohydrate-contg. component of 170,000 daltons apparent mol. wt. which was not obsd. in wild type cells.  This component was a cell surface glycoprotein, and was designated as P glycoprotein.  The relative amt. of surface labeled P glycoprotein correlated with the degree of drug resistance in a no. of independent mutant and revertant clones.  A similar high mol. wt. glycoprotein was also present in drug-resistant mutants from another hamster cell line.  Thus, certain surface glycoproteins may control drug permeation by modulating the properties of hydrophobic membrane regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ZxAfIismuLVg90H21EOLACvtfcHk0li4laBRSWz_Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XlvV2qs70%253D&md5=04dae856aaeb328d977c36df532b0072</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0005-2736%2876%2990160-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2736%252876%252990160-7%26sid%3Dliteratum%253Aachs%26aulast%3DJuliano%26aufirst%3DR.%2BL.%26aulast%3DLing%26aufirst%3DV.%26atitle%3DA%2520Surface%2520Glycoprotein%2520Modulating%2520Drug%2520Permeability%2520in%2520Chinese%2520Hamster%2520Ovary%2520Cell%2520Mutants%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D1976%26volume%3D455%26spage%3D152%26epage%3D162%26doi%3D10.1016%2F0005-2736%2876%2990160-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almquist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, E. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span> <span> </span><span class="NLM_article-title">Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">1650</span>â <span class="NLM_lpage">1654</span>, <span class="refDoi">Â DOI: 10.1126/science.1360704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1126%2Fscience.1360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1360704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1650-1654&author=S.+P.+Coleauthor=G.+Bhardwajauthor=J.+H.+Gerlachauthor=J.+E.+Mackieauthor=C.+E.+Grantauthor=K.+C.+Almquistauthor=A.+J.+Stewartauthor=E.+U.+Kurzauthor=A.+M.+Duncanauthor=R.+G.+Deeley&title=Overexpression+of+a+Transporter+Gene+in+a+Multidrug-Resistant+Human+Lung+Cancer+Cell+Line&doi=10.1126%2Fscience.1360704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span></div><div class="casAuthors">Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5088</span>),
    <span class="NLM_cas:pages">1650-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents.  However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on ATP and is assocd. with multidrug resistance.  CDNA clones corresponding to mRNAs overexpressed in H69AR cells were isolated.  One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells.  Overexpression was assocd. with amplification of the cognate gene located on chromosome 16 at band p13.1.  Reversion to drug sensitivity was assocd. with loss of gene amplification and a marked decrease in mRNA expression.  The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS-PschUsW7Vg90H21EOLACvtfcHk0li4laBRSWz_Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D&md5=7002d3f14cd64c4f39e44d938db665f7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1360704%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DBhardwaj%26aufirst%3DG.%26aulast%3DGerlach%26aufirst%3DJ.%2BH.%26aulast%3DMackie%26aufirst%3DJ.%2BE.%26aulast%3DGrant%26aufirst%3DC.%2BE.%26aulast%3DAlmquist%26aufirst%3DK.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BJ.%26aulast%3DKurz%26aufirst%3DE.%2BU.%26aulast%3DDuncan%26aufirst%3DA.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26atitle%3DOverexpression%2520of%2520a%2520Transporter%2520Gene%2520in%2520a%2520Multidrug-Resistant%2520Human%2520Lung%2520Cancer%2520Cell%2520Line%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1650%26epage%3D1654%26doi%3D10.1126%2Fscience.1360704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, K. H.</span></span> <span> </span><span class="NLM_article-title">Reduced Intracellular Drug Accumulation in the Absence of P-Glycoprotein (mdrl) Overexpression in Mitoxantrone-Resistant Human MCF-7 Breast Cancer Cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6175</span>â <span class="NLM_lpage">6181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=6175-6181&author=M.+Nakagawaauthor=E.+Schneiderauthor=K.+H.+Dixonauthor=J.+Hortonauthor=K.+Kelleyauthor=C.+Morrowauthor=K.+H.+Cowan&title=Reduced+Intracellular+Drug+Accumulation+in+the+Absence+of+P-Glycoprotein+%28mdrl%29+Overexpression+in+Mitoxantrone-Resistant+Human+MCF-7+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DDixon%26aufirst%3DK.%2BH.%26aulast%3DHorton%26aufirst%3DJ.%26aulast%3DKelley%26aufirst%3DK.%26aulast%3DMorrow%26aufirst%3DC.%26aulast%3DCowan%26aufirst%3DK.%2BH.%26atitle%3DReduced%2520Intracellular%2520Drug%2520Accumulation%2520in%2520the%2520Absence%2520of%2520P-Glycoprotein%2520%2528mdrl%2529%2520Overexpression%2520in%2520Mitoxantrone-Resistant%2520Human%2520MCF-7%2520Breast%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D6175%26epage%3D6181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Drug Transporters: Recent Advances Concerning BCRP and Tyrosine Kinase Inhibitors</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">857</span>â <span class="NLM_lpage">862</span>, <span class="refDoi">Â DOI: 10.1038/sj.bjc.6604213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fsj.bjc.6604213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=18253130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVOgt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=857-862&author=C.+Lemosauthor=G.+Jansenauthor=G.+J.+Peters&title=Drug+Transporters%3A+Recent+Advances+Concerning+BCRP+and+Tyrosine+Kinase+Inhibitors&doi=10.1038%2Fsj.bjc.6604213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors</span></div><div class="casAuthors">Lemos, C.; Jansen, G.; Peters, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">857-862</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance is often assocd. with the (over)expression of drug efflux transporters of the ATP-binding cassette (ABC) protein family.  This minireview discusses the role of one selected ABC-transporter family member, the breast cancer resistance protein (BCRP/ABCG2), in the (pre)clin. efficacy of novel exptl. anticancer drugs, in particular tyrosine kinase inhibitors.  British Journal of Cancer (2008) 98, 857-862. doi:10.1038/sj.bjc.6604213 www.bjcancer.com Published online 5 Feb. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXa5TRFWT8LVg90H21EOLACvtfcHk0li4laBRSWz_Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVOgt7o%253D&md5=8f5e7070b71052b6f52ea6c90078d24c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604213%26sid%3Dliteratum%253Aachs%26aulast%3DLemos%26aufirst%3DC.%26aulast%3DJansen%26aufirst%3DG.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DDrug%2520Transporters%253A%2520Recent%2520Advances%2520Concerning%2520BCRP%2520and%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D857%26epage%3D862%26doi%3D10.1038%2Fsj.bjc.6604213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. D.</span></span> <span> </span><span class="NLM_article-title">Multidrug Resistance Mediated by the Breast Cancer Resistance Protein BCRP (ABCG2)</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">7340</span>â <span class="NLM_lpage">7358</span>, <span class="refDoi">Â DOI: 10.1038/sj.onc.1206938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fsj.onc.1206938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=14576842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BD3svpvFCjug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7340-7358&author=L.+A.+Doyleauthor=D.+D.+Ross&title=Multidrug+Resistance+Mediated+by+the+Breast+Cancer+Resistance+Protein+BCRP+%28ABCG2%29&doi=10.1038%2Fsj.onc.1206938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)</span></div><div class="casAuthors">Doyle L Austin; Ross Douglas D</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">7340-58</span>
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines without overexpression of P-glycoprotein or multidrug resistance protein (MRP) family members suggested the existence of another ATP-binding cassette (ABC) transporter capable of causing cancer drug resistance.  In one such cell line (MCF-7/AdrVp), the overexpression of a novel member of the G subfamily of ABC transporters was found.  The new transporter was termed the breast cancer resistance protein (BCRP), because of its identification in MCF-7 human breast carcinoma cells.  BCRP is a 655 amino-acid polypeptide, formally designated as ABCG2.  Like all members of the ABC G (white) subfamily, BCRP is a half transporter.  Transfection and enforced overexpression of BCRP in drug-sensitive MCF-7 or MDA-MB-231 cells recapitulates the drug-resistance phenotype of MCF-7/AdrVp cells, consistent with current evidence suggesting that functional BCRP is a homodimer.  BCRP maps to chromosome 4q22, downstream from a TATA-less promoter.  The spectrum of anticancer drugs effluxed by BCRP includes mitoxantrone, camptothecin-derived and indolocarbazole topoisomerase I inhibitors, methotrexate, flavopiridol, and quinazoline ErbB1 inhibitors.  Transport of anthracyclines is variable and appears to depend on the presence of a BCRP mutation at codon 482.  Potent and specific inhibitors of BCRP are now being developed, opening the door to clinical applications of BCRP inhibition.  Owing to tissue localization in the placenta, bile canaliculi, colon, small bowel, and brain microvessel endothelium, BCRP may play a role in protecting the organism from potentially harmful xenobiotics.  BCRP expression has also been demonstrated in pluripotential "side population" stem cells, responsible for the characteristic ability of these cells to exclude Hoechst 33342 dye, and possibly for the maintenance of the stem cell phenotype.  Studies are emerging on the role of BCRP expression in drug resistance in clinical cancers.  More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional assays, in order to determine the contribution of BCRP to drug resistance in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVhfZWKJa6Ui6Ufuk_1xoTfW6udTcc2eZE56DKRex6Urntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svpvFCjug%253D%253D&md5=e47830ac42603a5253b8148ca0e86fe2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206938%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DMultidrug%2520Resistance%2520Mediated%2520by%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520BCRP%2520%2528ABCG2%2529%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7340%26epage%3D7358%26doi%3D10.1038%2Fsj.onc.1206938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abruzzo, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rishi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. D.</span></span> <span> </span><span class="NLM_article-title">A Multidrug Resistance Transporter from Human MCF-7 Breast Cancer Cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">15665</span>â <span class="NLM_lpage">15670</span>, <span class="refDoi">Â DOI: 10.1073/pnas.95.26.15665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=T.+Krogmannauthor=Y.+Gaoauthor=A.+K.+Rishiauthor=D.+D.+Ross&title=A+Multidrug+Resistance+Transporter+from+Human+MCF-7+Breast+Cancer+Cells&doi=10.1073%2Fpnas.95.26.15665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0lh8D2mGVNwV0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DA%2520Multidrug%2520Resistance%2520Transporter%2520from%2520Human%2520MCF-7%2520Breast%2520Cancer%2520Cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670%26doi%3D10.1073%2Fpnas.95.26.15665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westover, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">New Trends for Overcoming ABCG2/BCRP-Mediated Resistance to Cancer Therapies</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">159</span>, <span class="refDoi">Â DOI: 10.1186/s13046-015-0275-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1186%2Fs13046-015-0275-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=26714461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFCmtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=159&author=D.+Westoverauthor=F.+Li&title=New+Trends+for+Overcoming+ABCG2%2FBCRP-Mediated+Resistance+to+Cancer+Therapies&doi=10.1186%2Fs13046-015-0275-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New trends for overcoming ABCG2/BCRP mediated resistance to cancer therapies</span></div><div class="casAuthors">Westover, David; Li, Fengzhi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159/1-159/9</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">ATP-binding cassette (ABC) transporters make up a superfamily of transmembrane proteins that play a crit. role in the development of drug resistance.  This phenomenon is esp. important in oncol., where superfamily member ABCG2 (also called BCRP - breast cancer resistance protein) is known to interact with dozens of anticancer agents that are ABCG2 substrates.  In addn. to the well-studied and well-reviewed list of cytotoxic and targeted agents that are substrates for the ABCG2 transporter, a growing body of work links ABCG2 to multiple photodynamic therapy (PDT) agents, and there is a limited body of evidence suggesting that ABCG2 may also play a role in resistance to radiation therapy.  In addn., the focus of ABC transporter research in regards to therapeutic development has begun to shift in the past few years.  The shift has been away from using pump inhibitors for reversing resistance, toward the development of therapeutic agents that are poor substrates for these efflux pump proteins.  This approach may result in the development of drug regimens that circumvent ABC transporter-mediated resistance entirely.  Here, it is our intention to review: (1) recent discoveries that further characterize the role of ABCG2 in oncol., and (2) advances in reversing and circumventing ABC transporter-mediated resistance to anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkbggbUBffW7Vg90H21EOLACvtfcHk0lh8D2mGVNwV0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFCmtbY%253D&md5=afd4146e72bb46ca30e5ebb81a7af1be</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2Fs13046-015-0275-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-015-0275-x%26sid%3Dliteratum%253Aachs%26aulast%3DWestover%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DNew%2520Trends%2520for%2520Overcoming%2520ABCG2%252FBCRP-Mediated%2520Resistance%2520to%2520Cancer%2520Therapies%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D34%26spage%3D159%26doi%3D10.1186%2Fs13046-015-0275-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">19781</span>â <span class="NLM_lpage">19789</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M310785200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1074%2Fjbc.M310785200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=15001581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Wit7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=19781-19789&author=J.+Xuauthor=Y.+Liuauthor=Y.+Yangauthor=S.+Batesauthor=J.+T.+Zhang&title=Characterization+of+Oligomeric+Human+Half-ABC+Transporter+ATP-binding+Cassette+G2&doi=10.1074%2Fjbc.M310785200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2</span></div><div class="casAuthors">Xu, Junkang; Liu, Yang; Yang, Youyun; Bates, Susan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">19781-19789</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human ATP-binding cassette G2 (ABCG2, also known as mitoxantrone resistance protein, breast cancer-resistance protein, ABC placenta) is a member of the superfamily of ATP-binding cassette (ABC) transporters that have a wide variety of substrates.  Overexpression of human ABCG2 in model cancer cell lines causes multidrug resistance by actively effluxing anticancer drugs.  Unlike most of the other ABC transporters which usually have two nucleotide-binding domains and two transmembrane domains, ABCG2 consists of only one nucleotide-binding domain followed by one transmembrane domain.  Thus, ABCG2 has been thought to be a half-transporter that may function as a homodimer.  In this study, we characterized the oligomeric feature of human ABCG2 using non-denaturing detergent perfluoro-octanoic acid and Triton X-100 in combination with gel filtration, sucrose d. gradient sedimentation, and gel electrophoresis.  Unexpectedly, we found that human ABCG2 exists mainly as a tetramer, with a possibility of a higher form of oligomerization.  Monomeric and dimeric ABCG2 did not appear to be the major form of the protein.  Further immunopptn. anal. showed that the oligomeric ABCG2 did not contain any other proteins.  Taken together, we conclude that human ABCG2 likely exists and functions as a homotetramer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS9hRAh_FSbVg90H21EOLACvtfcHk0lh8D2mGVNwV0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Wit7g%253D&md5=c45adb759c2de874ef4c299eb3d0c99e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M310785200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M310785200%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBates%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DCharacterization%2520of%2520Oligomeric%2520Human%2520Half-ABC%2520Transporter%2520ATP-binding%2520Cassette%2520G2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D19781%26epage%3D19789%26doi%3D10.1074%2Fjbc.M310785200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mc
Devitt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, R.</span></span> <span> </span><span class="NLM_article-title">Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1623</span>â <span class="NLM_lpage">1632</span>, <span class="refDoi">Â DOI: 10.1016/j.str.2006.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.str.2006.08.014" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1623-1632&author=C.+A.+Mc%0ADevittauthor=R.+F.+Collinsauthor=M.+Conwayauthor=S.+Modokauthor=J.+Stormauthor=I.+D.+Kerrauthor=R.+C.+Fordauthor=R.+Callaghan&title=Purification+and+3D+Structural+Analysis+of+Oligomeric+Human+Multidrug+Transporter+ABCG2&doi=10.1016%2Fj.str.2006.08.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2006.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2006.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DMc%2BDevitt%26aufirst%3DC.%2BA.%26aulast%3DCollins%26aufirst%3DR.%2BF.%26aulast%3DConway%26aufirst%3DM.%26aulast%3DModok%26aufirst%3DS.%26aulast%3DStorm%26aufirst%3DJ.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DFord%26aufirst%3DR.%2BC.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DPurification%2520and%25203D%2520Structural%2520Analysis%2520of%2520Oligomeric%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D1623%26epage%3D1632%26doi%3D10.1016%2Fj.str.2006.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velamakanni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veen, H.</span></span> <span> </span><span class="NLM_article-title">The Emerging Pharmacotherapeutic Significance of the Breast Cancer Resistance Protein (ABCG2)</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">163</span>â <span class="NLM_lpage">174</span>, <span class="refDoi">Â DOI: 10.1038/sj.bjp.0707218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fsj.bjp.0707218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=17375082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Wku74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2007&pages=163-174&author=L.+Hardwickauthor=S.+Velamakanniauthor=H.+van+Veen&title=The+Emerging+Pharmacotherapeutic+Significance+of+the+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1038%2Fsj.bjp.0707218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2)</span></div><div class="casAuthors">Hardwick, L. J. A.; Velamakanni, S.; van Veen, H. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-174</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The breast cancer resistance protein (also termed ABCG2) is an ATP-binding cassette transporter, which mediates the extrusion of toxic compds. from the cell, and which was originally identified in relation to the development of multidrug resistance of cancer cells.  ABCG2 interacts with a range of substrates including clin. drugs but also substances such as sterols, porphyrins and a variety of dietary compds.  Physiol. functions of ABCG2 at both cellular and systemic levels are reviewed.  For example, ABCG2 expression in erythrocytes may function in porphyrin homeostasis.  In addn., ABCG2 expression at apical membranes of cells such as hepatocytes, enterocytes, endothelial and syncytiotrophoblast cells may correlate to protective barrier or secretory functions against environmental or clin. administered substances.  ABCG2 also appears influential in the inter-patient variation and generally poor oral bioavailability of certain chemotherapeutic drugs such as topotecan.  As this often precludes an oral drug administration strategy, genotypic and environmental factors altering ABCG2 expression and activity are considered.  Finally, clin. modulation of ABCG2 activity is discussed.  Some of the more recent strategies include co-administered modulating agents, hammerhead ribozymes or antisense oligonucleotides, and with specificity in cell targeting, these may be used to reduce drug resistance and increase drug bioavailability to improve the profile of chemotherapeutic efficacy vs. toxicity.  While many such strategies remain in relative infancy at present, increased knowledge of modulators of ABCG2 could hold the key to novel approaches in medical treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3w5nPxaNRLVg90H21EOLACvtfcHk0lgNnqww8j6ifg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Wku74%253D&md5=fdd17189ef8fdb4a95c21d96fd0fd7a5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707218%26sid%3Dliteratum%253Aachs%26aulast%3DHardwick%26aufirst%3DL.%26aulast%3DVelamakanni%26aufirst%3DS.%26aulast%3Dvan%2BVeen%26aufirst%3DH.%26atitle%3DThe%2520Emerging%2520Pharmacotherapeutic%2520Significance%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D151%26spage%3D163%26epage%3D174%26doi%3D10.1038%2Fsj.bjp.0707218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ãzvegy-Laczka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemet, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ¡radi, A.</span></span> <span> </span><span class="NLM_article-title">ABCG2 â a Transporter for all Seasons</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>567</i></span>,  <span class="NLM_fpage">116</span>â <span class="NLM_lpage">120</span>, <span class="refDoi">Â DOI: 10.1016/j.febslet.2004.03.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.febslet.2004.03.123" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=567&publication_year=2004&pages=116-120&author=B.+Sarkadiauthor=C.+%C3%96zvegy-Laczkaauthor=K.+Nemetauthor=A.+V%C3%A1radi&title=ABCG2+%E2%80%93+a+Transporter+for+all+Seasons&doi=10.1016%2Fj.febslet.2004.03.123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2004.03.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2004.03.123%26sid%3Dliteratum%253Aachs%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3D%25C3%2596zvegy-Laczka%26aufirst%3DC.%26aulast%3DNemet%26aufirst%3DK.%26aulast%3DV%25C3%25A1radi%26aufirst%3DA.%26atitle%3DABCG2%2520%25E2%2580%2593%2520a%2520Transporter%2520for%2520all%2520Seasons%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D567%26spage%3D116%26epage%3D120%26doi%3D10.1016%2Fj.febslet.2004.03.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briddon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holliday, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span> <span> </span><span class="NLM_article-title">Plasma Membrane Dynamics and Tetrameric Organisation of ABCG2 Transporters in Mammalian Cells Revealed by Single Particle Imaging Techniques</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">19</span>â <span class="NLM_lpage">29</span>, <span class="refDoi">Â DOI: 10.1016/j.bbamcr.2015.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bbamcr.2015.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=26453803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Chtb%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2016&pages=19-29&author=K.+Wongauthor=S.+J.+Briddonauthor=N.+D.+Hollidayauthor=I.+D.+Kerr&title=Plasma+Membrane+Dynamics+and+Tetrameric+Organisation+of+ABCG2+Transporters+in+Mammalian+Cells+Revealed+by+Single+Particle+Imaging+Techniques&doi=10.1016%2Fj.bbamcr.2015.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane dynamics and tetrameric organisation of ABCG2 transporters in mammalian cells revealed by single particle imaging techniques</span></div><div class="casAuthors">Wong, Kelvin; Briddon, Stephen J.; Holliday, Nicholas D.; Kerr, Ian D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-29</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ABCG2 is one of three human ATP binding cassette (ABC) transporters involved in the export from cells of a chem. and structurally diverse range of compds.  This multidrug efflux capability, together with a broad tissue distribution in the body, means that ABCG2 exerts a range of effects on normal physiol. such as kidney urate transport, as well as contributing towards the pharmacokinetic profiles of many exogenous drugs.  The primary sequence of ABCG2 contains only half the no. of domains required for a functioning ABC transporter and so it must oligomerise in order to function, yet its oligomeric state in intact cell membranes remains uncharacterized.  We have analyzed ABCG2 in living cell membranes using a combination of fluorescence correlation spectroscopy, photon counting histogram anal., and stepwise photobleaching to demonstrate a predominantly tetrameric structure for ABCG2 in the presence or absence of transport substrates.  These results provide the essential basis for exploring pharmacol. manipulation of oligomeric state as a strategy to modulate ABCG2 activity in future selective therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCBGt4Y70W5LVg90H21EOLACvtfcHk0lgNnqww8j6ifg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Chtb%252FN&md5=89fe45505b932fa860e4c9151fc610e0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2015.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2015.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DK.%26aulast%3DBriddon%26aufirst%3DS.%2BJ.%26aulast%3DHolliday%26aufirst%3DN.%2BD.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26atitle%3DPlasma%2520Membrane%2520Dynamics%2520and%2520Tetrameric%2520Organisation%2520of%2520ABCG2%2520Transporters%2520in%2520Mammalian%2520Cells%2520Revealed%2520by%2520Single%2520Particle%2520Imaging%2520Techniques%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2016%26volume%3D1863%26spage%3D19%26epage%3D29%26doi%3D10.1016%2Fj.bbamcr.2015.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Multidrug Resistance in Cancer: Role of ATP-Dependent Transporters</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">48</span>â <span class="NLM_lpage">58</span>, <span class="refDoi">Â DOI: 10.1038/nrc706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+Resistance+in+Cancer%3A+Role+of+ATP-Dependent+Transporters&doi=10.1038%2Fnrc706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lghWrhusp9eCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520Resistance%2520in%2520Cancer%253A%2520Role%2520of%2520ATP-Dependent%2520Transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58%26doi%3D10.1038%2Fnrc706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C. H.</span></span> <span> </span><span class="NLM_article-title">ABC Transporters as Multidrug Resistance Mechanisms and the Development of Chemosensitizers for Their Reversal</span>. <i>Cancer Cell Int.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">30</span>, <span class="refDoi">Â DOI: 10.1186/1475-2867-5-30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1186%2F1475-2867-5-30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=16202168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BD2Mrpt1Cktw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=30&author=C.+H.+Choi&title=ABC+Transporters+as+Multidrug+Resistance+Mechanisms+and+the+Development+of+Chemosensitizers+for+Their+Reversal&doi=10.1186%2F1475-2867-5-30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal</span></div><div class="casAuthors">Choi Cheol-Hee</div><div class="citationInfo"><span class="NLM_cas:title">Cancer cell international</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">One of the major problems related with anticancer chemotherapy is resistance against anticancer drugs.  The ATP-binding cassette (ABC) transporters are a family of transporter proteins that are responsible for drug resistance and a low bioavailability of drugs by pumping a variety of drugs out cells at the expense of ATP hydrolysis.  One strategy for reversal of the resistance of tumor cells expressing ABC transporters is combined use of anticancer drugs with chemosensitizers.  In this review, the physiological functions and structures of ABC transporters, and the development of chemosensitizers are described focusing on well-known proteins including P-glycoprotein, multidrug resistance associated protein, and breast cancer resistance protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB3dpAGea7Lv6AExegM5LLfW6udTcc2eYYrDqbyqXx8rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mrpt1Cktw%253D%253D&md5=8c71bb7c9430849683582877cfb64a19</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1475-2867-5-30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2867-5-30%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DC.%2BH.%26atitle%3DABC%2520Transporters%2520as%2520Multidrug%2520Resistance%2520Mechanisms%2520and%2520the%2520Development%2520of%2520Chemosensitizers%2520for%2520Their%2520Reversal%26jtitle%3DCancer%2520Cell%2520Int.%26date%3D2005%26volume%3D5%26spage%3D30%26doi%3D10.1186%2F1475-2867-5-30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikadi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span> <span> </span><span class="NLM_article-title">The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes With Mitoxantrone</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">482</span>â <span class="NLM_lpage">493</span>, <span class="refDoi">Â DOI: 10.1016/j.str.2010.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.str.2010.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=20399185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKnu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=482-493&author=M.+F.+Rosenbergauthor=Z.+Bikadiauthor=J.+Chanauthor=X.+Liuauthor=Z.+Niauthor=X.+Caiauthor=R.+C.+Fordauthor=Q.+Mao&title=The+Human+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29+Shows+Conformational+Changes+With+Mitoxantrone&doi=10.1016%2Fj.str.2010.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone</span></div><div class="casAuthors">Rosenberg, Mark F.; Bikadi, Zsolt; Chan, Janice; Liu, Xiaoping; Ni, Zhanglin; Cai, Xiaokun; Ford, Robert C.; Mao, Qingcheng</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">482-493</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">BCRP/ABCG2 mediates efflux of drugs and xenobiotics.  BCRP was expressed in Pichia pastoris, purified to > 90% homogeneity, and subjected to two-dimensional (2D) crystn.  The 2D crystals showed a p121 symmetry and projection maps were detd. at 5 Ã resoln. by cryo-electron microscopy.  Two crystal forms with and without mitoxantrone were obsd. with unit cell dimensions of a = 55.4 Ã, b = 81.4 Ã, Î³ = 89.8Â°, and a = 57.3 Ã, b = 88.0 Ã, Î³ = 89.7Â°, resp.  The projection map without mitoxantrone revealed an asym. structure with ring-shaped d. features probably corresponding to a bundle of transmembrane Î± helixes, and appeared more open and less sym. than the map with mitroxantrone.  The open and closed inward-facing forms of BCRP were generated by homol. modeling, representing the substrate-free and substrate-bound conformations in the absence of nucleotide, resp.  These models are consistent with the exptl. obsd. conformational change upon substrate binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy41Lg_ARysLVg90H21EOLACvtfcHk0lghWrhusp9eCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKnu7s%253D&md5=259f90447cbb30589018f12c155cf19e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2010.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2010.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DM.%2BF.%26aulast%3DBikadi%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DFord%26aufirst%3DR.%2BC.%26aulast%3DMao%26aufirst%3DQ.%26atitle%3DThe%2520Human%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%2520Shows%2520Conformational%2520Changes%2520With%2520Mitoxantrone%26jtitle%3DStructure%26date%3D2010%26volume%3D18%26spage%3D482%26epage%3D493%26doi%3D10.1016%2Fj.str.2010.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abruzzo, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rishi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. D.</span></span> <span> </span><span class="NLM_article-title">A Multidrug Resistance Transporter From Human MCF-7 Breast Cancer Cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">15665</span>â <span class="NLM_lpage">15670</span>, <span class="refDoi">Â DOI: 10.1073/pnas.95.26.15665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=T.+Krogmannauthor=Y.+Gaoauthor=A.+K.+Rishiauthor=D.+D.+Ross&title=A+Multidrug+Resistance+Transporter+From+Human+MCF-7+Breast+Cancer+Cells&doi=10.1073%2Fpnas.95.26.15665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0lghWrhusp9eCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DA%2520Multidrug%2520Resistance%2520Transporter%2520From%2520Human%2520MCF-7%2520Breast%2520Cancer%2520Cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670%26doi%3D10.1073%2Fpnas.95.26.15665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abruzzo, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. A.</span></span> <span> </span><span class="NLM_article-title">Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell Lines</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">429</span>â <span class="NLM_lpage">433</span>, <span class="refDoi">Â DOI: 10.1093/jnci/91.5.429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1093%2Fjnci%2F91.5.429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10070941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFKitL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=429-433&author=D.+D.+Rossauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=W.+S.+Daltonauthor=E.+Schneiderauthor=H.+Lageauthor=M.+Dietelauthor=L.+Greenbergerauthor=S.+P.+Coleauthor=L.+A.+Doyle&title=Atypical+Multidrug+Resistance%3A+Breast+Cancer+Resistance+Protein+Messenger+RNA+Expression+in+Mitoxantrone-Selected+Cell+Lines&doi=10.1093%2Fjnci%2F91.5.429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines</span></div><div class="casAuthors">Ross, Douglas D.; Yang, Weidong; Abruzzo, Lynne V.; Dalton, William S.; Schneider, Erasmus; Lage, Hermann; Dietel, Manfred; Greenberger, Lee; Cole, Susan P. C.; Doyle, L. Austin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">429-433</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Human cancer cell lines grown in the presence of the cytotoxic agent mitoxantrone frequently develop resistance assocd. with a redn. in intracellular drug accumulation without increased expression of the known drug resistance transporters P-glycoprotein and multidrug resistance protein (also known as multidrug resistance-assocd. protein).  Breast cancer resistance protein (BCRP) is a recently described ATP-binding cassette transporter assocd. with resistance to mitoxantrone and anthracyclines.  This study was undertaken to test the prevalence of BCRP overexpression in cell lines selected for growth in the presence of mitoxantrone.  Total cellular RNA or poly A+ RNA and genomic DNA were isolated from parental and drug-selected cell lines.  Expression of BCRP mRNA (mRNA) and amplification of the BCRP gene were analyzed by northern and Southern blot hybridization, resp.  A variety of drug-resistant human cancer cell lines derived by selection with mitoxantrone markedly overexpressed BCRP mRNA; these cell lines included sublines of human breast carcinoma (MCF-7), colon carcinoma (S1 and HT29), gastric carcinoma (EPG85-257), fibrosarcoma (EPF86-079), and myeloma (8226) origins.  Anal. of genomic DNA from BCRP-overexpressing MCF-7/MX cells demonstrated that the BCRP gene was also amplified in these cells.  Overexpression of BCRP mRNA is frequently obsd. in multidrug-resistant cell lines selected with mitoxantrone, suggesting that BCRP is likely to be a major cellular defense mechanism elicited in response to exposure to this drug.  It is likely that BCRP is the putative "mitoxantrone transporter" hypothesized to be present in these cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzGmjzgx9WyLVg90H21EOLACvtfcHk0lgEYQ25E5ZwWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFKitL8%253D&md5=04bd7b3c3d73f64ea10f9bb43b9d67e5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.5.429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.5.429%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%2BD.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DDalton%26aufirst%3DW.%2BS.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DLage%26aufirst%3DH.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DGreenberger%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26atitle%3DAtypical%2520Multidrug%2520Resistance%253A%2520Breast%2520Cancer%2520Resistance%2520Protein%2520Messenger%2520RNA%2520Expression%2520in%2520Mitoxantrone-Selected%2520Cell%2520Lines%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D429%26epage%3D433%26doi%3D10.1093%2Fjnci%2F91.5.429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span> <span> </span><span class="NLM_article-title">Cross-Resistance to Camptothecin Analogues in a Mitoxantrone-Resistant Human Breast Carcinoma Cell Line is Not Due to DNA Topoisomerase I Alterations</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4004</span>â <span class="NLM_lpage">4009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=4004-4009&author=C.+J.+Yangauthor=J.+K.+Hortonauthor=K.+H.+Cowanauthor=E.+Schneider&title=Cross-Resistance+to+Camptothecin+Analogues+in+a+Mitoxantrone-Resistant+Human+Breast+Carcinoma+Cell+Line+is+Not+Due+to+DNA+Topoisomerase+I+Alterations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BJ.%26aulast%3DHorton%26aufirst%3DJ.%2BK.%26aulast%3DCowan%26aufirst%3DK.%2BH.%26aulast%3DSchneider%26aufirst%3DE.%26atitle%3DCross-Resistance%2520to%2520Camptothecin%2520Analogues%2520in%2520a%2520Mitoxantrone-Resistant%2520Human%2520Breast%2520Carcinoma%2520Cell%2520Line%2520is%2520Not%2520Due%2520to%2520DNA%2520Topoisomerase%2520I%2520Alterations%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D4004%26epage%3D4009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacy, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">(2013). Molecular Pharmacology of ABCG2 and its Role in Chemoresistance</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">655</span>â <span class="NLM_lpage">669</span>, <span class="refDoi">Â DOI: 10.1124/mol.113.088609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1124%2Fmol.113.088609" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=655-669&author=A.+E.+Stacyauthor=P.+J.+Janssonauthor=D.+R.+Richardson&title=%282013%29.+Molecular+Pharmacology+of+ABCG2+and+its+Role+in+Chemoresistance&doi=10.1124%2Fmol.113.088609"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.088609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.088609%26sid%3Dliteratum%253Aachs%26aulast%3DStacy%26aufirst%3DA.%2BE.%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3D%25282013%2529.%2520Molecular%2520Pharmacology%2520of%2520ABCG2%2520and%2520its%2520Role%2520in%2520Chemoresistance%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D655%26epage%3D669%26doi%3D10.1124%2Fmol.113.088609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krapf, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5449</span>â <span class="NLM_lpage">5461</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b00330</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00330" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCnurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5449-5461&author=M.+K.+Krapfauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+4-Anilino-quinazolines+and+-quinolines+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1021%2Facs.jmedchem.6b00330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span></div><div class="casAuthors">Krapf, Michael K.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5449-5461</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemotherapeutic treatment of cancer often fails due to overexpression of the ATP-binding cassette (ABC) transport proteins, like ABCG2, triggering active efflux of various structurally unrelated drugs.  This so-called multidrug resistance (MDR) may be reversed by selective, potent, and nontoxic inhibitors of ABCG2.  As only a few potent inhibitors are known, new compds. based on a 4-substituted-2-phenylquinazoline scaffold were investigated.  Substitution with hydroxy, cyano, nitro, acetamido, and fluoro, e.g., I, led to high inhibitory activities toward ABCG2.  The ability to reverse MDR of the most active compds. was confirmed in a MTT efficacy assay.  Moreover, a negligibly low intrinsic cytotoxicity was found resulting in a high therapeutic ratio.  Investigations of the inhibitory activity toward ABCB1 and ABCC1 yielded a high selectivity toward ABCG2 for the quinazoline compds.  Quinoline-based analogs showed lower inhibitory activity and selectivity.  The study yielded a variety of promising compds., some with superior properties compared to those of the std. inhibitor Ko143.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdz9Uvqz3i6rVg90H21EOLACvtfcHk0lgEYQ25E5ZwWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCnurY%253D&md5=a127c60fe7ecf9d5fc76a13903e794db</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00330%26sid%3Dliteratum%253Aachs%26aulast%3DKrapf%26aufirst%3DM.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25204-Anilino-quinazolines%2520and%2520-quinolines%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5449%26epage%3D5461%26doi%3D10.1021%2Facs.jmedchem.6b00330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benderra, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faussat, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayada, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaoui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morjani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzac, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marie, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, O.</span></span> <span> </span><span class="NLM_article-title">MRP3, BCRP, and P-glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">7764</span>â <span class="NLM_lpage">7772</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-04-1895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1158%2F1078-0432.CCR-04-1895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=16278398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2isL7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=7764-7772&author=Z.+Benderraauthor=A.+M.+Faussatauthor=L.+Sayadaauthor=J.+Y.+Perrotauthor=R.+Tangauthor=D.+Chaouiauthor=H.+Morjaniauthor=C.+Marzacauthor=J.+P.+Marieauthor=O.+Legrand&title=MRP3%2C+BCRP%2C+and+P-glycoprotein+Activities+are+Prognostic+Factors+in+Adult+Acute+Myeloid+Leukemia&doi=10.1158%2F1078-0432.CCR-04-1895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia</span></div><div class="casAuthors">Benderra, Zineb; Faussat, Anne Marie; Sayada, Lydia; Perrot, Jean-Yves; Tang, Ruoping; Chaoui, Driss; Morjani, Hamid; Marzac, Christophe; Marie, Jean-Pierre; Legrand, Ollivier</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7764-7772</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: P-Glycoprotein (Pgp) is assocd. with poor outcome in acute myeloid leukemia (AML).  We have investigated other ATP-binding cassette proteins such as BCRP, MRP1, MRP2, MRP3, and MRP5 for their potential implication in chemoresistance.  Exptl. Design and Results: Eighty five AML patient samples were analyzed in this study.  First, MRP3 function was higher in patients which had a high level of leukocytes (P = 0.01), a M5 FAB subtype (P = 0.04), and an intermediate or poor cytogenesis (P = 0.05).  BCRP activity was not correlated with clin. or biol. variables, but high Pgp activity was correlated with the following variables: CD34 expression (P = 0.002), FAB subtype (P = 0.002), intermediate or poor cytogenesis (P = 0.02), and elderly patients (P = 0.03).  Second, Pgp, MRP3, and BCRP activities were correlated with complete remission (P = 0.02, P = 0.04, and P = 0.04, resp.), disease-free survival (P = 0.02, P = 0.03, and P = 0.25, resp.), and overall survival (P = 0.04, P = 0.04, and P = 0.05, resp.) in multivariate anal.  The patient samples expressing one or none of these Pgp, MRP3, or BCRP functional proteins have a better prognosis than the patients expressing two or three of these functional proteins (complete remission, P = 0.02; disease-free survival, P = 0.01; overall survival, P < 0.001).  CONCLUSIONS: BCRP and MRP3 may also be involved in chemoresistance in AML, esp. MRP3 in patients with M5 FAB.  Addnl. modulation of BCRP or MRP3 to Pgp modulation may be necessary in some patients in order to improve the treatment outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzcXu2YFnW5rVg90H21EOLACvtfcHk0limFUO7Mo7bVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2isL7J&md5=9ca416f2f8183a2db04ac4993dc2af02</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1895%26sid%3Dliteratum%253Aachs%26aulast%3DBenderra%26aufirst%3DZ.%26aulast%3DFaussat%26aufirst%3DA.%2BM.%26aulast%3DSayada%26aufirst%3DL.%26aulast%3DPerrot%26aufirst%3DJ.%2BY.%26aulast%3DTang%26aufirst%3DR.%26aulast%3DChaoui%26aufirst%3DD.%26aulast%3DMorjani%26aufirst%3DH.%26aulast%3DMarzac%26aufirst%3DC.%26aulast%3DMarie%26aufirst%3DJ.%2BP.%26aulast%3DLegrand%26aufirst%3DO.%26atitle%3DMRP3%252C%2520BCRP%252C%2520and%2520P-glycoprotein%2520Activities%2520are%2520Prognostic%2520Factors%2520in%2520Adult%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D7764%26epage%3D7772%26doi%3D10.1158%2F1078-0432.CCR-04-1895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M. G.</span></span> <span> </span><span class="NLM_article-title">Enhanced Efficacy of Photodynamic Therapy by Inhibiting ABCG2 in Colon Cancers</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">504</span>, <span class="refDoi">Â DOI: 10.1186/s12885-015-1514-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1186%2Fs12885-015-1514-4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=504&author=J.+H.+Kimauthor=J.+M.+Parkauthor=Y.+J.+Rohauthor=I.+W.+Kimauthor=T.+Hasanauthor=M.+G.+Choi&title=Enhanced+Efficacy+of+Photodynamic+Therapy+by+Inhibiting+ABCG2+in+Colon+Cancers&doi=10.1186%2Fs12885-015-1514-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1514-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1514-4%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BM.%26aulast%3DRoh%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DI.%2BW.%26aulast%3DHasan%26aufirst%3DT.%26aulast%3DChoi%26aufirst%3DM.%2BG.%26atitle%3DEnhanced%2520Efficacy%2520of%2520Photodynamic%2520Therapy%2520by%2520Inhibiting%2520ABCG2%2520in%2520Colon%2520Cancers%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D504%26doi%3D10.1186%2Fs12885-015-1514-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, A.</span></span> <span> </span><span class="NLM_article-title">Expression of Breast Cancer Resistance Protein is Associated With a Poor Clinical Outcome in Patients With Small-Cell Lung Cancer</span>. <i>Lung Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">105</span>â <span class="NLM_lpage">111</span>, <span class="refDoi">Â DOI: 10.1016/j.lungcan.2008.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.lungcan.2008.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=19036469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BD1Mzotl2hsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=105-111&author=Y.+H.+Kimauthor=G.+Ishiiauthor=K.+Gotoauthor=S.+Otaauthor=K.+Kubotaauthor=Y.+Murataauthor=M.+Mishimaauthor=N.+Saijoauthor=Y.+Nishiwakiauthor=A.+Ochiai&title=Expression+of+Breast+Cancer+Resistance+Protein+is+Associated+With+a+Poor+Clinical+Outcome+in+Patients+With+Small-Cell+Lung+Cancer&doi=10.1016%2Fj.lungcan.2008.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer</span></div><div class="casAuthors">Kim Young Hak; Ishii Genichiro; Goto Koichi; Ota Shuji; Kubota Kaoru; Murata Yukinori; Mishima Michiaki; Saijo Nagahiro; Nishiwaki Yutaka; Ochiai Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Lung cancer (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  ATP-binding cassette (ABC) transporter and DNA excision repair proteins play a pivotal role in the mechanisms of drug resistance.  The aim of this study was to investigate the expression of ABC transporter and DNA excision repair proteins, and to elucidate the clinical significance of their expression in biopsy specimens from patients with small-cell lung cancer (SCLC).  METHODS:  We investigated expression of the ABC transporter proteins, P-glycoprotein (Pgp), multidrug resistance associated-protein 1 (MRP1), MRP2, MRP3, and breast cancer resistance protein (BCRP), and the DNA excision repair proteins, excision repair cross-complementation group 1 (ERCC1) protein and breast cancer susceptibility gene 1 (BRCA1) protein, in tumor biopsy specimens obtained before chemotherapy from 130 SCLC patients who later received platinum-based combination chemotherapy, and investigated the relationship between their expression and both response and survival.  RESULTS:  No significant associations were found between expression of Pgp, MRP1, MRP2, MRP3, ERCC1, or BRCA1 and either response or survival.  However, there was a significant association between BCRP expression and both response (p=0.026) and progression-free survival (PFS; p=0.0103).  CONCLUSIONS:  BCRP expression was significantly predictive of both response and progression-free survival (PFS) in SCLC patients receiving chemotherapy.  These findings suggest that BCRP may play a crucial role in drug resistance mechanisms, and that it may serve as an ideal molecular target for the treatment of SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbY9UEAyJVSs-crCu0nI_sfW6udTcc2eYNawQSYxgRgbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mzotl2hsw%253D%253D&md5=879423621387778616666b1a58bb5f6f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2008.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2008.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DIshii%26aufirst%3DG.%26aulast%3DGoto%26aufirst%3DK.%26aulast%3DOta%26aufirst%3DS.%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DMishima%26aufirst%3DM.%26aulast%3DSaijo%26aufirst%3DN.%26aulast%3DNishiwaki%26aufirst%3DY.%26aulast%3DOchiai%26aufirst%3DA.%26atitle%3DExpression%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520is%2520Associated%2520With%2520a%2520Poor%2520Clinical%2520Outcome%2520in%2520Patients%2520With%2520Small-Cell%2520Lung%2520Cancer%26jtitle%3DLung%2520Cancer%26date%3D2009%26volume%3D65%26spage%3D105%26epage%3D111%26doi%3D10.1016%2Fj.lungcan.2008.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabindran, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annable, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, L. M.</span></span> <span> </span><span class="NLM_article-title">Reversal of a Novel Multidrug Resistance Mechanism in Human Colon Carcinoma Cells by Fumitremorgin C</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5850</span>â <span class="NLM_lpage">5858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=9865745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXivFah" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=5850-5858&author=S.+K.+Rabindranauthor=H.+Heauthor=M.+Singhauthor=E.+Brownauthor=K.+I.+Collinsauthor=T.+Annableauthor=L.+M.+Greenberger&title=Reversal+of+a+Novel+Multidrug+Resistance+Mechanism+in+Human+Colon+Carcinoma+Cells+by+Fumitremorgin+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C</span></div><div class="casAuthors">Rabindran, Sridhar K.; He, Haiyin; Singh, Maya; Brown, Eileen; Collins, Karen I.; Annable, Tami; Greenberger, Lee M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5850-5858</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">We selected a human colon carcinoma cell line in increasing concns. of mitoxantrone to obtain a resistant subline, S1-M1-3.2, with the following characteristics: profound resistance to mitoxantrone; significant cross-resistance to doxorubicin, bisantrene, and topotecan; and very low levels of resistance to Taxol, vinblastine, colchicine, and camptothecin.  This multidrug resistance (MDR) phenotype, which was not reversed by verapamil or another potent P-glycoprotein (Pgp) inhibitor, CL 329,753, was dependent, in part, upon an energy-dependent drug efflux mechanism.  Pgp and the multidrug resistance protein (MRP) were not elevated in the resistant cells relative to the drug-sensitive parent, suggesting that resistance was mediated by a novel pathway of drug transport.  A cell-based screen with S1-M1-3.2 cells was used to identify agents capable of circumventing this non-Pgp, non-MRP MDR.  One of the active agents identified was a mycotoxin, fumitremorgin C.  This mol. was extremely effective in reversing resistance to mitoxantrone, doxorubicin, and topotecan in multidrug-selected cell lines showing this novel phenotype.  Reversal of resistance was assocd. with an increase in drug accumulation.  The compd. did not reverse drug resistance in cells with elevated expression of Pgp or MRP.  We suggest that fumitremorgin C is a highly selective chemosensitizing agent for the resistance pathway we have identified and can be used as a specific pharmacol. probe to distinguish between the diverse resistance mechanisms that occur in the MDR cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-Y6qf2FmRbVg90H21EOLACvtfcHk0limFUO7Mo7bVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFah&md5=cacafc261f829003219cdd9f518ac900</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DK.%2BI.%26aulast%3DAnnable%26aufirst%3DT.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26atitle%3DReversal%2520of%2520a%2520Novel%2520Multidrug%2520Resistance%2520Mechanism%2520in%2520Human%2520Colon%2520Carcinoma%2520Cells%2520by%2520Fumitremorgin%2520C%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D5850%26epage%3D5858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loevezijn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakhai, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Valk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Tellingen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koomen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">Potent and Specific Inhibition of the Breast Cancer Resistance Protein Multidrug Transporter in Vitro and in Mouse Intestine by a Novel Analogue of Fumitremorgin C</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">417</span>â <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.4161%2Fcbt.1.4.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=12477054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=417-425&author=J.+D.+Allenauthor=A.+van+Loevezijnauthor=J.+M.+Lakhaiauthor=M.+van+der+Valkauthor=O.+van+Tellingenauthor=G.+Reidauthor=J.+H.+Schellensauthor=G.+J.+Koomenauthor=A.+H.+Schinkel&title=Potent+and+Specific+Inhibition+of+the+Breast+Cancer+Resistance+Protein+Multidrug+Transporter+in+Vitro+and+in+Mouse+Intestine+by+a+Novel+Analogue+of+Fumitremorgin+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C</span></div><div class="casAuthors">Allen, John D.; Van Loevezijn, Arnold; Lakhai, Jeany M.; Van der Valk, Martin; Van Tellingen, Olaf; Reid, Glen; Schellens, Jan H. M.; Koomen, Gerrit-Jan; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">417-425</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitors of the breast cancer resistance protein (BCRP/ABCG2) multidrug transporter are of interest as chemosensitizers for clin. drug resistance, for improving the pharmacokinetics of substrate chemotherapeutic drugs, and in functional assays of BCRP activity for tailoring chemotherapy.  The fungal toxin fumitremorgin C (FTC) is a potent and specific inhibitor of BCRP, but its neurotoxic effects preclude use in vivo.  We have therefore evaluated a new tetracyclic analog of FTC, Ko143, as a practical inhibitor of BCRP, comparing it with two other analogs in the same class and with GF120918.  All three FTC analogs are effective inhibitors of both mouse Bcrp1 and human BCRP, proving highly active for increasing the intracellular drug accumulation and reversing Bcrp1/BCRP-mediated multidrug resistance.  Indeed, Ko143 appears to be the most potent BCRP inhibitor known thus far.  In contrast, the compds. have only low activity against P-glycoprotein, the multidrug resistance-assocd. protein (MRP1), or other known drug transporters.  They are nontoxic in vitro at useful concns. and evinced no signs of toxicity in mice at high oral or i.p. doses.  Administered p.o. to inhibit intestinal Bcrp1, Ko143 markedly increased the oral availability of topotecan in mice.  It is thus the first highly potent and specific BCRP inhibitor applicable in vivo.  As such, Ko143 and other FTC analogs of this type represent valuable reagents for anal. of drug resistance mechanisms and may be candidates for development as clin. BCRP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdmIQAa5j5rVg90H21EOLACvtfcHk0lhY2L2YJI_-Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7g%253D&md5=8a54c6c38d9639ec70faa97a279d0a12</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.4161%2Fcbt.1.4.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.1.4.22%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3Dvan%2BLoevezijn%26aufirst%3DA.%26aulast%3DLakhai%26aufirst%3DJ.%2BM.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DM.%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DKoomen%26aufirst%3DG.%2BJ.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DPotent%2520and%2520Specific%2520Inhibition%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520Multidrug%2520Transporter%2520in%2520Vitro%2520and%2520in%2520Mouse%2520Intestine%2520by%2520a%2520Novel%2520Analogue%2520of%2520Fumitremorgin%2520C%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D417%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weidner, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambudkar, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span> <span> </span><span class="NLM_article-title">The Inhibitor Ko143 is Not Specific for ABCG2</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">384</span>â <span class="NLM_lpage">393</span>, <span class="refDoi">Â DOI: 10.1124/jpet.115.225482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1124%2Fjpet.115.225482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=26148857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=384-393&author=L.+D.+Weidnerauthor=S.+S.+Zoghbiauthor=S.+Luauthor=S.+Shuklaauthor=S.+V.+Ambudkarauthor=V.+W.+Pikeauthor=J.+Mulderauthor=M.+M.+Gottesmanauthor=R.+B.+Innisauthor=M.+D.+Hall&title=The+Inhibitor+Ko143+is+Not+Specific+for+ABCG2&doi=10.1124%2Fjpet.115.225482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitor Ko143 is not specific for ABCG2</span></div><div class="casAuthors">Weidner, Lora D.; Zoghbi, Sami S.; Lu, Shuiyu; Shukla, Suneet; Ambudkar, Suresh V.; Pike, Victor W.; Mulder, Jan; Gottesman, Michael M.; Innis, Robert B.; Hall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-393</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Imaging ATP-binding cassette (ABC) transporter activity in vivo with positron emission tomog. requires both a substrate and a transporter inhibitor.  However, for ABCG2, there is no inhibitor proven to be specific to that transporter alone at the blood-brain barrier.  Ko143 [(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester], a nontoxic analog of fungal toxin fumitremorgin C, is a potent inhibitor of ABCG2, although its specificity in mouse and human systems is unclear.  This study examd. the selectivity of Ko143 using human embryonic kidney cell lines transfected with ABCG2, ABCB1, or ABCC1 in several in vitro assays.  The stability of Ko143 in rat plasma was measured using high performance liq. chromatog.  Our results show that, in addn. to being a potent inhibitor of ABCG2, at higher concns. (â¥1 Î¼M) Ko143 also has an effect on the transport activity of both ABCB1 and ABCC1.  Furthermore, Ko143 was found to be unstable in rat plasma.  These findings indicate that Ko143 lacks specificity for ABCG2 and this should be taken into consideration when using Ko143 for both in vitro and in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqWjvTByDwbLVg90H21EOLACvtfcHk0lhY2L2YJI_-Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L&md5=4336228ff99f608f6452dca312e78a5a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.225482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.225482%26sid%3Dliteratum%253Aachs%26aulast%3DWeidner%26aufirst%3DL.%2BD.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DS.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DHall%26aufirst%3DM.%2BD.%26atitle%3DThe%2520Inhibitor%2520Ko143%2520is%2520Not%2520Specific%2520for%2520ABCG2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D384%26epage%3D393%26doi%3D10.1124%2Fjpet.115.225482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barron, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moseley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, J. A.</span></span> <span> </span><span class="NLM_article-title">Differential Sensitivity in Cell Lines to Photodynamic Therapy in Combination with ABCG2 Inhibition</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1016/j.jphotobiol.2013.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.jphotobiol.2013.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=23911860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGrurvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=87-96&author=G.+A.+Barronauthor=H.+Moseleyauthor=J.+A.+Woods&title=Differential+Sensitivity+in+Cell+Lines+to+Photodynamic+Therapy+in+Combination+with+ABCG2+Inhibition&doi=10.1016%2Fj.jphotobiol.2013.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition</span></div><div class="casAuthors">Barron, Gemma A.; Moseley, Harry; Woods, Julie A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ABCG2 is an ATP-binding cassette transporter protein which has a role in the regulation of endogenous protoporphyrin IX (PpIX) levels.  To understand the influence of ABCG2 on porphyrin-based photodynamic therapy (PDT) and fluorescence diagnosis (FD), we examd. the role of endogenous ABCG2 in four human cell lines from the epidermis (HaCaT keratinocytes), esophagus (OE19 adenocarcinoma), brain (SH-SY5Y neuroblastoma) and bladder (HT1197 carcinoma).  Cells were incubated with ALA or MAL in the presence or absence of the ABCG2 activity inhibitor Ko-143.  Porphyrin accumulation was detected by spectrofluorimetric anal. and high performance liq. chromatog. (HPLC) with porphyrin localization obsd. by confocal laser scanning microscopy.  PDT efficacy was assessed 24 h post irradn. (1.5 J/cm2 red light) by the neutral red (NR) assay.  We show cell-specific differences when Ko-143 was co-incubated with ALA or, in particular with, MAL.  Enhanced PDT-induced cell kill was shown in HaCaT, OE19 and HT1197 cells, but not SH-SY5Y cells and could be explained by porphyrin accumulation and expression of ABCG2.  We have also found that despite high levels of intracellular PpIX, the OE19 cells were protected from phototoxic cell death by PpIX compartmentalization.  This could be reversed by Ko-143.  The results from this study show a possible cause of reduced sensitivity to ALA/MAL-PDT, with a potential soln. to overcome this effect in certain tissue types.  The potential to improve PDT with Ko-143 remains promising.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrYmt0BikYq7Vg90H21EOLACvtfcHk0lhY2L2YJI_-Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGrurvE&md5=379430547d7baba8aca03101681d1b30</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2013.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2013.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DBarron%26aufirst%3DG.%2BA.%26aulast%3DMoseley%26aufirst%3DH.%26aulast%3DWoods%26aufirst%3DJ.%2BA.%26atitle%3DDifferential%2520Sensitivity%2520in%2520Cell%2520Lines%2520to%2520Photodynamic%2520Therapy%2520in%2520Combination%2520with%2520ABCG2%2520Inhibition%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2013%26volume%3D126%26spage%3D87%26epage%3D96%26doi%3D10.1016%2Fj.jphotobiol.2013.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozvegy-Laczka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegedus, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ¡rady, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujhelly, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuetz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ¡radi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ©ri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orfi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">NÃ©met, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">High-affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2Multidrug Transporter</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1485</span>â <span class="NLM_lpage">1495</span>, <span class="refDoi">Â DOI: 10.1124/mol.65.6.1485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1124%2Fmol.65.6.1485" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=1485-1495&author=C.+Ozvegy-Laczkaauthor=T.+Hegedusauthor=G.+V%C3%A1radyauthor=O.+Ujhellyauthor=J.+D.+Schuetzauthor=A.+V%C3%A1radiauthor=G.+K%C3%A9riauthor=L.+Orfiauthor=K.+N%C3%A9metauthor=B.+Sarkadi&title=High-affinity+Interaction+of+Tyrosine+Kinase+Inhibitors+with+the+ABCG2Multidrug+Transporter&doi=10.1124%2Fmol.65.6.1485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fmol.65.6.1485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.65.6.1485%26sid%3Dliteratum%253Aachs%26aulast%3DOzvegy-Laczka%26aufirst%3DC.%26aulast%3DHegedus%26aufirst%3DT.%26aulast%3DV%25C3%25A1rady%26aufirst%3DG.%26aulast%3DUjhelly%26aufirst%3DO.%26aulast%3DSchuetz%26aufirst%3DJ.%2BD.%26aulast%3DV%25C3%25A1radi%26aufirst%3DA.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DOrfi%26aufirst%3DL.%26aulast%3DN%25C3%25A9met%26aufirst%3DK.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DHigh-affinity%2520Interaction%2520of%2520Tyrosine%2520Kinase%2520Inhibitors%2520with%2520the%2520ABCG2Multidrug%2520Transporter%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D1485%26epage%3D1495%26doi%3D10.1124%2Fmol.65.6.1485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harwood, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuetz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchdunger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traxler, P.</span></span> <span> </span><span class="NLM_article-title">Imatinib Mesylate is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in Vitro</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">2333</span>â <span class="NLM_lpage">2337</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-03-3344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1158%2F0008-5472.CAN-03-3344" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=2333-2337&author=P.+J.+Houghtonauthor=G.+S.+Germainauthor=F.+C.+Harwoodauthor=J.+D.+Schuetzauthor=C.+F.+Stewartauthor=E.+Buchdungerauthor=P.+Traxler&title=Imatinib+Mesylate+is+a+Potent+Inhibitor+of+the+ABCG2+%28BCRP%29+Transporter+and+Reverses+Resistance+to+Topotecan+and+SN-38+in+Vitro&doi=10.1158%2F0008-5472.CAN-03-3344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-3344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-3344%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DGermain%26aufirst%3DG.%2BS.%26aulast%3DHarwood%26aufirst%3DF.%2BC.%26aulast%3DSchuetz%26aufirst%3DJ.%2BD.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3DImatinib%2520Mesylate%2520is%2520a%2520Potent%2520Inhibitor%2520of%2520the%2520ABCG2%2520%2528BCRP%2529%2520Transporter%2520and%2520Reverses%2520Resistance%2520to%2520Topotecan%2520and%2520SN-38%2520in%2520Vitro%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D2333%26epage%3D2337%26doi%3D10.1158%2F0008-5472.CAN-03-3344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SzakÃ¡cs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boumendjel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachadourian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baubichon-Cortay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, A.</span></span> <span> </span><span class="NLM_article-title">Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">5753</span>â <span class="NLM_lpage">5774</span>, <span class="refDoi">Â DOI: 10.1021/cr4006236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4006236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmslSqs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=5753-5774&author=G.+Szak%C3%A1csauthor=M.+D.+Hallauthor=M.+M.+Gottesmanauthor=A.+Boumendjelauthor=R.+Kachadourianauthor=B.+J.+Dayauthor=H.+Baubichon-Cortayauthor=A.+Di+Pietro&title=Targeting+the+Achilles+Heel+of+Multidrug-Resistant+Cancer+by+Exploiting+the+Fitness+Cost+of+Resistance&doi=10.1021%2Fcr4006236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance</span></div><div class="casAuthors">Szakacs, Gergely; Hall, Matthew D.; Gottesman, Michael M.; Boumendjel, Ahcene; Kachadourian, Remy; Day, Brian J.; Baubichon-Cortay, Helene; Di Pietro, Attilio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5753-5774</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of multidrug resistance (MDR) in patients suffering cancer remains a significant clin. challenge, with drug efflux by ABC (ATP-binding cassette) transporters contributing significantly.  Strategies to circumvent the reduced drug accumulation conferred by these polyspecific efflux transporters have relied on attempts to develop drugs that bypass extrusion or the exploration of clin. inhibitors that, although showing promise in vitro, have not translated to the clinic.  Alterations that confer selective advantage during the evolution of cancer cells might also create vulnerabilities that can be exploited therapeutically.  As defined by Szybalski and Bryson, collateral sensitivity is a "phenomenon in drug-resistant cells (prokaryotic or eukaryotic) identified during most in vitro studies... [whereby] the development of resistance in cells to one agent can confer higher sensitivity to an alternate agent than seen in the original (parental) line" .  In other words, the resistant cell line is more sensitive to a cytotoxin than the parental line from which it is derived.  From this perspective, resistance can be interpreted as a trait that could be targeted by new drugs.  In this review, we discuss general mechanisms underlying collateral sensitivity and focus on small mols. reported to elicit increased toxicity in cells overexpressing one of the 3 major multidrug transporters.  Such mols. (termed MDR-selective compds.) target multidrug-resistant cycling cells, suggesting that MDR Abc transporters could be considered as the ultimate "Achilles' heel" - the exquisite spot to fatally wound a multidrug-resistant cancer cell.  Herein, we discuss the potential of this emerging technol., cataloging MDR-selective compds. reported in the literature and highlighting chem. features that are assocd. with MDR-selective toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMLnJNMfm0QLVg90H21EOLACvtfcHk0ljGaBA-UIOTRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmslSqs7Y%253D&md5=7d834ffe642887c535fc295efc772d73</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr4006236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4006236%26sid%3Dliteratum%253Aachs%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DKachadourian%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26aulast%3DBaubichon-Cortay%26aufirst%3DH.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520Achilles%2520Heel%2520of%2520Multidrug-Resistant%2520Cancer%2520by%2520Exploiting%2520the%2520Fitness%2520Cost%2520of%2520Resistance%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D5753%26epage%3D5774%26doi%3D10.1021%2Fcr4006236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tawar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwarakanath, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhury, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaitan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tandon, V.</span></span> <span> </span><span class="NLM_article-title">Influence of Phenyl Ring Disubstitution on Benzimidazole and Terbenzimidazole Cytotoxicity: Synthesis and Evaluation as Radioprotectors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3785</span>â <span class="NLM_lpage">3792</span>, <span class="refDoi">Â DOI: 10.1021/jm030114w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030114w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3785-3792&author=U.+Tawarauthor=A.+K.+Jainauthor=B.+S.+Dwarakanathauthor=R.+Chandraauthor=Y.+Singhauthor=N.+K.+Chaudhuryauthor=D.+Khaitanauthor=V.+Tandon&title=Influence+of+Phenyl+Ring+Disubstitution+on+Benzimidazole+and+Terbenzimidazole+Cytotoxicity%3A+Synthesis+and+Evaluation+as+Radioprotectors&doi=10.1021%2Fjm030114w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm030114w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030114w%26sid%3Dliteratum%253Aachs%26aulast%3DTawar%26aufirst%3DU.%26aulast%3DJain%26aufirst%3DA.%2BK.%26aulast%3DDwarakanath%26aufirst%3DB.%2BS.%26aulast%3DChandra%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DY.%26aulast%3DChaudhury%26aufirst%3DN.%2BK.%26aulast%3DKhaitan%26aufirst%3DD.%26aulast%3DTandon%26aufirst%3DV.%26atitle%3DInfluence%2520of%2520Phenyl%2520Ring%2520Disubstitution%2520on%2520Benzimidazole%2520and%2520Terbenzimidazole%2520Cytotoxicity%253A%2520Synthesis%2520and%2520Evaluation%2520as%2520Radioprotectors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3785%26epage%3D3792%26doi%3D10.1021%2Fjm030114w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krapf, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4474</span>â <span class="NLM_lpage">4495</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00441</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00441" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFSks7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4474-4495&author=M.+K.+Krapfauthor=J.+Gallusauthor=M.+Wiese&title=4-Anilino-2-pyridylquinazolines+and+-pyrimidines+as+Highly+Potent+and+Nontoxic+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1021%2Facs.jmedchem.7b00441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span></div><div class="casAuthors">Krapf, Michael K.; Gallus, Jennifer; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4474-4495</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transport proteins remains a major problem in the chemotherapeutic treatment of cancer and might be overcome by inhibition of the transporter.  Because of the lack of understanding, the complex mechanisms involved in the transport process, in particular for breast cancer resistance protein (BCRP/ABCG2), there is a persistent need for studies of inhibitors of ABCG2.  In this study, the authors investigated a systematic series of 4-substituted-2-pyridylquinazolines in terms of their inhibitory potency as well as selectivity toward ABCG2.  For comparison, the quinazoline scaffold was reduced to the significantly smaller 4-methylpyrimidine basic structure.  Furthermore, the cytotoxicity and the ability to reverse MDR was tested with the chemotherapeutic agents SN-38 and mitoxantrone (MX).  Interaction of the compds. with ABCG2 was investigated by a colorimetric ATPase assay.  Enzyme kinetic studies were carried out with Hoechst 33342 as fluorescent dye and substrate of ABCG2 to elucidate the compds. binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBVIj0DPElPrVg90H21EOLACvtfcHk0liomG0qahwrFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFSks7k%253D&md5=cd9380f0b33fb110c3cde721345f6fe5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00441%26sid%3Dliteratum%253Aachs%26aulast%3DKrapf%26aufirst%3DM.%2BK.%26aulast%3DGallus%26aufirst%3DJ.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3D4-Anilino-2-pyridylquinazolines%2520and%2520-pyrimidines%2520as%2520Highly%2520Potent%2520and%2520Nontoxic%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4474%26epage%3D4495%26doi%3D10.1021%2Facs.jmedchem.7b00441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraege, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">The Combination of Quinazoline and Chalcone Moieties Leads to Novel Potent Heterodimeric Modulators of Breast Cancer Resistance Protein (BCRP/ABCG2)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">212</span>â <span class="NLM_lpage">229</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.03.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.ejmech.2016.03.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=27100033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFyms7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=212-229&author=S.+Kraegeauthor=K.+Stefanauthor=K.+Juvaleauthor=T.+Rossauthor=T.+Willmesauthor=M.+Wiese&title=The+Combination+of+Quinazoline+and+Chalcone+Moieties+Leads+to+Novel+Potent+Heterodimeric+Modulators+of+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29&doi=10.1016%2Fj.ejmech.2016.03.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kraege, Stefanie; Stefan, Katja; Juvale, Kapil; Ross, Thomas; Willmes, Thomas; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">212-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">During the last decade it has been found that chalcones and quinazolines are promising inhibitors of ABCG2.  The combination of these two scaffolds offers a new class of heterocyclic compds. with potentially high inhibitory activity against ABCG2.  For this purpose we investigated 22 different heterodimeric derivs.  In this series only methoxy groups were used as substituents as these had been proven superior for inhibitory activity of chalcones.  All compds. were tested for their inhibitory activity, specificity and cytotoxicity.  The most potent ABCG2 inhibitor in this series showed an IC50 value of 0.19 Î¼M.  It possesses low cytotoxicity (GI50 = 93 Î¼M), the ability to reverse MDR and is nearly selective toward ABCG2.  Most compds. contg. dimethoxy groups showed slight activity against ABCB1 too.  Among these three compds. (17, 19 and 24) showed even higher activity toward ABCB1 than ABCG2.  All inhibitors were further screened for their effect on basal ATPase activity.  Although the basal ATPase activity was partially stimulated, the compds. were not transported by ABCG2.  Thus, quinazoline-chalcones are a new class of effective ABCG2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAiBrpQVZkPrVg90H21EOLACvtfcHk0liomG0qahwrFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFyms7Y%253D&md5=91877b15d0301ec2bbcd468f63ea1a2b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.067%26sid%3Dliteratum%253Aachs%26aulast%3DKraege%26aufirst%3DS.%26aulast%3DStefan%26aufirst%3DK.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DRoss%26aufirst%3DT.%26aulast%3DWillmes%26aufirst%3DT.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DThe%2520Combination%2520of%2520Quinazoline%2520and%2520Chalcone%2520Moieties%2520Leads%2520to%2520Novel%2520Potent%2520Heterodimeric%2520Modulators%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D212%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2016.03.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Litman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skovsgaard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeuthen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, W.-D.</span></span> <span> </span><span class="NLM_article-title">ATPase Activity of P-glycoprotein Related to Emergence of Drug Resistance in Ehrlich Ascites Tumor Cell Lines</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1361</i></span>,  <span class="NLM_fpage">147</span>â <span class="NLM_lpage">158</span>, <span class="refDoi">Â DOI: 10.1016/S0925-4439(97)00025-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2FS0925-4439%2897%2900025-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=9300796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK2sXks12gur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=1997&pages=147-158&author=T.+Litmanauthor=D.+Nielsenauthor=T.+Skovsgaardauthor=T.+Zeuthenauthor=W.-D.+Stein&title=ATPase+Activity+of+P-glycoprotein+Related+to+Emergence+of+Drug+Resistance+in+Ehrlich+Ascites+Tumor+Cell+Lines&doi=10.1016%2FS0925-4439%2897%2900025-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines</span></div><div class="casAuthors">Litman, Thomas; Nielsen, Dorte; Skovsgaard, Torben; Zeuthen, Thomas; Stein, Wilfred D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ATPase activities of a sensitive and five progressively daunorubicin-resistant Ehrlich ascites tumor cell lines passaged in mice were characterized.  For the nine different modulators of drug resistance that the authors have studied, the ATPase activity first rose with the modulator concn. and then declined.  The authors analyzed the ATPase activity profiles in terms of an activation const. and an inhibition const. for each of the nine drugs and six cell lines.  In this series of cell lines, the drug-stimulatable ATPase activity was directly proportional to the amt. of P-glycoprotein.  Pumping of daunorubicin was also correlated with the amt. of P-glycoprotein, except that, for a highly passaged line more daunorubicin was pumped than could be accounted for by the content of P-glycoprotein.  Between the 12th and the 36th passage an addnl. source of resistance emerged, which was not correlated with P-glycoprotein.  Pumping of daunorubicin was neg. correlated with the cell vol. for the different lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4nNQbXUAWILVg90H21EOLACvtfcHk0liomG0qahwrFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXks12gur4%253D&md5=1a125c51d7d41d1451958f014693bd30</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2897%2900025-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252897%252900025-2%26sid%3Dliteratum%253Aachs%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DNielsen%26aufirst%3DD.%26aulast%3DSkovsgaard%26aufirst%3DT.%26aulast%3DZeuthen%26aufirst%3DT.%26aulast%3DStein%26aufirst%3DW.-D.%26atitle%3DATPase%2520Activity%2520of%2520P-glycoprotein%2520Related%2520to%2520Emergence%2520of%2520Drug%2520Resistance%2520in%2520Ehrlich%2520Ascites%2520Tumor%2520Cell%2520Lines%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D1997%26volume%3D1361%26spage%3D147%26epage%3D158%26doi%3D10.1016%2FS0925-4439%2897%2900025-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, E.</span></span> <span> </span><span class="NLM_article-title">Co-operating ATP Sites in the Multiple Drug Resistance Transporter Mdr1</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">54</span>â <span class="NLM_lpage">63</span>, <span class="refDoi">Â DOI: 10.1046/j.1432-1327.1999.00643.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1046%2Fj.1432-1327.1999.00643.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10491157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFKlu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1999&pages=54-63&author=E.+Buxbaum&title=Co-operating+ATP+Sites+in+the+Multiple+Drug+Resistance+Transporter+Mdr1&doi=10.1046%2Fj.1432-1327.1999.00643.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Co-operating ATP sites in the multiple drug resistance transporter Mdr1</span></div><div class="casAuthors">Buxbaum, Engelbert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-63</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The ATPase activity of the multiple drug resistance transporter Mdr1 (P-glycoprotein, gp170) depended on the concn. of ATP with both pos. and neg. co-operativity both in the absence and in the presence of verapamil.  Four co-operating binding sites for ATP were required to adequately model the exptl. findings.  The activation energy for the ATPase activity increased from â 385 kJÂ·mol-1 at 10 Î¼M ATP to 512 kJÂ·mol-1 at 1600 Î¼M, while changes in verapamil concn. had little effect.  This indicates that the reaction mechanism of ATP hydrolysis depends on ATP concn. and is further evidence for co-operation of ATP binding sites.  Free ATP in higher concn. was inhibitory; however, this inhibition could be reduced by complexing the ATP with Mg2+.  Free Mg2+ had little effect on Mdrl apart from complexing ATP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_Ls-awEH0bVg90H21EOLACvtfcHk0lhpfdezqTQTEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFKlu70%253D&md5=bdf80cb1013bf698360a5dadd8492c9d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1999.00643.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1999.00643.x%26sid%3Dliteratum%253Aachs%26aulast%3DBuxbaum%26aufirst%3DE.%26atitle%3DCo-operating%2520ATP%2520Sites%2520in%2520the%2520Multiple%2520Drug%2520Resistance%2520Transporter%2520Mdr1%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1999%26volume%3D265%26spage%3D54%26epage%3D63%26doi%3D10.1046%2Fj.1432-1327.1999.00643.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telbisz, Ã.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HegedÃ¼s, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ãzvegy-Laczka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ¡rady, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TakÃ¡ts, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrentino, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">Antibody Binding Shift Assay for Rapid Screening of Drug Interactions With the Human ABCG2Multidrug Transporter</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">101</span>â <span class="NLM_lpage">109</span>, <span class="refDoi">Â DOI: 10.1016/j.ejps.2011.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.ejps.2011.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=22115866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Cqt7bF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=101-109&author=%C3%81.+Telbiszauthor=C.+Heged%C3%BCsauthor=C.+%C3%96zvegy-Laczkaauthor=K.+Godaauthor=G.+V%C3%A1radyauthor=Z.+Tak%C3%A1tsauthor=E.+Szaboauthor=B.+P.+Sorrentinoauthor=A.+Varadiauthor=B.+Sarkadi&title=Antibody+Binding+Shift+Assay+for+Rapid+Screening+of+Drug+Interactions+With+the+Human+ABCG2Multidrug+Transporter&doi=10.1016%2Fj.ejps.2011.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter</span></div><div class="casAuthors">Telbisz, Agnes; Hegedues, Csilla; Oezvegy-Laczka, Csilla; Goda, Katalin; Varady, Gyoergy; Takats, Zoltan; Szabo, Eszter; Sorrentino, Brian P.; Varadi, Andras; Sarkadi, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ABCG2 multidrug transporter protein has been identified as a key player in cancer drug resistance and xenobiotic elimination, as its actively transported substrates include anticancer drugs, intermediates of heme metab., xenobiotics, and also drug conjugates.  Several transported substrates at higher concns., and some anticancer agents even at low concns. directly inhibit the ABCG2 transporter, thus it is difficult to provide estn. for pharmacol. important ABCG2-dependent interactions.  In addn., as documented here, in mutant variants of the transporter, inhibitors of the wild-type ABCG2 may become actively transported substrates.  In this paper we describe a rapid in vitro assay to identify transport modulation by measuring the cell surface interaction of a conformation sensitive monoclonal antibody (5D3) with ABCG2 in intact cells.  As documented, in conjunction with membrane ATPase, transport and cytotoxicity measurements, this assay provides a reliable est. of concn.-dependent modulation of ABCG2 by newly emerging pharmacophores.  A high-throughput, 96-well plate assay platform is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3a5A3vWQ8HrVg90H21EOLACvtfcHk0lhpfdezqTQTEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Cqt7bF&md5=7d1d81b876abcccbf0d963eff1bd3b25</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2011.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2011.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DTelbisz%26aufirst%3D%25C3%2581.%26aulast%3DHeged%25C3%25BCs%26aufirst%3DC.%26aulast%3D%25C3%2596zvegy-Laczka%26aufirst%3DC.%26aulast%3DGoda%26aufirst%3DK.%26aulast%3DV%25C3%25A1rady%26aufirst%3DG.%26aulast%3DTak%25C3%25A1ts%26aufirst%3DZ.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DSorrentino%26aufirst%3DB.%2BP.%26aulast%3DVaradi%26aufirst%3DA.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DAntibody%2520Binding%2520Shift%2520Assay%2520for%2520Rapid%2520Screening%2520of%2520Drug%2520Interactions%2520With%2520the%2520Human%2520ABCG2Multidrug%2520Transporter%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D45%26spage%3D101%26epage%3D109%26doi%3D10.1016%2Fj.ejps.2011.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolaridis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locher, K. P.</span></span> <span> </span><span class="NLM_article-title">Structure of the Human Multidrug Transporter ABCG2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>546</i></span>,  <span class="NLM_fpage">504</span>â <span class="NLM_lpage">509</span>, <span class="refDoi">Â DOI: 10.1038/nature22345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fnature22345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=28554189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosFWntbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=504-509&author=N.+M.+I.+Taylorauthor=I.+Manolaridisauthor=S.+M.+Jacksonauthor=J.+Kowalauthor=H.+Stahlbergauthor=K.+P.+Locher&title=Structure+of+the+Human+Multidrug+Transporter+ABCG2&doi=10.1038%2Fnature22345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human multidrug transporter ABCG2</span></div><div class="casAuthors">Taylor, Nicholas M. I.; Manolaridis, Ioannis; Jackson, Scott M.; Kowal, Julia; Stahlberg, Henning; Locher, Kaspar P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7659</span>),
    <span class="NLM_cas:pages">504-509</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ABCG2 is a constitutively expressed ATP-binding cassette (ABC) transporter that protects many tissues against xenobiotic mols.  Its activity affects the pharmacokinetics of commonly used drugs and limits the delivery of therapeutics into tumor cells, thus contributing to multidrug resistance.  Here we present the structure of human ABCG2 detd. by cryo-electron microscopy, providing the first high-resoln. insight into a human multidrug transporter.  We visualize ABCG2 in complex with two antigen-binding fragments of the human-specific, inhibitory antibody 5D3 that recognizes extracellular loops of the transporter.  We observe two cholesterol mols. bound in the multidrug-binding pocket that is located in a central, hydrophobic, inward-facing translocation pathway between the transmembrane domains.  Combined with functional in vitro analyses, our results suggest a multidrug recognition and transport mechanism of ABCG2, rationalize disease-causing single nucleotide polymorphisms (SNP) and the allosteric inhibition by the 5D3 antibody, and provide the structural basis of cholesterol recognition by other G-subfamily ABC transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYOlfrPNtVhrVg90H21EOLACvtfcHk0lhpfdezqTQTEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosFWntbk%253D&md5=a3fd5157f639d2958e5abd996e2a6470</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnature22345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22345%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DN.%2BM.%2BI.%26aulast%3DManolaridis%26aufirst%3DI.%26aulast%3DJackson%26aufirst%3DS.%2BM.%26aulast%3DKowal%26aufirst%3DJ.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DLocher%26aufirst%3DK.%2BP.%26atitle%3DStructure%2520of%2520the%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DNature%26date%3D2017%26volume%3D546%26spage%3D504%26epage%3D509%26doi%3D10.1038%2Fnature22345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolaridis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zechner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bause, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomaeus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locher, K. P.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Small-Molecule Inhibition of Human Multidrug Transporter ABCG2</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">333</span>â <span class="NLM_lpage">340</span>, <span class="refDoi">Â DOI: 10.1038/s41594-018-0049-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fs41594-018-0049-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=29610494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOjsr7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=333-340&author=S.+M.+Jacksonauthor=I.+Manolaridisauthor=J.+Kowalauthor=M.+Zechnerauthor=N.+M.+I.+Taylorauthor=M.+Bauseauthor=S.+Bauerauthor=R.+Bartholomaeusauthor=G.+Bernhardtauthor=B.+Koenigauthor=A.+Buschauerauthor=H.+Stahlbergauthor=K.-H.+Altmannauthor=K.+P.+Locher&title=Structural+Basis+of+Small-Molecule+Inhibition+of+Human+Multidrug+Transporter+ABCG2&doi=10.1038%2Fs41594-018-0049-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of small-molecule inhibition of human multidrug transporter ABCG2</span></div><div class="casAuthors">Jackson, Scott M.; Manolaridis, Ioannis; Kowal, Julia; Zechner, Melanie; Taylor, Nicholas M. I.; Bause, Manuel; Bauer, Stefanie; Bartholomaeus, Ruben; Bernhardt, Guenther; Koenig, Burkhard; Buschauer, Armin; Stahlberg, Henning; Altmann, Karl-Heinz; Locher, Kaspar P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">333-340</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">ABCG2 is an ATP-binding cassette (ABC) transporter that protects tissues against xenobiotics, affects the pharmacokinetics of drugs and contributes to multidrug resistance.  Although many inhibitors and modulators of ABCG2 have been developed, understanding their structure-activity relationship requires high-resoln. structural insight.  Here, we present cryo-EM structures of human ABCG2 bound to synthetic derivs. of the fumitremorgin C-related inhibitor Ko143 or the multidrug resistance modulator tariquidar.  Both compds. are bound to the central, inward-facing cavity of ABCG2, blocking access for substrates and preventing conformational changes required for ATP hydrolysis.  The high resolns. allowed for de novo building of the entire transporter and also revealed tightly bound phospholipids and cholesterol interacting with the lipid-exposed surface of the transmembrane domains (TMDs).  Extensive chem. modifications of the Ko143 scaffold combined with in vitro functional analyses revealed the details of ABCG2 interactions with this compd. family and provide a basis for the design of novel inhibitors and modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJBdcwrlGmAbVg90H21EOLACvtfcHk0lhpfdezqTQTEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOjsr7M&md5=b892ceb7a3ede9784a09c2cc98042d03</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fs41594-018-0049-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-018-0049-1%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BM.%26aulast%3DManolaridis%26aufirst%3DI.%26aulast%3DKowal%26aufirst%3DJ.%26aulast%3DZechner%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DN.%2BM.%2BI.%26aulast%3DBause%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DBartholomaeus%26aufirst%3DR.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DKoenig%26aufirst%3DB.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DLocher%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520Basis%2520of%2520Small-Molecule%2520Inhibition%2520of%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D333%26epage%3D340%26doi%3D10.1038%2Fs41594-018-0049-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khunweeraphong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchler, K.</span></span> <span> </span><span class="NLM_article-title">The Structure of the Human ABC Transporter ABCG2 Reveals a Novel Mechanism for Drug Extrusion</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13767</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-11794-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fs41598-017-11794-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=29061978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BC1M7js1yksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=13767&author=N.+Khunweeraphongauthor=T.+Stocknerauthor=K.+Kuchler&title=The+Structure+of+the+Human+ABC+Transporter+ABCG2+Reveals+a+Novel+Mechanism+for+Drug+Extrusion&doi=10.1038%2Fs41598-017-11794-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion</span></div><div class="casAuthors">Khunweeraphong Narakorn; Kuchler Karl; Stockner Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13767</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The human ABC transporter ABCG2 (Breast Cancer Resistance Protein, BCRP) is implicated in anticancer resistance, in detoxification across barriers and linked to gout.  Here, we generate a novel atomic model of ABCG2 using the crystal structure of ABCG5/G8.  Extensive mutagenesis verifies the structure, disclosing hitherto unrecognized essential residues and domains in the homodimeric ABCG2 transporter.  The elbow helix, the first intracellular loop (ICL1) and the nucleotide-binding domain (NBD) constitute pivotal elements of the architecture building the transmission interface that borders a central cavity which acts as a drug trap.  The transmission interface is stabilized by salt-bridge interactions between the elbow helix and ICL1, as well as within ICL1, which is essential to control the conformational switch of ABCG2 to the outward-open drug-releasing conformation.  Importantly, we propose that ICL1 operates like a molecular spring that holds the NBD dimer close to the membrane, thereby enabling efficient coupling of ATP hydrolysis during the catalytic cycle.  These novel mechanistic data open new opportunities to therapeutically target ABCG2 in the context of related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9zxYb5ouxkL0AGQpJZWpJfW6udTcc2eZPRWktiYpAqbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7js1yksQ%253D%253D&md5=13b9d4f177ed8f979a173b5e2ce45fb8</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-11794-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-11794-w%26sid%3Dliteratum%253Aachs%26aulast%3DKhunweeraphong%26aufirst%3DN.%26aulast%3DStockner%26aufirst%3DT.%26aulast%3DKuchler%26aufirst%3DK.%26atitle%3DThe%2520Structure%2520of%2520the%2520Human%2520ABC%2520Transporter%2520ABCG2%2520Reveals%2520a%2520Novel%2520Mechanism%2520for%2520Drug%2520Extrusion%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D13767%26doi%3D10.1038%2Fs41598-017-11794-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegedus, T.</span></span> <span> </span><span class="NLM_article-title">Jump into a New Fold - A Homology Based Model for the ABCG2/BCRP Multidrug Transporter</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0164426</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0164426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1371%2Fjournal.pone.0164426" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0164426&author=L.+Laszloauthor=B.+Sarkadiauthor=T.+Hegedus&title=Jump+into+a+New+Fold+-+A+Homology+Based+Model+for+the+ABCG2%2FBCRP+Multidrug+Transporter&doi=10.1371%2Fjournal.pone.0164426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0164426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0164426%26sid%3Dliteratum%253Aachs%26aulast%3DLaszlo%26aufirst%3DL.%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DHegedus%26aufirst%3DT.%26atitle%3DJump%2520into%2520a%2520New%2520Fold%2520-%2520A%2520Homology%2520Based%2520Model%2520for%2520the%2520ABCG2%252FBCRP%2520Multidrug%2520Transporter%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0164426%26doi%3D10.1371%2Fjournal.pone.0164426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikadi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span> <span> </span><span class="NLM_article-title">Transmembrane Helices 1 and 6 of the Human Breast Cancer Resistance Protein (BCRP/ABCG2): Identification of Polar Residues Important for Drug Transport</span>. <i>Am. J. Physiol. Cell Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>299</i></span>,  <span class="NLM_fpage">C1100</span>â <span class="NLM_lpage">11009</span>, <span class="refDoi">Â DOI: 10.1152/ajpcell.00160.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1152%2Fajpcell.00160.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=20739628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSgu7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=C1100-11009&author=Z.+Niauthor=Z.+Bikadiauthor=X.+Caiauthor=M.+F.+Rosenbergauthor=Q.+Mao&title=Transmembrane+Helices+1+and+6+of+the+Human+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29%3A+Identification+of+Polar+Residues+Important+for+Drug+Transport&doi=10.1152%2Fajpcell.00160.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport</span></div><div class="casAuthors">Ni, Zhanglin; Bikadi, Zsolt; Cai, Xiaokun; Rosenberg, Mark F.; Mao, Qingcheng</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">5, Pt. 1</span>),
    <span class="NLM_cas:pages">C1100-C1109</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">The human breast cancer resistance protein (BCRP/ABCG2) mediates efflux of drugs and xenobiotics.  In this study, we investigated the role of polar residues within or near the predicted transmembrane Î±-helixes 1 and 6 of BCRP in drug transport.  We substituted Asn387, Gln398, Asn629, and Thr642 with Ala, Thr402 with Ala and Arg, and Tyr645 with Phe, and the mutants were stably expressed in human embryonic kidney-293 or Flp-In-293 cells.  Immunoblotting and confocal microscopy anal. revealed that all of the mutants were well expressed and predominantly targeted to the plasma membrane.  While T402A and T402R showed a significant global redn. in the efflux of mitoxantrone, Hoechst 33342, and BODIPY-prazosin, N629A exhibited significantly increased efflux activities for all of the substrates.  N387A and Q398A displayed significantly impaired efflux for mitoxantrone and Hoechst 33342, but not for BODIPY-prazosin.  In contrast, T642A and Y645F showed a moderate redn. in Hoechst 33342 efflux only.  Drug resistance profiles of human embryonic kidney-293 cells expressing the mutants generally correlated with the efflux data.  Furthermore, N629A was assocd. with a marked increase, and N387A and T402A with a significant redn., in BCRP ATPase activity.  Mutations of some of the polar residues may cause conformational changes, as manifested by the altered binding of the 5D3 antibody to BCRP in the presence of prazosin.  The inward-facing homol. model of BCRP indicated that Thr402 within transmembrane 1 may be important for helical interactions, and Asn629 may be involved in BCRP-substrate interaction.  In conclusion, we have demonstrated the functional importance of some of these polar residues in BCRP activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBqeiT17Gj47Vg90H21EOLACvtfcHk0lids1SdOGMgvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSgu7jK&md5=116e4feb0a454e8782a804c526832398</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00160.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00160.2010%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DZ.%26aulast%3DBikadi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DRosenberg%26aufirst%3DM.%2BF.%26aulast%3DMao%26aufirst%3DQ.%26atitle%3DTransmembrane%2520Helices%25201%2520and%25206%2520of%2520the%2520Human%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%253A%2520Identification%2520of%2520Polar%2520Residues%2520Important%2520for%2520Drug%2520Transport%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell%2520Physiol.%26date%3D2010%26volume%3D299%26spage%3DC1100%26epage%3D11009%26doi%3D10.1152%2Fajpcell.00160.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honjo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Q. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Perez, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Laar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Acquired Mutations in the MXR/BCRP/ABCP Gene Alter Substrate Specificity in MXR/BCRP/ABCP-Overexpressing Cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6635</span>â <span class="NLM_lpage">6639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=11559526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFaisr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=6635-6639&author=Y.+Honjoauthor=C.+A.+Hrycynaauthor=Q.+W.+Yanauthor=W.+Y.+Medina-Perezauthor=R.+W.+Robeyauthor=A.+van+de+Laarauthor=T.+Litmanauthor=M.+Deanauthor=S.+E.+Bates&title=Acquired+Mutations+in+the+MXR%2FBCRP%2FABCP+Gene+Alter+Substrate+Specificity+in+MXR%2FBCRP%2FABCP-Overexpressing+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells</span></div><div class="casAuthors">Honjo, Yasumasa; Hrycyna, Christine A.; Yan, Qing-Wu; Medina-Perez, Wilma Y.; Robey, Robert W.; Van de Laar, Anne; Litman, Thomas; Dean, Michael; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6635-6639</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A disparity was noted in the transport of rhodamine 123 among nine MXR/BCRP/ABCP-overexpressing cells studied; all demonstrated mitoxantrone transport, whereas only two effluxed rhodamine 123.  When the MXR/BCRP/ABCP gene was sequenced in the cell lines studied, differences were noted at amino acid 482, predicted to be at the start of the third transmembrane domain.  Sequencing genomic DNA revealed wild-type MXR/BCRP/ABCP to have an arginine at position 482.  Cells having a threonine or glycine at position 482 were able to efflux rhodamine 123, whereas cells having an arginine were not.  A vaccinia virus expression system confirmed that rhodamine as well as doxorubicin efflux is obsd. with R482T or R482G but not with the wild-type R482; all three MXR/BCRP/ABCP forms transported mitoxantrone.  Cross-resistance studies suggest that, compared with wild-type MXR/BCRP/ABCP, cells having an R482T mutation have higher anthracycline resistance, whereas an R482G mutation seems to confer relatively less resistance to SN-38 and topotecan.  These results suggest that amino acid 482 has a crucial role in MXR/BCRP/ABCP function and that mutation of a single amino acid residue significantly changes substrate specificity, thus altering the drug resistance phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmMsJibyZBJrVg90H21EOLACvtfcHk0lgAJ4yvJLNm3Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFaisr0%253D&md5=7d803180613f9f5fb9031bced175dbca</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHonjo%26aufirst%3DY.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DYan%26aufirst%3DQ.%2BW.%26aulast%3DMedina-Perez%26aufirst%3DW.%2BY.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3Dvan%2Bde%2BLaar%26aufirst%3DA.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DAcquired%2520Mutations%2520in%2520the%2520MXR%252FBCRP%252FABCP%2520Gene%2520Alter%2520Substrate%2520Specificity%2520in%2520MXR%252FBCRP%252FABCP-Overexpressing%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D6635%26epage%3D6639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozvegy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">Characterization of Drug Transport, ATP Hydrolysis, and Nucleotide Trapping by the Human ABCG2Multidrug Transporter. Modulation of Substrate Specificity by a Point Mutation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">47980</span>â <span class="NLM_lpage">47990</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M207857200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1074%2Fjbc.M207857200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=47980-47990&author=C.+Ozvegyauthor=A.+Varadiauthor=B.+Sarkadi&title=Characterization+of+Drug+Transport%2C+ATP+Hydrolysis%2C+and+Nucleotide+Trapping+by+the+Human+ABCG2Multidrug+Transporter.+Modulation+of+Substrate+Specificity+by+a+Point+Mutation&doi=10.1074%2Fjbc.M207857200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M207857200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M207857200%26sid%3Dliteratum%253Aachs%26aulast%3DOzvegy%26aufirst%3DC.%26aulast%3DVaradi%26aufirst%3DA.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520Drug%2520Transport%252C%2520ATP%2520Hydrolysis%252C%2520and%2520Nucleotide%2520Trapping%2520by%2520the%2520Human%2520ABCG2Multidrug%2520Transporter.%2520Modulation%2520of%2520Substrate%2520Specificity%2520by%2520a%2520Point%2520Mutation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D47980%26epage%3D47990%26doi%3D10.1074%2Fjbc.M207857200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volk, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span> <span> </span><span class="NLM_article-title">Overexpression of Wild-Type Breast Cancer Resistance Protein Mediates Methotrexate Resistance</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5035</span>â <span class="NLM_lpage">5040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=5035-5040&author=E.+L.+Volkauthor=K.+M.+Farleyauthor=Y.+Wuauthor=F.+Liauthor=R.+W.+Robeyauthor=E.+Schneider&title=Overexpression+of+Wild-Type+Breast+Cancer+Resistance+Protein+Mediates+Methotrexate+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolk%26aufirst%3DE.%2BL.%26aulast%3DFarley%26aufirst%3DK.%2BM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DSchneider%26aufirst%3DE.%26atitle%3DOverexpression%2520of%2520Wild-Type%2520Breast%2520Cancer%2520Resistance%2520Protein%2520Mediates%2520Methotrexate%2520Resistance%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D5035%26epage%3D5040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Functional Validation of the Genetic Polymorphisms of Human ATP-binding Cassette (ABC) Transporter ABCG2: Identification of Alleles that are Defective in Porphyrin Transport</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">287</span>â <span class="NLM_lpage">296</span>, <span class="refDoi">Â DOI: 10.1124/mol.106.023556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1124%2Fmol.106.023556" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=287-296&author=A.+Tamuraauthor=M.+Watanabeauthor=H.+Saitoauthor=H.+Nakagawaauthor=T.+Kamachiauthor=I.+Okuraauthor=T.+Ishikawa&title=Functional+Validation+of+the+Genetic+Polymorphisms+of+Human+ATP-binding+Cassette+%28ABC%29+Transporter+ABCG2%3A+Identification+of+Alleles+that+are+Defective+in+Porphyrin+Transport&doi=10.1124%2Fmol.106.023556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.023556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.023556%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DKamachi%26aufirst%3DT.%26aulast%3DOkura%26aufirst%3DI.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DFunctional%2520Validation%2520of%2520the%2520Genetic%2520Polymorphisms%2520of%2520Human%2520ATP-binding%2520Cassette%2520%2528ABC%2529%2520Transporter%2520ABCG2%253A%2520Identification%2520of%2520Alleles%2520that%2520are%2520Defective%2520in%2520Porphyrin%2520Transport%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D287%26epage%3D296%26doi%3D10.1124%2Fmol.106.023556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Purohit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, A.</span></span> <span> </span><span class="NLM_article-title">Mutagenicity of nitroaromatic compounds</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">673</span>â <span class="NLM_lpage">692</span>, <span class="refDoi">Â DOI: 10.1021/tx000002x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx000002x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFSitLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=673-692&author=V.+Purohitauthor=A.+Basu&title=Mutagenicity+of+nitroaromatic+compounds&doi=10.1021%2Ftx000002x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenicity of Nitroaromatic Compounds</span></div><div class="casAuthors">Purohit, Vandana; Basu, Ashis K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">673-692</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review and discussion with 222 refs.  Metab. and DNA binding, mechanism of mutagenesis and repair in bacteria, mutagenesis in mammalian systems, and structure-activity relationship are discussed in relation to the title topic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybDHR1RJ20rVg90H21EOLACvtfcHk0lgAJ4yvJLNm3Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFSitLg%253D&md5=74477b2805d2365e208538cdce0dec39</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Ftx000002x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx000002x%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DV.%26aulast%3DBasu%26aufirst%3DA.%26atitle%3DMutagenicity%2520of%2520nitroaromatic%2520compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2000%26volume%3D13%26spage%3D673%26epage%3D692%26doi%3D10.1021%2Ftx000002x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity Relationships of New Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">8224</span>â <span class="NLM_lpage">8236</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2008.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2008.07.034" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8224-8236&author=A.+Pickauthor=H.+M%C3%BCllerauthor=M.+Wiese&title=Structure-activity+Relationships+of+New+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1016%2Fj.bmc.2008.07.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-activity%2520Relationships%2520of%2520New%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8224%26epage%3D8236%26doi%3D10.1016%2Fj.bmc.2008.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells Via the PI3K/Akt Signaling Pathway</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">650</span>â <span class="NLM_lpage">662</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201100543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1002%2Fcmdc.201100543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=22354538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFyis78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=650-662&author=A.+Pickauthor=M.+Wiese&title=Tyrosine+Kinase+Inhibitors+Influence+ABCG2+Expression+in+EGFR-Positive+MDCK+BCRP+Cells+Via+the+PI3K%2FAkt+Signaling+Pathway&doi=10.1002%2Fcmdc.201100543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway</span></div><div class="casAuthors">Pick, Anne; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">650-662</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Multidrug resistance obsd. in cancer chemotherapy is commonly attributed to overexpression of efflux transporter proteins.  These proteins act as ATP-dependent drug efflux pumps, actively extruding chemotherapeutic agents from cells and causing a decrease in intracellular drug accumulation.  Besides the well-recognized role of P-glycoprotein (P-gp, ABCB1), the breast cancer resistance protein (BCRP, ABCG2) is becoming increasingly accepted as playing an important role in multidrug resistance.  In contrast to P-glycoprotein, only a few inhibitors of ABCG2 are known.  According to the literature, tyrosine kinase inhibitors (TKIs) can be considered to be broad-spectrum inhibitors, interacting with ABCB1, ABCC1 and ABCG2.  Here, the authors investigated seven different TKIs, gefitinib, erlotinib, AG1478, PD158780, PD153035, nilotinib and imatinib, for their potential to restore ABCG2 sensitivity to cells.  Furthermore, the authors analyzed the alteration of ABCG2 expression caused by TKIs and demonstrated that EGFR inhibitors such as gefitinib and PD158780 reduced both total and surface expression of ABCG2 in EGRF-pos. MDCK BCRP cells by interaction with the PI3K/Akt signaling pathway.  The reduced ABCG2 content led to an increased effect of XR9577, a well-known ABCG2 modulator, lowering the concn. required for half maximal inhibition.  BCR-ABL inhibitors had no influence on ABCG2 expression and modulator activity.  Interestingly, a combination of an EGFR inhibitor with the PI3K/Akt inhibitor LY294002 led to a significant redn. of ABCG2 expression at low concns. of the drugs.  Based on the authors' results, the authors assume that EGFR exerts a post-transcriptional enhancing effect on ABCG2 expression via the PI3K/Akt signaling pathway, which can be attenuated by EGFR inhibitors.  Blocking the key signaling pathway regulating ABCG2 expression with EGFR inhibitors, combined with the inhibition of ABCG2 with potent modulators might be a promising approach to circumvent MDR in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouvP7V8QMUi7Vg90H21EOLACvtfcHk0lgsEUBlQF3bCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFyis78%253D&md5=c78fc69da2c5a134dd3f669c165364c2</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100543%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors%2520Influence%2520ABCG2%2520Expression%2520in%2520EGFR-Positive%2520MDCK%2520BCRP%2520Cells%2520Via%2520the%2520PI3K%252FAkt%2520Signaling%2520Pathway%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D650%26epage%3D662%26doi%3D10.1002%2Fcmdc.201100543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">4-Substituted-2-phenylquinazolines as Inhibitors of BCRP</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6766</span>â <span class="NLM_lpage">6769</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2012.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmcl.2012.08.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=23017888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6766-6769&author=K.+Juvaleauthor=M.+Wiese&title=4-Substituted-2-phenylquinazolines+as+Inhibitors+of+BCRP&doi=10.1016%2Fj.bmcl.2012.08.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">4-Substituted-2-phenylquinazolines as inhibitors of BCRP</span></div><div class="casAuthors">Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6766-6769</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated several 2-phenylquinazolines with different substitutions at position 4 for their BCRP inhibition.  Compds. with Ph ring attached via an amine-contg. linker at position 4 were found to be potent inhibitors of BCRP.  In general compds. with meta substitution of Ph ring at position 4 were found to have higher inhibitory effect, compd. 12 being the most potent and selective towards BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf-v9OH4Nxr7Vg90H21EOLACvtfcHk0lgsEUBlQF3bCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrbJ&md5=e96d4566ff6ae54c8e454bda7b50c873</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3D4-Substituted-2-phenylquinazolines%2520as%2520Inhibitors%2520of%2520BCRP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6766%26epage%3D6769%26doi%3D10.1016%2Fj.bmcl.2012.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinkhammer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1498</span>â <span class="NLM_lpage">1505</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201000216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1002%2Fcmdc.201000216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=20632361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWgsbnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1498-1505&author=A.+Pickauthor=W.+Klinkhammerauthor=M.+Wiese&title=Specific+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%29&doi=10.1002%2Fcmdc.201000216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)</span></div><div class="casAuthors">Pick, Anne; Klinkhammer, Werner; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1498-1505</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A new class of specific breast cancer resistance protein (BCRP) inhibitors was identified, showing no inhibition of the ATP binding cassette (ABC) transporters P-gp and MRP1.  Some of these modulators inhibit BCRP with high potency; they are only slightly less potent than Ko143 and could serve as promising lead structures for the design of novel effective BCRP inhibitors.  These inhibitors are structurally related to tariquidar (XR9576) and belong to a library of multidrug-resistance modulators synthesized by our research group.  The absence of the tetrahydroisoquinoline substructure appears to play a crucial role for specificity; we found that the presence of this substructure is not essential for interaction with BCRP.  To det. the type of interaction between pheophorbide A and compds. with and without the tetrahydroisoquinoline substructure, various substrate pheophorbide A concns. were used in enzyme kinetics assays.  The resulting data show that these compds. share a noncompetitive-type interaction with pheophorbide A.  Expts. with imatinib and pheophorbide A revealed a mixed-type interaction.  The combination of imatinib and compds. with and without the tetrahydroisoquinoline substructure resulted in a pos. cooperative effect, indicating that imatinib engages a binding site distinct from that of the new compds. on one side and distinct from that of pheophorbide A on the other side as well.  The results of this study suggest that the category of BCRP-specific inhibitors, which includes only fumitremorgin C, Ko143 and analogs, and novobiocin needs to be extended by this new class of inhibitors, which possess three key characteristics: specificity, potency, and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbFkR4oCa3bVg90H21EOLACvtfcHk0lgsEUBlQF3bCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWgsbnK&md5=751e5cb7fb4a5db8645196ff3b3ae28a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000216%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSpecific%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%2529%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1498%26epage%3D1505%26doi%3D10.1002%2Fcmdc.201000216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marighetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steggemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Quantitative Structure-Activity Relationships of Selective BCRP Inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">125</span>â <span class="NLM_lpage">135</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201200377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1002%2Fcmdc.201200377" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=125-135&author=F.+Marighettiauthor=K.+Steggemannauthor=M.+Hanlauthor=M.+Wiese&title=Synthesis+and+Quantitative+Structure-Activity+Relationships+of+Selective+BCRP+Inhibitors&doi=10.1002%2Fcmdc.201200377"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200377%26sid%3Dliteratum%253Aachs%26aulast%3DMarighetti%26aufirst%3DF.%26aulast%3DSteggemann%26aufirst%3DK.%26aulast%3DHanl%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Quantitative%2520Structure-Activity%2520Relationships%2520of%2520Selective%2520BCRP%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D125%26epage%3D135%26doi%3D10.1002%2Fcmdc.201200377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marighetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steggemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Scaffold Identification of a New Class of Potent and Selective BCRP-inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">742</span>â <span class="NLM_lpage">751</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201402498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1002%2Fcmdc.201402498" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=742-751&author=F.+Marighettiauthor=K.+Steggemannauthor=M.+Karbaumauthor=M.+Wiese&title=Scaffold+Identification+of+a+New+Class+of+Potent+and+Selective+BCRP-inhibitors&doi=10.1002%2Fcmdc.201402498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402498%26sid%3Dliteratum%253Aachs%26aulast%3DMarighetti%26aufirst%3DF.%26aulast%3DSteggemann%26aufirst%3DK.%26aulast%3DKarbaum%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DScaffold%2520Identification%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520and%2520Selective%2520BCRP-inhibitors%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D742%26epage%3D751%26doi%3D10.1002%2Fcmdc.201402498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haenisch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajeva, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¶nisch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationships of Flavonoids as Inhibitors of Breast Cancer Resistance Protein (BCRP)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2090</span>â <span class="NLM_lpage">2102</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2010.12.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2010.12.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=21354800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFCnu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2090-2102&author=A.+Pickauthor=H.+M%C3%BCllerauthor=R.+Mayerauthor=B.+Haenischauthor=I.+K.+Pajevaauthor=M.+Weigtauthor=H.+B%C3%B6nischauthor=C.+E.+M%C3%BCllerauthor=M.+Wiese&title=Structure-Activity+Relationships+of+Flavonoids+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28BCRP%29&doi=10.1016%2Fj.bmc.2010.12.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)</span></div><div class="casAuthors">Pick, Anne; Mueller, Henrik; Mayer, Ralf; Haenisch, Britta; Pajeva, Ilza K.; Weigt, Mathias; Boenisch, Heinz; Mueller, Christa E.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2090-2102</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Flavonoids are an interesting group of natural products ubiquitously present in human diet.  Their consumption has been assocd. with various and differing beneficial health effects.  However, several flavonoids have been reported to inhibit the breast cancer resistance protein (BCRP) encoded by the ABCG2 gene.  Thus, the consumption of flavonoids with high inhibitory activity could change pharmacokinetics and drug levels of drugs that are BCRP substrates.  In cancer patients receiving chemotherapy an increased intake of such flavonoids could lead to adverse effects.  We investigated a structurally diverse set of flavonoids, including derivs. with a rare C-methylated structure that were isolated from plants used in traditional medicine.  The flavones retusin and ayanin were found to be highly potent inhibitors of BCRP, showing only slightly less potency than Ko143, the most potent ABCG2 inhibitor known so far.  The activity data were analyzed by 2D and 3D QSAR analyses and the results revealed the impact of the different substituents at the various positions of the flavonoid core on activity.  Addnl., a lateral 2D QSAR anal. of data collected from the literature was performed aiming to derive more general information about the influence of distinct structural features on the inhibitory potency of flavonoids.  The comparative QSAR analyses led to a consistent picture of the effects of the different substituents at various positions of the flavone backbone.  The following structural features were found to contribute pos. to BCRP inhibition: a hydroxyl group in position 5, double bond between position 2 and 3, and a methoxy group in position 3.  The exchange of a 3-methoxy group by an OH-group acting also as a hydrogen bond donor, resulted in decrease in activity underlining the potential role of the hydrogen bond acceptor 3-OCH3 for the interaction with BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre-4pma6sNmrVg90H21EOLACvtfcHk0lixv8Zp1Hu6lQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFCnu7g%253D&md5=2a9156b065c5df1a3e517cca93f59db8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.043%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DR.%26aulast%3DHaenisch%26aufirst%3DB.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWeigt%26aufirst%3DM.%26aulast%3DB%25C3%25B6nisch%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-Activity%2520Relationships%2520of%2520Flavonoids%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2090%26epage%3D2102%26doi%3D10.1016%2Fj.bmc.2010.12.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinkhammer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Globisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajeva, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">New Functional Assay of P-glycoprotein Activity Using Hoechst 33342</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">7470</span>â <span class="NLM_lpage">7479</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2007.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2007.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=17890094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKitb3E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7470-7479&author=H.+M%C3%BCllerauthor=W.+Klinkhammerauthor=C.+Globischauthor=M.+U.+Kassackauthor=I.+K.+Pajevaauthor=M.+Wiese&title=New+Functional+Assay+of+P-glycoprotein+Activity+Using+Hoechst+33342&doi=10.1016%2Fj.bmc.2007.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">New functional assay of P-glycoprotein activity using Hoechst 33342</span></div><div class="casAuthors">Mueller, Henrik; Klinkhammer, Werner; Globisch, Christoph; Kassack, Matthias U.; Pajeva, Ilza K.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7470-7479</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study the authors describe a simplified, HTS-capable functional assay for the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) based on its substrate Hoechst 33342.  The physicochem. properties of Hoechst 33342 and the enormous milieu dependency of its fluorescence intensity allowed performing the assay in a homogeneous manner.  This new assay served as an effective tool to est. the potency of 10 well recognized P-gp substrates and modulators.  Further, the potency of these compds. was also estd. in the calcein AM assay.  The Hoechst 33342 and calcein AM assays yielded significantly comparable results for all compds. tested.  Principal component anal. (PCA) applied to literature data on inhibition of P-gp activity and the authors' results obtained in the Hoechst 33342 and calcein AM assay indicated similarity of compared functional transport assays.  However, no correlation could be detected between these functional assays and the ATPase activity assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSVlzt7xQp7Vg90H21EOLACvtfcHk0lixv8Zp1Hu6lQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKitb3E&md5=265484311a72ee68d952e31d700195b0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DNew%2520Functional%2520Assay%2520of%2520P-glycoprotein%2520Activity%2520Using%2520Hoechst%252033342%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7470%26epage%3D7479%26doi%3D10.1016%2Fj.bmc.2007.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Investigation of Chalcones and Benzochalcones as Inhibitors of Breast Cancer Resistance Protein</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">346</span>â <span class="NLM_lpage">355</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2011.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2011.10.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=22112540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=346-355&author=K.+Juvaleauthor=V.+F.+Papeauthor=M.+Wiese&title=Investigation+of+Chalcones+and+Benzochalcones+as+Inhibitors+of+Breast+Cancer+Resistance+Protein&doi=10.1016%2Fj.bmc.2011.10.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein</span></div><div class="casAuthors">Juvale, Kapil; Pape, Veronika F. S.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast cancer resistance protein (BCRP/ABCG2) belongs to the ATP binding cassette family of transport proteins.  BCRP has been found to confer multidrug resistance in cancer cells.  A strategy to overcome resistance due to BCRP overexpression is the investigation of potent and specific BCRP inhibitors.  The aim of the current study was to investigate different multi-substituted chalcones for their BCRP inhibition.  We synthesized chalcones and benzochalcones with different substituents (viz. OH, OCH3, Cl) on ring A and B of the chalcone structure.  All synthesized compds. were tested by Hoechst 33342 accumulation assay to det. inhibitory activity in MCF-7 MX and MDCK cells expressing BCRP.  The compds. were also screened for their P-glycoprotein (P-gp) and Multidrug resistance-assocd. protein 1 (MRP1) inhibitory activity in the calcein AM accumulation assay and were found to be selective towards inhibition of BCRP.  Substituents at position 2' and 4' on chalcone ring A were found to be essential for activity; addnl. there was a great influence of substituents on ring B. Presence of 3,4-dimethoxy substitution on ring B was found to be optimal, while presence of 2- and 4-chloro substitution also showed a pos. effect on BCRP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoTQiCUqdyrLVg90H21EOLACvtfcHk0lixv8Zp1Hu6lQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGgtw%253D%253D&md5=0884fa3575f8e159c7500abbacb31c9b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DPape%26aufirst%3DV.%2BF.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DInvestigation%2520of%2520Chalcones%2520and%2520Benzochalcones%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D346%26epage%3D355%26doi%3D10.1016%2Fj.bmc.2011.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, A.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Dual P-gp-BCRP Inhibitors as Nanoparticle Formulation</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">8</span>, <span class="refDoi">Â DOI: 10.1016/j.ejps.2015.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.ejps.2015.04.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=25976226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGntrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=1-8&author=M.+S.+Singhauthor=K.+Juvaleauthor=M.+Wieseauthor=A.+Lamprecht&title=Evaluation+of+Dual+P-gp-BCRP+Inhibitors+as+Nanoparticle+Formulation&doi=10.1016%2Fj.ejps.2015.04.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulation</span></div><div class="casAuthors">Singh, Manu Smriti; Juvale, Kapil; Wiese, Michael; Lamprecht, Alf</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Overcoming multidrug resistance (MDR) in cancer is a major challenge and efforts are on-going to develop inhibitors against the most characterized and ubiquitous MDR transporters: P-glycoprotein (P-gp), multidrug resistance-assocd. protein (MRP1) and breast cancer resistance protein (BCRP).  Recently reported, two 4-anilinoquinazolines (compds. 1 and 2), demonstrate potential MDR reversal activity against BCRP and to a lesser extent, P-gp.  In this work, we formulated the compds. as polymeric nanoparticles (NPs) and assessed their MDR inhibitory activity in relevant BCRP and P-gp over-expressing cell line models.  Particles in the size range 300-365 nm with a loading efficiency of 69% (compd. 1 NP) and 77% (compd. 2 NP) resp. were obtained.  BCRP inhibition was obsd. in Hoechst 33342 and pheophorbide A assays while P-gp inhibition was evaluated in calcein AM and rhodamine-123 assays.  In cytotoxicity studies, while BCRP expressing cells showed complete reversal of drug resistance in nearly all treatment groups (both compds. and their resp. NP); a higher reversal in NP treated group was obtained as compared with inhibitory compd. treated group in P-gp expressing cells.  These results demonstrate promising inhibitory activity of both formulations, esp. against P-gp expressing cells; which is possibly due to a prolonged presence of encapsulated compds. in NPs and consequently a prolonged sensitization of transmembrane drug transporter.  These formulations can therefore be considered as dual-transporter inhibitors and it is imperative to investigate both inhibitors in animal models of MDR owing to the presence of multiple efflux transporters in several cancer models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB94y74OV717Vg90H21EOLACvtfcHk0lhxoLTMQN_5wQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGntrY%253D&md5=b0cb7e6ed2815efd7d7471776525bc31</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2015.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2015.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DM.%2BS.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26aulast%3DLamprecht%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520Dual%2520P-gp-BCRP%2520Inhibitors%2520as%2520Nanoparticle%2520Formulation%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D77%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.ejps.2015.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Flavones and Benzoflavones as Inhibitors of BCRP/ABCG2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">115</span>â <span class="NLM_lpage">126</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2013.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.ejmech.2013.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=23851114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeis73E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=115-126&author=K.+Juvaleauthor=K.+Stefanauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+Flavones+and+Benzoflavones+as+Inhibitors+of+BCRP%2FABCG2&doi=10.1016%2Fj.ejmech.2013.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2</span></div><div class="casAuthors">Juvale, Kapil; Stefan, Katja; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) often leads to a failure of cancer chemotherapy.  Breast Cancer Resistance Protein (BCRP/ABCG2), a member of the superfamily of ATP binding cassette proteins has been found to confer MDR in cancer cells by transporting mols. with amphiphilic character out of the cells using energy from ATP hydrolysis.  Inhibiting BCRP can be a soln. to overcome MDR.  The authors synthesized a series of flavones, 7,8-benzoflavones and 5,6-benzoflavones with varying substituents at positions 3, 3' and 4' of the (benzo)flavone structure.  All synthesized compds. were tested for BCRP inhibition in Hoechst 33342 and pheophorbide A accumulation assays using MDCK cells expressing BCRP.  All the compds. were further screened for their P-glycoprotein (P-gp) and Multidrug resistance-assocd. protein 1 (MRP1) inhibitory activity by calcein AM accumulation assay to check the selectivity towards BCRP.  In addn. most active compds. were investigated for their cytotoxicity.  It was obsd. that in most cases 7,8-benzoflavones are more potent in comparison to the 5,6-benzoflavones.  In general it was found that presence of a 3-OCH3 substituent leads to increase in activity in comparison to presence of OH or no substitution at position 3.  Also, it was found that presence of 3',4'-OCH3 on Ph ring lead to increase in activity as compared to other substituents.  Compd. 24, a 7,8-benzoflavone deriv. was found to be most potent being 50 times selective for BCRP and showing very low cytotoxicity at higher concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoep2o4_wG7XrVg90H21EOLACvtfcHk0lhxoLTMQN_5wQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeis73E&md5=961e1899a816717d108c5c8e71944f70</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DStefan%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Flavones%2520and%2520Benzoflavones%2520as%2520Inhibitors%2520of%2520BCRP%252FABCG2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D67%26spage%3D115%26epage%3D126%26doi%3D10.1016%2Fj.ejmech.2013.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajeva, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Globisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Functional Assay and Structure-Activity Relationships of New Third-Generation P-glycoprotein Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2448</span>â <span class="NLM_lpage">2462</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2007.11.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2007.11.057" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2448-2462&author=H.+M%C3%BCllerauthor=I.+K.+Pajevaauthor=C.+Globischauthor=M.+Wiese&title=Functional+Assay+and+Structure-Activity+Relationships+of+New+Third-Generation+P-glycoprotein+Inhibitors&doi=10.1016%2Fj.bmc.2007.11.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.11.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.11.057%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DFunctional%2520Assay%2520and%2520Structure-Activity%2520Relationships%2520of%2520New%2520Third-Generation%2520P-glycoprotein%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2448%26epage%3D2462%26doi%3D10.1016%2Fj.bmc.2007.11.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶hler, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3910</span>â <span class="NLM_lpage">3921</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3910-3921&author=S.+C.+K%C3%B6hlerauthor=M.+Wiese&title=HM30181+Derivatives+as+Novel+Potent+and+Selective+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29&doi=10.1021%2Facs.jmedchem.5b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kohler Sebastian C; Wiese Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3910-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The breast cancer resistance protein (BCRP, ABCG2) belongs to the superfamily of ATP binding-cassette (ABC) proteins.  In addition to other physiological functions, it transports potentially cell-damaging compounds out of the cell using the energy from ATP hydrolysis.  Certain tumors overexpressing BCRP were found to become resistant against various anticancer drugs.  In previous work, we found that tariquidar analogues lacking the tetrahydroisoquinoline moiety selectively inhibit BCRP.  In the present study, we synthesized 21 derivatives of the third-generation P-gp inhibitor HM30181, which is structurally related to tariquidar.  The compounds were tested for their inhibitory activities against BCRP and screened against P-glycoprotein (P-gp, ABCB1) and multidrug resistance protein 1 (MRP1, ABCC1) to confirm the selectivity toward BCRP.  The most potent compounds are selective toward BCRP and 2-fold more potent than the reference Ko143.  Qualitative structure-activity relationship (SAR) analysis revealed that the presence of a methoxy group in the ortho or para position of at least one phenyl ring is beneficial for inhibitory activity.  Furthermore, the cytotoxicity and multidrug resistance (MDR)-reversal ability of selected compounds were investigated.  It was shown that they have a low cytotoxicity and the ability to reverse the BCRP-mediated SN-38 resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_-1BYW7HmO9-cVm4E2RlLfW6udTcc2eaxM5yKtjDUNrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D&md5=777b13f427105e8909ae751d11e8c7b4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00188%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DS.%2BC.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DHM30181%2520Derivatives%2520as%2520Novel%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3910%26epage%3D3921%26doi%3D10.1021%2Facs.jmedchem.5b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leyers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HÃ¤cker, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiendlocha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¼tschow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">A 4-aminobenzoic Acid Derivative as Novel Lead For Selective Inhibitors of Multidrug Resistance-Associated Proteins</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4761</span>â <span class="NLM_lpage">4763</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2008.07.127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmcl.2008.07.127" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4761-4763&author=S.+Leyersauthor=H.-G.+H%C3%A4ckerauthor=J.+Wiendlochaauthor=M.+G%C3%BCtschowauthor=M.+Wiese&title=A+4-aminobenzoic+Acid+Derivative+as+Novel+Lead+For+Selective+Inhibitors+of+Multidrug+Resistance-Associated+Proteins&doi=10.1016%2Fj.bmcl.2008.07.127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.127%26sid%3Dliteratum%253Aachs%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.-G.%26aulast%3DWiendlocha%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DA%25204-aminobenzoic%2520Acid%2520Derivative%2520as%2520Novel%2520Lead%2520For%2520Selective%2520Inhibitors%2520of%2520Multidrug%2520Resistance-Associated%2520Proteins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4761%26epage%3D4763%26doi%3D10.1016%2Fj.bmcl.2008.07.127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klinkhammer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Globisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajeva, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of a Small Molecule Library of 3rd Generation Multidrug Resistance Modulators</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2524</span>â <span class="NLM_lpage">2535</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2009.01.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bmc.2009.01.072" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2524-2535&author=W.+Klinkhammerauthor=H.+M%C3%BCllerauthor=C.+Globischauthor=I.+K.+Pajevaauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+a+Small+Molecule+Library+of+3rd+Generation+Multidrug+Resistance+Modulators&doi=10.1016%2Fj.bmc.2009.01.072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.072%26sid%3Dliteratum%253Aachs%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520Small%2520Molecule%2520Library%2520of%25203rd%2520Generation%2520Multidrug%2520Resistance%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2524%26epage%3D2535%26doi%3D10.1016%2Fj.bmc.2009.01.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">HÃ¤cker, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiendlocha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¼tschow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Aromatic 2-(Thio)ureidocarboxylic Acids As a New Family of Modulators of Multidrug Resistance-Associated Protein 1: Synthesis, Biological Evaluation, and Structure-Activity Relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4586</span>â <span class="NLM_lpage">4595</span>, <span class="refDoi">Â DOI: 10.1021/jm900688v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900688v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4586-4595&author=H.-G.+H%C3%A4ckerauthor=S.+Leyersauthor=J.+Wiendlochaauthor=M.+G%C3%BCtschowauthor=M.+Wiese&title=Aromatic+2-%28Thio%29ureidocarboxylic+Acids+As+a+New+Family+of+Modulators+of+Multidrug+Resistance-Associated+Protein+1%3A+Synthesis%2C+Biological+Evaluation%2C+and+Structure-Activity+Relationships&doi=10.1021%2Fjm900688v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm900688v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900688v%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.-G.%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DWiendlocha%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DAromatic%25202-%2528Thio%2529ureidocarboxylic%2520Acids%2520As%2520a%2520New%2520Family%2520of%2520Modulators%2520of%2520Multidrug%2520Resistance-Associated%2520Protein%25201%253A%2520Synthesis%252C%2520Biological%2520Evaluation%252C%2520and%2520Structure-Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4586%26epage%3D4595%26doi%3D10.1021%2Fjm900688v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juvale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">Characterization of 3-Methoxy Flavones for Their Interaction With ABCG2 as Suggested by ATPase Activity</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1838</i></span>,  <span class="NLM_fpage">2929</span>â <span class="NLM_lpage">2938</span>, <span class="refDoi">Â DOI: 10.1016/j.bbamem.2014.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1016%2Fj.bbamem.2014.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=25128152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKmt7vE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=2929-2938&author=J.+Gallusauthor=K.+Juvaleauthor=M.+Wiese&title=Characterization+of+3-Methoxy+Flavones+for+Their+Interaction+With+ABCG2+as+Suggested+by+ATPase+Activity&doi=10.1016%2Fj.bbamem.2014.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity</span></div><div class="casAuthors">Gallus, Jennifer; Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2929-2938</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast Cancer Resistance Protein (BCRP/ABCG2) belongs to the superfamily of ATP binding cassette (ABC) transporters.  Characteristic of some of these transporter proteins is the transport of a variety of structurally unrelated substances against a concn. gradient by using the energy of ATP hydrolysis.  ABCG2 has been found to confer multidrug resistance (MDR) in cancer cells.  Several anticancer drugs have been identified as ABCG2 substrates including mitoxantrone, etoposide and topotecan.  As inhibition of the transporter is one of the strategies to overcome MDR, we have synthesized and tested several 3-methoxy flavones and investigated them for their ABCG2 inhibition.  Among these, pentamethyl quercetin (compd. 4) and pentamethyl morin (compd. 5) were found to be fluorescent and hence screened for their possible transport by ABCG2 using confocal microscopy.  This study showed that pentamethyl quercetin was far less accumulated in ABCG2 overexpressing MDCK BCRP cells as compared to MDCK sensitive cells, suggesting possible efflux of this compd. by ABCG2.  Pentamethyl morin showed no visible difference in both cell lines.  Based on this observation, we studied several other fluorescent 3-methoxy flavones for their accumulation in ABCG2 overexpressing cells.  To confirm the substrate or inhibitor nature of the tested compds., these compds. were further investigated by ATPase assay.  If stimulation of the transporter ATPase activity is detected, one can conclude that the compd. is probably a transported substrate.  All compds. except pentamethyl morin (compd. 5) and tetra-Me quercetin (compd. 6) were found to stimulate ATPase activity pointing to possible substrates despite being potent inhibitors of ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTbvTdBi-Ut7Vg90H21EOLACvtfcHk0li-R_VEcmrGCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKmt7vE&md5=a7418d37edaaec640ebadd9305d152b1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2014.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2014.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DGallus%26aufirst%3DJ.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DCharacterization%2520of%25203-Methoxy%2520Flavones%2520for%2520Their%2520Interaction%2520With%2520ABCG2%2520as%2520Suggested%2520by%2520ATPase%2520Activity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26spage%3D2929%26epage%3D2938%26doi%3D10.1016%2Fj.bbamem.2014.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germann, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarborough, G. A.</span></span> <span> </span><span class="NLM_article-title">Expression of the Human Multidrug Resistance cDNA in Insect Cells Generates a High Activity Drug-Stimulated Membrane ATPase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">4854</span>â <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=4854-4858&author=B.+Sarkadiauthor=E.+M.+Priceauthor=R.+C.+Boucherauthor=U.+A.+Germannauthor=G.+A.+Scarborough&title=Expression+of+the+Human+Multidrug+Resistance+cDNA+in+Insect+Cells+Generates+a+High+Activity+Drug-Stimulated+Membrane+ATPase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DE.%2BM.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DScarborough%26aufirst%3DG.%2BA.%26atitle%3DExpression%2520of%2520the%2520Human%2520Multidrug%2520Resistance%2520cDNA%2520in%2520Insect%2520Cells%2520Generates%2520a%2520High%2520Activity%2520Drug-Stimulated%2520Membrane%2520ATPase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D4854%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolaridis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zechner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bause, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomaeus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locher, K. P.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Small-Molecule Inhibition of Human Multidrug Transporter ABCG2</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">333</span>â <span class="NLM_lpage">340</span>, <span class="refDoi">Â DOI: 10.1038/s41594-018-0049-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1038%2Fs41594-018-0049-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=29610494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOjsr7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=333-340&author=S.+M.+Jacksonauthor=I.+Manolaridisauthor=J.+Kowalauthor=M.+Zechnerauthor=N.+M.+I.+Taylorauthor=M.+Bauseauthor=S.+Bauerauthor=R.+Bartholomaeusauthor=G.+Bernhardtauthor=B.+Koenigauthor=A.+Buschauerauthor=H.+Stahlbergauthor=K.-H.+Altmannauthor=K.+P.+Locher&title=Structural+Basis+of+Small-Molecule+Inhibition+of+Human+Multidrug+Transporter+ABCG2&doi=10.1038%2Fs41594-018-0049-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of small-molecule inhibition of human multidrug transporter ABCG2</span></div><div class="casAuthors">Jackson, Scott M.; Manolaridis, Ioannis; Kowal, Julia; Zechner, Melanie; Taylor, Nicholas M. I.; Bause, Manuel; Bauer, Stefanie; Bartholomaeus, Ruben; Bernhardt, Guenther; Koenig, Burkhard; Buschauer, Armin; Stahlberg, Henning; Altmann, Karl-Heinz; Locher, Kaspar P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">333-340</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">ABCG2 is an ATP-binding cassette (ABC) transporter that protects tissues against xenobiotics, affects the pharmacokinetics of drugs and contributes to multidrug resistance.  Although many inhibitors and modulators of ABCG2 have been developed, understanding their structure-activity relationship requires high-resoln. structural insight.  Here, we present cryo-EM structures of human ABCG2 bound to synthetic derivs. of the fumitremorgin C-related inhibitor Ko143 or the multidrug resistance modulator tariquidar.  Both compds. are bound to the central, inward-facing cavity of ABCG2, blocking access for substrates and preventing conformational changes required for ATP hydrolysis.  The high resolns. allowed for de novo building of the entire transporter and also revealed tightly bound phospholipids and cholesterol interacting with the lipid-exposed surface of the transmembrane domains (TMDs).  Extensive chem. modifications of the Ko143 scaffold combined with in vitro functional analyses revealed the details of ABCG2 interactions with this compd. family and provide a basis for the design of novel inhibitors and modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJBdcwrlGmAbVg90H21EOLACvtfcHk0li-R_VEcmrGCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOjsr7M&md5=b892ceb7a3ede9784a09c2cc98042d03</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fs41594-018-0049-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-018-0049-1%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BM.%26aulast%3DManolaridis%26aufirst%3DI.%26aulast%3DKowal%26aufirst%3DJ.%26aulast%3DZechner%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DN.%2BM.%2BI.%26aulast%3DBause%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DBartholomaeus%26aufirst%3DR.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DKoenig%26aufirst%3DB.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DLocher%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520Basis%2520of%2520Small-Molecule%2520Inhibition%2520of%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D333%26epage%3D340%26doi%3D10.1038%2Fs41594-018-0049-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span> <i>Molecular Operating Environment (MOE)</i>, <span class="NLM_edition">2013.08</span>; <span class="NLM_publisher-name">Chemical Computing Group ULC</span>: <span class="NLM_publisher-loc">1010 Sherbooke St. West, Suite #910, Montreal, QC,
Canada, H3A 2R7</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating+Environment+%28MOE%29%2C+2013.08%3B+Chemical+Computing+Group+ULC%3A+1010+Sherbooke+St.+West%2C+Suite+%23910%2C+Montreal%2C+QC%2C%0ACanada%2C+H3A+2R7%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520ULC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span> <i>LeadIT</i>, <span class="NLM_edition">version 2.3.2</span>; <span class="NLM_publisher-name">BioSolveIT GmbH</span>: <span class="NLM_publisher-loc">Sankt Augustin,
Germany</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LeadIT%2C+version+2.3.2%3B+BioSolveIT+GmbH%3A+Sankt+Augustin%2C%0AGermany%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLeadIT%26pub%3DBioSolveIT%2520GmbH%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rarey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">A Fast Flexible Docking Method Using an Incremental Construction Algorithm</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">470</span>â <span class="NLM_lpage">489</span>, <span class="refDoi">Â DOI: 10.1006/jmbi.1996.0477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=10.1006%2Fjmbi.1996.0477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=8780787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;key=1%3ACAS%3A528%3ADyaK28XltlKisLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1996&pages=470-489&author=M.+Rareyauthor=B.+Kramerauthor=T.+Lengauerauthor=G.+Klebe&title=A+Fast+Flexible+Docking+Method+Using+an+Incremental+Construction+Algorithm&doi=10.1006%2Fjmbi.1996.0477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A fast flexible docking method using an incremental construction algorithm</span></div><div class="casAuthors">Rarey, Matthias; Kramer, Bernd; Lengauer, Thomas; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">470-489</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">We present an automatic method for docking org. ligands into protein binding sites.  The method can be used in the design process of specific protein ligands.  It combines an appropriate model of the physico-chem. properties of the docked mols. with efficient methods for sampling the conformational space of the ligand.  If the ligand is flexible, it can adopt a large variety of different conformations.  Each such min. in conformational space presents a potential candidate for the conformation of the ligand in the complexed state.  Our docking method samples the conformation space of the ligand on the basis of a discrete model and uses a tree-search technique for placing the ligand incrementally into the active site.  For placing the first fragment of the ligand into the protein, we use hashing techniques adapted from computer vision.  The incremental construction algorithm is based on a greedy strategy combined with efficient methods for overlap detection and for the search of new interactions.  We present results on 19 complexes of which the binding geometry has been crystallog. detd.  All considered ligands are docked in at most three minutes on a current workstation.  The exptl. obsd. binding mode of the ligand is reproduced with 0.5 to 1.2 Ã rms deviation.  It is almost always found among the highest-ranking conformations computed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx9N2sFXkOfLVg90H21EOLACvtfcHk0lhDiuJJIKux3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlKisLo%253D&md5=8cd8f384906ed90e894d118399e4dc4a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0477%26sid%3Dliteratum%253Aachs%26aulast%3DRarey%26aufirst%3DM.%26aulast%3DKramer%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DT.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DA%2520Fast%2520Flexible%2520Docking%2520Method%2520Using%2520an%2520Incremental%2520Construction%2520Algorithm%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D261%26spage%3D470%26epage%3D489%26doi%3D10.1006%2Fjmbi.1996.0477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span> <i>The PyMOL Molecular Graphics System</i>, <span class="NLM_edition">version
1.8</span>; <span class="NLM_publisher-name">Schrodinger, LLC</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+PyMOL+Molecular+Graphics+System%2C+version%0A1.8%3B+Schrodinger%2C+LLC%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchrodinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC','PDB','6FFC'); return false;">PDB: 6FFC</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i92"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01011">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62854"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01011">10.1021/acs.jmedchem.8b01011</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and the biological data(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_001.csv">CSV</a>)</p></li><li><p class="inline">ABCG2â<b>31</b> complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_002.pdb">PDB</a>)</p></li><li><p class="inline">ABCG2â<b>41</b> complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_003.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_001.csv">jm8b01011_si_001.csv (3.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_002.pdb">jm8b01011_si_002.pdb (707.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01011/suppl_file/jm8b01011_si_003.pdb">jm8b01011_si_003.pdb (706.92 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FFC">6FFC</a> (<b>31</b>, <b>41</b>). Authors will release the atomic coordinates upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01011&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01011%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01011" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ab6d9ad4b3cbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
